0001410578-23-001371.txt : 20230526 0001410578-23-001371.hdr.sgml : 20230526 20230525211821 ACCESSION NUMBER: 0001410578-23-001371 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 55 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230526 DATE AS OF CHANGE: 20230525 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Greencity Acquisition Corp CENTRAL INDEX KEY: 0001768910 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39404 FILM NUMBER: 23962784 BUSINESS ADDRESS: STREET 1: SUITE 807 TOWER 2 CENTURY LINK PLAZA STREET 2: NO. 1196 CENTURY AVENUE CITY: PUDONG DISTRICT STATE: F4 ZIP: 20000 BUSINESS PHONE: 02150630073 MAIL ADDRESS: STREET 1: SUITE 807 TOWER 2 CENTURY LINK PLAZA STREET 2: NO. 1196 CENTURY AVENUE CITY: PUDONG DISTRICT STATE: F4 ZIP: 20000 10-K 1 grcyu-20221231x10k.htm 10-K
0001768910--12-312022FYfalse001260000126000000339209412600004000000126000000-0000000P10D426000000.260.220.300.100.5100000012600001260000P30DP20Dhttp://fasb.org/us-gaap/2021-01-31#FairValueAdjustmentOfWarrantshttp://fasb.org/us-gaap/2021-01-31#FairValueAdjustmentOfWarrants0001768910grcyu:SponsorMember2020-09-102020-09-100001768910grcyu:ClosingOfBusinessCombinationMemberus-gaap:WarrantMember2022-12-310001768910us-gaap:MeasurementInputSharePriceMember2022-12-310001768910us-gaap:MeasurementInputRiskFreeInterestRateMember2022-12-310001768910us-gaap:MeasurementInputPriceVolatilityMember2022-12-310001768910us-gaap:MeasurementInputExpectedTermMember2022-12-310001768910us-gaap:MeasurementInputExercisePriceMember2022-12-310001768910us-gaap:MeasurementInputSharePriceMember2021-12-310001768910us-gaap:MeasurementInputRiskFreeInterestRateMember2021-12-310001768910us-gaap:MeasurementInputPriceVolatilityMember2021-12-310001768910us-gaap:MeasurementInputExpectedTermMember2021-12-310001768910us-gaap:MeasurementInputExercisePriceMember2021-12-310001768910srt:MaximumMember2022-12-310001768910grcyu:CommonStockSubjectToPossibleRedemptionMember2022-12-310001768910grcyu:CommonStockSubjectToPossibleRedemptionMember2021-12-310001768910grcyu:SponsorMember2019-02-212019-02-210001768910grcyu:SponsorMember2018-01-012018-12-310001768910us-gaap:RetainedEarningsMember2022-12-310001768910us-gaap:RetainedEarningsMember2021-12-310001768910us-gaap:RetainedEarningsMember2020-12-310001768910grcyu:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001768910grcyu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001768910us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001768910us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001768910grcyu:PublicWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001768910grcyu:PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001768910us-gaap:FairValueMeasurementsRecurringMember2022-12-310001768910grcyu:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001768910grcyu:PrivatePlacementWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001768910us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001768910us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001768910grcyu:PublicWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001768910grcyu:PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001768910us-gaap:FairValueMeasurementsRecurringMember2021-12-310001768910us-gaap:CommonStockMember2022-12-310001768910us-gaap:CommonStockMember2021-12-310001768910us-gaap:CommonStockMember2020-12-310001768910us-gaap:PrivatePlacementMember2022-12-310001768910grcyu:SponsorMember2022-12-310001768910grcyu:ClosingOfBusinessCombinationMember2022-12-310001768910grcyu:MarketValue16.50Memberus-gaap:WarrantMember2022-12-310001768910us-gaap:WarrantMember2022-12-310001768910us-gaap:PrivatePlacementMember2020-07-282020-07-280001768910grcyu:PublicWarrantsMember2022-12-310001768910grcyu:PrivatePlacementWarrantsMember2022-12-310001768910grcyu:PublicWarrantsMember2021-12-310001768910grcyu:PrivatePlacementWarrantsMember2021-12-310001768910grcyu:PublicWarrantsMember2020-12-310001768910grcyu:PrivatePlacementWarrantsMember2020-12-310001768910grcyu:PublicWarrantsMember2022-01-012022-12-310001768910grcyu:PrivatePlacementWarrantsMember2022-01-012022-12-310001768910grcyu:PublicWarrantsMember2021-01-012021-12-310001768910grcyu:PrivatePlacementWarrantsMember2021-01-012021-12-310001768910grcyu:CommonStockSubjectToPossibleRedemptionMember2022-01-012022-12-310001768910grcyu:CommonStockNotSubjectToPossibleRedemptionMember2022-01-012022-12-310001768910grcyu:CommonSharesSubjectToRedemptionMember2022-01-012022-12-310001768910grcyu:CommonSharesNotSubjectToRedemptionMember2022-01-012022-12-310001768910grcyu:CommonStockSubjectToPossibleRedemptionMember2021-01-012021-12-310001768910grcyu:CommonStockNotSubjectToPossibleRedemptionMember2021-01-012021-12-310001768910grcyu:CommonSharesSubjectToRedemptionMember2021-01-012021-12-310001768910grcyu:CommonSharesNotSubjectToRedemptionMember2021-01-012021-12-310001768910us-gaap:UnsecuredDebtMember2021-12-310001768910us-gaap:UnsecuredDebtMember2022-12-310001768910us-gaap:UnsecuredDebtMembergrcyu:SponsorMember2019-12-310001768910srt:MaximumMemberus-gaap:UnsecuredDebtMember2019-06-300001768910us-gaap:UnsecuredDebtMember2019-02-2100017689102023-12-310001768910grcyu:SponsorMember2020-09-1000017689102019-02-210001768910us-gaap:IPOMember2022-12-310001768910grcyu:SponsorMemberus-gaap:IPOMember2020-07-280001768910us-gaap:PrivatePlacementMember2020-06-2800017689102020-12-310001768910us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2022-12-310001768910us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2022-12-310001768910us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2021-12-310001768910us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2021-12-310001768910grcyu:UnitPurchaseOptionMember2020-07-2800017689102018-12-012018-12-310001768910us-gaap:UnsecuredDebtMembergrcyu:SponsorMemberus-gaap:SubsequentEventMember2023-05-182023-05-180001768910us-gaap:UnsecuredDebtMembergrcyu:SponsorMemberus-gaap:SubsequentEventMember2023-04-302023-04-300001768910us-gaap:UnsecuredDebtMembergrcyu:SponsorMemberus-gaap:SubsequentEventMember2023-03-312023-03-310001768910us-gaap:UnsecuredDebtMembergrcyu:SponsorMemberus-gaap:SubsequentEventMember2023-02-282023-02-280001768910us-gaap:UnsecuredDebtMembergrcyu:SponsorMemberus-gaap:SubsequentEventMember2023-01-312023-01-310001768910us-gaap:UnsecuredDebtMembergrcyu:SponsorMemberus-gaap:SubsequentEventMember2023-01-042023-01-040001768910grcyu:RelatedPartyLoansMember2022-12-310001768910grcyu:RelatedPartyExtensionLoansMembergrcyu:SponsorMember2023-05-182023-05-180001768910grcyu:SponsorMember2023-05-182023-05-180001768910grcyu:RelatedPartyExtensionLoansMembergrcyu:SponsorMember2023-04-302023-04-300001768910grcyu:SponsorMember2023-04-302023-04-300001768910grcyu:SponsorMember2023-03-312023-03-310001768910grcyu:SponsorMember2023-02-282023-02-280001768910grcyu:SponsorMember2023-01-312023-01-310001768910grcyu:RelatedPartyExtensionLoansMembergrcyu:SponsorMember2023-01-042023-03-310001768910grcyu:SponsorMember2023-01-042023-01-040001768910grcyu:RelatedPartyExtensionLoansMembergrcyu:SponsorMember2022-12-012022-12-310001768910grcyu:RelatedPartyExtensionLoansMembergrcyu:SponsorMember2022-11-272022-11-270001768910grcyu:SponsorMember2022-11-272022-11-270001768910grcyu:RelatedPartyExtensionLoansMembergrcyu:SponsorMember2022-10-272022-10-270001768910grcyu:SponsorMember2022-10-272022-10-270001768910grcyu:RelatedPartyExtensionLoansMembergrcyu:SponsorMember2022-09-272022-09-270001768910grcyu:SponsorMember2022-09-272022-09-270001768910grcyu:RelatedPartyExtensionLoansMembergrcyu:SponsorMember2022-08-272022-08-270001768910grcyu:SponsorMember2022-08-272022-08-270001768910grcyu:RelatedPartyExtensionLoansMembergrcyu:SponsorMember2022-07-272022-07-270001768910grcyu:SponsorMember2022-07-272022-07-270001768910grcyu:RelatedPartyExtensionLoansMembergrcyu:SponsorMember2022-06-272022-06-270001768910grcyu:SponsorMember2022-06-272022-06-270001768910grcyu:RelatedPartyExtensionLoansMembergrcyu:SponsorMember2022-05-272022-05-270001768910grcyu:SponsorMember2022-05-272022-05-270001768910grcyu:RelatedPartyExtensionLoansMembergrcyu:SponsorMember2022-04-272022-04-270001768910grcyu:SponsorMember2022-04-272022-04-270001768910grcyu:SponsorMember2022-03-272022-03-270001768910grcyu:SponsorMember2022-02-272022-02-270001768910grcyu:RelatedPartyExtensionLoansMembergrcyu:SponsorMember2022-01-272022-01-270001768910grcyu:SponsorMember2022-01-272022-01-270001768910grcyu:RelatedPartyExtensionLoansMembergrcyu:SponsorMember2022-01-012022-12-310001768910grcyu:RelatedPartyExtensionLoansMembergrcyu:SponsorMember2021-12-272021-12-270001768910grcyu:SponsorMember2021-12-272021-12-270001768910grcyu:RelatedPartyExtensionLoansMembergrcyu:SponsorMember2021-11-272021-11-270001768910grcyu:SponsorMember2021-11-272021-11-270001768910grcyu:RelatedPartyExtensionLoansMembergrcyu:SponsorMember2021-10-272021-10-270001768910grcyu:SponsorMember2021-10-272021-10-270001768910grcyu:RelatedPartyExtensionLoansMembergrcyu:SponsorMember2021-09-272021-09-270001768910grcyu:SponsorMember2021-09-272021-09-270001768910grcyu:RelatedPartyExtensionLoansMembergrcyu:SponsorMember2021-08-272021-08-270001768910grcyu:SponsorMember2021-08-272021-08-270001768910grcyu:RelatedPartyExtensionLoansMembergrcyu:SponsorMember2021-07-272021-07-270001768910grcyu:SponsorMember2021-07-272021-07-270001768910grcyu:RelatedPartyExtensionLoansMembergrcyu:SponsorMember2021-01-012021-12-310001768910grcyu:UnderwritingAgreementMember2022-01-012022-12-310001768910grcyu:ClosingOfBusinessCombinationMember2022-01-012022-12-310001768910grcyu:SponsorMemberus-gaap:IPOMember2020-07-282020-07-280001768910us-gaap:PrivatePlacementMember2022-01-012022-12-310001768910us-gaap:PrivatePlacementMember2020-06-282020-06-280001768910us-gaap:IPOMember2020-07-282020-07-280001768910srt:MinimumMember2022-01-012022-12-310001768910srt:MaximumMember2022-01-012022-12-3100017689102023-04-2500017689102022-10-2800017689102022-04-200001768910us-gaap:SubsequentEventMember2023-04-252023-04-250001768910grcyu:UnitPurchaseOptionMember2020-07-282020-07-280001768910grcyu:MarketValueIsBelow9.2PerShareMembergrcyu:ClosingOfBusinessCombinationMember2022-01-012022-12-310001768910grcyu:MarketValue16.50Membergrcyu:ClosingOfBusinessCombinationMember2022-01-012022-12-310001768910us-gaap:WarrantMember2022-01-012022-12-3100017689102021-12-310001768910us-gaap:IPOMember2020-07-280001768910grcyu:ClosingOfBusinessCombinationMemberus-gaap:WarrantMember2022-01-012022-12-310001768910srt:MaximumMembergrcyu:MarketValue16.50Memberus-gaap:WarrantMember2022-01-012022-12-310001768910grcyu:MarketValue16.50Memberus-gaap:WarrantMember2022-01-012022-12-310001768910us-gaap:IPOMember2022-01-012022-12-3100017689102023-04-252023-04-2500017689102022-10-282022-10-2800017689102022-04-202022-04-200001768910grcyu:SponsorMember2022-01-012022-12-310001768910grcyu:SponsorMember2018-12-012018-12-310001768910grcyu:CommonClassaNotSubjectToRedemptionMember2022-01-012022-12-310001768910grcyu:CommonClassaNotSubjectToRedemptionMember2021-01-012021-12-310001768910us-gaap:RetainedEarningsMember2022-01-012022-12-310001768910grcyu:CommonClassaSubjectToRedemptionMember2022-01-012022-12-310001768910us-gaap:RetainedEarningsMember2021-01-012021-12-310001768910grcyu:CommonClassaSubjectToRedemptionMember2021-01-012021-12-310001768910us-gaap:CommonStockMember2022-01-012022-12-310001768910grcyu:UnitsEachConsistingOfOneClassOrdinaryShareAndOneRedeemableWarrantMember2022-01-012022-12-310001768910grcyu:RedeemableWarrantsEachExercisableForOneHalfOfOneOrdinaryShareFor11.50PerShareMember2022-01-012022-12-3100017689102022-12-3100017689102023-05-2500017689102021-01-012021-12-3100017689102022-01-012022-12-31xbrli:sharesiso4217:USDxbrli:puregrcyu:itemiso4217:USDxbrli:sharesgrcyu:Votegrcyu:Y

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2022

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                  to                  

Commission File Number: 001-39404

GREENCITY ACQUISITION CORPORATION

(Exact Name of Registrant as Specified in Its Charter)

Cayman Islands

    

n/a

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.) 

505 Eshan Road, Floor 6,

Pudong New District, Shanghai, China 200120

(Address of principal executive offices) (Zip Code)

(+86) 21-20257919

Issuer’s telephone number, including area code

Securities registered pursuant to Section 12(b) of the Exchange Act

Title of Each Class

 

Trading Symbol

 

Name of Each Exchange on Which Registered

Ordinary Shares, Par Value $0.0001 Per Share

 

GRCY

 

The Nasdaq Stock Market, LLC

Redeemable Warrants Entitling the Holder to Purchase One-half (1/2) of One Ordinary Share

 

GRCYW

 

The Nasdaq Stock Market, LLC

Units, Each Consisting of One Ordinary Share and One Warrant

 

GRCYU

 

The Nasdaq Stock Market, LLC

Securities registered pursuant to Section 12(g) of the Securities Exchange Act: NONE

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15 (d) of the Securities Exchange Act. Yes  No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes   No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes    No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer 

Accelerated filer 

Non-accelerated filer 

Smaller reporting company 

 

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

The number of shares and aggregate market value of common stock held by non-affiliates as of the last business day of the registrant’s most recently completed second fiscal quarter were 3,921,950 and $41,258,914 respectively.

APPLICABLE ONLY TO CORPORATE REGISTRANTS

Indicate the number of shares outstanding of each of the registrant’s classes of ordinary shares, as of the latest practicable date: On May 25, 2023 there were 1,465,047 ordinary shares outstanding of the registrant.

DOCUMENTS INCORPORATED BY REFERENCE

List hereunder the following documents if incorporated by reference and the Part of the Form 10-K (e.g., Part I, Part II, etc.) into which the document is incorporated:

None

TABLE OF CONTENTS

PAGE

PART I

1

Item 1. Business

4

Item 1A. Risk Factors

12

Item 1B. Unresolved Staff Comments

47

Item 2. Properties

47

Item 3. Legal Proceedings

47

Item 4. Mine Safety Disclosures

47

PART II

48

Item 5. Market for the Registrant’s Common Equity, and Related Shareholder Matters and Issuer Purchases of Equity Securities

48

Item 6. Reserved

49

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

49

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

53

Item 8. Financial Statements and Supplemental Data

53

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

53

Item 9A. Controls and Procedures

53

Item 9B. Other Information

55

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

55

PART III

56

Item 10. Directors and Executive Officers of the Registrant

56

Item 11. Executive Compensation

58

Item 12. Security Ownership of Certain Beneficial Owners and Management

58

Item 13. Certain Relationships and Related Transactions

59

Item 14. Principal Accountant Fees and Services

61

PART IV

63

Item 15. Exhibits and Financial Statement Schedules

63

Item 16. Form 10-K Summary

64

2

FORWARD LOOKING STATEMENTS

This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, or the “Securities Act,” and Section 21E of the Securities Exchange Act of 1934, or the “Exchange Act”. The statements contained in this report that are not purely historical are forward-looking statements. Our forward-looking statements include, but are not limited to, statements regarding our or our management’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipates,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predicts,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this Form 10-K may include, for example, statements about our:

ability to complete our initial business combination;
success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination;
officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination, as a result of which they would then receive expense reimbursements;
potential ability to obtain additional financing to complete a business combination;
pool of prospective target businesses;
ability of our officers and directors to generate a number of potential investment opportunities;
potential change in control if we acquire one or more target businesses for shares or other forms of equity;
public securities’ potential liquidity and trading;
the lack of a market for our securities;
expectations regarding the time during which we will be an “emerging growth company” under the JOBS Act;
use of proceeds not held in the trust account or available to us from interest income on the trust account balance; or
financial performance following our business combination, if we compete a business combination.

The forward-looking statements contained in this Form 10-K are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

3

Item 1. BUSINESS

Company Profile

Greencity Acquisition Corporation is a blank check company incorporated in 2018 as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this Annual Report on Form 10-K as our initial business combination.

The registration statement for our initial public offering was declared effective by the Securities and Exchange Commission on July 23, 2020. We completed our initial public offering on July 28, 2020. In our initial public offering, we sold units at an offering price of $10.00 and consisting of one ordinary share and one redeemable warrant. Each warrant entitles the holder thereof to purchase one-half of one ordinary share. We will not issue fractional shares in connection with the exercise of the warrants. As a result, a warrant holder must exercise warrants in multiples of two warrants, at a price of $11.50 per full share, subject to adjustment as described in our prospectus dated as of July 23, 2020 as filed with the Securities and Exchange Commission on July 24, 2020. Each warrant will become exercisable on the later of the completion of an initial business combination and 12 months from July 23, 2020 and will expire five years after the completion of an initial business combination, or earlier upon redemption.

In connection with our initial public offering, we sold 4,000,000 units, generating gross proceeds of $40,000,000. Simultaneously with the closing of the IPO, pursuant to the Private Placement Units Purchase Agreement by and between the Company and our sponsor, Cynthia Management Corporation (the “Sponsor”), a British Virgin Islands company, the Company completed the private sale of an aggregate of 260,000 units (the “Private Placement Units”) to the Sponsor at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds to the Company of $2,600,000. The Private Placement Units are identical to the Units in the IPO, except that the Sponsor has agreed not to transfer, assign or sell any of the Private Placement Units (except to certain permitted transferees) until 30 days after the completion of the Company’s initial business combination. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Units was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

Transaction costs amounted to $2,646,665, consisting of $1,000,000 of underwriting fees, $1,000,000 of deferred underwriting fees and $646,665 of other offering costs. A total of $40,600,000, comprised of $38,000,000 of the proceeds from the IPO (which amount includes $1,000,000 of the underwriter’s deferred discount) and $2,600,000 of the proceeds of the sale of the Private Placement Units, was placed in a U.S.-based trust account, maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds in the trust account that may be released to the Company to pay its taxes, the funds held in the trust account will not be released from the trust account until the earliest of (i) the completion of the Company’s initial business combination, (ii) the redemption of any of the Company’s public shares properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to (A) modify the substance or timing of its obligation to redeem 100% of the Company’s public shares if it does not complete its initial business combination within 33 months from the closing of the IPO, or (B) with respect to any other provision relating to shareholders’ rights or pre-business combination activity, and (iii) the redemption of the Company’s public shares if it is unable to complete its initial business combination within 33 months from the closing of the IPO.

At December 31, 2022 and 2021, cash of $6,918 and $61,773 were held outside of the Trust Account (as defined below) and are available for working capital purposes.

The Company’s units are listed on The Nasdaq Capital Market (“Nasdaq”) and commenced trading under the ticker symbol “GRCYU” on July 24, 2020. Each unit consists of one ordinary share of the Company and one warrant, each warrant entitling the holder thereof to purchase one-half of one ordinary share of the Company at a price of $11.50 per whole share. The units begin separate trading effective August 28, 2020 and the ordinary shares and warrants commenced trading on Nasdaq under the symbols “GRCY” and “GRCYW,” respectively.

Since our IPO, our sole business activity has been identifying and evaluating suitable acquisition transaction candidates and engaging in non-binding discussions with potential target entities. To date we have not entered into any binding agreement with any target entity.

4

Recent Developments

Our timeframe to complete the initial business combination expired on April 28, 2022. On April 20, 2022, we held an Annual General Meeting of Shareholders. Among other things, shareholders approved the proposal to extend the time to complete our initial business company by six monthly extensions to October 28, 2022. In connection with the vote to approve the Extension Amendment, the holders of 78,050 shares of the Company’s ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.46 per share, for an aggregate redemption amount of $816,101.13. As a result, an amount of $41,008,428.63 remained in the trust account. In connection with the extension, our sponsor, or its designees, loaned us $0.033 for each public share that is not redeemed as monthly extension fee. Our Sponsor had loaned the monthly extension fee to us and we deposited the monthly extension fee to our trust account maintained at Continental Trust Stock Transfer & Trust Company to extend the date to complete the business combination to October 28, 2022.

On October 28, 2022, we held an Extraordinary General Meeting of Shareholders. Shareholders approved the proposal to extend the time to complete our initial business company by six monthly extension to April 28, 2023. In connection with the vote to approve the Extension Amendment, the holders of 3,311,198 shares of the Company’s ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.73 per share, for an aggregate redemption amount of $35,540,143.87. As a result, an amount of $6,555,395.97 remained in the trust account. In connection with the extension, our sponsor, or its designees, loaned us $0.033 for each public share that was not redeemed as monthly extension fee. Our Sponsor had loaned the monthly extension fee to us and we have deposited the monthly extension fee to the trust account maintained at Continental Trust Stock Transfer & Trust Company to extend the date to complete the business combination to April 28, 2023.

We held another Extraordinary Shareholder Meeting on April 25, 2023 for our shareholders to vote for the proposal to amend the Company’s amended and restated memorandum and articles of association to extend the date by which the Company has to consummate a business combination six (6) times for an additional one (1) month each time from April 28, 2023 to October 28, 2023 by amending the Amended and Restated Memorandum and Articles of Association by deleting the existing Section 48.7 thereof and replacing them with the new Section 48.7. Shareholders approved the proposal to extend the time to complete our initial business company by six monthly extension to October 28, 2023. A total of 405,705 shares of common stock were presented for redemption in connection with the Extraordinary General Meeting.

Acquisition Strategy and Management Business Combination Experience

Our efforts in identifying prospective target businesses will not be limited to a particular geographic region, although we intend to focus on businesses that have a connection to the Asian market. We believe that we will add value to these businesses primarily by providing them with access to the U.S. capital markets.

We will seek to capitalize on the strength of our management team. Our team consists of experienced professionals and senior operating executives. Collectively, our officers and directors have decades of experience in mergers and acquisitions, and operating companies, in Asia. We believe we will benefit from their accomplishments, and specifically their current and recent activities with companies that have a connection to the Asian market, in identifying attractive acquisition opportunities. However, there is no assurance that we will complete a business combination. Our officers and directors have no prior experience consummating a business combination for a “blank check” company.

5

Investment Criteria

Our management team intends to focus on creating shareholder value by leveraging its experience in the management, operation and financing of businesses to improve the efficiency of operations while implementing strategies to scale revenue organically and/or through acquisitions. We have identified the following general criteria and guidelines, which we believe are important in evaluating prospective target businesses. While we intend to use these criteria and guidelines in evaluating prospective businesses, we may deviate from these criteria and guidelines should we see justification to do so.

Middle-Market Growth Business. We will primarily seek to acquire one or more growth businesses with a total enterprise value of between $150,000,000 and $300,000,000. We believe that there are a substantial number of potential target businesses within this valuation range that can benefit from new capital for scalable operations to yield significant revenue and earnings growth. We currently do not intend to acquire either a start-up company (a company that has not yet established commercial operations) or a company with negative cash flow.
Companies in Business Segments that are Strategically Significant to the Asian Markets. We will seek to acquire those businesses that are currently strategically significant in the Asian markets. Such sectors include: Internet and high technology, financial technology (including technology applied in financial services or used to help companies manage the financial aspects of their business), logistics, clean energy, health care, consumer and retail, energy and resources, food processing, manufacturing and education.
Business with Revenue and Earnings Growth Potential. We will seek to acquire one or more businesses that have the potential for significant revenue and earnings growth through a combination of both existing and new product development, increased production capacity, expense reduction and synergistic follow-on acquisitions resulting in increased operating leverage.
Companies with Potential for Strong Free Cash Flow Generation. We will seek to acquire one or more businesses that have the potential to generate strong, stable and increasing free cash flow. We intend to focus on one or more businesses that have predictable revenue streams and definable low working capital and capital expenditure requirements. We may also seek to prudently leverage this cash flow in order to enhance shareholder value.
Benefit from Being a Public Company. We intend to only acquire a business or businesses that will benefit from being publicly traded and which can effectively utilize access to broader sources of capital and a public profile that are associated with being a publicly traded company.

These criteria are not intended to be exhaustive. Any evaluation relating to the merits of a particular initial business combination may be based, to the extent relevant, on these general guidelines as well as other considerations, factors and criteria that our sponsor and management team may deem relevant. In the event that we decide to enter into an initial business combination with a target business that does not meet the above criteria and guidelines, we will disclose that the target business does not meet the above criteria in our shareholder communications related to our initial business combination, which, as discussed in this prospectus, would be in the form of proxy solicitation or tender offer materials, as applicable, that we would file with the United States Securities and Exchange Commission, or the SEC. In evaluating a prospective target business, we expect to conduct a due diligence review which may encompass, among other things, meetings with incumbent ownership, management and employees, document reviews, interviews of customers and suppliers, inspections of facilities, as well as reviewing financial and other information which will be made available to us.

Our management team continues to actively source target candidates where they believe will be attractive candidates for acquisition, utilizing their deal-making track record, professional relationships, and capital markets expertise to enhance the growth potential and value of a target business and provide opportunities for an attractive return to our shareholders.

6

Sourcing of Potential Business Combination Targets

Our management team has developed a broad network of contacts and corporate relationships. We believe that the network of contacts and relationships of our management team and our sponsor will provide us with an important source of business combination opportunities. In addition, we anticipate that target business candidates will be brought to our attention from various unaffiliated sources, including investment banking firms, private equity firms, consultants, accounting firms and business enterprises. We are not prohibited from pursuing an initial business combination with a company that is affiliated with our sponsor, officers or directors, or completing the business combination through a joint venture or other form of shared ownership with our sponsor, officers or directors.

If any of our officers or directors becomes aware of a business combination opportunity that falls within the line of business of any entity to which he or she has then-existing fiduciary or contractual obligations, he or she may be required to present such business combination opportunity to such entity prior to presenting such business combination opportunity to us.

Unless we complete our initial business combination with an affiliated entity, or our Board of Directors cannot independently determine the fair market value of the target business or businesses, we are not required to obtain an opinion from an independent investment banking firm, another independent firm that commonly renders valuation opinions for the type of company we are seeking to acquire or from an independent accounting firm that the price we are paying for a target is fair to our company from a financial point of view. If no opinion is obtained, our shareholders will be relying on the business judgment of our Board of Directors, which will have significant discretion in choosing the standard used to establish the fair market value of the target or targets, and different methods of valuation may vary greatly in outcome from one another. Such standards used will be disclosed in our tender offer documents or proxy solicitation materials, as applicable, related to our initial business combination.

Members of our management team may directly or indirectly own our ordinary shares and/or private placement units following our initial public offering, and, accordingly, may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination. Further, each of our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect to our initial business combination.

Each of our directors and officers presently has, and in the future any of our directors and our officers may have additional, fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present acquisition opportunities to such entity. Accordingly, subject to his or her fiduciary duties under Cayman Islands law, if any of our officers or directors becomes aware of an acquisition opportunity which is suitable for an entity to which he or she has then current fiduciary or contractual obligations, he or she will need to honor his or her fiduciary or contractual obligations to present such acquisition opportunity to such entity, and only present it to us if such entity rejects the opportunity. Our amended and restated memorandum and articles of association will provide that, subject to his or her fiduciary duties under Cayman Islands law, we renounce our interest in any corporate opportunity offered to any officer or director unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of our company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue. We do not believe, however, that any fiduciary duties or contractual obligations of our directors or officers would materially undermine our ability to complete our business combination.

Our officers and directors are not prohibited from becoming an officer or director of another special purpose acquisition company with a class of securities registered under the Securities Exchange Act of 1934, as amended.

7

Competition

In identifying, evaluating and selecting a target business for our initial business combination, we may encounter intense competition from other entities having a business objective similar to ours, including other blank check companies, private equity groups and leveraged buyout funds, and operating businesses seeking strategic acquisitions. Many of these entities are well established and have extensive experience identifying and effecting business combinations directly or through affiliates. Moreover, many of these competitors possess greater financial, technical, human and other resources than us. Our ability to acquire larger target businesses will be limited by our available financial resources. This inherent limitation gives others an advantage in pursuing the acquisition of a target business. Furthermore, our obligation to pay cash in connection with our public shareholders who exercise their redemption rights may reduce the resources available to us for our initial business combination and our outstanding warrants, and the future dilution they potentially represent, may not be viewed favorably by certain target businesses. Either of these factors may place us at a competitive disadvantage in successfully negotiating an initial business combination.

We believe our structure will make us an attractive business combination partner to target businesses. As an existing public company, we offer a target business an alternative to the traditional initial public offering through a merger or other business combination. In this situation, the owners of the target business would exchange their shares of stock in the target business for our shares or for a combination of our shares and cash, allowing us to tailor the consideration to the specific needs of the sellers. Although there are various costs and obligations associated with being a public company, we believe target businesses will find this method a more certain and cost effective method to becoming a public company than the typical initial public offering. In a typical initial public offering, there are additional expenses incurred in marketing, road show and public reporting efforts that may not be present to the same extent in connection with a business combination with us.

Furthermore, once a proposed business combination is completed, the target business will have effectively become public, whereas an initial public offering is always subject to the underwriters’ ability to complete the offering, as well as general market conditions, which could delay or prevent the offering from occurring. Once public, we believe the target business would then have greater access to capital and an additional means of providing management incentives consistent with shareholders’ interests. It can offer further benefits by augmenting a company’s profile among potential new customers and vendors and aid in attracting talented employees.

While we believe that our structure and our management team’s backgrounds will make us an attractive business partner, some potential target businesses may have a negative view of us since we are a blank check company, without an operating history, and there is uncertainty relating to our ability to obtain shareholder approval of our proposed initial business combination and retain sufficient funds in our trust account in connection therewith.

Initial Business Combination Timeframe and Nasdaq Rules

Initially, we have until 21 months from July 28, 2020 (the closing of our IPO) to consummate our initial business combination. In 2022, we held two shareholders meetings to amend the memorandum and articles of association of the Company in order to extend the time to complete our initial business combination to April 28, 2023. We have deposited the required monthly extension fee to extend the date to complete our business combination to April 28, 2023. In order to further extend the date to complete our initial business combination, we held another Extraordinary General Meeting of shareholders to vote for the proposal in order to extend the date to complete our initial business combination to October 28, 2023. Pursuant to the terms of our amended memorandum and articles of association and the trust agreement entered into between us and Continental Stock Transfer & Trust Company, in order for the time available for us to consummate our initial business combination to be extended, our sponsor or its affiliates or designees, upon five (5) days advance notice prior to the applicable deadline, must deposit into the trust account $0.033 each month for each unredeemed public share on or prior to the date of the applicable deadline, for each monthly extension. Our sponsor and its affiliates or designees are not obligated to fund the trust account to extend the time for us to complete our initial business combination. If we are unable to consummate our initial business combination within the applicable time period, we will, as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares for a pro rata portion of the funds held in the trust account and as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, dissolve and liquidate, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. In such event, the warrants will be worthless.

8

The NASDAQ rules require that our initial business combination must be with one or more target businesses that together have an aggregate fair market value equal to at least 80% of the balance in the trust account (less any deferred underwriting commissions and taxes payable on interest earned) at the time of our signing a definitive agreement in connection with our initial business combination. If our Board of Directors is not able to independently determine the fair market value of the target business or businesses, we will obtain an opinion from an independent investment banking firm or another independent firm that commonly renders valuation opinions for the type of company we are seeking to acquire or an independent accounting firm. We do not intend to purchase multiple businesses in unrelated industries in conjunction with our initial business combination. Additionally, pursuant to NASDAQ rules, any initial business combination must be approved by a majority of our independent directors.

The NASDAQ rules require that within 36 months of the effectiveness of its IPO registration statement (July 28, 2023), or such shorter period that the Company specifies in its registration statement, the Company must complete one or more business combinations having an aggregate fair market value of at least 80% of the value of the deposit account (excluding any deferred underwriters fees and taxes payable on the income earned on the deposit account) at the time of the agreement to enter into the initial combination. As a result, even though our proposal to extend the time to extend the date to consummate the business combination to October 28, 2023 is approved by our shareholders at the Extraordinary General Meeting of shareholder scheduled on April 25, 2023, we may have to liquidate if we cannot complete our business combination by July 28, 2023.

We anticipate structuring our initial business combination so that the post-transaction company in which our public shareholders own shares will own or acquire 100% of the equity interests or assets of the target business or businesses. We may, however, structure our initial business combination such that the post-transaction company owns or acquires less than 100% of such interests or assets of the target business in order to meet certain objectives of the target management team or shareholders or for other reasons, but we will only complete such business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended, or the Investment Company Act. Even if the post-transaction company owns or acquires 50% or more of the voting securities of the target, our shareholders prior to the business combination may collectively own a minority interest in the post-transaction company, depending on valuations ascribed to the target and us in the business combination transaction. For example, we could pursue a transaction in which we issue a substantial number of new shares in exchange for all of the outstanding capital stock of a target. In this case, we would acquire a 100% controlling interest in the target. However, as a result of the issuance of a substantial number of new shares, our shareholders immediately prior to our initial business combination could own less than a majority of our outstanding shares subsequent to our initial business combination. If less than 100% of the equity interests or assets of a target business or businesses are owned or acquired by the post-transaction company, the portion of such business or businesses that is owned or acquired is what will be valued for purposes of the 80% of net assets test. If our initial business combination involves more than one target business, the 80% of net assets test will be based on the aggregate value of all of the target businesses.

Summary Information Related to Our Securities, Redemption Rights and Liquidation

We are a Cayman Islands exempted company (company number 337092) and our affairs are governed by our amended and restated memorandum and articles of association, the Companies Law and common law of the Cayman Islands. Pursuant to our amended and restated memorandum and articles of association which will be adopted upon the consummation of our initial public offering, we will be authorized to issue 100,000,000 ordinary shares, $0.0001 par value each, and 1,000,000 undesignated preference shares, $0.0001 par value each. The information provided below is a summary only and we refer you to our prospectus dated as of July 23, 2020, our amended and restated memorandum and articles of association and our warrant agreement with Continental Stock Transfer & Trust Company as warrant agent for additional important and material information.

As stated elsewhere in this Report on Form 10-K, we completed our initial public offering on July 28, 2020. In our initial public offering, we sold units at an offering price of $10.00 and consisting of one ordinary share and one redeemable warrant. Each warrant entitles the holder thereof to purchase one-half of one ordinary share. We will not issue fractional shares in connection with the exercise of the warrants. As a result, a warrant holder must exercise warrants in multiples of two warrants, at a price of $11.50 per full share, subject to adjustment. Each warrant will become exercisable on the later of the completion of an initial business combination and 12 months from July 23, 2020 and will expire five years after the completion of an initial business combination, or earlier upon redemption. Effective August 28,2020, the component parts of the units began trading separately.

9

As of May 15, 2023, there were 1,465,047 ordinary shares issued and outstanding. Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders and vote together as a single class, except as required by law. Unless specified in the Companies Law, our amended and restated memorandum and articles of association or applicable stock exchange rules, the affirmative vote of a majority of our ordinary shares that are voted is required to approve any such matter voted on by our shareholders.

As of May 15, 2023, there are warrants outstanding to acquire and aggregate of 2,130,000 ordinary shares. We will not be obligated to deliver any ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to our satisfying our obligations described below with respect to registration. We will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the ordinary share underlying such unit.

Once the warrants become exercisable, we may call the warrants for redemption (excluding the private placement warrants but including any outstanding warrants issued upon exercise of the unit purchase option issued to the underwriters or their designees):

in whole and not in part;
at a price of $0.01 per warrant;
upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrant holder; and
if, and only if, the reported last sale price of the ordinary shares equal or exceed $16.50 per share (as adjusted for share splits, share capitalizations, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date we send to the notice of redemption to the warrant holders.

We will provide our public shareholders with the opportunity to redeem all or a portion of their ordinary shares upon the completion of our initial business combination either (i) in connection with a shareholder meeting called to approve the business combination or (ii) by means of a tender offer. The decision as to whether we will seek shareholder approval of a proposed business combination or conduct a tender offer will be made by us, solely in our discretion, and will be based on a variety of factors such as the timing of the transaction, whether the terms of the transaction would require us to seek shareholder approval under the law or stock exchange listing requirement or whether we were deemed to be a foreign private issuer (which would require that we conduct a tender offer under SEC rules rather than seeking shareholder approval). Under NASDAQ rules, asset acquisitions and stock purchases would not typically require shareholder approval while direct mergers with our company where we do not survive and any transactions where we issue more than 20% of our issued and outstanding ordinary shares (unless we are deemed to be a foreign private issuer at such time) or seek to amend our amended and restated memorandum and articles of association would require shareholder approval. We intend to conduct redemptions without a shareholder vote pursuant to the tender offer rules of the SEC unless shareholder approval is required by law or stock exchange listing requirement or we choose to seek shareholder approval for business or other legal reasons. So long as we obtain and maintain a listing for our securities on the NASDAQ, we will be required to comply with NASDAQ rules.

10

We will provide our public shareholders with the opportunity to redeem all or a portion of their ordinary shares upon the completion of our initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account as of two business days prior to the consummation of the initial business combination, including interest (which interest shall be net of taxes payable) divided by the number of then issued and outstanding public shares, subject to the limitations described herein. As of the date of the Form 10-K, the extension fee is about $0.726 per public share (subject to increase of up to an additional $0.20 per public share in the event that the shareholders approved our proposal to extend the date to complete our initial business combination to October 28, 2023 and our sponsor elects to extend the period of time to consummate a business combination). The per-share amount we will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions we will pay to the underwriters. Our sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to their founder shares, private placement shares and any public shares they may hold in connection with the completion of our initial business combination.

Our amended and restated memorandum and articles of association provides that in no event will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001 either immediately prior to or upon consummation of our initial business combination (so that we are not subject to the SEC’s “penny stock” rules). Redemptions of our public shares may also be subject to a higher net tangible asset test or cash requirement pursuant to an agreement relating to our initial business combination. For example, the proposed business combination may require: (i) cash consideration to be paid to the target or its owners, (ii) cash to be transferred to the target for working capital or other general corporate purposes or (iii) the retention of cash to satisfy other conditions in accordance with the terms of the proposed business combination. In the event the aggregate cash consideration we would be required to pay for all ordinary shares that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms of the proposed business combination exceed the aggregate amount of cash available to us, we will not complete the business combination or redeem any shares, and all ordinary shares submitted for redemption will be returned to the holders thereof.

Corporate Information

We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, or the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.

In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We intend to take advantage of the benefits of this extended transition period.

We will remain an emerging growth company until the earlier of (1) the last day of the fiscal year following the fifth anniversary of the completion of our IPO, (b) in which we have total annual gross revenue of at least $1.235 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value of our ordinary shares that is held by non-affiliates exceeds $700 million as of the prior June 30th, and (2) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period. References herein to “emerging growth company” shall have the meaning associated with it in the JOBS Act.

Additionally, we are a “smaller reporting company” as defined in Rule 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our ordinary shares held by non-affiliates exceeds $250 million as of the prior June 30th, or (2) our annual revenues exceed $100 million during such completed fiscal year and the market value of our ordinary shares held by non-affiliates exceeds $700 million as of the prior June 30.

11

We are previously a “foreign private issuer” as defined in Rule 405, but are voluntarily choosing to register and report using domestic forms. We were required to determine our status as a foreign private issuer for the 2022 fiscal year as of the last day of our second quarter of 2021, or June 30, 2021. On such date, we were no longer qualify as a “foreign private issuer” (as set forth in Rule 3b-4 of the Exchange Act), and we became subject to the U.S. domestic issuer rules as of the first day of our 2022 fiscal year, or January 1, 2022. As a result, as we determined on June 30, 2021 that we are no longer a “foreign private issuer,” after December 31, 2021. we are subject to the U.S. domestic issuer rules and we have the option of conducting redemptions like other blank check companies in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules.

Exempted companies are Cayman Islands companies wishing to conduct business outside the Cayman Islands and, as such, are exempted from complying with certain provisions of the Companies Law. As an exempted company, we have received a tax exemption undertaking from the Cayman Islands government that, in accordance with Section 6 of the Tax Concessions Law (2018 Revision) of the Cayman Islands, for a period of 20 years from the date of the undertaking, no law which is enacted in the Cayman Islands imposing any tax to be levied on profits, income, gains or appreciations shall apply to us or our operations and, in addition, that no tax to be levied on profits, income, gains or appreciations or which is in the nature of estate duty or inheritance tax shall be payable (i) on or in respect of our shares, debentures or other obligations or (ii) by way of the withholding in whole or in part of a payment of dividend or other distribution of income or capital by us to our shareholders or a payment of principal or interest or other sums due under a debenture or other obligation of us.

We are a Cayman Islands exempted company incorporated on May 14, 2018. Our executive offices are located at 505 Eshan Road, Floor 6, Pudong New District, Shanghai, 200120, China and our telephone number is (86) 21-2025 7919.

Item 1A RISK FACTORS

As a smaller reporting company, we are not required to include risk factors in this Annual Report. However, below is a partial list of material risks, uncertainties and other factors that could have a material effect on the Company and its operations.

Investment in our securities involves a high degree of risk. You should consider carefully all of the risks described below, together with the other information contained in this report, before making a decision to invest in our units. If any of the following events occur, our business, financial condition and operating results may be materially adversely affected. In that event, the trading price of our securities could decline, and you could lose all or part of your investment.

Our search for a business combination, and any target business with which we ultimately consummate a business combination, may be materially adversely affected by the recent coronavirus (COVID-19) pandemic.

The COVID-19 pandemic has resulted in a widespread health crisis that has adversely affected the economies and financial markets worldwide, and the business of any potential target business with which we consummate a business combination could be materially and adversely affected. Furthermore, we may be unable to complete a business combination if continued concerns relating to COVID-19 restrict travel, limit the ability to have meetings with potential investors or the target company’s personnel, vendors and services providers are unavailable to negotiate and consummate a transaction in a timely manner. The extent to which COVID-19 impacts our search for a business combination will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions to contain COVID-19 or treat its impact, among others. If the disruptions posed by COVID-19 or other matters of global concern continue for an extensive period of time, our ability to consummate a business combination, or the operations of a target business with which we ultimately consummate a business combination, may be materially adversely affected.

12

The occurrence of natural disasters may adversely affect our business, financial condition and results of operations following our business combination.

The occurrence of natural disasters, including hurricanes, floods, earthquakes, tornadoes, fires and pandemic disease may adversely affect our business, financial condition or results of operations following our business combination. The potential impact of a natural disaster on our results of operations and financial position is speculative, and would depend on numerous factors. The extent and severity of these natural disasters will determine their effect on a given economy. Although the long term effect of diseases such as the H5N1 “avian flu,” or H1N1, the swine flu, cannot currently be predicted, previous occurrences of avian flu and swine flu had an adverse effect on the economies of those countries in which they were most prevalent. An outbreak of a communicable disease could adversely affect our business, financial condition and results of operations following our business combination. We cannot assure you that natural disasters will not occur in the future or that its business, financial condition and results of operations will not be adversely affected.

U.S. laws in the future may restrict or eliminate our ability to complete a business combination with certain companies.

Future developments in U.S. laws may restrict our ability or willingness to complete certain business combinations with companies. For instance, the federal government has recently proposed legislation that would restrict our ability to consummate a business combination with a target business unless that business met certain standards of the Public Company Accounting Oversight Board (United States), or PCAOB, and would require delisting of a company from national securities exchanges if it failed to retain an accounting firm that the PCAOB has inspected to the satisfaction of the SEC. Such proposed legislation would also require public companies to disclose whether they are owned or controlled by a foreign government, specifically those based in China. We may not be able to consummate a business combination with a favored target business due to these laws. Furthermore, the documentation we may be required to submit to the SEC proving certain beneficial ownership requirements and establishing that we are not owned or controlled by a foreign government in the event that we use a foreign public accounting firm not subject to inspection by the PCAOB or where the PCAOB is unable to completely inspect or investigate our accounting practices or financial statements because of a position taken by an authority in the foreign jurisdiction could be onerous and time consuming to prepare.

Our public shareholders may not be afforded an opportunity to vote on our proposed business combination, which means we may complete our initial business combination even though a majority of our public shareholders does not support such a combination.

We may not hold a shareholder vote to approve our initial business combination unless we are no longer a foreign private issuer and the business combination would require shareholder approval under applicable Cayman Islands law or the rules of the NASDAQ or if we decide to hold a shareholder vote for business or other reasons. Examples of transactions that would not ordinarily require shareholder approval include asset acquisitions and share purchases, while transactions such as direct mergers with our company or transactions where we issue more than 20% of our outstanding shares would require shareholder. For instance, the NASDAQ rules currently allow us to engage in a tender offer in lieu of a shareholder meeting but would still require us to obtain shareholder approval if we were not a foreign private issuer and were seeking to issue more than 20% of our outstanding shares to a target business as consideration in any business combination. Therefore, if we were structuring a business combination that required us to issue more than 20% of our outstanding shares and we were not a foreign private issuer, we would seek shareholder approval of such business combination. Except as required by law or NASDAQ rules, the decision as to whether we will seek shareholder approval of a proposed business combination or will allow shareholders to sell their shares to us in a tender offer will be made by us, solely in our discretion, and will be based on a variety of factors, such as the timing of the transaction, whether the terms of the transaction would otherwise require us to seek shareholder approval or whether we were deemed to be a foreign private issuer (which would require that we conduct a tender offer under SEC rules rather than seeking shareholder approval). Accordingly, we may consummate our initial business combination even if holders of a majority of the issued and outstanding ordinary shares do not approve of the business combination we consummate.

13

If we seek shareholder approval of our initial business combination, our sponsor, officers and directors have agreed to vote in favor of such initial business combination, regardless of how our public shareholders vote.

Unlike other blank check companies in which the initial shareholders agree to vote their founder shares in accordance with the majority of the votes cast by the public shareholders in connection with an initial business combination, our sponsor, officers and directors have agreed (and their permitted transferees will agree), pursuant to the terms of a letter agreement entered into with us, to vote any founder shares and private placement shares held by them, as well as any public shares purchased during or after our initial public offering, in favor of our initial business combination. We expect that our sponsor and its permitted transferees will own approximately 86% of our issued and outstanding ordinary shares at the time of any such shareholder vote (assuming it does not purchase units in our initial public offering, and taking into account ownership of the private placement units). As a result, in addition to our initial shareholder’s founder shares, we do not need public shares sold in our initial public offering to be voted in favor of a transaction (assuming all outstanding shares are voted) in order to have our initial business combination approved (assuming the over-allotment option is not exercised). Accordingly, if we seek shareholder approval of our initial business combination, it is more likely that the necessary shareholder approval will be received than would be the case if such persons agreed to vote their founder shares in accordance with the majority of the votes cast by our public shareholders.

Shareholders’ only opportunity to affect the investment decision regarding a potential business combination will be limited to the exercise of your right to redeem your shares from us for cash, unless we seek shareholder approval of the business combination.

At the time of your investment in us, you will not be provided with an opportunity to evaluate the specific merits or risks of one or more target businesses. Since our Board of Directors may complete a business combination without seeking shareholder approval, public shareholders may not have the right or opportunity to vote on the business combination, unless we seek such shareholder approval. Accordingly, if we do not seek shareholder approval, shareholders only opportunity to affect the investment decision regarding a potential business combination may be limited to exercising your redemption rights within the period of time (which will be at least 20 business days) set forth in our tender offer documents mailed to our public shareholders in which we describe our initial business combination.

The ability of our public shareholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it difficult for us to enter into a business combination with a target.

We may seek to enter into a business combination transaction agreement with a prospective target that requires as a closing condition that we have a minimum net worth or a certain amount of cash. If too many public shareholders exercise their redemption rights, we would not be able to meet such closing condition and, as a result, would not be able to proceed with the business combination. Furthermore, in no event will we redeem our public shares in an amount that would cause our net tangible assets, after payment of the deferred underwriting commissions, to be less than $5,000,001 either immediately prior to or upon consummation of our initial business combination (so that we are not subject to the SEC’s “penny stock” rules) or any greater net tangible asset or cash requirement which may be contained in the agreement relating to our initial business combination. Consequently, if accepting all properly submitted redemption requests would cause our net tangible assets to be less than $5,000,001 either immediately prior to or upon consummation of our initial business combination or such greater amount necessary to satisfy a closing condition as described above, we would not proceed with such redemption and the related business combination and may instead search for an alternate business combination. Prospective targets will be aware of these risks and, thus, may be reluctant to enter into a business combination transaction with us.

The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete the most desirable business combination or optimize our capital structure.

At the time we enter into an agreement for our initial business combination, we will not know how many shareholders may exercise their redemption rights, and therefore we will need to structure the transaction based on our expectations as to the number of shares that will be submitted for redemption. If our initial business combination agreement requires us to use a portion of the cash in the trust account to pay the purchase price, or requires us to have a minimum amount of cash at closing, we will need to reserve a portion of the cash in the trust account to meet such requirements, or arrange for third party financing. In addition, if a larger number of shares are submitted for redemption than we initially expected, we may need to restructure the transaction to reserve a greater portion of the cash in the trust account or arrange for third party financing. Raising additional third party financing may involve dilutive equity issuances or the incurrence of indebtedness at higher than desirable levels. The above considerations may limit our ability to complete the most desirable business combination available to us or optimize our capital structure.

14

The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares could increase the probability that our initial business combination would be unsuccessful and that you would have to wait for liquidation in order to redeem your shares.

If our initial business combination agreement requires us to use a portion of the cash in the trust account to pay the purchase price, or requires us to have a minimum amount of cash at closing, the probability that our initial business combination would be unsuccessful is increased. If our initial business combination is unsuccessful, you would not receive your pro rata portion of the trust account until we liquidate the trust account. If you are in need of immediate liquidity, you could attempt to sell your shares in the open market; however, at such time our shares may trade at a discount to the pro rata amount per share in the trust account. In either situation, you may suffer a material loss on your investment or lose the benefit of funds expected in connection with our redemption until we liquidate or you are able to sell your shares in the open market.

The requirement that we complete our initial business combination within the prescribed time frame may give potential target businesses leverage over us in negotiating a business combination and may decrease our ability to conduct due diligence on potential business combination targets as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination on terms that would produce value for our shareholders.

Any potential target business with which we enter into negotiations concerning a business combination will be aware that we must complete our initial business combination within 36 months from the closing of our initial public offering. Consequently, such target business may obtain leverage over us in negotiating a business combination, knowing that if we do not complete our initial business combination with that particular target business, we may be unable to complete our initial business combination with any target business. This risk will increase as we get closer to the timeframe described above. In addition, we may have limited time to conduct due diligence and may enter into our initial business combination on terms that we would have rejected upon a more comprehensive investigation.

We may not be able to complete our initial business combination within the prescribed time frame, in which case we would cease all operations except for the purpose of winding up and we would redeem our public shares and liquidate, in which case our public shareholders may only receive $11.18 per share, or less than such amount in certain circumstances, and our warrants will expire worthless.

Our sponsor, officers and directors have agreed that we must complete our initial business combination within 39 months from the closing of our initial public offering. We may not be able to find a suitable target business and complete our initial business combination within such time period. If we have not completed our initial business combination within such time period, we will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (which interest shall be net of taxes payable, and less up to $50,000 of interest to pay dissolution expenses) divided by the number of then issued and outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our Board of Directors, liquidate and dissolve, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. In such case, our public shareholders may only receive $11.18 per share, and our warrants will expire worthless. In certain circumstances, our public shareholders may receive less than $11.18 per share on the redemption of their shares.

15

Our sponsor may decide not to extend the term we have to consummate our initial business combination, in which case we would cease all operations except for the purpose of winding up and we would redeem our public shares and liquidate, and the warrants will be worthless.

We have deposited the monthly extension fee 23 times to extend the time we have to consummate our initial business combination. In order to further extend the date to consummate our initial business combination, on April 25, 2023, on the Extraordinary General Meeting, our shareholders have approved the proposal an additional six monthly extension so that the deadline to consummate the business combination has been extended to October 28, 2023 subject to the sponsor depositing additional funds into the trust account as set out below. In order for the time available for us to consummate our initial business combination to be extended, our sponsor or its affiliates or designees must deposit into the trust account up to an aggregate $0.20 per public share, on or prior to the date of the applicable deadline. Any such payments would be made in the form of a loan. The terms of the promissory note to be issued in connection with any such loans will be payable upon the closing of a business combination

Consequently, such loans might not be made on the terms described in the prospectus. Our sponsor and its affiliates or designees are not obligated to fund the trust account to extend the time for us to complete our initial business combination. If we are unable to consummate our initial business combination within the applicable time period, we will, as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares for a pro rata portion of the funds held in the trust account and as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, dissolve and liquidate, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. In such event, the warrants will be worthless.

If we seek shareholder approval of our initial business combination, our sponsor, directors, officers, advisors and their affiliates may elect to purchase shares from public shareholders, which may influence a vote on a proposed business combination and reduce the public “float” of our ordinary shares.

If we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our sponsor, directors, officers, advisors or their affiliates may purchase shares in privately negotiated transactions or in the open market either prior to or following the completion of our initial business combination, although they are under no obligation to do so. Please see “Proposed Business — Permitted purchases of our securities” for a description of how such persons will determine which shareholders to seek to acquire shares from. Such a purchase may include a contractual acknowledgement that such shareholder, although still the record holder of our shares is no longer the beneficial owner thereof and therefore agrees not to exercise its redemption rights. In the event that our sponsor, directors, officers, advisors or their affiliates purchase shares in privately negotiated transactions from public shareholders who have already elected to exercise their redemption rights, such selling shareholders would be required to revoke their prior elections to redeem their shares. The price per share paid in any such transaction may be different from the amount per share a public shareholder would receive if it elected to redeem its shares in connection with our initial business combination. The purpose of such purchases could be to vote such shares in favor of the business combination and thereby increase the likelihood of obtaining shareholder approval of the business combination or to satisfy a closing condition in an agreement with a target that requires us to have a minimum net worth or a certain amount of cash at the closing of our initial business combination, where it appears that such requirement would otherwise not be met. This may result in the completion of our initial business combination that may not otherwise have been possible.

In addition, if such purchases are made, the public “float” of our ordinary shares and the number of beneficial holders of our securities may be reduced, possibly making it difficult to maintain or obtain the quotation, listing or trading of our securities on a national securities exchange.

If a shareholder fails to receive notice of our offer to redeem our public shares in connection with our initial business combination, or fails to comply with the procedures for tendering its shares, such shares may not be redeemed.

We will comply with the tender offer rules or proxy rules, as applicable, when conducting redemptions in connection with our initial business combination. Despite our compliance with these rules, if a shareholder fails to receive our tender offer or proxy materials, as applicable, such shareholder may not become aware of the opportunity to redeem its shares. In addition, the tender offer documents or proxy materials, as applicable, that we will furnish to holders of our public shares in connection with our initial business combination will describe the various procedures that must be complied with in order to validly tender or redeem public shares. In the event that a shareholder fails to comply with these procedures, its shares may not be redeemed.

16

You will not have any rights or interests in funds from the trust account, except under certain limited circumstances. To liquidate your investment, therefore, you may be forced to sell your public shares or warrants, potentially at a loss.

Our public shareholders will be entitled to receive funds from the trust account only upon the earlier to occur of: (i) the completion of our initial business combination, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend our amended and restated memorandum and articles of association to (A) modify the substance or timing of our obligation to redeem 100% of our public shares if we do not complete our initial business combination within 12 months from the closing of our initial public offering (or up to 39 months from the closing of our initial public offering if we extend the period of time to consummate a business combination, as described in more detail in this prospectus) or (B) with respect to any other provision relating to shareholders’ rights or pre-business combination activity and (iii) the redemption of all of our public shares if we are unable to complete our initial business combination within 12 months from the closing of our initial public offering (or up to 39 months from the closing of our initial public offering if we extend the period of time to consummate a business combination, as described in more detail in this prospectus), subject to applicable law and as further described herein. In no other circumstances will a public shareholder have any right or interest of any kind in the trust account. Accordingly, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a loss.

NASDAQ may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions.

Our units, ordinary shares and warrants are listed on the NASDAQ. We cannot guarantee that our securities will continue to be, listed on NASDAQ in the future or prior to our initial business combination. In order to continue listing our securities on NASDAQ prior to our initial business combination, we must maintain certain financial, distribution and stock price levels. Generally, we must maintain a minimum amount in shareholders’ equity (generally $2,500,000) or a minimum value of listed securities (generally $35,000,000), and a minimum number of holders of our securities (generally 300 public holders).

On March 24, 2023, the Company received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market stating that the Company was not in compliance with Listing Rule 5550(b)(2) (the “Minimum Market Value of Listed Securities” or “MVLS”), which required the Company to have at least 35 million market value of listed securities for continued listing on the NASDAQ Capital Market. The Notice was only a notification of deficiency and had no current effect on the listing or trading of the Company’s securities on the Nasdaq Capital Market. The Notice states that the Company has a compliance period of 180 calendar days until September 20, 2023 in which to regain compliance.

On March 8, 2023, the Company received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) stating that the Company was not in compliance with Listing Rule 5550(a)(4) (the “Minimum Publicly Held Shares Rule”), which requires the Company to have at least 500,000 Publicly Held Shares for continued listing on the NASDAQ Capital Market. The Notice was only a notification of deficiency, not of imminent delisting, and had no current effect on the listing or trading of the Company’s securities on the Nasdaq Capital Market. The Notice stated that the Company had until April 24, 2023 to submit a plan to achieve and sustain compliance with the Minimum Publicly Held Shares Rule. The Company intends to submit a plan to achieve and sustain compliance with the Minimum Publicly Held Shares Rule within the required timeframe. After reviewing the plan, Nasdaq will provide the Company a written notice of Nasdaq’s decision. If Nasdaq does not accept the Company’s plan, the Company will have the opportunity to appeal the decision in front of a Nasdaq Hearings Panel.

If NASDAQ delists our securities from trading on its exchange and we are not able to list our securities on another national securities exchange, we expect our securities could be quoted on an over-the-counter market. If this were to occur, we could face significant material adverse consequences, including:

a limited availability of market quotations for our securities;
reduced liquidity for our securities;
a determination that our ordinary shares is a “penny stock” which will require brokers trading in our ordinary shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities;
a limited amount of news and analyst coverage; and

17

a decreased ability to issue additional securities or obtain additional financing in the future.

The National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as “covered securities.” Because we expect that our units and eventually our ordinary shares and warrants will be listed on NASDAQ, our units, ordinary shares and warrants will be covered securities. Although the states are preempted from regulating the sale of our securities, the federal statute does allow the states to investigate companies if there is a suspicion of fraud, and, if there is a finding of fraudulent activity, then the states can regulate or bar the sale of covered securities in a particular case. While we are not aware of a state having used these powers to prohibit or restrict the sale of securities issued by blank check companies, other than the State of Idaho, certain state securities regulators view blank check companies unfavorably and might use these powers, or threaten to use these powers, to hinder the sale of securities of blank check companies in their states. Further, if we were no longer listed on NASDAQ, our securities would not be covered securities and we would be subject to regulation in each state in which we offer our securities, including in connection with our initial business combination.

You will not be entitled to protections normally afforded to investors of many other blank check companies.

Since the net proceeds of our initial public offering and the sale of the private placement units are intended to be used to complete an initial business combination with a target business that has not been identified, we may be deemed to be a “blank check” company under the United States securities laws. However, because we will have net tangible assets in excess of $5,000,000 upon the successful completion of our initial public offering and the sale of the private placement units and will file a Current Report on Form 8-K, including an audited balance sheet demonstrating this fact, we are exempt from rules promulgated by the SEC to protect investors in blank check companies, such as Rule 419. Accordingly, investors will not be afforded the benefits or protections of those rules. Among other things, this means our units will be immediately tradable and we may have a longer period of time to complete our initial business combination than do companies subject to Rule 419. Moreover, if our initial public offering were subject to Rule 419, that rule would prohibit the release of any interest earned on funds held in the trust account to us unless and until the funds in the trust account were released to us in connection with our completion of an initial business combination.

If we seek shareholder approval of our initial business combination and we do not conduct redemptions pursuant to the tender offer rules, and if you or a “group” of shareholders are deemed to hold in excess of 15% of the ordinary shares sold in our initial public offering, you will lose the ability to redeem all such shares in excess of 15% of our ordinary shares sold in our initial public offering.

If we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our amended and restated memorandum and articles of association will provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act), will be restricted from seeking redemption rights with respect to more than an aggregate of 15% of the shares sold in our initial public offering, which we refer to throughout this prospectus as the “Excess Shares.” However, we would not be restricting our shareholders’ ability to vote all of their shares (including Excess Shares) for or against our initial business combination. Your inability to redeem the Excess Shares will reduce your influence over our ability to complete our initial business combination and you could suffer a material loss on your investment in us if you sell Excess Shares in open market transactions. Additionally, you will not receive redemption distributions with respect to the Excess Shares if we complete our initial business combination. And as a result, you will continue to hold that number of shares exceeding 15% and, in order to dispose of such shares, would be required to sell your shares in open market transactions, potentially at a loss.

18

Because of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete our initial business combination. If we are unable to complete our initial business combination, our public shareholders may receive only approximately $11.18 per share, or less in certain circumstances, on our redemption, and our warrants will expire worthless.

We expect to encounter intense competition from other entities having a business objective similar to ours, including private investors (which may be individuals or investment partnerships), other blank check companies and other entities, domestic and international, competing for the types of businesses we intend to acquire. Many of these individuals and entities are well-established and have extensive experience in identifying and effecting, directly or indirectly, acquisitions of companies operating in or providing services to various industries. Many of these competitors possess greater technical, human and other resources or more local industry knowledge than we do and our financial resources will be relatively limited when contrasted with those of many of these competitors. While we believe there are numerous target businesses we could potentially acquire with the net proceeds of our initial public offering and the sale of the private placement units, our ability to compete with respect to the acquisition of certain target businesses that are sizable will be limited by our available financial resources. This inherent competitive limitation gives others an advantage in pursuing the acquisition of certain target businesses. Furthermore, if we are obligated to pay cash for the ordinary shares redeemed and, in the event we seek shareholder approval of our initial business combination, we make purchases of our ordinary shares, potentially reducing the resources available to us for our initial business combination. Any of these obligations may place us at a competitive disadvantage in successfully negotiating a business combination. If we are unable to complete our initial business combination, our public shareholders may receive only approximately $11.18 per share (or less in certain circumstances) on the liquidation of our trust account and our warrants will expire worthless. In certain circumstances, our public shareholders may receive less than $11.18 per share on the redemption of their shares.

If the net proceeds of our initial public offering not being held in the trust account are insufficient to allow us to operate for at least the next one month, we may be unable to complete our initial business combination.

The funds available to us outside of the trust account may not be sufficient to allow us to operate for at least the next one month, assuming that our initial business combination is not completed during that time. We expect to incur significant costs in pursuit of our acquisition plans. Management’s plans to address this need for capital through our initial public offering and potential loans from certain of our affiliates are discussed in the section of this prospectus titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” However, our affiliates are not obligated to make loans to us in the future, and we may not be able to raise additional financing from unaffiliated parties necessary to fund our expenses. Any such event in the future may negatively impact the analysis regarding our ability to continue as a going concern at such time.

We believe that, upon the closing of our initial public offering, the funds available to us outside of the trust account, will be sufficient to allow us to operate for at least the next one month; however, we cannot assure you that our estimate is accurate. Of the funds available to us, we could use a portion of the funds available to us to pay fees to consultants to assist us with our search for a target business. We could also use a portion of the funds as a down payment or to fund a “no-shop” provision (a provision in letters of intent designed to keep target businesses from “shopping” around for transactions with other companies on terms more favorable to such target businesses) with respect to a particular proposed business combination, although we do not have any current intention to do so. If we entered into a letter of intent where we paid for the right to receive exclusivity from a target business and were subsequently required to forfeit such funds (whether as a result of our breach or otherwise), we might not have sufficient funds to continue searching for, or conduct due diligence with respect to, a target business. If we are unable to complete our initial business combination, our public shareholders may receive only approximately $11.18 per share (or less in certain circumstances) on the liquidation of our trust account and our warrants will expire worthless. In such case, our public shareholders may only receive $11.18 per share, and our warrants will expire worthless. In certain circumstances, our public shareholders may receive less than $11.18 per share on the redemption of their shares. 

19

If the net proceeds of our initial public offering and the sale of the private placement units not being held in the trust account are insufficient, it could limit the amount available to fund our search for a target business or businesses and complete our initial business combination and we will depend on loans from our sponsor or management team to fund our search, to pay our taxes and to complete our initial business combination.

Of the net proceeds of our initial public offering and the sale of the private placement units, only approximately $768,280 was available to us initially outside the trust account to fund our working capital requirements. As of December 31, 2022, our sponsor has loaned $745,504 to us under promissory note payable and $2,016,863 under extension loan note payable. If we are required to seek additional capital, we would need to borrow funds from our sponsor, management team or other third parties to operate or may be forced to liquidate. Neither our sponsor, members of our management team nor any of their affiliates is under any obligation to advance funds to us in such circumstances. Any such advances would be repaid only from funds held outside the trust account or from funds released to us upon completion of our initial business combination. If we are unable to complete our initial business combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account. Consequently, our public shareholders may only receive approximately $11.18 per share (or less in certain circumstances) on our redemption of our public shares, and our warrants will expire worthless. In such case, our public shareholders may only receive $11.18 per share, and our warrants will expire worthless. In certain circumstances, our public shareholders may receive less than $11.18 per share on the redemption of their shares.

Subsequent to the completion of our initial business combination, we may be required to take write-downs or write-offs, restructuring and impairment or other charges that could have a significant negative effect on our financial condition, results of operations and our share price, which could cause you to lose some or all of your investment.

Even if we conduct extensive due diligence on a target business with which we combine, we cannot assure you that this diligence will surface all material issues that may be present inside a particular target business, that it would be possible to uncover all material issues through a customary amount of due diligence, or that factors outside of the target business and outside of our control will not later arise. As a result of these factors, we may be forced to later write-down or write-off assets, restructure our operations, or incur impairment or other charges that could result in our reporting losses. Even if our due diligence successfully identifies certain risks, unexpected risks may arise and previously known risks may materialize in a manner not consistent with our preliminary risk analysis. Even though these charges may be non-cash items and not have an immediate impact on our liquidity, the fact that we report charges of this nature could contribute to negative market perceptions about our securities or us. In addition, charges of this nature may cause us to violate net worth or other covenants to which we may be subject as a result of assuming pre-existing debt held by a target business or by virtue of our obtaining post-combination debt financing. Accordingly, any shareholders who choose to remain shareholders following the business combination could suffer a reduction in the value of their shares. Such shareholders are unlikely to have a remedy for such reduction in value.

If third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received by shareholders may be less than $11.18 per share.

Our placing of funds in the trust account may not protect those funds from third-party claims against us. Although we will seek to have all vendors, service providers (other than our independent auditors), prospective target businesses or other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the trust account for the benefit of our public shareholders, such parties may not execute such agreements, or even if they execute such agreements they may not be prevented from bringing claims against the trust account, including, but not limited to, fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain advantage with respect to a claim against our assets, including the funds held in the trust account. If any third party refuses to execute an agreement waiving such claims to the monies held in the trust account, our management will perform an analysis of the alternatives available to it and will only enter into an agreement with a third party that has not executed a waiver if management believes that such third party’s engagement would be significantly more beneficial to us than any alternative.

20

Examples of possible instances where we may engage a third party that refuses to execute a waiver include the engagement of a third party consultant whose particular expertise or skills are believed by management to be significantly superior to those of other consultants that would agree to execute a waiver or in cases where management is unable to find a service provider willing to execute a waiver. In addition, there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with us and will not seek recourse against the trust account for any reason. Upon redemption of our public shares, if we are unable to complete our initial business combination within the prescribed timeframe, or upon the exercise of a redemption right in connection with our initial business combination, we will be required to provide for payment of claims of creditors that were not waived that may be brought against us within the 10 years following redemption.

Accordingly, the per-share redemption amount received by public shareholders could be less than the $11.18 per share initially held in the trust account, due to claims of such creditors.

Our sponsor has agreed that it will be liable to us if and to the extent any claims by a vendor (other than our independent auditors) for services rendered or products sold to us, or a prospective target business with which we have discussed entering into a transaction agreement, reduce the amount of funds in the trust account to below (i) $11.18 per public share or (ii) such lesser amount per public share held in the trust account as of the date of the liquidation of the trust account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the trust account and except as to any claims under our indemnity of the underwriters of our initial public offering against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, our sponsor will not be responsible to the extent of any liability for such third party claims. We have not independently verified whether our sponsor has sufficient funds to satisfy their indemnity obligations and believe that our sponsor’s only assets are securities of our company. Our sponsor may not have sufficient funds available to satisfy those obligations. We have not asked our sponsor to reserve for such obligations, and therefore, no funds are currently set aside to cover any such obligations. As a result, if any such claims were successfully made against the trust account, the funds available for our initial business combination and redemptions could be reduced to less than $11.18 per public share. In such event, we may not be able to complete our initial business combination, and you would receive such lesser amount per share in connection with any redemption of your public shares. None of our officers or directors will indemnify us for claims by third parties including, without limitation, claims by vendors and prospective target businesses.

Our directors may decide not to enforce the indemnification obligations of our sponsor, resulting in a reduction in the amount of funds in the trust account available for distribution to our public shareholders.

In the event that the proceeds in the trust account are reduced below the lesser of (i) $11.18 per public share or (ii) such lesser amount per share held in the trust account as of the date of the liquidation of the trust account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, and our sponsor asserts that it is unable to satisfy its obligations or that it has no indemnification obligations related to a particular claim, our independent directors would determine whether to take legal action against our sponsor to enforce its indemnification obligations. While we currently expect that our independent directors would take legal action on our behalf against our sponsor to enforce its indemnification obligations to us, it is possible that our independent directors in exercising their business judgment may choose not to do so in any particular instance. If our independent directors choose not to enforce these indemnification obligations, the amount of funds in the trust account available for distribution to our public shareholders may be reduced below $11.18 per share.

If, after we distribute the proceeds in the trust account to our public shareholders, we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, a bankruptcy court may seek to recover such proceeds, and the members of our Board of Directors may be viewed as having breached their fiduciary duties to our creditors, thereby exposing the members of our Board of Directors and us to claims of punitive damages.

If, after we distribute the proceeds in the trust account to our public shareholders, we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, any distributions received by shareholders could be viewed under applicable debtor/creditor and/or bankruptcy laws as either a “preferential transfer” or a “fraudulent conveyance.” As a result, a bankruptcy court could seek to recover all amounts received by our shareholders. In addition, our Board of Directors may be viewed as having breached its fiduciary duty to our creditors and/or having acted in bad faith, thereby exposing itself and us to claims of punitive damages, by paying public shareholders from the trust account prior to addressing the claims of creditors.

21

If, before distributing the proceeds in the trust account to our public shareholders, we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, the claims of creditors in such proceeding may have priority over the claims of our shareholders and the per-share amount that would otherwise be received by our shareholders in connection with our liquidation may be reduced.

If, before distributing the proceeds in the trust account to our public shareholders, we file a bankruptcy petition or an involuntary bankruptcy petition is filed against us that is not dismissed, the proceeds held in the trust account could be subject to applicable bankruptcy law, and may be included in our bankruptcy estate and subject to the claims of third parties with priority over the claims of our shareholders. To the extent any bankruptcy claims deplete the trust account, the per-share amount that would otherwise be received by our shareholders in connection with our liquidation may be reduced.

If we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be restricted, which may make it difficult for us to complete our initial business combination.

If we are deemed to be an investment company under the Investment Company Act, our activities may be restricted, including:

restrictions on the nature of our investments; and
restrictions on the issuance of securities;

each of which may make it difficult for us to complete our initial business combination. In addition, we may have imposed upon us burdensome requirements, including:

registration as an investment company;
adoption of a specific form of corporate structure; and
reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations.

We do not believe that our anticipated principal activities will subject us to the Investment Company Act. The proceeds held in the trust account may be invested by the trustee only in United States government treasury bills with a maturity of 180 days or less or in money market funds investing solely in United States Treasuries and meeting certain conditions under Rule 2a-7 under the Investment Company Act. Because the investment of the proceeds will be restricted to these instruments, we believe we will meet the requirements for the exemption provided in Rule 3a-1 promulgated under the Investment Company Act. If we were deemed to be subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for which we have not allotted funds and may hinder our ability to complete a business combination. If we are unable to complete our initial business combination, our public shareholders may receive only approximately $11.18 per share, or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless.

Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, investments and results of operations.

We are subject to laws and regulations enacted by national, regional and local governments. In particular, we will be required to comply with certain SEC and other legal requirements. Compliance with, and monitoring of, applicable laws and regulations may be difficult, time consuming and costly. Those laws and regulations and their interpretation and application may also change from time to time and those changes could have a material adverse effect on our business, investments and results of operations. In addition, a failure to comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business and results of operations.

22

If we are unable to consummate our initial business combination within the next one month or up to 39 months from the closing of our initial public offering of the closing of our initial public offering, we may be forced to liquidate our trust account.

If we are unable to consummate our initial business combination by October 28, 2023, we will distribute the aggregate amount then on deposit in the trust account (less up to $50,000 of the net interest earned thereon to pay dissolution expenses), pro rata to our public shareholders by way of redemption and cease all operations except for the purposes of winding up of our affairs, as further described herein. Any redemption of public shareholders from the trust account shall be effected automatically by function of our amended and restated memorandum and articles of association prior to any voluntary winding up. If we are required to windup, liquidate the trust account and distribute such amount therein, pro rata, to our public shareholders, as part of any liquidation process, such winding up, liquidation and distribution must comply with the applicable provisions of the Companies Law.

Our shareholders may be held liable for claims by third parties against us to the extent of distributions received by them upon redemption of their shares.

If we are forced to enter into an insolvent liquidation, any distributions received by shareholders could be viewed as an unlawful payment if it was proved that immediately following the date on which the distribution was made, we were unable to pay our debts as they fall due in the ordinary course of business. As a result, a liquidator could seek to recover all amounts received by our shareholders. Furthermore, our directors may be viewed as having breached their fiduciary duties to us or our creditors and/or may have acted in bad faith, and thereby exposing themselves and our company to claims, by paying public shareholders from the trust account prior to addressing the claims of creditors. We cannot assure you that claims will not be brought against us for these reasons. We and our directors and officers who knowingly and willfully authorized or permitted any distribution to be paid out of our share premium account while we were unable to pay our debts as they fall due in the ordinary course of business would be guilty of an offence and may be liable to a fine and to imprisonment for five years in the Cayman Islands.

We are not registering the ordinary shares issuable upon exercise of the warrants under the Securities Act or any state securities laws at this time, and such registration may not be in place when an investor desires to exercise warrants, thus precluding such investor from being able to exercise its warrants except on a cashless basis and potentially causing such warrants to expire worthless.

We are not registering the ordinary shares issuable upon exercise of the warrants under the Securities Act or any state securities laws at this time. However, under the terms of the warrant agreement, we have agreed that as soon as practicable, but in no event later than 15 business days after the closing of our initial business combination, we will use our best efforts to file, and within 60 business days following our initial business combination to have declared effective, a registration statement covering such shares and maintain a current prospectus relating to the ordinary shares issuable upon exercise of the warrants, until the expiration of the warrants in accordance with the provisions of the warrant agreement. We cannot assure you that we will be able to do so if, for example, any facts or events arise which represent a fundamental change in the information set forth in the registration statement or prospectus, the financial statements contained or incorporated by reference therein are not current or correct or the SEC issues a stop order. If the shares issuable upon exercise of the warrants are not registered under the Securities Act, we will be required to permit holders to exercise their warrants on a cashless basis. However, no warrant will be exercisable for cash or on a cashless basis, and we will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available.

23

Notwithstanding the foregoing, if a registration statement covering the ordinary shares issuable upon exercise of the warrants is not effective within a specified period following the consummation of our initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when we shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. We will use our best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. In no event will we be required to net cash settle any warrant, or issue securities or other compensation in exchange for the warrants in the event that we are unable to register or qualify the shares underlying the warrants under applicable state securities laws and no exemption is available. If the issuance of the shares upon exercise of the warrants is not so registered or qualified or exempt from registration or qualification, the holder of such warrant shall not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In such event, holders who acquired their warrants as part of a purchase of units will have paid the full unit purchase price solely for the ordinary shares included in the units. If and when the warrants become redeemable by us, we may not exercise our redemption right if the issuance of shares upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or we are unable to effect such registration or qualification. We will use our best efforts to register or qualify such shares under the blue sky laws of the state of residence in those states in which the warrants were offered by us in our initial public offering.

The grant of registration rights to our sponsor and holders of our private placement units may make it more difficult to complete our initial business combination, and the future exercise of such rights may adversely affect the market price of our ordinary shares.

Pursuant to an agreement to be entered into concurrently with the issuance and sale of the securities in our initial public offering, our sponsor and its permitted transferees can demand that we register their founder shares. In addition, holders of our private placement units and their permitted transferees can demand that we register the private placement units and their underlying securities, holders of the shares, and the shares underlying the warrants, underlying the unit purchase option being issued to the underwriters of our initial public offering can demand that we register such securities, and holders of units that may be issued upon conversion of working capital loans, may demand that we register such units and their underlying securities. We will bear the cost of registering these securities. The registration and availability of such a significant number of securities for trading in the public market may have an adverse effect on the market price of our ordinary shares. In addition, the existence of the registration rights may make our initial business combination more costly or difficult to conclude. This is because the shareholders of the target business may increase the equity stake they seek in the combined entity or ask for more cash consideration to offset the negative impact on the market price of our ordinary shares that is expected when the ordinary shares owned by our sponsor, holders of our private placement units or holders of our working capital loans or their respective permitted transferees are registered.

Because we are not limited to a particular industry or any specific target businesses with which to pursue our initial business combination, you will be unable to ascertain the merits or risks of any particular target business’s operations.

We may seek to complete a business combination with an operating company in any industry or sector. However, we will not, under our amended and restated memorandum and articles of association, be permitted to effectuate our initial business combination with another blank check company or similar company with nominal operations. Because we have not yet identified or approached any specific target business with respect to a business combination, there is no basis to evaluate the possible merits or risks of any particular target business’s operations, results of operations, cash flows, liquidity, financial condition or prospects. To the extent we complete our initial business combination, we may be affected by numerous risks inherent in the business operations with which we combine. For example, if we combine with a financially unstable business or an entity lacking an established record of sales or earnings, we may be affected by the risks inherent in the business and operations of a financially unstable entity. Although our officers and directors will endeavor to evaluate the risks inherent in a particular target business, we cannot assure you that we will properly ascertain or assess all of the significant risk factors or that we will have adequate time to complete due diligence. Furthermore, some of these risks may be outside of our control and leave us with no ability to control or reduce the chances that those risks will adversely impact a target business. We also cannot assure you that an investment in our units will ultimately prove to be more favorable to investors than a direct investment, if such opportunity were available, in a business combination target. Accordingly, any shareholders who choose to remain shareholders following the business combination could suffer a reduction in the value of their shares. Such shareholders are unlikely to have a remedy for such reduction in value.

24

Past performance by our management team and their respective affiliates may not be indicative of future performance of an investment in us.

Information regarding performance by, or businesses associated with, our management team and their affiliates is presented for informational purposes only. Past performance by our management team, including their affiliates’ past performance, is not a guarantee either (i) of success with respect to any business combination we may consummate or (ii) that we will be able to locate a suitable candidate for our initial business combination. You should not rely on the historical record of our management team and their affiliates as indicative of our future performance. Additionally, in the course of their respective careers, members of our management team have been involved in businesses and deals that were unsuccessful.

We may seek acquisition opportunities in industries or sectors that may be outside of our management’s areas of expertise.

We will consider a business combination outside of our management’s areas of expertise if a business combination candidate is presented to us and we determine that such candidate offers an attractive acquisition opportunity for our company. In the event we elect to pursue an acquisition outside of the areas of our management’s expertise, our management’s expertise may not be directly applicable to its evaluation or operation, and the information contained in this prospectus regarding the areas of our management’s expertise would not be relevant to an understanding of the business that we elect to acquire. As a result, our management may not be able to adequately ascertain or assess all of the significant risk factors. Accordingly, any shareholders who choose to remain shareholders following our initial business combination could suffer a reduction in the value of their shares. Such shareholders are unlikely to have a remedy for such reduction in value.

Although we have identified general criteria and guidelines that we believe are important in evaluating prospective target businesses, we may enter into our initial business combination with a target that does not meet such criteria and guidelines, and as a result, the target business with which we enter into our initial business combination may not have attributes entirely consistent with our general criteria and guidelines.

Although we have identified general criteria and guidelines for evaluating prospective target businesses, it is possible that a target business with which we enter into our initial business combination will not have all of these positive attributes. If we complete our initial business combination with a target that does not meet some or all of these guidelines, such combination may not be as successful as a combination with a business that does meet all of our general criteria and guidelines. In addition, if we announce a prospective business combination with a target that does not meet our general criteria and guidelines, a greater number of shareholders may exercise their redemption rights, which may make it difficult for us to meet any closing condition with a target business that requires us to have a minimum net worth or a certain amount of cash. In addition, if we are no longer a foreign private issuer and shareholder approval of the transaction is required by law, or we decide to obtain shareholder approval for business or other legal reasons, it may be more difficult for us to attain shareholder approval of our initial business combination if the target business does not meet our general criteria and guidelines. If we are unable to complete our initial business combination, our public shareholders may receive only approximately $11.18 per share on the liquidation of our trust account and our warrants will expire worthless.

We may seek acquisition opportunities with a financially unstable business or an entity lacking an established record of revenue or earnings.

To the extent we complete our initial business combination with a financially unstable business or an entity lacking an established record of sales or earnings, we may be affected by numerous risks inherent in the operations of the business with which we combine. These risks include volatile revenues or earnings and difficulties in obtaining and retaining key personnel. Although our officers and directors will endeavor to evaluate the risks inherent in a particular target business, we may not be able to properly ascertain or assess all of the significant risk factors and we may not have adequate time to complete due diligence.

Furthermore, some of these risks may be outside of our control and leave us with no ability to control or reduce the chances that those risks will adversely impact a target business.

25

We are not required to obtain an opinion from an independent investment banking firm or from an independent accounting firm, and consequently, you may have no assurance from an independent source that the price we are paying for the business is fair to our company from a financial point of view.

Unless we complete our initial business combination with an affiliated entity, or our Board of Directors cannot independently determine the fair market value of the target business or businesses, we are not required to obtain an opinion from an independent investment banking firm, another independent firm that commonly renders valuation opinions for the type of company we are seeking to acquire or from an independent accounting firm that the price we are paying for a target is fair to our company from a financial point of view. If no opinion is obtained, our shareholders will be relying on the business judgment of our Board of Directors, which will have significant discretion in choosing the standard used to establish the fair market value of the target or targets, and different methods of valuation may vary greatly in outcome from one another. Such standards used will be disclosed in our tender offer documents or proxy solicitation materials, as applicable, related to our initial business combination. However, if our Board of Directors is unable to determine the fair value of an entity with which we seek to complete an initial business combination based on such standards, we will be required to obtain an opinion as described above.

We may issue additional ordinary or preference shares to complete our initial business combination or under an employee incentive plan after completion of our initial business combination. Any such issuances would dilute the interest of our shareholders and likely present other risks.

Our amended and restated memorandum and articles of association will authorize the issuance of up to 100,000,000 ordinary shares, par value $0.0001 per share, and 1,000,000 undesignated preference shares, par value $0.0001 per share. Immediately after our initial public offering, there is 92,250,000 authorized but unissued ordinary shares available for issuance, which amount takes into account shares reserved for issuance upon exercise of outstanding warrants.

Immediately after our initial public offering, there will be no preference shares issued and outstanding.

We may issue a substantial number of additional ordinary shares, and may issue preference shares, in order to complete our initial business combination or under an employee incentive plan after completion of our initial business combination. However, our amended and restated memorandum and articles of association will provide, among other things, that prior to our initial business combination, we may not issue additional ordinary shares that would entitle the holders thereof to (i) receive funds from the trust account or (ii) vote on any initial business combination. The issuance of additional ordinary shares or preference shares:

may significantly dilute the equity interest of investors in our initial public offering;
may subordinate the rights of holders of ordinary shares if preference shares are issued with rights senior to those afforded our ordinary shares;
could cause a change in control if a substantial number of ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; and
may adversely affect prevailing market prices for our units, ordinary shares and/or warrants.

26

We may be a passive foreign investment company, or “PFIC,” which could result in adverse U.S. federal income tax consequences to U.S. investors.

If we are a PFIC for any taxable year (or portion thereof) that is included in the holding period of a U.S. Holder (as defined in the section of this prospectus captioned “Income Tax Considerations — Certain U.S. Federal Income Tax Considerations — U.S. Holders”) of our ordinary shares or warrants, the U.S. Holder may be subject to adverse U.S. federal income tax consequences and may be subject to additional reporting requirements. Our PFIC status for our current and subsequent taxable years may depend on whether we qualify for the PFIC start-up exception (see the section of this prospectus captioned “Income Tax Considerations — Certain U.S. Federal Income Tax Considerations — U.S. Holders — Passive Foreign Investment Company Rules”). Depending on the particular circumstances the application of the start-up exception may be subject to uncertainty, and there cannot be any assurance that we will qualify for the start-up exception. Accordingly, there can be no assurances with respect to our status as a PFIC for our current taxable year or any subsequent taxable year. Our actual PFIC status for any taxable year, however, will not be determinable until after the end of such taxable year. Moreover, if we determine we are a PFIC for any taxable year, we will endeavor to provide to a U.S. Holder such information as the Internal Revenue Service (“IRS”) may require, including a PFIC annual information statement, in order to enable the U.S. Holder to make and maintain a “qualified electing fund” election, but there can be no assurance that we will timely provide such required information, and such election would be unavailable with respect to our warrants in all cases. We urge U.S. Holders to consult their own tax advisors regarding the possible application of the PFIC rules to holders of our ordinary shares and warrants.

We may reincorporate in another jurisdiction in connection with our initial business combination and such reincorporation may result in taxes imposed on shareholders.

We may, in connection with our initial business combination and subject to requisite shareholder approval under the Companies Law, reincorporate in the jurisdiction in which the target company or business is located. The transaction may require a shareholder to recognize taxable income in the jurisdiction in which the shareholder is a tax resident or in which its members are resident if it is a tax transparent entity. We do not intend to make any cash distributions to shareholders to pay such taxes. Shareholders may be subject to withholding taxes or other taxes with respect to their ownership of us after the reincorporation.

Resources could be wasted in researching acquisitions that are not completed, which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If we are unable to complete our initial business combination, our public shareholders may receive only approximately $11.18 per share, or less than such amount in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless.

We anticipate that the investigation of each specific target business and the negotiation, drafting and execution of relevant agreements, disclosure documents and other instruments will require substantial management time and attention and substantial costs for accountants, attorneys and others. If we decide not to complete a specific initial business combination, the costs incurred up to that point for the proposed transaction likely would not be recoverable. Furthermore, if we reach an agreement relating to a specific target business, we may fail to complete our initial business combination for any number of reasons including those beyond our control. Any such event will result in a loss to us of the related costs incurred which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If we are unable to complete our initial business combination, our public shareholders may receive only approximately $11.18 per share on the liquidation of our trust account and our warrants will expire worthless.

We are dependent upon our officers and directors and their departure could adversely affect our ability to operate.

Our operations are dependent upon a relatively small group of individuals and, in particular, our officers and directors. We believe that our success depends on the continued service of our officers and directors, at least until we have completed our initial business combination. In addition, our officers and directors are not required to commit any specified amount of time to our affairs and, accordingly, will have conflicts of interest in allocating management time among various business activities, including identifying potential business combinations and monitoring the related due diligence. We do not have an employment agreement with, or key-man insurance on the life of, any of our directors or officers. The unexpected loss of the services of one or more of our directors or officers could have a detrimental effect on us.

27

Our ability to successfully effect our initial business combination and to be successful thereafter will be totally dependent upon the efforts of our key personnel, some of whom may join us following our initial business combination. The loss of key personnel could negatively impact the operations and profitability of our post-combination business.

Our ability to successfully effect our initial business combination is dependent upon the efforts of our key personnel. The role of our key personnel in the target business, however, cannot presently be ascertained. Although some of our key personnel may remain with the target business in senior management or advisory positions following our initial business combination, it is likely that some or all of the management of the target business will remain in place. While we intend to closely scrutinize any individuals we engage after our initial business combination, we cannot assure you that our assessment of these individuals will prove to be correct. These individuals may be unfamiliar with the requirements of operating a company regulated by the SEC, which could cause us to have to expend time and resources helping them become familiar with such requirements.

Our key personnel may negotiate employment or consulting agreements with a target business in connection with a particular business combination. These agreements may provide for them to receive compensation following our initial business combination and as a result, may cause them to have conflicts of interest in determining whether a particular business combination is the most advantageous.

Our key personnel may be able to remain with the company after the completion of our initial business combination only if they are able to negotiate employment or consulting agreements in connection with the business combination. Such negotiations would take place simultaneously with the negotiation of the business combination and could provide for such individuals to receive compensation in the form of cash payments and/or our securities for services they would render to us after the completion of the business combination. The personal and financial interests of such individuals may influence their motivation in identifying and selecting a target business, subject to his or her fiduciary duties under Cayman Islands law. However, we believe the ability of such individuals to remain with us after the completion of our initial business combination will not be the determining factor in our decision as to whether or not we will proceed with any potential business combination. There is no certainty, however, that any of our key personnel will remain with us after the completion of our initial business combination. We cannot assure you that any of our key personnel will remain in senior management or advisory positions with us. The determination as to whether any of our key personnel will remain with us will be made at the time of our initial business combination.

We may have a limited ability to assess the management of a prospective target business and, as a result, may effect our initial business combination with a target business whose management may not have the skills, qualifications or abilities to manage a public company.

When evaluating the desirability of effecting our initial business combination with a prospective target business, our ability to assess the target business’s management may be limited due to a lack of time, resources or information. Our assessment of the capabilities of the target’s management, therefore, may prove to be incorrect and such management may lack the skills, qualifications or abilities we suspected. Should the target’s management not possess the skills, qualifications or abilities necessary to manage a public company, the operations and profitability of the post-combination business may be negatively impacted. Accordingly, any shareholders who choose to remain shareholders following the business combination could suffer a reduction in the value of their shares. Such shareholders are unlikely to have a remedy for such reduction in value.

The officers and directors of an acquisition candidate may resign upon completion of our initial business combination. The departure of a business combination target’s key personnel could negatively impact the operations and profitability of our post-combination business. The role of an acquisition candidate’s key personnel upon the completion of our initial business combination cannot be ascertained at this time. Although we contemplate that certain members of an acquisition candidate’s management team will remain associated with the acquisition candidate following our initial business combination, it is possible that members of the management of an acquisition candidate will not wish to remain in place.

28

Our officers and directors will allocate their time to other businesses thereby causing conflicts of interest in their determination as to how much time to devote to our affairs. This conflict of interest could have a negative impact on our ability to complete our initial business combination.

Our officers and directors are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations and our search for a business combination and their other businesses. We do not intend to have any full-time employees prior to the completion of our initial business combination. Each of our officers is engaged in several other business endeavors for which he or she may be entitled to substantial compensation and our officers are not obligated to contribute any specific number of hours per week to our affairs. Our independent directors also serve as officers and board members for other entities. If our officers’ and directors’ other business affairs require them to devote substantial amounts of time to such affairs in excess of their current commitment levels, it could limit their ability to devote time to our affairs which may have a negative impact on our ability to complete our initial business combination.

Certain of our officers and directors are now, and all of them may in the future become, affiliated with entities engaged in business activities similar to those intended to be conducted by us and, accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should be presented.

Following the completion of our initial public offering and until we consummate our initial business combination, we intend to engage in the business of identifying and combining with one or more businesses. Our sponsor and officers and directors are, or may in the future become, affiliated with other blank check companies like ours or other entities (such as operating companies or investment vehicles) that are engaged in making and managing investments in a similar business.

Our officers and directors also may become aware of business opportunities which may be appropriate for presentation to us and the other entities to which they owe certain fiduciary or contractual duties. Accordingly, they may have conflicts of interest in determining to which entity a particular business opportunity should be presented. These conflicts may not be resolved in our favor and a potential target business may be presented to other entities prior to its presentation to us, subject to his or her fiduciary duties under Cayman Islands law.

Our officers, directors, security holders and their respective affiliates may have competitive pecuniary interests that conflict with our interests.

We have not adopted a policy that expressly prohibits our directors, officers, security holders or affiliates from having a direct or indirect pecuniary or financial interest in any investment to be acquired or disposed of by us or in any transaction to which we are a party or have an interest. In fact, we may enter into a business combination with a target business that is affiliated with our sponsor, our directors or officers, although we do not intend to do so. Nor do we have a policy that expressly prohibits any such persons from engaging for their own account in business activities of the types conducted by us. Accordingly, such persons or entities may have a conflict between their interests and ours.

We may engage in a business combination with one or more target businesses that have relationships with entities that may be affiliated with our sponsor, officers, directors or existing holders which may raise potential conflicts of interest.

In light of the involvement of our sponsor, officers and directors with other entities, we may decide to acquire one or more businesses affiliated with our sponsor, officers and directors. Our officers and directors also serve as officers and board members for other entities. Such entities may compete with us for business combination opportunities. Our sponsor, officers and directors are not currently aware of any specific opportunities for us to complete our initial business combination with any entities with which they are affiliated, and there have been no preliminary discussions concerning a business combination with any such entity or entities. Although we will not be specifically focusing on, or targeting, any transaction with any affiliated entities, we would pursue such a transaction if we determined that such affiliated entity met our criteria for a business combination and such transaction was approved by a majority of our disinterested directors. Despite our agreement to obtain an opinion from an independent investment banking firm or another independent firm that commonly renders valuation opinions for the type of company we are seeking to acquire or an independent accounting firm, regarding the fairness to our company from a financial point of view of a business combination with one or more domestic or international businesses affiliated with our officers, directors or existing holders, potential conflicts of interest still may exist and, as a result, the terms of the business combination may not be as advantageous to our public shareholders as they would be absent any conflicts of interest.

29

Since our sponsor, officers and directors will lose their entire investment in us if our initial business combination is not completed, a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination.

In February 2019, our sponsor purchased an aggregate of 1,150,000 founder shares for an aggregate purchase price of $25,000, or approximately $0.02 per share. Prior to the initial investment in the company of $25,000 by our sponsor, the company had no assets, tangible or intangible. Upon expiration of the period for the underwriter to exercise the overallotment option, our sponsor forfeited 150,000 founder shares. As a result, our sponsor owns 1,000,000 founder shares. The founder shares will be worthless if we do not complete an initial business combination. In addition, our sponsor has purchased an aggregate of 260,000 private placement units for a purchase price of $2,600,000 in the aggregate, or $10.00 per unit, that will also be worthless if we do not complete a business combination. Each private placement unit consists of one private placement share and one private placement warrant. Each private placement warrant may be exercised for one-half of one ordinary share at a price of $11.50 per whole share, subject to adjustment as provided herein.

The founder shares are identical to the ordinary shares included in the units being sold in our initial public offering except that (i) the founder shares are subject to certain transfer restrictions and (ii) our sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed (A) to waive their redemption rights with respect to their founder shares, private placement shares and public shares in connection with the completion of our initial business combination, (B) to waive their redemption rights with respect to any founder shares, private placement shares and public shares held by them in connection with a shareholder vote to approve an amendment to our amended and restated memorandum and articles of association (x) to modify the substance or timing of our obligation to provide for the redemption of our public shares in connection with an initial business combination or to redeem 100% of our public shares if we have not consummated our initial business combination within the timeframe set forth therein or with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity and (C) to waive their rights to liquidating distributions from the trust account with respect to their founder shares and private placement shares if we fail to complete our initial business combination within 12 months from the closing of our initial public offering (or up to 39 months from the closing of our initial public offering if we extend the period of time to consummate a business combination, as described in more detail in this prospectus) (although they will be entitled to liquidating distributions from the trust account with respect to any public shares they hold if we fail to complete our initial business combination within the prescribed time frame).

The personal and financial interests of our officers and directors may influence their motivation in identifying and selecting a target business combination, completing an initial business combination and influencing the operation of the business following the initial business combination.

Since our sponsor, officers and directors may not be eligible to be reimbursed for their out-of-pocket expenses if our initial business combination is not completed, a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination.

At the closing of our initial business combination, our sponsor, officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred in connection with activities on our behalf. These financial interests of our sponsor, officers and directors may influence their motivation in identifying and selecting a target business combination and completing an initial business combination.

30

We may issue notes or other debt securities, or otherwise incur substantial debt, to complete a business combination, which may adversely affect our leverage and financial condition and thus negatively impact the value of our shareholders’ investment in us.

Although we have no commitments as of the date of this prospectus to issue any notes or other debt securities, or to otherwise incur outstanding debt following our initial public offering, we may choose to incur substantial debt to complete our initial business combination. We have agreed that we will not incur any indebtedness unless we have obtained from the lender a waiver of any right, title, interest or claim of any kind in or to the monies held in the trust account. As such, no issuance of debt will affect the per-share amount available for redemption from the trust account. Nevertheless, the incurrence of debt could have a variety of negative effects, including:

default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations;
acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;
our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand;
our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding;
our inability to pay dividends on our ordinary shares;
using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes;
limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;
increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and
limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt.

We may only be able to complete one business combination with the proceeds of our initial public offering and the sale of the private placement units, which will cause us to be solely dependent on a single business which may have a limited number of products or services. This lack of diversification may negatively impact our operations and profitability.

Of the net proceeds from our initial public offering and the sale of the private placement units, $40,600,000 was available to complete our business combination and pay related fees and expenses (which includes $1,000,000 for the payment of deferred underwriting commissions).

We may effectuate our initial business combination with a single target business or multiple target businesses simultaneously or within a short period of time. However, we may not be able to effectuate our initial business combination with more than one target business because of various factors, including the existence of complex accounting issues and the requirement that we prepare and file pro forma financial statements with the SEC that present operating results and the financial condition of several target businesses as if they had been operated on a combined basis. By completing our initial business combination with only a single entity our lack of diversification may subject us to numerous economic, competitive and regulatory risks. Further, we would not be able to diversify our operations or benefit from the possible spreading of risks or offsetting of losses, unlike other entities which may have the resources to complete several business combinations in different industries or different areas of a single industry.

31

Accordingly, the prospects for our success may be:

solely dependent upon the performance of a single business, property or asset; or
dependent upon the development or market acceptance of a single or limited number of products, processes or services.

This lack of diversification may subject us to numerous economic, competitive and regulatory risks, any or all of which may have a substantial adverse impact upon the particular industry in which we may operate subsequent to our initial business combination.

We may attempt to simultaneously complete business combinations with multiple prospective targets, which may hinder our ability to complete our initial business combination and give rise to increased costs and risks that could negatively impact our operations and profitability.

If we determine to simultaneously acquire several businesses that are owned by different sellers, we will need for each of such sellers to agree that our purchase of its business is contingent on the simultaneous closings of the other business combinations, which may make it more difficult for us, and delay our ability, to complete our initial business combination. With multiple business combinations, we could also face additional risks, including additional burdens and costs with respect to possible multiple negotiations and due diligence investigations (if there are multiple sellers) and the additional risks associated with the subsequent assimilation of the operations and services or products of the acquired companies in a single operating business. If we are unable to adequately address these risks, it could negatively impact our profitability and results of operations.

We may attempt to complete our initial business combination with a private company about which little information is available, which may result in a business combination with a company that is not as profitable as we suspected, if at all.

In pursuing our acquisition strategy, we may seek to effectuate our initial business combination with a privately held company. Very little public information generally exists about private companies, and we could be required to make our decision on whether to pursue a potential initial business combination on the basis of limited information, which may result in a business combination with a company that is not as profitable as we suspected, if at all.

Our management may not be able to maintain control of a target business after our initial business combination. We cannot provide assurance that, upon loss of control of a target business, new management will possess the skills, qualifications or abilities necessary to profitably operate such business.

We may structure a business combination so that the post-transaction company in which our public shareholders own shares will own less than 100% of the equity interests or assets of a target business, but we will only complete such business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for us not to be required to register as an investment company under the Investment Company Act. We will not consider any transaction that does not meet such criteria. Even if the post-transaction company owns 50% or more of the voting securities of the target, our shareholders prior to the business combination may collectively own a minority interest in the post business combination company, depending on valuations ascribed to the target and us in the business combination transaction. For example, we could pursue a transaction in which we issue a substantial number of new ordinary shares in exchange for all of the outstanding capital stock of a target. In this case, we would acquire a 100% interest in the target. However, as a result of the issuance of a substantial number of new ordinary shares, our shareholders immediately prior to such transaction could own less than a majority of our issued and outstanding ordinary shares subsequent to such transaction. In addition, other minority shareholders may subsequently combine their holdings resulting in a single person or group obtaining a larger share of the company’s stock than we initially acquired. Accordingly, this may make it more likely that our management will not be able to maintain our control of the target business.

32

We do not have a specified maximum redemption threshold. The absence of such a redemption threshold may make it possible for us to complete a business combination with which a substantial majority of our shareholders do not agree.

Our amended and restated memorandum and articles of association will not provide a specified maximum redemption threshold, except that in no event will we redeem our public shares in an amount that would cause our net tangible assets, after payment of the deferred underwriting commissions, to be less than $5,000,001 either immediately prior to or upon consummation of our initial business combination (such that we are not subject to the SEC’s “penny stock” rules) or any greater net tangible asset or cash requirement which may be contained in the agreement relating to our initial business combination. As a result, we may be able to complete our initial business combination even though a substantial majority of our public shareholders do not agree with the transaction and have redeemed their shares or, if we are no longer a foreign private issuer and we seek shareholder approval of our initial business combination and do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, have entered into privately negotiated agreements to sell their shares to our sponsor, officers, directors, advisors or their affiliates. In the event the aggregate cash consideration we would be required to pay for all ordinary shares that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms of the proposed business combination exceed the aggregate amount of cash available to us, we will not complete the business combination or redeem any shares, all ordinary shares submitted for redemption will be returned to the holders thereof, and we instead may search for an alternate business combination.

Investors may view our units as less attractive than those of other blank check companies.

Unlike other blank check companies that sell units comprised of shares and warrants each to purchase one full share in their initial public offerings, we are selling units comprised of ordinary shares and warrants to purchase one-half (½) of one ordinary share. The warrants will not have any voting rights and will expire and be worthless if we do not consummate an initial business combination. Furthermore, no fractional shares will be issued upon exercises of the warrants. As a result, unless you acquire at least two warrants, you will not be able to receive a share upon exercise of your warrants. Accordingly, investors in our initial public offering will not be issued the same securities as part of their investment as they may have in other blank check company offerings, which may have the effect of limiting the potential upside value of your investment in our company.

In order to effectuate an initial business combination, blank check companies have, in the recent past, amended various provisions of their charters and modified governing instruments. We cannot assure you that we will not seek to amend our amended and restated memorandum and articles of association or governing instruments in a manner that will make it easier for us to complete our initial business combination that our shareholders may not support.

In order to effectuate a business combination, blank check companies have, in the past, amended various provisions of their charters and modified governing instruments. For example, blank check companies have amended the definition of business combination, increased redemption thresholds and extended the period of time in which it had to consummate a business combination. We cannot assure you that we will not seek to amend our amended and restated memorandum and articles of association or governing instruments or extend the time in which we have to consummate a business combination through amending our amended and restated memorandum and articles of association will require a special resolution of our shareholders as a matter of Cayman Islands law.

33

The provisions of our amended and restated memorandum and articles of association that relate to our pre-initial business combination activity (and corresponding provisions of the agreement governing the release of funds from our trust account), including an amendment to permit us to withdraw funds from the trust account such that the per share amount investors will receive upon any redemption or liquidation is substantially reduced or eliminated, may be amended with the approval of holders of at least two-thirds of our ordinary shares who attend and vote in a general meeting, which is a lower amendment threshold than that of some other blank check companies. It may be easier for us, therefore, to amend our amended and restated memorandum and articles of association and the trust agreement to facilitate the completion of an initial business combination that some of our shareholders may not support.

Some other blank check companies have a provision in their charter which prohibits the amendment of certain of its provisions, including those which relate to a company’s pre-initial business combination activity, without approval by a certain percentage of the company’s shareholders. In those companies, amendment of these provisions requires approval by between 90% and 100% of the company’s public shareholders. Our amended and restated memorandum and articles of association will provide that any of its provisions, including those related to pre-initial business combination activity (including the requirement to deposit proceeds of our initial public offering and the private placement of warrants into the trust account and not release such amounts except in specified circumstances, and to provide redemption rights to public shareholders as described herein and in our amended and restated memorandum and articles of association or an amendment to permit us to withdraw funds from the trust account such that the per share amount investors will receive upon any redemption or liquidation is substantially reduced or eliminated), but excluding the provision of the articles relating to the appointment of directors, may be amended if approved by holders of at least two-thirds of our ordinary shares who attend and vote in a general meeting, and corresponding provisions of the trust agreement governing the release of funds from our trust account may be amended if approved by holders of 65% of our ordinary shares. We may not issue additional securities that can vote on amendments to our amended and restated memorandum and articles of association. Our sponsor, which beneficially owns 24%, will participate in any vote to amend our amended and restated memorandum and articles of association and/or trust agreement and will have the discretion to vote in any manner it chooses. As a result, we may be able to amend the provisions of our amended and restated memorandum and articles of association which govern our pre-business combination behavior more easily than some other blank check companies, and this may increase our ability to complete a business combination with which you do not agree. Our shareholders may pursue remedies against us for any breach of our amended and restated memorandum and articles of association.

Certain agreements related to our initial public offering may be amended without shareholder approval.

Certain agreements, including the underwriting agreement relating to our initial public offering, the investment management trust agreement between us and Continental Stock Transfer & Trust Company, the letter agreement among us and our sponsor, officers, directors and director nominees, the registration rights agreement among us and our sponsor and the administrative services agreement between us and our sponsor, may be amended without shareholder approval. These agreements contain various provisions that our public shareholders might deem to be material. For example, the underwriting agreement related to our initial public offering contains a covenant that the target company that we acquire must have a fair market value equal to at least 80% of the balance in the trust account at the time of signing the definitive agreement for the transaction with such target business (excluding the deferred underwriting commissions and taxes payable on the income earned on the trust account) so long as we obtain and maintain a listing for our securities on the NASDAQ. While we do not expect our board to approve any amendment to any of these agreements prior to our initial business combination, it may be possible that our board, in exercising its business judgment and subject to its fiduciary duties, chooses to approve one or more amendments to any such agreement in connection with the consummation of our initial business combination. Any such amendment may have an adverse effect on the value of an investment in our securities.

34

We may be unable to obtain additional financing to complete our initial business combination or to fund the operations and growth of a target business, which could compel us to restructure or abandon a particular business combination.

Although we believe that the net proceeds of our initial public offering and the sale of the private placement units will be sufficient to allow us to complete our initial business combination, because we have not yet identified any prospective target business we cannot ascertain the capital requirements for any particular transaction. If the net proceeds of our initial public offering and the sale of the private placement units prove to be insufficient, either because of the size of our initial business combination, the depletion of the available net proceeds in search of a target business, the obligation to redeem for cash a significant number of shares from shareholders who elect redemption in connection with our initial business combination or the terms of negotiated transactions to purchase shares in connection with our initial business combination, we may be required to seek additional financing or to abandon the proposed business combination. We cannot assure you that such financing will be available on acceptable terms, if at all. To the extent that additional financing proves to be unavailable when needed to complete our initial business combination, we would be compelled to either restructure the transaction or abandon that particular business combination and seek an alternative target business candidate. In addition, even if we do not need additional financing to complete our initial business combination, we may require such financing to fund the operations or growth of the target business. The failure to secure additional financing could have a material adverse effect on the continued development or growth of the target business. None of our officers, directors or shareholders is required to provide any financing to us in connection with or after our initial business combination. If we are unable to complete our initial business combination, our public shareholders may only receive approximately $11.18 per share on the liquidation of our trust account, and our warrants will expire worthless. In certain circumstances, our public shareholders may receive less than $11.18 per share on the redemption of their shares.

We may amend the terms of the warrants in a manner that may be adverse to holders of public warrants with the approval by the holders of a majority of the then issued and outstanding warrants.

Our warrants will be issued in registered form under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, but requires the approval by the holders of a majority of the then issued and outstanding warrants (including private warrants) to make any change that adversely affects the interests of the registered holders of warrants. Accordingly, we may amend the terms of the warrants in a manner adverse to a holder if holders of a majority of the then issued and outstanding warrants (including private warrants) approve of such amendment. Although our ability to amend the terms of the public warrants with the consent of a majority of the then issued and outstanding warrants is unlimited, examples of such amendments could be amendments to, among other things, increase the exercise price of the warrants, shorten the exercise period or decrease the number of ordinary shares purchasable upon exercise of a warrant.

We may redeem your unexpired warrants prior to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless.

We have the ability to redeem outstanding warrants at any time after they become exercisable and prior to their expiration, at a price of $0.01 per warrant, provided that the last reported sales price of our ordinary shares equal or exceed $16.50 per share (as adjusted for share splits, share capitalizations, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 trading-day period ending on the third trading day prior to the date we send the notice of redemption to the warrant holders. If and when the warrants become redeemable by us, we may not exercise our redemption right if the issuance of shares upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or we are unable to effect such registration or qualification. We will use our best efforts to register or qualify such shares under the blue sky laws of the state of residence in those states in which the warrants were offered by us in our initial public offering. Redemption of the outstanding warrants could force you (i) to exercise your warrants and pay the exercise price therefor at a time when it may be disadvantageous for you to do so, (ii) to sell your warrants at the then-current market price when you might otherwise wish to hold your warrants or (iii) to accept the nominal redemption price which, at the time the outstanding warrants are called for redemption, is likely to be substantially less than the market value of your warrants. None of the private placement warrants will be redeemable by us so long as they are held by our sponsor or its permitted transferees.

35

Our management’s ability to require holders of our warrants to exercise such warrants on a cashless basis will cause holders to receive fewer ordinary shares upon their exercise of the warrants than they would have received had they been able to exercise their warrants for cash.

If we call our public warrants for redemption after the redemption criteria described elsewhere in this prospectus have been satisfied, our management will have the option to require any holder that wishes to exercise his warrant (including any warrants held by our sponsor, officers or directors, other purchasers of our founders’ units, or their permitted transferees) to do so on a “cashless basis.” If our management chooses to require holders to exercise their warrants on a cashless basis, the number of ordinary shares received by a holder upon exercise will be fewer than it would have been had such holder exercised his warrant for cash. This will have the effect of reducing the potential “upside” of the holder’s investment in our company.

Our warrants and founder shares may have an adverse effect on the market price of our ordinary shares and make it more difficult to effectuate our initial business combination.

Our sponsor, Cynthia Management Corporation, a British Virgin Islands business company, has purchase an aggregate of 260,000 unit at a price of $10.00 per unit for an aggregate purchase price of $2,600,000 in a private placement that closed simultaneously with the closing of our initial public offering. Each private placement unit consists of one ordinary share and one private placement warrant exercisable to purchase one-half of one ordinary share at a price of $11.50 per whole share. Prior to our initial public offering, our sponsor purchased an aggregate of 1,150,000 founder shares in a private placement and 150,000 founder shares have been forfeited as the underwriter did not exercise the overallotment option. As a result, our sponsor owns an aggregate of 1,000,000 founder shares. In addition, if our sponsor makes any working capital loans, up to $2,500,000 of such loans may be converted into units, at the price of $10.00 per unit (which, for example, would result in the holders being issued 250,000 ordinary shares if $2,500,000 of notes were so converted, as well as 250,000 warrants to purchase 125,000 shares) at the option of the lender. Such units would be identical to the private placement units. To the extent we issue ordinary shares to effectuate a business transaction, the potential for the issuance of a substantial number of additional ordinary shares upon exercise of these warrants could make us a less attractive acquisition vehicle to a target business. Any such issuance will increase the number of issued and outstanding ordinary shares and reduce the value of the ordinary shares issued to complete the business transaction. Therefore, our warrants and founder shares may make it more difficult to effectuate a business combination or increase the cost of acquiring the target business.

The private placement units are identical to the units sold in our initial public offering except that, so long as the warrants underlying such units are held by our sponsor or its permitted transferees, (i) they will not be redeemable by us, (ii) they (including the ordinary shares issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the sponsor until 30 days after the completion of our initial business combination and (iii) they may be exercised by the holders on a cashless basis.

A provision of our warrant agreement may make it more difficult for us to consummate an initial business combination.

Unlike some other blank check companies, if

(i)we issue additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at a Newly Issued Price of less than $9.20 per share;
(ii)the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the consummation of our initial business combination (net of redemptions), and
(iii)the Market Value is below $9.20 per share,

then the exercise price of the warrants will be adjusted to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $16.50 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 165% of the higher of the Market Value and the Newly Issued Price. This may make it more difficult for us to consummate an initial business combination with a target business.

36

Because we must furnish our shareholders with target business financial statements, we may lose the ability to complete an otherwise advantageous initial business combination with some prospective target businesses.

The federal proxy rules require that a proxy statement with respect to a vote on a business combination meeting certain financial significance tests include historical and/or pro forma financial statement disclosure in periodic reports. We will include the same financial statement disclosure in connection with our tender offer documents, whether or not they are required under the tender offer rules. These financial statements may be required to be prepared in accordance with, or be reconciled to, accounting principles generally accepted in the United States of America, or U.S. GAAP, or international financing reporting standards as issued by the International Accounting Standards Board, or IFRS, depending on the circumstances and the historical financial statements may be required to be audited in accordance with the standards of the PCAOB. These financial statement requirements may limit the pool of potential target businesses we may acquire because some targets may be unable to provide such statements in time for us to disclose such statements in accordance with federal proxy rules and complete our initial business combination within the prescribed time frame.

We are an emerging growth company and a smaller reporting company within the meaning of the Securities Act, and if we take advantage of certain exemptions from disclosure requirements available to emerging growth companies and smaller reporting companies, this could make our securities less attractive to investors and may make it more difficult to compare our performance with other public companies.

We are an “emerging growth company” within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. As a result, our shareholders may not have access to certain information they may deem important. We could be an emerging growth company for up to five years, although circumstances could cause us to lose that status earlier, including if the market value of our ordinary shares held by non-affiliates exceeds $700 million as of any June 30 before that time, in which case we would no longer be an emerging growth company as of the following December 31. We cannot predict whether investors will find our securities less attractive because we will rely on these exemptions. If some investors find our securities less attractive as a result of our reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there may be a less active trading market for our securities and the trading prices of our securities may be more volatile.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accountant standards used.

Additionally, we are a “smaller reporting company” as defined in Rule 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our ordinary shares held by non-affiliates exceeds $250 million as of the end of the prior June 30th, or (2) our annual revenues exceeded $100 million during such completed fiscal year and the market value of our ordinary shares held by non-affiliates exceeds $700 million as of the prior June 30th. To the extent we take advantage of such reduced disclosure obligations, it may also make comparison of our financial statements with other public companies difficult or impossible.

37

Compliance obligations under the Sarbanes-Oxley Act may make it more difficult for us to effectuate our initial business combination, require substantial financial and management resources, and increase the time and costs of completing an acquisition.

Section 404 of the Sarbanes-Oxley Act requires that we evaluate and report on our system of internal controls beginning with our Annual Report on Form 10-K for the year ended December 31, 2021. Only in the event we are deemed to be a large accelerated filer or an accelerated filer will we be required to comply with the independent registered public accounting firm attestation requirement on our internal control over financial reporting. Further, for as long as we remain an emerging growth company, we will not be required to comply with the independent registered public accounting firm attestation requirement on our internal control over financial reporting. The fact that we are a blank check company makes compliance with the requirements of the Sarbanes-Oxley Act particularly burdensome on us as compared to other public companies because a target company with which we seek to complete our initial business combination may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding adequacy of its internal controls. The development of the internal control of any such entity to achieve compliance with the Sarbanes-Oxley Act may increase the time and costs necessary to complete any such acquisition.

Because we are incorporated under the laws of the Cayman Islands, you may face difficulties in protecting your interests, and your ability to protect your rights through the U.S. Federal courts may be limited.

We are an exempted company incorporated under the laws of the Cayman Islands. As a result, it may be difficult for investors to effect service of process within the United States upon our directors or officers, or enforce judgments obtained in the United States courts against our directors or officers.

Our corporate affairs are governed by our amended and restated memorandum and articles of association, the Companies Law (as the same may be supplemented or amended from time to time) and the common law of the Cayman Islands. The rights of shareholders to take action against the directors, actions by minority shareholders and the fiduciary responsibilities of our directors to us under Cayman Islands law are to a large extent governed by the common law of the Cayman Islands. The common law of the Cayman Islands is derived in part from comparatively limited judicial precedent in the Cayman Islands as well as from English common law, the decisions of whose courts are of persuasive authority, but are not binding on a court in the Cayman Islands. The rights of our shareholders and the fiduciary responsibilities of our directors under Cayman Islands law are different from what they would be under statutes or judicial precedent in some jurisdictions in the United States. In particular, the Cayman Islands has a different body of securities laws as compared to the United States, and certain states, such as Delaware, may have more fully developed and judicially interpreted bodies of corporate law. In addition, Cayman Islands companies may not have standing to initiate a shareholders derivative action in a Federal court of the United States.

We have been advised by our Cayman Islands legal counsel that the courts of the Cayman Islands are unlikely (i) to recognize or enforce against us judgments of courts of the United States predicated upon the civil liability provisions of the federal securities laws of the United States or any state; and (ii) in original actions brought in the Cayman Islands, to impose liabilities against us predicated upon the civil liability provisions of the federal securities laws of the United States or any state, so far as the liabilities imposed by those provisions are penal in nature. In those circumstances, although there is no statutory enforcement in the Cayman Islands of judgments obtained in the United States, the courts of the Cayman Islands will recognize and enforce a foreign money judgment of a foreign court of competent jurisdiction without retrial on the merits based on the principle that a judgment of a competent foreign court imposes upon the judgment debtor an obligation to pay the sum for which judgment has been given provided certain conditions are met. For a foreign judgment to be enforced in the Cayman Islands, such judgment must be final and conclusive and for a liquidated sum, and must not be in respect of taxes or a fine or penalty, inconsistent with a Cayman Islands judgment in respect of the same matter, impeachable on the grounds of fraud or obtained in a manner, or be of a kind the enforcement of which is, contrary to natural justice or the public policy of the Cayman Islands (awards of punitive or multiple damages may well be held to be contrary to public policy). A Cayman Islands Court may stay enforcement proceedings if concurrent proceedings are being brought elsewhere.

As a result of all of the above, public shareholders may have more difficulty in protecting their interests in the face of actions taken by management, members of the Board of Directors or controlling shareholders than they would as public shareholders of a United States company.

38

Provisions in our amended and restated memorandum and articles of association may inhibit a takeover of us, which could limit the price investors might be willing to pay in the future for our ordinary shares and could entrench management.

Our amended and restated memorandum and articles of association will contain provisions that may discourage unsolicited takeover proposals that shareholders may consider to be in their best interests. These provisions include two-year director terms and the ability of the Board of Directors to designate the terms of and issue new series of preference shares, which may make more difficult the removal of management and may discourage transactions that otherwise could involve payment of a premium over prevailing market prices for our securities.

After our initial business combination, it is possible that a majority of our directors and officers will live outside the United States and all of our assets will be located outside the United States; therefore investors may not be able to enforce federal securities laws or their other legal rights.

It is possible that after our initial business combination, a majority of our directors and officers will reside outside of the United States and all of our assets will be located outside of the United States. As a result, it may be difficult, or in some cases not possible, for investors in the United States to enforce their legal rights, to effect service of process upon all of our directors or officers or to enforce judgments of United States courts predicated upon civil liabilities and criminal penalties on our directors and officers under United States laws.

There are uncertainties under the PRC Securities Law relating to the procedures and time requirement for the U.S. securities regulatory agencies to bring about investigations and evidence collection within the territory of the PRC.

On December 28, 2019, the newly amended Securities Law of the PRC (the “PRC Securities Law”) was promulgated, which became effective on March 1, 2020. According to Article 177 of the PRC Securities Law (the “Article 177”), the securities regulatory authority of the State Council may establish a regulatory cooperation mechanism with securities regulatory authorities of another country or region for the implementation of cross-border supervision and administration. Article 177 further provides that overseas securities regulatory authorities shall not engage in activities pertaining to investigating or obtaining evidence directly within the territories of the PRC, and that no Chinese entities or individuals shall provide documents and information in connection with securities business activities to any organizations and/or persons aboard without the prior consent of the securities regulatory authority of the State Council and the competent departments of the State Council. As of the date of this prospectus, we are not aware of any implementing rules or regulations which have been published regarding application of the Article 177.

We believe that Article 177 is only applicable in circumstances related to direct investigation or evidence collection conducted by overseas authorities within the territory of the PRC. Our principal business operation is conducted in the PRC. In the event that the U.S. securities regulatory agencies carry out an investigation on us, such as an enforcement action by the Department of Justice, the SEC or other authorities, and there is a need to conduct investigation or collect evidence within the territory of the PRC, the U.S. securities regulatory agencies may consider cross-border cooperation with the securities regulatory authority of the PRC by way of judicial assistance, diplomatic channels or regulatory cooperation mechanism established with the securities regulatory authority of the PRC. However, there is no assurance that the U.S. securities regulatory agencies will succeed in establishing such cross-border cooperation in a specific case or establish such cooperation in a timely manner.

Furthermore, as the Article 177 is a recently promulgated provision and, as the date of this prospectus, there have not been implementing rules or regulations regarding the application of the Article 177, it remains unclear how it will be interpreted, implemented or applied by the Chinese Securities Regulatory Commission or other relevant government authorities. As such, there are uncertainties as to the procedures and time requirement for the U.S. securities regulatory agencies to conduct investigations and evidence collection within the territory of the PRC. If U.S. securities regulatory agencies are unable to conduct such investigations, they may determine to suspend or de-register our registration with the SEC and our securities may also be delisted from Nasdaq or other applicable trading market.

In addition, our security holders could face hurdles in bringing an original action in foreign courts to enforce liabilities based on the U.S. federal securities laws against our officers.

39

The fact that our sponsor is, is controlled by, and has substantial ties with a non-U.S. person could impact our ability to complete our initial business combination.

Our sponsor, Cynthia Management Corporation, is controlled by our Chairman and Chief Executive Officer Jinlong Liu, who is a Chinese citizen. Our sponsor owns approximately 86% of the outstanding shares of the Company. Certain federally licensed businesses in the United States, such as broadcasters and airlines, may be subject to rules or regulations that limit foreign ownership. As a result, this may limit the pool of acquisition candidates we may acquire in the United States, in particular, relative to other special purpose acquisition companies that are not subject to such restrictions, which could make it more difficult and costly for us to consummate a business combination with a target business operating in the United States relative to such other companies.

In addition, CFIUS is an interagency committee authorized to review certain transactions involving foreign investment in the United States by foreign persons in order to determine the effect of such transactions on the national security of the United States. Because we may be considered a “foreign person” under such rules and regulations, any proposed business combination between us and a U.S. business engaged in a regulated industry or which may affect national security, we could be subject to such foreign ownership restrictions and/or CFIUS review. The scope of CFIUS review was expanded by the Foreign Investment Risk Review Modernization Act of 2018 (“FIRRMA”) to include certain non-passive, non-controlling investments in sensitive U.S. businesses and certain acquisitions of real estate even with no underlying U.S. business. FIRRMA, and subsequent implementing regulations that are now in force, also subject certain categories of investments to mandatory filings. If our initial business combination with any potential target company falls within the scope of foreign ownership restrictions, we may be unable to consummate a business combination with such business. In addition, if our business combination falls within CFIUS’s jurisdiction, we may be required to make a mandatory filing or determine to submit a voluntary notice to CFIUS, or to proceed with the initial business combination without notifying CFIUS and risk CFIUS intervention, before or after closing the initial business combination. CFIUS may decide to block or delay our initial business combination, impose conditions to mitigate national security concerns with respect to such initial business combination or order us to divest all or a portion of a U.S. business of the combined company if we had proceeded without first obtaining CFIUS clearance.

Moreover, the process of government review, whether by CFIUS or otherwise, could be lengthy. Because we have only a limited time to complete its initial business combination, our failure to obtain any required approvals within the requisite time period may require us to liquidate. If we liquidate, our public shareholders may only receive the cash held in the trust account, and our warrants and rights will expire worthless. This will also cause you to lose any potential investment opportunity in a target company and the chance of realizing future gains on your investment through any price appreciation in the combined company.

If we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be restricted, which may make it difficult for us to complete our initial business combination.

A company that, among other things, is or holds itself out as being engaged primarily, or proposes to engage primarily, in the business of investing, reinvesting, owning, trading or holding certain types of securities would be deemed an investment company under the Investment Company Act. Since we currently invest the proceeds held in the trust account, it is possible the SEC could deem the Company to be currently an inadvertent but nevertheless unregistered investment company.

If we are deemed to be an investment company under the Investment Company Act, our activities may be restricted, including:

restrictions on the nature of our investments; and
restrictions on the issuance of securities, each of which may make it difficult for us to complete our initial business combination.

In addition, we may have imposed upon us burdensome requirements, including:

registration as an investment company;
adoption of a specific form of corporate structure; and
reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations.

40

In order not to be regulated as an investment company under the Investment Company Act, unless we can qualify for an exclusion, we must ensure that we are engaged primarily in a business other than investing, reinvesting or trading in securities and that our activities do not include investing, reinvesting, owning, holding or trading “investment securities” constituting more than 40% of our total assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis. Our business is to identify and complete an initial business combination and thereafter to operate the post-transaction business or assets for the long term. We do not plan to buy businesses or assets with a view to resale or profit from their resale. We do not plan to buy unrelated businesses or assets or to be a passive investor.

We do not believe that our anticipated principal activities will subject us to the Investment Company Act. To this end, the proceeds held in the trust account may only be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. By restricting the investment of the proceeds to these instruments, and by having a business plan targeted at acquiring and growing businesses for the long term (rather than on buying and selling businesses in the manner of a merchant bank or private equity fund), we have intended from completion of our initial public offering and continue to intend to avoid being deemed an “investment company” within the meaning of the Investment Company Act. Our initial public offering was not intended for persons who are seeking a return on investments in government securities or investment securities. The trust account set up in connection with the closing of our initial public offering was and is intended as a holding place for funds pending the earliest to occur of: (i) the completion of our initial business combination; (ii) the redemption of any public shares properly submitted in connection with a shareholder vote to amend our amended and restated Memorandum and Articles of Association (A) to modify the substance or timing of our obligation to redeem 100% of our public shares if we do not complete our initial business combination within 12 months (or if extended, 33 months) from the closing of our initial public offering, or (B) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity; or (iii) absent an initial business combination within 39 months from the closing of our initial public offering, our return of the funds held in the trust account to our public shareholders as part of our redemption of the public shares. On April 25, 2023, however, our shareholders approved an amendment to our Memorandum and Articles of Association extending the period we have to complete an initial business combination from April 28, 2023 to October 28, 2023, or an additional six months. If we do not invest the proceeds as discussed above, we may be deemed to be subject to the Investment Company Act. If we were deemed to be subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for which we have not allotted funds and may hinder our ability to complete an initial business combination or may result in our liquidation. If we are unable to complete our initial business combination, our public shareholders may receive only approximately $11.05 per share on the liquidation of our trust account and our warrants will expire worthless. There can be, however, no assurance that the foregoing redemption price per share will be paid and as a result of expenses related to compliance with the Investment Company Act, such redemption price may be lower.

Notwithstanding the foregoing, as indicated above, on March 30, 2022, the SEC issued proposed rules relating to, among other items, the extent to which SPACs could become subject to regulation under the Investment Company Act of 1940. The SEC’s proposed rules would provide a safe harbor for companies from the definition of “investment company” under Section 3(a)(1)(A) of the Investment Company Act, provided that they satisfy certain conditions that limit a company’s duration, asset composition, business purpose and activities. The duration component of the proposed safe harbor rule would require company to file a Current Report on Form 8-K with the SEC announcing that it has entered into an agreement with the target company (or companies) to engage in an initial business combination no later than 18 months after the effective date of the Company’s registration statement for its initial public offering. A company would then be required to complete its initial business combination no later than 24 months after the effective date of its registration statement for its initial public offering. These rules, if adopted, whether in the form proposed or in revised form, may materially adversely affect our ability to negotiate and complete our initial business combination and may increase the costs and time related thereto. Unfortunately, our Company may not qualify for the safe harbor because an initial business combination will not be completed within the foregoing 18-months and 24-month time requirements and will require additional months to complete. Accordingly, our Company may already be deemed an unregistered investment company and subject to the requirements of the Investment Company Act as well as further expenses and possible penalties.

41

To the extent it takes our company the longer to complete its initial business combination the greater will be the risk to our company and its shareholders that Greencity may be deemed to be an unregistered investment company. The risk of our company being determined to be an unregistered investment company may be mitigated if our company shifts the assets in its trust account from securities into cash only.

Risks Associated with Acquiring and Operating a Business Outside of the United States

If we effect our initial business combination with a company located outside of the United States, we would be subject to a variety of additional risks that may negatively impact our operations.

If we effect our initial business combination with a company located outside of the United States, we would be subject to any special considerations or risks associated with companies operating in the target business’ home jurisdiction, including any of the following:

rules and regulations or currency redemption or corporate withholding taxes on individuals;
laws governing the manner in which future business combinations may be effected;
tariffs and trade barriers;
regulations related to customs and import/export matters;
longer payment cycles;
tax issues, such as tax law changes and variations in tax laws as compared to the United States;
currency fluctuations and exchange controls;
rates of inflation;
challenges in collecting accounts receivable;
cultural and language differences;
employment regulations;
crime, strikes, riots, civil disturbances, terrorist attacks and wars; and
deterioration of political relations with the United States which could result in any number of difficulties, both normal course such as above or extraordinary such as sanctions being imposed. We may not be able to adequately address these additional risks. If we were unable to do so, our operations might suffer.

If our management following our initial business combination is unfamiliar with United States securities laws, they may have to expend time and resources becoming familiar with such laws, which could lead to various regulatory issues.

Following our initial business combination, any or all of our management could resign from their positions as officers of the Company, and the management of the target business at the time of the business combination will remain in place. Management of the target business may not be familiar with United States securities laws. If new management is unfamiliar with United States securities laws, they may have to expend time and resources becoming familiar with such laws. This could be expensive and time-consuming and could lead to various regulatory issues which may adversely affect our operations.

42

If we effect a business combination with a company located outside of the United States, the laws applicable to such company will likely govern all of our material agreements and we may not be able to enforce our legal rights.

If we effect a business combination with a company located outside of the United States, the laws of the country in which such company operates will govern almost all of the material agreements relating to its operations. We cannot assure you that the target business will be able to enforce any of its material agreements or that remedies will be available in this new jurisdiction. The system of laws and the enforcement of existing laws in such jurisdiction may not be as certain in implementation and interpretation as in the United States. The inability to enforce or obtain a remedy under any of our future agreements could result in a significant loss of business, business opportunities or capital. Additionally, if we acquire a company located outside of the United States, it is likely that substantially all of our assets would be located outside of the United States and some of our officers and directors might reside outside of the United States. As a result, it may not be possible for investors in the United States to enforce their legal rights, to effect service of process upon our directors or officers or to enforce judgments of United States courts predicated upon civil liabilities and criminal penalties of our directors and officers under Federal securities laws.

Because of the costs and difficulties inherent in managing cross-border business operations after we acquire it, our results of operations may be negatively impacted following a business combination.

Managing a business, operations, personnel or assets in another country is challenging and costly. Management of the target business that we may hire (whether based abroad or in the U.S.) may be inexperienced in cross-border business practices and unaware of significant differences in accounting rules, legal regimes and labor practices. Even with a seasoned and experienced management team, the costs and difficulties inherent in managing cross-border business operations, personnel and assets can be significant (and much higher than in a purely domestic business) and may negatively impact our financial and operational performance.

Many countries, and especially those in emerging markets, have difficult and unpredictable legal systems and underdeveloped laws and regulations that are unclear and subject to corruption and inexperience, which may adversely impact our results of operations and financial condition.

Our ability to seek and enforce legal protections, including with respect to intellectual property and other property rights, or to defend ourselves with regard to legal actions taken against us in a given country, may be difficult or impossible, which could adversely impact our operations, assets or financial condition.

Rules and regulations in many countries, including some of the emerging markets within the regions we will initially focus, are often ambiguous or open to differing interpretation by responsible individuals and agencies at the municipal, state, regional and federal levels. The attitudes and actions of such individuals and agencies are often difficult to predict and inconsistent.

Delay with respect to the enforcement of particular rules and regulations, including those relating to customs, tax, environmental and labor, could cause serious disruption to operations abroad and negatively impact our results.

After our initial business combination, substantially all of our assets may be located in a foreign country and substantially all of our revenue may be derived from our operations in such country. Accordingly, our results of operations and prospects will be subject, to a significant extent, to the economic, political and legal policies, developments and conditions in the country in which we operate.

The economic, political and social conditions, as well as government policies, of the country in which our operations are located could affect our business. The economies in developing markets we will initially focus on differ from the economies of most developed countries in many respects. Such economic growth has been uneven, both geographically and among various sectors of the economy and such growth may not be sustained in the future. If in the future such country’s economy experiences a downturn or grows at a slower rate than expected, there may be less demand for spending in certain industries. A decrease in demand for spending in certain industries could materially and adversely affect our ability to find an attractive target business with which to consummate our initial business combination and if we effect our initial business combination, the ability of that target business to become profitable.

43

Exchange rate fluctuations and currency policies may cause a target business’ ability to succeed in the international markets to be diminished.

In the event we acquire a non-U.S. target, all revenues and income would likely be received in a foreign currency, the dollar equivalent of our net assets and distributions, if any, could be adversely affected by reductions in the value of the local currency. The value of the currencies in our target regions fluctuate and are affected by, among other things, changes in political and economic conditions. Any change in the relative value of such currency against our reporting currency may affect the attractiveness of any target business or, following consummation of our initial business combination, our financial condition and results of operations. Additionally, if a currency appreciates in value against the dollar prior to the consummation of our initial business combination, the cost of a target business as measured in dollars will increase, which may make it less likely that we are able to consummate such transaction.

Because our business objective includes the possibility of acquiring one or more operating businesses with primary operations in emerging markets we will focus on, changes in the exchange rate between the U.S. dollar and the currency of any relevant jurisdiction may affect our ability to achieve such objective. For instance, the exchange rates between the Turkish lira or the Indian rupee and the U.S. dollar has changed substantially in the last two decades and may fluctuate substantially in the future. If the U.S. dollar declines in value against the relevant currency, any business combination will be more expensive and therefore more difficult to complete. Furthermore, we may incur costs in connection with conversions between U.S. dollars and the relevant currency, which may make it more difficult to consummate a business combination.

Because foreign law could govern almost all of our material agreements, we may not be able to enforce our rights within such jurisdiction or elsewhere, which could result in a significant loss of business, business opportunities or capital.

Foreign law could govern almost all of our material agreements. The target business may not be able to enforce any of its material agreements or that remedies will be available outside of such foreign jurisdiction’s legal system. The system of laws and the enforcement of existing laws and contracts in such jurisdiction may not be as certain in implementation and interpretation as in the United States. Judiciaries in such jurisdiction may also be relatively inexperienced in enforcing corporate and commercial law, leading to a higher than usual degree of uncertainty as to the outcome of any litigation. As a result, the inability to enforce or obtain a remedy under any of our future agreements could result in a significant loss of business and business opportunities.

Corporate governance standards in foreign countries may not be as strict or developed as in the United States and such weakness may hide issues and operational practices that are detrimental to a target business.

General corporate governance standards in some countries are weak in that they do not prevent business practices that cause unfavorable related party transactions, over-leveraging, improper accounting, family company interconnectivity and poor management. Local laws often do not go far to prevent improper business practices. Therefore, shareholders may not be treated impartially and equally as a result of poor management practices, asset shifting, conglomerate structures that result in preferential treatment to some parts of the overall company, and cronyism. The lack of transparency and ambiguity in the regulatory process also may result in inadequate credit evaluation and weakness that may precipitate or encourage financial crisis. In our evaluation of a business combination we will have to evaluate the corporate governance of a target and the business environment, and in accordance with United States laws for reporting companies take steps to implement practices that will cause compliance with all applicable rules and accounting practices. Notwithstanding these intended efforts, there may be endemic practices and local laws that could add risk to an investment we ultimately make and that result in an adverse effect on our operations and financial results.

Companies in foreign countries may be subject to accounting, auditing, regulatory and financial standards and requirements that differ, in some cases significantly, from those applicable to public companies in the United States, which may make it more difficult or complex to consummate a business combination. In particular, the assets and profits appearing on the financial statements of a foreign company may not reflect its financial position or results of operations in the way they would be reflected had such financial statements been prepared in accordance with U.S. GAAP and there may be substantially less publicly available information about companies in certain jurisdictions than there is about comparable United States companies. Moreover, foreign companies may not be subject to the same degree of regulation as are United States companies with respect to such matters as insider trading rules, tender offer regulation, shareholder proxy requirements and the timely disclosure of information.

44

Legal principles relating to corporate affairs and the validity of corporate procedures, directors’ fiduciary duties and liabilities and shareholders’ rights for foreign corporations may differ from those that may apply in the U.S., which may make the consummation of a business combination with a foreign company more difficult. We therefore may have more difficulty in achieving our business objective.

A slowdown in economic growth in the markets that our business target operates in may adversely affect our business, financial condition, results of operations, the value of its equity shares and the trading price of our shares following our business combination.

Following the business combination, our results of operations and financial condition may be dependent on, and may be adversely affected by, conditions in financial markets in the global economy, and, particularly in the markets where the business operates. The specific economy could be adversely affected by various factors such as political or regulatory action, including adverse changes in liberalization policies, business corruption, social disturbances, terrorist attacks and other acts of violence or war, natural calamities, interest rates, inflation, commodity and energy prices and various other factors which may adversely affect our business, financial condition, results of operations, value of our equity shares and the trading price of our shares following the business combination.

Regional hostilities, terrorist attacks, communal disturbances, civil unrest and other acts of violence or war may result in a loss of investor confidence and a decline in the value of our equity shares and trading price of our shares following our business combination.

Terrorist attacks, civil unrest and other acts of violence or war may negatively affect the markets in which we may operates our business following our business combination and also adversely affect the worldwide financial markets. In addition, the countries we will focus on, have from time to time experienced instances of civil unrest and hostilities among or between neighboring countries. Any such hostilities and tensions may result in investor concern about stability in the region, which may adversely affect the value of our equity shares and the trading price of our shares following our business combination. Events of this nature in the future, as well as social and civil unrest, could influence the economy in which our business target operates, and could have an adverse effect on our business, including the value of equity shares and the trading price of our shares following our business combination.

Any downgrade of credit ratings of the country in which the company we acquire does business may adversely affect our ability to raise debt financing following our business combination.

No assurance can be given that any rating organization will not downgrade the credit ratings of the sovereign foreign currency long-term debt of the country in which our business target operates, which reflect an assessment of the overall financial capacity of the government of such country to pay its obligations and its ability to meet its financial commitments as they become due. Any downgrade could cause interest rates and borrowing costs to rise, which may negatively impact both the perception of credit risk associated with our future variable rate debt and our ability to access the debt markets on favorable terms in the future. This could have an adverse effect on our financial condition following our business combination.

Returns on investment in foreign companies may be decreased by withholding and other taxes.

Our investments will incur tax risk unique to investment in developing economies. Income that might otherwise not be subject to withholding of local income tax under normal international conventions may be subject to withholding of income tax in a developing economy. Additionally, proof of payment of withholding taxes may be required as part of the remittance procedure. Any withholding taxes paid by us on income from our investments in such country may or may not be creditable on our income tax returns. We intend to seek to minimize any withholding tax or local tax otherwise imposed. However, there is no assurance that the foreign tax authorities will recognize application of such treaties to achieve a minimization of such tax. We may also elect to create foreign subsidiaries to effect the business combinations to attempt to limit the potential tax consequences of a business combination.

45

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Some statements contained in this prospectus are forward-looking in nature. Our forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this prospectus may include, for example, statements about:

our ability to complete our initial business combination;
our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination;
our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination, as a result of which they would then receive expense reimbursements;
our potential ability to obtain additional financing to complete our initial business combination;
our pool of prospective target businesses;
the ability of our officers and directors to generate a number of potential acquisition opportunities;
our public securities’ potential liquidity and trading;
the lack of a market for our securities;
the use of proceeds not held in the trust account or available to us from interest income on the trust account balance; or
our financial performance following our initial public offering.

The forward-looking statements contained in this prospectus are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described under the heading “Risk Factors”. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

46

Item 1B. Unresolved Staff Comments

None

Item 2. Properties

We currently maintain our executive offices at 505 Eshan Road, Floor 6, Pudong New District, Shanghai, 200120, China. The cost for this space is included in the $10,000 per month fee that we will pay our sponsor for office space, administrative and support services. We consider our current office space adequate for our current operations.

Item 3. Legal Proceedings

As of December 31, 2022, there is no material litigation, arbitration or governmental proceeding currently pending against us or any members of our management team in their capacity as such.

Item 4. Mine Safety Disclosures

Not Applicable

47

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Our units are currently traded on The Nasdaq Capital Market under the symbol “GRCYU” and started trading on the Nasdaq Capital Market on July 24, 2020. The ordinary shares and warrants and began separate trading on August 28, 2020, under the symbols “GRCY” and “GCRYW” respectively.

Holders of Record

At December 31, 2022 there were 1,870,752 of ordinary shares issued and outstanding by 2 holder of record. The number of record holders was determined from the records of our transfer agent and does not include beneficial owners of any of our securities whose securities are held in the names of various security brokers, dealers, and registered clearing agencies.

Dividends

We have not paid any cash dividends on our shares of ordinary shares to date and do not intend to pay cash dividends prior to the completion of an initial business combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition subsequent to completion of a business combination. The payment of any dividends subsequent to a business combination will be, subject to the laws of the Cayman Islands, within the discretion of our board of directors at such time. It is the present intention of our board of directors to retain all earnings, if any, for use in our business operations and, accordingly, our board of directors does not anticipate declaring any cash dividends in the foreseeable future. In addition, our board of directors is not currently contemplating and does not anticipate declaring any share dividends in the foreseeable future. Further, if we incur any indebtedness, our ability to declare dividends may be limited by restrictive covenants we may agree to under the terms of such indebtedness.

Sales of Unregistered Securities

None

Securities Authorized for Issuance Under Equity Compensation Plans

None.

Use of Proceeds

The registration statement for our initial public offering was declared effective by the Securities and Exchange Commission on July 23, 2020. We completed our initial public offering on July 28, 2020. In our initial public offering, we sold units at an offering price of $10.00 and consisting of one ordinary share and one redeemable warrant. Each warrant entitles the holder thereof to purchase one-half of one ordinary share. We will not issue fractional shares in connection with the exercise of the warrants.

In connection with our initial public offering, we sold 4,000,000 units, generating gross proceeds of $40,000,000. Simultaneously with the closing of the IPO, pursuant to the Private Placement Units Purchase Agreement by and between the Company and our sponsor, Cynthia Management Corporation (the “Sponsor”), a British Virgin Islands company, the Company completed the private sale of an aggregate of 260,000 units (the “Private Placement Units”) to the Sponsor at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds to the Company of $2,600,000.

48

Transaction costs amounted to $2,646,665, consisting of $1,000,000 of underwriting fees, $1,000,000 of deferred underwriting fees and $646,665 of other offering costs. A total of $40,600,000, comprised of $38,000,000 of the proceeds from the IPO (which amount includes $1,000,000 of the underwriter’s deferred discount) and $2,600,000 of the proceeds of the sale of the Private Placement Units, was placed in a U.S.-based trust account, maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds in the trust account that may be released to the Company to pay its taxes, the funds held in the trust account will not be released from the trust account until the earliest of (i) the completion of the Company’s initial business combination, (ii) the redemption of any of the Company’s public shares properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to (A) modify the substance or timing of its obligation to redeem 100% of the Company’s public shares if it does not complete its initial business combination within 33 months from the closing of the IPO, or (B) with respect to any other provision relating to shareholders’ rights or pre-business combination activity, and (iii) the redemption of the Company’s public shares if it is unable to complete its initial business combination within 33 months from the closing of the IPO.

At December 31, 2022 and 2021, cash of $6,918 and $61,773 were held outside of the Trust Account and are available for working capital purposes.

ITEM 6. Reserved

Not applicable.

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with our audited financial statements and the notes related thereto which are included in “Item 8. Financial Statements and Supplementary Data” of this Annual Report on Form 10-K. Certain information contained in the discussion and analysis set forth below includes forward-looking statements. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those set forth under “Special Note Regarding Forward-Looking Statements,” “Item 1A. Risk Factors” and elsewhere in this Annual Report on Form 10-K.

Overview

We are a blank check company incorporated in the Cayman Islands on May 14, 2018 formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses. We intend to effectuate our Business Combination using cash derived from the proceeds of the Initial Public Offering and the sale of the Private Units, our shares, debt or a combination of cash, shares and debt.

We expect to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

Results of Operations

Since our IPO, our sole business activity has been identifying and evaluating suitable acquisition transaction candidates and engaging in non-binding discussions with potential target entities. To date we have not entered into any binding agreement with any target entity. We presently have no revenue and have had net income during the years ended December 31, 2022 and 2021. We have generated non-operating income in the form of interest income on marketable securities held in the trust account. We have increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a Business Combination.

For the year ended December 31, 2022, we had a net income of $611,525, which consisted of interest income on marketable securities held in the Trust Account of $378,536 and gain on the change in fair value of warrant liabilities of $886,866 offset by operating costs of $653,877.

49

For the year ended December 31, 2021, we had a net income of $1,345,808, which consisted of interest income on marketable securities held in the Trust Account of $4,341 and gain on the change in fair value of warrant liabilities of $1,980,000 offset by operating costs of $638,533.

Liquidity and Capital Resources

On July 28, 2020, we consummated the Initial Public Offering of 4,000,000 Units, generating gross proceeds of $40,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 260,000 Private Units to the Sponsor at a price of $10.00 per Private Unit generating gross proceeds of $2,600,000.

Following the Initial Public Offering and the sale of the Private Units, a total of $40,600,000 was placed in the Trust Account. We incurred $2,646,665 in transaction costs, including $1,000,000 of underwriting fees, $1,000,000 of deferred underwriting fees and $646,665 of other offering costs.

Our timeframe to complete the initial business combination expired on April 28, 2022. On April 20, 2022, we held an Annual General Meeting of Shareholders. Among other things, shareholders approved the proposal to extend the time to complete our initial business company by six monthly extensions to October 28, 2022. In connection with the vote to approve the Extension Amendment, the holders of 78,050 shares of the Company’s ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.46 per share, for an aggregate redemption amount of $816,101.13. As a result, an amount of $41,008,428.63 remained in the trust account.

On October 28, 2022, we held an Extraordinary General Meeting of Shareholders. Shareholders approved the proposal to extend the time to complete our initial business company by six monthly extension to April 28, 2023. In connection with the vote to approve the Extension Amendment, the holders of 3,311,198 shares of the Company’s ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.73 per share, for an aggregate redemption amount of $35,540,143.87. As a result, an amount of $6,555,395.97 remained in the trust account.

We held another Extraordinary Shareholder Meeting on April 25, 2023 for our shareholders to vote for the proposal to amend the Company’s amended and restated memorandum and articles of association to extend the date by which the Company has to consummate a business combination six (6) times for an additional one (1) month each time from April 28, 2023 to October 28, 2023 by amending the Amended and Restated Memorandum and Articles of Association by deleting the existing Section 48.7 thereof and replacing them with the new Section 48.7. Shareholders approved the proposal to extend the time to complete our initial business company by six monthly extension to October 28, 2023. The holders of 405,705 shares of the Company’s ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $11.18 per share, for an aggregate redemption amount of $4,535,353.71. As a result, an amount of $ 2,292,209.07 remained in the trust account.

For the year ended December 31, 2022, net cash used in operating activities was $406,551. Net income of $611,525 was impacted by interest earned on investments of $378,536 and a change in fair value of warrant liabilities of $886,866. Changes in operating assets and liabilities provided $247,326 of cash from operating activities.

For the year ended December 31, 2021, net cash used in operating activities was $381,390. Net income of $1,345,808 was impacted by interest earned on investments of $4,341 and a change in fair value of warrant liabilities of $1,980,000. Changes in operating assets and liabilities provided $257,143 of cash from operating activities.

At December 31, 2022 we had investments held in the Trust Account of $6,658,707. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account, excluding deferred underwriting commissions, to complete our Business Combination. We may withdraw interest earned from the Trust Account to pay taxes, if any. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete a Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

50

At December 31, 2022, we had cash of $6,918 held outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. Such Working Capital Loans would be evidenced by promissory notes. If we complete a Business Combination, we may repay such notes out of the proceeds of the Trust Account released to us. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such notes, but no proceeds from our Trust Account would be used for such repayment. Up to $2,500,000 of the loans may be convertible into units, at a price of $10.00 per unit, at the option of the lender. The units would be identical to the Private Units.

If our initial business combination is not consummated, the Company will need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.

In connection with the Company’s assessment of going concern considerations in accordance with FASB ASU 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until June 28, 2023 to consummate a business combination. It is uncertain that the Company will be able to consummate a business combination by this time. If a business combination is not consummated by this date and an extension is not requested by the Sponsor, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the mandatory liquidation, should a business combination not occur, and an extension is not requested by the Sponsor, and potential subsequent dissolution as well as liquidity condition noted above raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after June 28, 2023. The Company intends to complete a business combination before the mandatory liquidation date.

Off-Balance Sheet Financing Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of December 31, 2022 and 2021. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay the Sponsor a monthly fee of $10,000 for certain general and administrative services, including office space, utilities and administrative services, provided to the Company. We began incurring these fees on July 24, 2020 and will continue to incur these fees monthly until the earlier of the completion of a Business Combination and the Company’s liquidation.

The underwriters are entitled to a deferred fee of two and one-half percent (2.5%) of the gross proceeds of the Initial Public Offering, or $1,000,000. The deferred fee will be paid in cash upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement.

51

Pursuant to a registration rights agreement entered into on July 23, 2020, the holders of the founder shares, Private Units (and their underlying securities), the shares underlying the warrants underlying the unit purchase option issued to the underwriters and any Units that may be issued upon conversion of the Working Capital Loans (and underlying securities) are entitled to registration rights. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. Notwithstanding the foregoing, the underwriters may not exercise their demand and “piggyback” registration rights after five (5) and seven (7) years after the effective date of the registration statement and may not exercise their demand rights on more than one occasion. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Critical Accounting Policies

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

Ordinary Shares Subject to Redemption

We account for our ordinary shares subject to possible conversion in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. Our ordinary shares feature certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of our balance sheets.

Net Income (Loss) Per Ordinary Share

The Company complies with accounting and disclosure requirements of ASC 260, Earnings Per Share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable common stock and non-redeemable common stock and the undistributed income (loss) is calculated using the total net income less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable common stock. Any remeasurement of the accretion to redemption value of the common stock subject to possible redemption was considered to be dividends paid to the public shareholders. As of December 31, 2022, the Company has not considered the effect of the warrants sold in the Initial Public Offering to purchase an aggregate of 2,130,000 shares in the calculation of diluted net income (loss) per share, since the exercise of the warrants is contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic (income) loss per share for the period presented.

52

Warrants

We accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC Topic 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the our own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of our control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of income.

Recent Accounting Standard

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. The amendments are effective for smaller reporting companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying financial statements.

Item 7A. Quantitative and Qualitative Disclosures about Market Risk

As a smaller reporting company, we are not required to make disclosures under this Item.

Item 8. Financial Statements and Supplementary Data

This information appears following Item 15 of this Report and is included herein by reference.

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Report, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Our management evaluated, with the participation of our current chief executive officer and chief financial officer (our “Certifying Officers”), the effectiveness of our disclosure controls and procedures as of December 31, 2022, pursuant to Rule 13a-15(b) under the Exchange Act. Based upon that evaluation, our Certifying Officers concluded that, solely due to the events that led to the Company’s restatement of its financial statements to reclassify the Company’s Warrants and reclassification of the public shares partially from permanent equity into temporary equity as of December 31, 2022, our disclosure controls and procedures were not effective.

53

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Our internal control over financial reporting did not result in the proper classification of our warrants. Since their issuance on July 28, 2020, our warrants have been accounted for as equity within our balance sheet. On April 12, 2021, the SEC Staff issued the SEC Staff Statement in which the SEC Staff expressed its view that certain terms and conditions common to SPAC warrants may require the warrants to be classified as liabilities on the SPAC’s balance sheet as opposed to equity. After discussion and evaluation, taking into consideration the SEC Staff Statement, including with our independent auditors, we have concluded that our warrants should be presented as liabilities with subsequent fair value remeasurement. As a result, management identified a material weakness in our internal control over financial reporting related to the accounting for warrants.

Our internal control over financial reporting did not result in the proper classification of our public shares. Historically, a portion of the public shares was classified as permanent equity to maintain shareholders’ equity greater than $5 million on the basis that the Company will not redeem its public shares in an amount that would cause its net tangible assets to be less than $5,000,001, as described in the Company’s amended and restated Memorandum and Article of Association (the “Charter”). Pursuant to re-evaluation by the management and audit committee, the Company’s management has determined that the public shares include certain provisions that require classification of all of the public shares as temporary equity regardless of the net tangible assets redemption limitation contained in the Charter.

To remediate these two material weaknesses, we developed a remediation plan with assistance from our accounting advisors and have dedicated significant resources and efforts to the remediation and improvement of our internal control over financial reporting. While we have processes to identify and appropriately apply applicable accounting requirements, we plan to enhance our system of evaluating and implementing the complex accounting standards that apply to our financial statements. Our plans at this time include providing enhanced access to accounting literature, research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.

54

Management’s Report on Internal Controls Over Financial Reporting

As required by SEC rules and regulations implementing Section 404 of the Sarbanes-Oxley Act (as defined in Rules 13a-15(e) and 15- d-15(e) under the Securities Exchange Act of 1934, as amended), our management is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements for external reporting purposes in accordance with U.S. GAAP. Our internal control over financial reporting includes those policies and procedures that:

(1)pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of our company,
(2)provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and
(3)provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect errors or misstatements in our financial statements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree or compliance with the policies or procedures may deteriorate. Management assessed the effectiveness of our internal control over financial reporting at December 31, 2022. In making these assessments, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control — Integrated Framework (2013). Based on our assessments and those criteria, management determined that our internal control over financial reporting as of December 31, 2022 was not effective due to material weakness identified related to warrant accounting and public shares classification.

This Annual Report on Form 10-K does not include an attestation report of internal controls from our independent registered public accounting firm due to our status as an emerging growth company under the JOBS Act.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting, as the circumstances that led to the restatement of our financial statements described in this Report had not yet been identified.

Item 9B. Other Information

None

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Not Applicable

55

PART III

Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.

Our current directors and executive officers are as follows:

Name

    

Age

    

Title

Jinlong Liu

32

Chairman and Chief Executive Officer

Panyan Yu

32

Chief Financial Officer

Zhijie Wang

 

37

 

Director

Anxin Wang

 

48

 

Director

Chao Liu

 

39

 

Director

Jinlong Liu, age 32, our Chairman since December 2019 and our Chief Executive Officer since July 2021, has been serving as chairman of Shanghai Midai Investment Group, an investment group in Shanghai, focusing on auto finance, real estate investment and investments relating to logistics, tourism and individual transportation, since August 2016. Mr. Liu has also served as chief executive officer of Shanghai Midai Automobile Corp., a subsidiary of Shanghai Midai Investment Group, dealing with auto sales, rental, finance and repairs, as well as gasoline trade, since June 2015. From 2009 to 2015, Mr. Liu served as the manager of Ye Chiu Resources Ltd., specializing in the manufacturing and exportation of aluminum materials in China. From 2010 to 2012, Mr. Liu was employed by Jianhua Group Ltd., a trade, finance, retail and construction company in China. From 2012 to 2015, Mr. Liu was employed by Pingan Group., a finance group in China. Mr. Liu received his Bachelor degree of Environmental Engineering from Jiangsu University. We believe Mr. Liu is qualified to serve on our board of directors because of his extensive management, investment and financial background.

Ms. Panyan Yu, age 32, has served as our Chief Financial Officer since August 2021. Ms. Yu been a certified public accountant since May 2020 in Shanghai Pujiang Certified Public Accountants, which focuses on corporate and government audit. From March 2019 to April 2020, Ms. Yu served as a Senior Investment Manager at Tojoy Holding, which focuses on investment and post-investment management. From July 2017 to March 2018, Ms. Yu joined Datong Securities, which focuses on IPO, re-finance and bond issuance. Ms. Yu received her bachelor degree from The University of Nottingham, Ningbo China, and was licensed as a CPA since 2016. Ms. Yu’s professional career over pass eight years has been in accounting and investment management roles at both Chinese and foreign companies. We believe Ms. Yu is well qualified to serve as our Chief Financial Officer because of her extensive experience and strong expertise in finance and investment.

Dr. Anxin Wang, age 48, has served as our independent director since August 2021. Mr. Wang has served as General Manager of Strategic Development Division of Zhenyan Asset Management Company, in China since July 2020. From March 2018 to July 2020, Dr. Wang served as the Chairman of the Investment and Financing Committee of Deepblue Technology Company in China. From February 2017 to February 2018, Dr. Wang served as Director of Industry Research in Pengxin Global Resource Company, a listed company in China (stock code:600470). From April 2016 to February 2017, Dr. Wang served as senior director of Strategic Development Center of Xiexin Holding Group in China. From June 2014 to April 2016, Dr. Wang served as General Manager of Research and Development Center of Zhongtai Trust Company Ltd. Dr. Wang received his Bachelor of Economics degree from Shanghai University in 1998, Master of Financial degree from East China Normal University in 2001, and Doctor of Financial degree from Fudan University in 2006. We believe Dr. Wang is well qualified to serve on our Board of Directors and Chairman of Audit Committee because of his extensive business and management experience in China.

Mr. Zhijie Wang, age 37, has served as our independent director since July 2021. Mr. Wang has served as secretary of the board of Jiangsu China Federation Transportation Industry Group Co., Ltd. since July 2020. From April 2019 to June 2020, Mr. Wang has served as the secretary of board of directors of CAR-T (Shanghai) Biotechnology Co., Ltd. Previously, Mr. Wang was secretary of the board of directors and director of Huatai Jewelry Development (Shanghai) Co., Ltd. from October 2015 to March 2019. Prior to that, Mr. Wang was a manager of Shanghai SASAC from July 2008 to September 2015. Mr. Wang received his MBA degree from Shanghai Fudan University in 2018 and his Bachelor of Business Management degree from Shanghai Maritime University in 2008. We believe Mr. Wang is well qualified to serve on our Board of Directors because of his extensive experience and strong expertise in finance, investment and capital markets.

56

Chao Liu, age 39, has served as a member of our board of directors since July 2020. Mr. Liu has served as the director of Shanghai Midai Investment Group since December 2018. From August 2016 to December 2018, Mr. Liu served as General Manager of Zhong Fei Finance & Leasing Corp. From August 2015 to August 2016, he served as South China General Manager at Zhong Rong International Trust Corp. From August 2006 to July 2015, he served as General Manager of Chengdu Chaotuo Culture Media Corp. Mr. Liu received a B.A. in Business Administration Science from South West University of Finance and Economics in China. We believe Mr. Liu is well qualified to serve on our board of directors because of his extensive business and management experience in China.

Our officers are elected by the Board of Directors and serve at the discretion of the Board of Directors, rather than for specific terms of office. Our Board of Directors is authorized to appoint persons to the offices set forth in our amended and restated memorandum and articles of association as it deems appropriate. Our amended and restated memorandum and articles of association provides that our officers may consist of a Chairman, Chief Executive Officer, President, Chief Financial Officer, Vice Presidents, Secretary, Assistant Secretaries, Treasurer and such other offices as may be determined by the Board of Directors.

Each of our directors holds office for a two-year term. Subject to any other special rights applicable to the shareholders, any vacancies on our Board of Directors may be filled by the affirmative vote of a majority of the directors present and voting at the meeting of our board or by a majority of the holders of our founder shares.

Director Independence

The NASDAQ listing standards require that a majority of our Board of Directors be independent. An “independent director” is defined generally as a person who has no material relationship with the listed company (either directly or as a partner, shareholder or officer of an organization that has a relationship with the company). We currently have two “independent directors” as defined in the NASDAQ listing standards and applicable SEC rules prior to completion of our initial public offering. Our board has determined that each of Messrs. Li, Wang and Chao Liu are independent directors under applicable SEC and NASDAQ rules. Our independent directors will have regularly scheduled meetings at which only independent directors are present.

Committees of the Board of Directors

Our Board of Directors has three standing committees: an audit committee, a compensation committee and nominating committee. Each committee will operate under a charter that has been approved by our board. Subject to phase-in rules and a limited exception, NASDAQ rules and Rule 10A-3 of the Exchange Act require that the audit committee of a listed company be comprised solely of independent directors, and NASDAQ rules require that the compensation committee of a listed company be comprised solely of independent directors.

The members of our audit committee are Messrs. Zhijie Wang, Anxin Wang and Chao Liu. Mr. Anxin Wang serves as chairman of the audit committee. Each member of the audit committee is financially literate and our Board of Directors has determined that Mr. Anxin Wang qualifies as an “audit committee financial expert” as defined in applicable SEC rules.

The members of our Audit Committee are Messrs. Zhijie Wang, Anxin Wang and Chao Liu. Mr. Anxin Wang serves as chairman of the Audit Committee.

The members of our Compensation Committee are Messrs. Zhijie Wang, Anxin Wang and Chao Liu. Mr. Zhijie Wang serves as chairman of the Compensation Committee.

The members of our Nominating Committees are Messrs. Zhijie Wang, Anxin Wang and Chao Liu. Mr. Chao Liu serves as chairman of the Nominating Committee.

57

Item 11. EXECUTIVE COMPENSATION.

No executive officer has received any cash compensation for services rendered to us during the year ended December 31, 2022.

No compensation or fees of any kind, including finder’s, consulting fees and other similar fees, will be paid to our founders, members of our management team or their respective affiliates, for services rendered prior to, or in order to effectuate the consummation of, our initial business combination (regardless of the type of transaction that it is). Directors, officers and founders will receive reimbursement for any out-of-pocket expenses incurred by them in connection with activities on our behalf, such as identifying potential target businesses, performing business due diligence on suitable target businesses and business combinations as well as traveling to and from the offices, plants or similar locations of prospective target businesses to examine their operations. There is no limit on the amount of out-of-pocket expenses reimbursable by us.

After completion of our initial business combination, members of our management team who remain with us may be paid employment, consulting, management or other fees from the combined company with any and all amounts being fully disclosed to shareholders, to the extent then known, in the proxy solicitation materials furnished to our shareholders. The amount of such compensation may not be known at the time of a shareholder meeting held to consider an initial business combination, as it will be up to the directors of the post-combination business to determine executive and director compensation. In this event, such compensation will be publicly disclosed at the time of its determination in an Exchange Act filing such as Current Report on Form 8-K, as required by the SEC.

Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS.

The following table sets forth information regarding the beneficial ownership of our shares of ordinary shares as of December 31, 2022 by:

each person known by us to be the beneficial owner of more than 5% of our outstanding shares of ordinary shares;
each of our officers and directors; and
all of our officers and directors as a group.

Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all ordinary shares beneficially owned by them. The following table does not reflect beneficial ownership of the warrants included in the units offered in our initial public offering or purchased by our sponsor I connection with our initial public offering as these warrants are not exercisable and these rights are not convertible within 60 days of December 31, 2022 or the date of this Form 10-K.

Approximate 

 

Percentage 

 

Amount and

of 

 

 Nature of

Outstanding 

 

 Beneficial 

Ordinary

 

Name and Address of Beneficial Owner(1)

    

Ownership

    

 Shares

Cynthia Management Corporation (2)

1,260,000

 

86

%

Jinlong Liu(3)

 

1,260,000

 

86

%

Anxin Wang

 

 

Zhijie Wang

 

 

Panyan Yu

 

 

Chao Liu

 

 

All directors and officers as a group

 

1,260,000

 

86

%

(1)Unless otherwise indicated, the business address of each of the individuals is 505 Eshan Road, Floor 6, Pudong New District, Shanghai, 200120.
(2)Represents 1,000,000 founder ordinary shares and 260,000 private placement ordinary shares held by Cynthia Management Corporation, our sponsor.

58

(3)Such individual does not beneficially own any of our ordinary shares. However, such individual has a pecuniary interest in our ordinary shares through his ownership of shares of our sponsor.

Our founders beneficially own approximately 86% of the issued and outstanding ordinary shares. Because of the ownership block held by our founders, officers and directors, such individuals may be able to effectively exercise influence over all matters requiring approval by our shareholders, including the election of directors and approval of significant corporate transactions other than approval of our initial business combination.

Our sponsor, officers and directors are deemed to be our “promoters” as such term is defined under the federal securities laws.

Section 16(a) Beneficial Ownership Reporting Compliance

Section 16(a) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, requires our executive officers, directors, and persons who beneficially own more than 10% of a registered class of our equity securities to file with the Securities and Exchange Commission initial reports of ownership and reports of changes in ownership of our ordinary shares and other equity securities. These executive officers, directors, and greater than 10% beneficial owners are required by SEC regulation to furnish us with copies of all Section 16(a) forms filed by such reporting persons.

Based solely on our review of such forms furnished to us and written representations from certain reporting persons, we believe that, during the fiscal year ended December 31, 2022, our directors, executive officers, and ten percent shareholders complied with all Section 16(a) filing requirements,

Item 13. Certain Relationships, and Related Transactions and Director Independence

Certain Relationships and Related Transactions

In February 2019, our sponsor purchased 1,150,000 founder shares for an aggregate purchase price of $25,000, or approximately $0.02 per share. 150,000 founder shares have been forfeited after the expiration of the periods for the underwriter to exercise the overallotment option.

Our sponsor purchased an aggregate of 260,000 private placement units at a price of $10.00 per unit in a private placement that was completed simultaneously with the closing of our initial public offering. Each unit consists of one private placement share and one private placement warrant. Each private placement warrant entitles the holder upon exercise to purchase one-half of one ordinary share at a price of $11.50 per whole share, subject to adjustment as provided herein. The private placement units (including the underlying securities) may not, subject to certain limited exceptions, be transferred, assigned or sold by it until 30 days after the completion of our initial business combination. Our sponsor owns in total 1,260,000 ordinary shares, approximately 67.35% of our issued and outstanding ordinary shares, as of December 31, 2022.

In connection with the completion of our initial public offering, we entered into an Administrative Services Agreement with our sponsor pursuant to which we will pay a total of $10,000 per month for office space, administrative and support services to such affiliate. Upon completion of our initial business combination or our liquidation, we will cease paying these monthly fees. Accordingly, in the event the consummation of our initial business combination takes the maximum 39 months, our sponsor will be paid a total of $390,000 ($10,000 per month) for office space, administrative and support services and will be entitled to be reimbursed for any out-of-pocket expenses. The administrative services were not paid during the years ended December 31, 2022 and 2021. As of December 31, 2022 and 2021, the balances due to related parties were $290,000 and $170,000, respectively. The balance is unsecured, interest-free and would be paid upon consummation of the Company’s initial Business Combination.

Our sponsor, officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made to our sponsor, officers, directors or our or their affiliates and will determine which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on our behalf.

59

Our sponsor has agreed to loan us up to $800,000 to be used for transactional expenses. As of the date of this Form 10-K, we had borrowed $745,504 under the promissory note with our sponsor. These loans are non-interest bearing, unsecured and were originally due the earlier of the consummation of our initial business combination.

Furthermore, we also had borrowed $2,016,863 under related party extension loan payable with our sponsor as of December 31, 2022. These loans are non-interest bearing, unsecured and would either be repaid upon consummation of a Business Combination, without interest.

In addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete an initial business combination, we would repay such loaned amounts. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $2,500,000 of such loans may be convertible into units at a price of $10.00 per unit (which, for example, would result in the holders being issued 250,000 ordinary shares if $2,500,000 of notes were so converted as well as 250,000 warrants to purchase 125,000 shares) at the option of the lender. The units would be identical to the placement units issued to the initial holder. The terms of such loans by our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our sponsor or an affiliate of our sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.

The holders of the founder shares, private placement units, units issuable to the underwriters if the underwriters’ over-allotment option is exercised, the shares underlying the warrants underlying the unit purchase option issued to the underwriters of our initial public offering, and units that may be issued on conversion of working capital loans (and any securities underlying the private placement units and the working capital loans) are entitled to registration rights pursuant to a registration rights agreement signed on the effective date of our initial public offering requiring us to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to our completion of our initial business combination and rights to require us to register for resale such securities pursuant to Rule 415 under the Securities Act. We will bear the expenses incurred in connection with the filing of any such registration statements during the year ended December 31, 2022.

Related Party Policy

Our Code of Ethics, which we have adopted upon consummation of the IPO, will require us to avoid, wherever possible, all related party transactions that could result in actual or potential conflicts of interests, except under guidelines approved by the board of directors (or the audit committee). Related-party transactions are defined as transactions in which (1) the aggregate amount involved will or may be expected to exceed $120,000 in any calendar year, (2) we or any of our subsidiaries is a participant, and (3) any (a) executive officer, director or nominee for election as a director, (b) greater than 5% beneficial owner of our ordinary shares, or (c) immediate family member, of the persons referred to in clauses (a) and (b), has or will have a direct or indirect material interest (other than solely as a result of being a director or a less than 10% beneficial owner of another entity). A conflict of interest situation can arise when a person takes actions or has interests that may make it difficult to perform his or her work objectively and effectively. Conflicts of interest may also arise if a person, or a member of his or her family, receives improper personal benefits as a result of his or her position.

We also require each of our directors and executive officers to annually complete a directors’ and officers’ questionnaire that elicits information about related party transactions.

60

Our audit committee, pursuant to its written charter, will be responsible for reviewing and approving related-party transactions to the extent we enter into such transactions. All ongoing and future transactions between us and any of our officers and directors or their respective affiliates will be on terms believed by us to be no less favorable to us than are available from unaffiliated third parties. Such transactions will require prior approval by our audit committee and a majority of our uninterested “independent” directors, or the members of our board who do not have an interest in the transaction, in either case who had access, at our expense, to our attorneys or independent legal counsel. We will not enter into any such transaction unless our audit committee and a majority of our disinterested “independent” directors determine that the terms of such transaction are no less favorable to us than those that would be available to us with respect to such a transaction from unaffiliated third parties. Additionally, we require each of our directors and executive officers to complete a directors’ and officers’ questionnaire that elicits information about related party transactions.

These procedures are intended to determine whether any such related party transaction impairs the independence of a director or presents a conflict of interest on the part of a director, employee or officer.

To further minimize potential conflicts of interest, we have agreed not to consummate a business combination with an entity which is affiliated with any of our initial shareholders unless we obtain an opinion from an independent investment banking firm that the business combination is fair to our unaffiliated shareholders from a financial point of view. Furthermore, in no event will any of our existing officers, directors or initial shareholders, or any entity with which they are affiliated, be paid any finder’s fee, consulting fee or other compensation prior to, or for any services they render in order to effectuate, the consummation of a business combination.

Director Independence

The NASDAQ listing standards require that a majority of our Board of Directors be independent. An “independent director” is defined generally as a person who has no material relationship with the listed company (either directly or as a partner, shareholder or officer of an organization that has a relationship with the company). We currently have two “independent directors” as defined in the NASDAQ listing standards and applicable SEC rules prior to completion of our initial public offering. Our board has determined that each of Messrs. Anxin Wang, Zhijie Wang and Chao Liu are independent directors under applicable SEC and NASDAQ rules.

Item 14. Principal Accountant Fees and Services.

The following is a summary of fees paid or to be paid to Marcum LLP (“Marcum”) and Friedman LLP (“Friedman”, prior to the acquisition of certain assets of Friedman by Marcum effective September 1, 2022) for services rendered.

Audit Fees. Audit fees consist of fees billed for professional services rendered for the audit of our year-end financial statements and services that are normally provided by Marcum and Friedman in connection with regulatory filings. The aggregate fees billed by Marcum and Friedman for professional services rendered for the audits of our annual financial statements, reviews of the financial information included in our Forms 10-Q for the respective periods and other required filings with the SEC for the year ended December 31, 2022 and December 31, 2021 totaled $68,000 and $58,000, respectively. The above amounts include interim procedures and audit fees, as well as attendance at audit committee meetings.

Audit-Related Fees. Audit-related services consist of fees billed for assurance and related services that are reasonably related to performance of the audit or review of our financial statements and are not reported under “Audit Fees.” These services include attest services that are not required by statute or regulation and consultations concerning financial accounting and reporting standards. We did not pay Marcum and Friedman for consultations concerning financial accounting and reporting standards for the year ended December 31, 2022 and 2021.

61

Tax Fees. We did not pay Marcum and Friedman for tax planning and tax advice for the year ended December 31, 2022 and 2021.

All Other Fees. We did not pay Marcum and Friedman for other services for the year ended December 31, 2022 and 2021.

Pre-Approval Policy

Our audit committee was formed upon the consummation of our Initial Public Offering. Since the formation of our audit committee, and on a going-forward basis, the audit committee has and will pre-approve all auditing services and permitted non-audit services to be performed for us by our auditors, including the fees and terms thereof (subject to the de minimis exceptions for non-audit services described in the Exchange Act which are approved by the audit committee prior to the completion of the audit). 

62

PART IV

Item 15. Exhibits, Financial Statement Schedules

(a)

The following documents are filed as part of this Form 10-K:

(1)

Financial Statements:

Page

Report of Independent Registered Public Accounting Firm – Marcum LLP (PCAOB ID 688)

F-2

Report of Independent Registered Public Accounting Firm – Friedman LLP (PCAOB ID 711)

F-3

Balance Sheets

F-4

Statements of Incomes

F-5

Statements of Changes in Shareholders’ Deficit

F-6

Statements of Cash Flows

F-7

Notes to Financial Statements

F-8

(2)

Financial Statement Schedules:

None.

63

(3)Exhibits

We hereby file as part of this Report the exhibits listed in the attached Exhibit Index. Exhibits which are incorporated herein by reference can be inspected and copied at the public reference facilities maintained by the SEC, 100 F Street, N.E., Room 1580, Washington, D.C. 20549. Copies of such material can also be obtained from the Public Reference Section of the SEC, 100 F Street, N.E., Washington, D.C. 20549, at prescribed rates or on the SEC website at www.sec.gov.

Exhibit No.

Description

4.2

Description of Registrant’s Securities *

10.1

Promissory note dated October 31, 2022.*

10.2

Promissory note dated December 31, 2022.*

21

List of subsidiaries.*

31.1

Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*

31.2

Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*

32.1

Certification of Principal Executive and Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

101.INS *

XBRL Instance Document

101.SCH *

XBRL Schema Document

101.CAL *

XBRL Calculation Linkbase Document

101.DEF *

XBRL Definition Linkbase Document

101.LAB *

XBRL Label Linkbase Document

101.PRE *

XBRL Presentation Linkbase Document

*

Filed herewith.

**

Furnished herewith.

ITEM 16. Form 10-K Summary

None.

64

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized as of May 25, 2023.

    

GREENCITY ACQUISITION CORPORATION

By:

/s/ Jinlong Liu

Jinlong Liu

Chief Executive Officer

(Principal Executive Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature

    

Capacity

    

Date

/s/ Jinlong Liu

Chairman of the Board, Chief Executive Officer

May 25, 2023

Jinlong Liu

And Principal Executive Officer

/s/ Panyan Yu

Chief Financial Officer

May 25, 2023

Panyan Yu

And Principal Accounting Officer

/s/ Anxin Wang

Anxin Wang

Director

May 25, 2023

/s/ Zhijie Wang

Zhijie Wang

Director

May 25, 2023

/s/ Chao Liu

Chao Liu

Director

May 25, 2023

65

GREENCITY ACQUISITION CORPORATION

INDEX TO FINANCIAL STATEMENTS

Report of Independent Registered Public Accounting FirmMarcum LLP (PCAOB ID 688)

F-2

Report of Independent Registered Public Accounting FirmFriedman LLP (PCAOB ID:711)

F-3

Financial Statements:

Balance Sheets

F-4

Statements of Income

F-5

Statements of Changes in Shareholders’ Deficit

F-6

Statements of Cash Flows

F-7

Notes to Financial Statements

F-8 to F-23

F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and Board of Directors of

Greencity Acquisition Corporation

Opinion on the Financial Statements

We have audited the accompanying balance sheet of Greencity Acquisition Corporation (the “Company”) as of December 31, 2022, the related statements of income, changes in shareholders’ deficit and cash flows for the year then ended and the related notes (collectively referred to as the “financial statements”).  In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.

Explanatory Paragraph – Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described in Note 1 to the financial statements, the Company is a Special Purpose Acquisition Corporation that was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. The Company must complete a business combination on or before June 28, 2023 or else it will be required to effectuate a mandatory plan of liquidation and dissolution. The Company’s has not identified a viable business combination target as of the issuance date of these financial or received the necessary approvals or funding that would be needed to extend the business combination deadline and a continued search for a viable business combination target. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans with regard to these matters are also described in Note 1. The financial statements do not include any adjustments that may be necessary should the Company be unable to continue as a going concern.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

/s/ Marcum LLP

Marcum LLP

We have served as the Company’s auditor since 2021 (such date takes into account the acquisition of certain assets of Friedman LLP by Marcum LLP effective September 1, 2022).

Costa Mesa, CA
May 25, 2023

F-2

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Shareholders of

Greencity Acquisition Corporation

Opinion on the Financial Statements

We have audited the accompanying balance sheet of Greencity Acquisition Corporation (the “Company”) as of December 31, 2021 and the related statements of income, changes in shareholders’ deficit and cash flows for the year ended December 31, 2021, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021, and the results of its operations and its cash flows for the year ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.

Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company’s business plan is dependent on the completion of a business combination and the Company’s cash and working capital as of December 31, 2021 are not sufficient to complete its planned activities for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

/s/Friedman LLP

Friedman LLP

We served as the Company’s auditor from 2021 through 2022.

New York, NY

March 31, 2022

F-3

GREENCITY ACQUISITION CORPORATION

BALANCE SHEETS

    

December 31, 

2022

    

2021

ASSETS

Current assets:

Cash

$

6,918

$

61,773

Prepaid expenses and other current assets

 

5,100

 

5,100

Total Current Assets

12,018

66,873

Marketable securities held in Trust Account

6,658,707

41,419,557

TOTAL ASSETS

$

6,670,725

$

41,486,430

LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS’ DEFICIT

 

  

 

  

Current liabilities:

Accrued expenses

$

170,798

$

43,472

Amount due to related party

290,000

170,000

Extension loan payable — related party

2,016,863

800,004

Promissory note payable — related party

745,504

393,808

Total Current Liabilities

3,223,165

1,407,284

Deferred underwriting compensation

 

1,000,000

 

1,000,000

Warrant liabilities

63,134

950,000

TOTAL LIABILITIES

 

4,286,299

 

3,357,284

 

  

 

  

Commitments and contingencies

 

  

 

  

Ordinary shares, subject to possible redemption: 610,752 and 4,000,000 shares as of December 31, 2022 and 2021 (at redemption value of $10.90 and $10.35 per share)

6,658,707

41,400,004

 

  

 

  

Shareholders’ Deficit:

 

  

 

  

Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding

 

 

Ordinary shares, $0.0001 par value; 100,000,000 shares authorized; 1,260,000 shares issued and outstanding as at December 31, 2022 and 2021

 

126

 

126

Accumulated deficit

 

(4,274,407)

 

(3,270,984)

Total Shareholders’ Deficit

 

(4,274,281)

 

(3,270,858)

TOTAL LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS’ DEFICIT

$

6,670,725

$

41,486,430

The accompanying notes are an integral part of the financial statements.

F-4

GREENCITY ACQUISITION CORPORATION

STATEMENTS OF INCOME

Years Ended December 31,

    

2022

    

2021

General and administrative expense

$

(653,877)

$

(638,533)

Total operating expenses

(653,877)

(638,533)

Other income (expense):

Change in fair value of warrant liabilities

886,866

1,980,000

Interest income earned from marketable securities held in Trust Account

378,536

4,341

Total other income, net

1,265,402

1,984,341

Income before income taxes

611,525

1,345,808

Income taxes

NET INCOME

$

611,525

$

1,345,808

Basic and diluted weighted average shares outstanding, ordinary shares subject to possible redemption

3,392,094

4,000,000

 

 

Basic and diluted net income per ordinary share, subject to possible redemption

$

0.26

$

0.30

Basic and diluted weighted average ordinary shares outstanding, ordinary shares attributable to Greencity Acquisition Corporation

1,260,000

 

1,260,000

 

 

Basic and diluted net income (loss) per ordinary share, ordinary shares attributable to Greencity Acquisition Corporation

$

(0.22)

$

0.10

The accompanying notes are an integral part of the financial statements.

F-5

GREENCITY ACQUISITION CORPORATION

STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

Year ended December 31, 2022

Total

Ordinary shares

Accumulated

shareholders’

    

No. of shares

    

Amount

    

deficit

    

deficit

Balance as of January 1, 2022

1,260,000

$

126

$

(3,270,984)

$

(3,270,858)

Accretion of carry value to redemption value

(1,614,948)

(1,614,948)

Net income for the year

611,525

611,525

Balance as of December 31, 2022

 

1,260,000

$

126

$

(4,274,407)

$

(4,274,281)

Year ended December 31, 2021

Total

Ordinary shares

Accumulated

shareholders’

    

No. of shares

    

Amount

    

deficit

    

deficit

Balance as of January 1, 2021

1,260,000

$

126

$

(3,816,788)

$

(3,816,662)

 

 

 

Accretion of carry value to redemption value

(800,004)

(800,004)

Net income for the year

 

 

1,345,808

 

1,345,808

Balance as of December 31, 2021

 

1,260,000

$

126

$

(3,270,984)

$

(3,270,858)

The accompanying notes are an integral part of the financial statements.

F-6

GREENCITY ACQUISITION CORPORATION

STATEMENTS OF CASH FLOWS

Years ended December 31,

    

2022

    

2021

Cash flows from operating activities

    

  

Net income

$

611,525

$

1,345,808

Adjustments to reconcile net income to net cash used in operating activities

 

 

Interest income earned from marketable securities held in Trust Account

(378,536)

(4,341)

Change in fair value of warrant liabilities

(886,866)

(1,980,000)

Change in operating assets and liabilities:

Prepaid expenses and other current assets

 

 

120,320

Accrued liabilities

127,326

16,823

Advances from a related party

120,000

120,000

Net cash used in operating activities

 

(406,551)

 

(381,390)

Cash flows from investing activities

Cash withdrawn from trust account to pay redeeming shareholders

36,356,245

Net cash provided by investing activities

36,356,245

 

  

 

  

Cash flows from financing activities

 

  

 

  

Payment of offering costs

 

 

(30,000)

Repayment of promissory note payable – related party

 

 

(782)

Proceeds from promissory note payable – related party

 

351,696

 

Redemption of ordinary share

(36,356,245)

Net cash used in financing activities

 

(36,004,549)

 

(30,782)

 

  

 

  

NET CHANGE IN CASH

 

(54,855)

 

(412,172)

Cash, beginning of year

 

61,773

 

473,945

Cash, end of year

$

6,918

$

61,773

 

 

SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:

 

 

Accretion of carrying value to redemption value of redeemable ordinary shares

$

1,614,948

$

800,004

Proceeds of extension loan payable — related party deposited in Trust Account by a founder shareholder

$

1,216,859

$

800,004

The accompanying notes are an integral part of the financial statements.

F-7

Table of Contents

GREENCITY ACQUISITION CORPORATION

NOTES TO FINANCIAL STATEMENTS

NOTE 1 - ORGANIZATION AND BUSINESS BACKGROUND

Greencity Acquisition Corporation (the “Company”) is a blank check company incorporated in the Cayman Islands on May 14, 2018. The Company was formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses that have a connection to the Asia market.

The Company’s entire activity from inception up to July 23, 2020 was in preparation for the initial public offering. Since the initial public offering, the Company’s activity has been limited to the evaluation of business combination candidates. The Company has selected December 31 as its fiscal year end and tax year end.

Financing

The registration statement for the Company’s initial public offering (the “Public Offering”as described in Note 3) was declared effective by the SEC on July 23, 2020. The Company consummated the Public Offering on July 28, 2020, the Company consummated the Initial Public Offering of 4,000,000 units at $10.00 per unit (the “Public Units”) and sold to the Sponsor to purchase 260,000 units at $10 per unit, generating gross proceeds of $42,600,000.

The Company incurred $2,646,665 in initial public offering related costs, including $1,000,000 of underwriting fees, $1,000,000 of deferred underwriting fees and $646,665 of other offering costs.

Trust Account

Following the closing of the Initial Public Offering on July 28, 2020, an amount of $40,600,000 from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Units was placed in a trust account (the “Trust Account”) invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a 7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, upon the Company’s failure to consummate a Business Combination within 39 months from the closing of the Public Offering. Placing funds in the Trust Account may not protect those funds from third party claims against the Company. Although the Company will seek to have all vendors, service providers, prospective target businesses or other entities it engages, execute agreements with the Company waiving any claim of any kind in or to any monies held in the Trust Account, there is no guarantee that such persons will execute such agreements. The remaining net proceeds (not held in the Trust Account) may be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative expenses. Additionally, the interest earned on the Trust Account balance may be released to the Company to pay the Company’s tax obligations.

The Company timeframe to complete the initial business combination expired on April 28, 2022. On April 20, 2022, the Company held an Annual General Meeting of Shareholders. Among other things, shareholders approved the proposal to extend the time to complete the Company’s initial business company by six monthly extensions to October 28, 2022. In connection with the vote to approve the Extension Amendment, the holders of 78,050 shares of the Company’s ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.46 per share, for an aggregate redemption amount of $816,101.13. As a result, an amount of $41,008,428.63 remained in the trust account.

On October 28, 2022, the Company held an Extraordinary General Meeting of Shareholders. Shareholders approved the proposal to extend the time to complete our initial business company by six monthly extension to April 28, 2023. In connection with the vote to approve the Extension Amendment, the holders of 3,311,198 shares of the Company’s ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.73 per share, for an aggregate redemption amount of $35,540,143.87. As a result, an amount of $6,555,395.97 remained in the trust account.

F-8

Table of Contents

GREENCITY ACQUISITION CORPORATION

NOTES TO FINANCIAL STATEMENTS

On April 25, 2023, the Company held an Extraordinary General Meeting of Shareholders. Shareholders approved the proposal to extend the time to complete our initial business company by six monthly extension to October 28, 2023. In connection with the vote to approve the Extension Amendment, the holders of 405,705 shares of the Company’s ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $11.18 per share, for an aggregate redemption amount of $4,535,353.71. As a result, an amount of $2,292,209.07 remained in the trust account.

Business Combination

Subject to the requirements that funds held in trust pending liquidation or completion of a Business Combination the Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and sale of the Private Units following completion of a Business Combination, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Additionally, NASDAQ rules which are applicable to the company as its securities are listed on NASDAQ, provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (less any deferred underwriting commissions and taxes payable on interest earned) at the time of the signing of an agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target or assets sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.

The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek shareholder approval of a Business Combination at a meeting called for such purpose at which shareholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination.

If the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to 15% or more of the Public Shares without the Company’s prior written consent.

If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.

The shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.15 per Public Share, subject to increase of up to an additional $0.30 per Public Share in the event that the Sponsor elects to extend the period of time to consummate a Business Combination (see below), plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter (as discussed in Note 6). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.

F-9

Table of Contents

GREENCITY ACQUISITION CORPORATION

NOTES TO FINANCIAL STATEMENTS

The Sponsor and any of the Company’s officers or directors that may hold founder shares (the “initial shareholders”) will agree (a) to vote their founder shares, the ordinary shares included in the Private Units (the “Private Shares”) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association with respect to the Company’s pre-Business Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the founder shares) and Private Shares into the right to receive cash from the Trust Account in connection with a shareholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek shareholder approval in connection therewith) or a vote to amend the provisions of the Amended and Restated Memorandum and Articles of Association relating to shareholders’ rights of pre-Business Combination activity and (d) that the founder shares and Private Shares shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the initial shareholders will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination.

If the Company does not complete a business combination within 12 months from the consummation of the Public Offering, the Company will trigger an automatic winding up, dissolution and liquidation pursuant to the terms of the amended and restated memorandum and articles of association. As a result, this has the same effect as if the Company had formally gone through a voluntary liquidation procedure under the Companies Law. If the Company does not complete a business combination within 12 months from the consummation of the Public Offering, the Company will trigger an automatic winding up, dissolution and liquidation pursuant to the terms of the amended and restated memorandum and articles of association. As a result, this has the same effect as if the Company had formally gone through a voluntary liquidation procedure under the Companies Law. Accordingly, no vote would be required from our shareholders to commence such a voluntary winding up, dissolution and liquidation. However, if the Company anticipate that the Company may not be able to consummate its initial business combination within 12 months, the Company may, but are not obligated to, extend the period of time to consummate a business combination nine times, each by an additional month (the “Combination Period”). The Company has amended and restated memorandum and articles of association to extend the Combination Period from April 28, 2022 to October 28, 2023 (for a total of 39 months to complete a Business Combination). As of the date of this report, the Company has extended twenty-three times the period of time to consummate a Business Combination until June 28, 2023.

On each of July 27, 2021, August 27, 2021, September 27, 2021, October 27, 2021, November 27, 2021, December 27, 2021, January 27, 2022, February 27, 2022 and March 27, 2022, the Company obtained loan extension in an amount of $133,334 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until April 28, 2022. On each of April 27, 2022, May 27, 2022, June 27, 2022, July 27, 2022, August 27, 2022 and September 27, 2022, the Company obtained loan extension in an amount of $129,425 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until October 28, 2022. On each of October 27, 2022 and November 27, 2022, the Company obtained loan extension in an amount of $20,155 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until December 28, 2022. On each of January 4, 2023, January 31, 2023, February 28, 2023 and March 31, 2023, the Company obtained loan extension in an amount of $20,155 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until April 28, 2023. On each of April 30, 2023 and May 18, 2023, the Company obtained loan extension in an amount of $6,767 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until June 28, 2023. As of December 31, 2022, the Sponsor has deposited an additional $2,016,863 of funds to extend the time frame.

F-10

Table of Contents

GREENCITY ACQUISITION CORPORATION

NOTES TO FINANCIAL STATEMENTS

If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable and less interest to pay dissolution expenses up to $50,000), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).

The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor (other than the Company’s independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below (i) $10.15 per share or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Risks and Uncertainties

Results of operations and the Company’s ability to complete the initial Business Combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond its control. The business could be impacted by, among other things, downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence and spending, the ongoing effects of the COVID-19 pandemic, including resurgences and the emergence of new variants, and geopolitical instability, such as the military conflict in the Ukraine. The Company cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact our business and our ability to complete an initial business combination.

Liquidity and Going Concern

As of December 31, 2022, the Company had $6,918 in its operating bank accounts and working capital deficit of $3,211,147.

Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination.

To complete a Business Combination, the Company will need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.

F-11

Table of Contents

GREENCITY ACQUISITION CORPORATION

NOTES TO FINANCIAL STATEMENTS

In connection with the Company’s assessment of going concern in accordance with the authoritative guidance in ASU 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has concluded that the Company has incurred significant operating losses and determined that the mandatory liquidation and subsequent dissolution, should the Company be unable to raise additional funds to meet its obligations and complete a Business Combination, raises substantial doubt about the Company’s ability to continue as a going concern. The Company has until June 28, 2023 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date without an extension to the acquisition period, there will be a mandatory liquidation and subsequent dissolution. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after June 28, 2023.

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation

The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the SEC.

Emerging growth company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Significant item subject to such estimates and assumptions includes the valuation of private warrants.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

F-12

Table of Contents

GREENCITY ACQUISITION CORPORATION

NOTES TO FINANCIAL STATEMENTS

Cash and Cash Equivalents

The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2022 and 2021.

Warrants

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC Topic 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations.

The Company accounts for the 4,260,000 Warrants issued with the Initial Public Offering as liabilities in accordance with ASC 480 and ASC 815-40.

Marketable Securities Held in Trust Account

As of December 31, 2022, $6,658,707 of the assets held in the Trust Account were held in money market funds, and consisted of U.S. Treasury securities carried at fair value.

Gains and losses resulting from the change in fair value of investments held in Trust Account are accounted as interest income in the accompanying statement of income. Interest income for the years ended December 31, 2022 and 2021 amounted to $378,536 and $4,341, respectively.

Ordinary Shares Subject to Possible Redemption

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are subject to occurrence of uncertain future events and are considered to be outside of the Company’s control. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets.

F-13

Table of Contents

GREENCITY ACQUISITION CORPORATION

NOTES TO FINANCIAL STATEMENTS

Income Taxes

The Company complies with the accounting and reporting requirements of ASC Topic 740, Income Taxes (“ASC 740”), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits as of December 31, 2022 and 2021 and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.

Net Income (Loss) Per Ordinary Share

The Company complies with accounting and disclosure requirements of ASC 260, Earnings Per Share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable common stock and non-redeemable common stock and the undistributed income (loss) is calculated using the total net income less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable common stock. Any remeasurement of the accretion to redemption value of the common stock subject to possible redemption was considered to be dividends paid to the public shareholders. As of December 31, 2022, the Company has not considered the effect of the warrants sold in the Initial Public Offering to purchase an aggregate of 2,130,000 shares in the calculation of diluted net income (loss) per share, since the exercise of the warrants is contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic (income) loss per share for the period presented.

F-14

Table of Contents

GREENCITY ACQUISITION CORPORATION

NOTES TO FINANCIAL STATEMENTS

The net income (loss) per share presented in the statement of income is based on the following:

    

For the

Years Ended

December 31,

    

2022

    

2021

Net income

$

611,525

$

1,345,808

Accretion of carrying value to redemption value

 

(1,614,948)

 

(800,004)

Undistributed income (loss)

$

(1,003,423)

$

545,804

For the years ended December 31,

2022

2021

Redeemable

Redeemable

Ordinary

Non-Redeemable

Ordinary

Non-Redeemable

    

Share

    

Ordinary Share

    

Share

    

Ordinary Share

Basic and diluted net income (loss) per share:

Numerators:

 

  

 

  

 

  

 

  

Allocation of undistributed income (loss)

$

(731,650)

$

(271,773)

$

415,060

$

130,744

Accretion of carrying value to redemption value of redeemable shares

 

1,614,948

 

 

800,004

 

Allocation of net income (loss)

$

883,298

$

(271,773)

$

1,215,064

$

130,744

Denominators:

 

 

 

 

Weighted-average shares outstanding

 

3,392,094

 

1,260,000

 

4,000,000

 

1,260,000

Basic and diluted net income (loss) per share

$

0.26

$

(0.22)

$

0.30

$

0.10

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Fair Value of Financial Instruments

ASC Topic 820 “Fair Value Measurements and Disclosures” (“ASC 820”) defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with the market approach, income approach and cost approach shall be used to measure fair value. ASC 820 establishes a fair value hierarchy for inputs, which represent the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances.

The fair value hierarchy is categorized into three levels based on the inputs as follows:

Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.

Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means.

Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

F-15

Table of Contents

GREENCITY ACQUISITION CORPORATION

NOTES TO FINANCIAL STATEMENTS

The fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC 820 approximates the carrying amounts represented in the balance sheet. The fair values of cash, and other current assets, accrued expenses, due to sponsor are estimated to approximate the carrying values as of December 31, 2022 and 2021, due to the short maturities of such instruments.

Convertible notes

The Company evaluates all convertible notes, to determine if such notes are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

Reclassification of Prior Year Presentation

Certain reclassifications have been made between accrued expenses and amount due to a related party, to conform to the current year presentation. The reclassifications did not impact previously reported total current liabilities, total liabilities, the net cash used in operating activities or net cash provided by financing activities.

Recently Issued Accounting Standards

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. The amendments are effective for smaller reporting companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying financial statements.

NOTE 3 - INITIAL PUBLIC OFFERING

Pursuant to the Initial Public Offering on July 28, 2020, the Company sold 4,000,000 Units at a purchase price of $10.00 per Unit. Each Unit consists of one ordinary share and one redeemable warrant (“Public Warrant”). Each Public Warrant will entitle the holder to purchase one-half of one ordinary share at an exercise price of $11.50 per whole share (see Note 8).

NOTE 4 - PRIVATE PLACEMENT

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 260,000 Private Units at a price of $10.00 per Private Unit, for an aggregate purchase price of $2,600,000. The proceeds from the Private Units were added to the net proceeds from the Initial Public Offering held in the Trust Account. The Private Units are identical to the Units sold in the Initial Public Offering, except for the private warrants (“Private Warrants”), as described in Note 8. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Units and underlying securities will be worthless.

F-16

Table of Contents

GREENCITY ACQUISITION CORPORATION

NOTES TO FINANCIAL STATEMENTS

NOTE 5 - RELATED PARTY TRANSACTIONS

Founder Shares

In December 2018, the Company received $25,000 for the anticipated issuance of 1,150,000 founder shares to the Sponsor. As of December 31, 2018, one founder share was issued to the Sponsor. The remaining 1,149,999 founder shares were issued to the Sponsor on February 21, 2019.

The 1,150,000 founder shares included an aggregate of up to 150,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the Sponsor will collectively own 20% of the Company’s issued and outstanding shares after the Initial Public Offering. On September 10, 2020, the underwriter did not exercise their over-allotment option election, resulting in the forfeiture of 150,000 founder shares. Accordingly, there were 1,000,000 Founder Shares issued and outstanding.

The initial shareholders have agreed not to transfer, assign or sell any of the founder shares (except to certain permitted transferees) until, with respect to 50% of the founder shares, the earlier of (i) six months after the date of the consummation of a Business Combination, or (ii) the date on which the closing price of the Company’s ordinary shares equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after a Business Combination, with respect to the remaining 50% of the founder shares, upon six months after the date of the consummation of a Business Combination, or earlier, in each case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property.

Private placement

Pursuant to the Initial Public Offering on July 28, 2020, the Sponsor purchased an aggregate of 260,000 Private Units at a price of $10.00 per Private Unit, for an aggregate purchase price of $2,600,000. Each Unit consists of one ordinary share and one Private Warrant. Each Private Warrant will entitle the holder to purchase one-half of one ordinary share at an exercise price of $11.50 per whole share.

Administrative Services Arrangement

The Company entered into an agreement whereby, commencing on July 24, 2020, through the earlier of the Company’s consummation of a Business Combination and its liquidation, the Company will pay the Sponsor a total of $10,000 per month for certain general and administrative services, including office space, utilities and administrative services, as the Company may require from time to time. For the year ended December 31, 2022 and 2021, the Company incurred $120,000 and $120,000 in fees for these services, respectively. These amounts were unpaid during the years. As of December 31, 2022 and 2021, the balances due to related parties were $290,000 and $170,000, respectively.

Promissory Note Payable — Related Party

On February 21, 2019, the Company issued a non-interest bearing, unsecured promissory note to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. On June 30, 2019, the Company amended the promissory note such that the Company may borrow up to an aggregate total principal amount of $500,000 (the “Promissory Note”) and on June 20, 2020, the Company further amended the Promissory Note such that the Promissory Note is payable on the earlier of (i) December 31, 2020 or (ii) the consummation of the Initial Public Offering. In connection with the Promissory Note, the Company converted $24,995 in advances as of December 31, 2018 into amounts outstanding under the Promissory Note. On July 28, 2020, the Company amended the Promissory Note such that it is payable upon the consummation of a Business Combination. On October 31, 2022, the Company further amended the promissory note such that the Company may borrow up to an aggregate total principal amount of $800,000. At December 31, 2022 and 2021, there was $745,504 and $393,808, respectively, outstanding under the Promissory Note. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Promissory Note but no proceeds held in the Trust Account would be used to repay the Promissory Note.

F-17

Table of Contents

GREENCITY ACQUISITION CORPORATION

NOTES TO FINANCIAL STATEMENTS

Working Capital Loans

In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $2,500,000 of notes may be converted upon consummation of a Business Combination into additional Private Units at a price of $10.00 per Unit. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December 31, 2022 and 2021, there was no outstanding balance under the Working Capital Loans.

Extension Loans Payable — Related Party

As discussed in Note 1, the Company has extended twenty-three times the period of time to consummate a Business Combination until June 28, 2023. On each of July 27, 2021, August 27, 2021, September 27, 2021, October 27, 2021, November 27, 2021, December 27, 2021, January 27, 2022, February 27, 2022 and March 27, 2022, the Company obtained loan extension in an amount of $133,334 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until April 28, 2022. On each of April 27, 2022, May 27, 2022, June 27, 2022, July 27, 2022, August 27, 2022 and September 27, 2022, the Company obtained loan extension in an amount of $129,425 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until October 28, 2022. On each of October 27, 2022 and November 27, 2022, the Company obtained loan extension in an amount of $20,155 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until December 28, 2022. On each of January 4, 2023, January 31, 2023, February 28, 2023 and March 31, 2023, the Company obtained loan extension in an amount of $20,155 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until April 28, 2023. On each of April 30, 2023 and May 18, 2023, the Company obtained loan extension in an amount of $6,767 from the sponsor, total amounting to $2,111,017 pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until June 28, 2023. Any such payments would be made in the form of a loan. The notes would either be repaid upon consummation of a Business Combination, without interest. If the Company completes a Business Combination, the Company would repay such loaned amounts out of the proceeds of the Trust Account released to the Company. If the Company does not complete a Business Combination, the Company will not repay such loans. Furthermore, the letter agreement with the initial shareholders contains a provision pursuant to which the Sponsor has agreed to waive its right to be repaid for such loans in the event that the Company does not complete a Business Combination. The Sponsor and its affiliates or designees are not obligated to fund the Trust Account to extend the time for the Company to complete a Business Combination. As of December 31, 2022, the Company has extended seventeen times the period of time to consummate a Business Combination. The Company obtained loan extension from the Sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination. The Notes are non-interest bearing and is payable upon the closing of a business combination. As of December 31, 2022 and 2021, there were $2,016,863 and $800,004, respectively, outstanding under the note payable to related party in balance sheets.

F-18

Table of Contents

GREENCITY ACQUISITION CORPORATION

NOTES TO FINANCIAL STATEMENTS

NOTE 6 – COMMITMENTS AND CONTINGENCIES

Registration Rights

Pursuant to a registration rights agreement entered into on July 23, 2020, the holders of the founder shares, Private Units (and their underlying securities), the shares underlying the warrants underlying the unit purchase option issued to the underwriters and any Units that may be issued upon conversion of the Working Capital Loans (and underlying securities) are entitled to registration rights. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. Notwithstanding the foregoing, the underwriters may not exercise their demand and “piggyback” registration rights after five (5) and seven (7) years after the effective date of the registration statement and may not exercise their demand rights on more than one occasion. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The underwriters were paid a cash underwriting discount of two and one-half percent (2.5%) of the gross proceeds of the Initial Public Offering, or $1,000,000. The underwriters are entitled to a deferred fee of two and one-half percent (2.5%) of the gross proceeds of the Initial Public Offering, or $1,000,000. The deferred fee will be paid in cash upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement.

NOTE 7 - SHAREHOLDERS’ DEFICIT

Preference Shares — On February 21, 2019, the Company filed an Amended and Restated Memorandum and Articles of Incorporation, pursuant to which the Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors. At December 31, 2022 and 2021, there were no preference shares designated, issued or outstanding.

Ordinary Shares — On February 21, 2019, the Company filed an Amended and Restated Memorandum and Articles of Incorporation, pursuant to which the Company is authorized to issue 100,000,000 ordinary shares, with a par value of $0.0001 per share. Holders of the ordinary shares are entitled to one vote for each ordinary share.

As of December 31, 2022, there were 1,260,000 ordinary shares issued and outstanding, excluding 610,752 ordinary shares subject to possible redemption, respectively.

As of December 31, 2021, there were 1,260,000 ordinary shares issued and outstanding, excluding 4,000,000 ordinary shares subject to possible redemption, respectively.

F-19

Table of Contents

GREENCITY ACQUISITION CORPORATION

NOTES TO FINANCIAL STATEMENTS

Unit Purchase Option

On July 28, 2020, the Company sold the underwriter (and/or its designees), for $100, an option to purchase up to 240,000 Units exercisable at $11.00 per Unit (or an aggregate exercise price of $2,640,000) commencing on the later of the consummation of a Business Combination and January 28, 2021. The unit purchase option may be exercised for cash or on a cashless basis, at the holder’s option, and expires five years from the effective date of the registration statement related to the Initial Public Offering. The Units issuable upon exercise of the option are identical to those offered in the Initial Public Offering. The Company accounted for the unit purchase option as liability classification. The unit purchase option is valued based on the fair value of the Units. These amounts are below the exercise price of the unit purchase option therefore the probability of exercise is low resulting in a de minimus value for the unit purchase option. The option and such units purchased pursuant to the option, as well as the ordinary shares underlying such units, the warrants included in such units, and the shares underlying such warrants, have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(g)(1) of FINRA’s NASDAQ Conduct Rules. Additionally, the option may not be sold, transferred, assigned, pledged or hypothecated for a one-year period (including the foregoing 180-day period) following July 28, 2020 except to any underwriter and selected dealer participating in the Initial Public Offering and their bona fide officers or partners. The option grants to holders demand and “piggy-back” rights for periods of five and seven years, respectively, from July 28, 2020 with respect to the registration under the Securities Act of the securities directly and indirectly issuable upon exercise of the option. The Company will bear all fees and expenses attendant to registering the securities, other than underwriting commissions which will be paid for by the holders themselves. The exercise price and number of units issuable upon exercise of the option may be adjusted in certain circumstances including in the event of a stock dividend, or the Company’s recapitalization, reorganization, merger or consolidation. However, the option will not be adjusted for issuances of ordinary shares at a price below its exercise price.

NOTE 8 - WARRANTS

Warrants — Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) the consummation of a Business Combination or (b) 12 months from the effective date of the registration statement relating to the Initial Public Offering. No Public Warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to such ordinary shares. Notwithstanding the foregoing, if a registration statement covering the ordinary shares issuable upon the exercise of the Public Warrants is not effective within 60 days, the holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise the Public Warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act. If an exemption from registration is not available, holders will not be able to exercise their Public Warrants on a cashless basis. The Public Warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation.

Redemption of warrants when the price per share of ordinary shares equals or exceeds $16.50. Once the Public Warrants become exercisable, the Company may redeem the Public Warrants (except with respect to the Private Placement Warrants):

in whole and not in part,
at a price of $0.01 per warrant,
upon not less than 30 days’ prior written notice of redemption to each Public Warrant holder,
if, and only if, the reported last sale price of the ordinary shares equal or exceed $16.50 per share, (as adjusted for share splits, share capitalizations, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 trading day period ending on the third trading day prior to the notice of redemption to Public Warrant holders, and
if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.

F-20

Table of Contents

GREENCITY ACQUISITION CORPORATION

NOTES TO FINANCIAL STATEMENTS

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless.

In addition, if (x) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $16.50 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 165% of the higher of the Market Value and the Newly Issued Price.

The Private Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Warrants and the ordinary shares issuable upon the exercise of the Private Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions and the Private Warrants underlying the Private Units issued to the underwriter may not be exercised after five years from the effective date of the Initial Public Offering. Additionally, the Private Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

A summary of warrants as of December 31, 2022 and 2021 is as follows:

    

Number of

    

Weighted

shares

Average life

Public warrants issued from the Company’s initial Public Offering in July 2020

4,000,000

  

Private warrants issued from the Company’s private placement in July 2020

 

260,000

 

  

Balance of warrants outstanding as of December 31, 2022 and 2021

 

4,260,000

 

5 years

NOTE 9 - FAIR VALUE MEASUREMENTS

The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.

F-21

Table of Contents

GREENCITY ACQUISITION CORPORATION

NOTES TO FINANCIAL STATEMENTS

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 1 — Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2 — Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

Level 3 — Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

The following tables present information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2022 and 2021, and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

Significant Other

Significant Other

Quoted Prices In

Observable

Unobservable

December 31,

Active Markets

Inputs

Inputs

Description

    

2022

    

(Level 1)

    

(Level 2)

    

(Level 3)

Assets:

 

  

  

  

  

U.S. Treasury Securities held in Trust Account*

$

6,658,707

$

6,658,707

$

$

Liabilities:

 

  

 

  

 

  

 

  

Derivative warrant liabilities – Public warrants

$

54,400

$

54,400

$

$

Derivative warrant liabilities – Private warrants

 

8,734

 

 

 

8,734

Total fair value

$

63,134

$

54,400

$

$

8,734

    

Quoted Prices In

Significant Other

Significant Other

Active Markets

Observable Inputs

Unobservable Inputs

Description

    

December 31, 2021

    

(Level 1)

    

(Level 2)

    

(Level 3)

Assets:

 

U.S. Treasury Securities held in Trust Account*

$

41,419,557

$

41,419,557

$

$

Liabilities:

 

 

 

 

Derivative warrant liabilities – Public warrants

$

840,000

$

840,000

$

$

Derivative warrant liabilities – Private warrants

 

110,000

 

 

 

110,000

Total fair value

$

950,000

$

840,000

$

$

110,000

*

included in marketable securities held in Trust Account on the Company’s balance sheets.

The warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on our balance sheets. At December 31, 2022 and 2021, the fair value of Public Warrants was measured using quoted prices in an active market (Level 1) and the fair value of Private Warrants was measured using Black-Scholes model. There were no transfers between Levels 1, 2 or 3 during the years ended December 31, 2022 and 2021.

F-22

Table of Contents

GREENCITY ACQUISITION CORPORATION

NOTES TO FINANCIAL STATEMENTS

The key inputs into Black-Scholes model for the Private Warrants were as follows at their measurement dates:

    

December 31,

December 31, 

 

    

2022

    

2021

 

Input

 

  

  

Share price

$

10.76

$

10.35

Risk-free interest rate

 

3.98

%

 

1.20

%

Volatility

 

1.00

%

 

12

%

Exercise price

$

11.50

$

11.50

Warrant life

 

5 years

 

5 years

The following table presents the changes in the fair value of warrant liabilities for the year ended December 31, 2022:

Public

    

Private

    

Total

    

Warrants

    

Warrants

    

Warrants

Fair Value at January 1, 2022

$

840,000

$

110,000

$

950,000

Change in fair value of public and private warrants

 

(785,600)

 

(101,266)

 

(886,866)

Fair Value at December 31, 2022

$

54,400

$

8,734

$

63,134

The following table presents the changes in the fair value of warrant liabilities for the year ended December 31, 2021:

Public

Private

Total

    

Warrants

    

Warrants

    

Warrants

Fair Value at January 1, 2021

$

2,740,000

$

190,000

$

2,930,000

Change in fair value of public and private warrants

(1,900,000)

(80,000)

(1,980,000)

Fair Value at December 31, 2021

$

840,000

$

110,000

$

950,000

NOTE 11 - SUBSEQUENT EVENTS

In accordance with ASC 855, Subsequent Events, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before the consolidated financial statements are issued, the Company has evaluated all events or transactions that occurred after the balance sheet date, up through the date was the Company issued the financial statements.

On January 4, 2023, January 31, 2023, February 28, 2023 and March 31, 2023, the Company obtained extension loan in an amount of $20,155 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until April 28, 2023.

On April 30, 2023 and May 18, 2023, the Company obtained extension loan in an amount of $6,767 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until June 28, 2023.

On April 25, 2023 the Company amended and restated memorandum and articles of association to extend the date by which the Company has to consummate a business combination six (6) times for an additional one (1) month each time from April 28, 2023 to October 28, 2023 by amending the Amended and Restated Memorandum and Articles of Association by deleting the existing Section 48.7 thereof and replacing them with the new Section 48.7.

On April 25, 2023, 405,705 shares of common stock were presented for redemption in connection with the Extraordinary General Meeting.

F-23

EX-4.2 2 grcyu-20221231xex4d2.htm EX-4.2

EXHIBIT 4.2

Description of Securities

GREENCITY ACQUISITION CORPORATION

The following summary of the securities of Greencity Acquisition Corporation is qualified and based on the company’s Amended and Restated Memorandum and Articles of Association and the Warrant Agreement dated as of July 23, 2020 with continental Stock Transfer & Trust Company, both of which have been filed as exhibits to the is Form 10-K/A or have been incorporated by reference.

Pursuant to our amended and restated memorandum and articles of association which will be adopted upon the consummation of this offering, we will be authorized to issue 100,000,000 ordinary shares, $0.0001 par value each, and 1,000,000 undesignated preference shares, $0.0001 par value each.

The registration statement for our initial public offering was declared effective by the Securities and Exchange Commission on July 23, 2020. We completed our initial public offering on July 28, 2020. In our initial public offering, we sold units at an offering price of $10.00 and consisting of one ordinary share and one redeemable warrant. Each warrant entitles the holder thereof to purchase one-half of one ordinary share. We will not issue fractional shares in connection with the exercise of the warrants. As a result, a warrant holder must exercise warrants in multiples of two warrants, at a price of $11.50 per full share, subject to adjustment as described in our prospectus dated as of July 23, 2020 as filed with the Securities and Exchange Commission on July 24, 2020. Each warrant will become exercisable on the later of the completion of an initial business combination and 12 months from July 23, 2020, and will expire five years after the completion of an initial business combination, or earlier upon redemption.

Market Information

Our units, ordinary shares and warrants are listed for trading on the NASDAQ Capital Market, or NASDAQ, under the symbol “GRCYU”, “GRCY” and “GRCYW”, respectively.

Units

We have issued and outstanding an aggregate of 4,260,000 units. The trading symbol for the units is GRCYU. Units at an offering price of $10.00 and consisting of one ordinary share and one redeemable warrant to purchase one-half of one ordinary share. The holders of units have no voting rights.

Ordinary Shares

As of May 15, 2023, there are 1,465,047 ordinary shares issued and outstanding. Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders and vote together as a single class, except as required by law. Unless specified in the Companies Law, our amended and restated memorandum and articles of association or applicable stock exchange rules, the affirmative vote of a majority of our ordinary shares that are voted is required to approve any such matter voted on by our shareholders. Approval of certain actions will require a special resolution under Cayman Islands law and pursuant to our amended and restated memorandum and articles of association; such actions include amending our amended and restated memorandum and articles of association and approving a statutory merger or consolidation with another company. Directors are elected for a term of two years. There is no cumulative voting with respect to the election of directors, with the result that the holders of more than 50% of the founder shares voted for the election of directors can elect all of the directors. Our shareholders are entitled to receive ratable dividends when, as and if declared by the Board of Directors out of funds legally available therefor.

We will provide our public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of our initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account as of two business days prior to the consummation of our initial business combination, including interest (which interest shall be net of taxes payable) divided by the number of then issued and outstanding public shares, subject to the limitations described herein. The amount in the trust account is initially anticipated to be approximately $10.15 per public share (subject to increase of up to an additional $0.30 per public share in the event that our sponsor elects to extend the period of time to consummate a business combination.

Pursuant to our amended and restated memorandum and articles of association, if we are unable to complete our initial business combination within 39 months from the closing of this offering, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days


thereafter, subject to lawfully available funds therefor, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (which interest shall be net of taxes payable and less up to $50,000 of interest to pay dissolution expenses) divided by the number of then issued and outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our Board of Directors, liquidate and dissolve, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

Warrants

Each warrant entitles the registered holder to purchase one-half of one ordinary share at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing on the later of 12 months from the date of this prospectus or the completion of our initial business combination. Because the warrants may only be exercised for whole numbers of shares, only an even number of warrants may be exercised at any given time. Pursuant to the warrant agreement, a warrantholder may exercise its warrants only for a whole number of shares. This means that only an even number of warrants may be exercised at any given time by a warrantholder. The warrants will expire five years after the completion of our initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.

We will not be obligated to deliver any ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to our satisfying our obligations described below with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and we will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless.

Once the warrants become exercisable, we may call the warrants for redemption (excluding the private placement warrants but including any outstanding warrants issued upon exercise of the unit purchase option issued to the underwriters or their designees):

in whole and not in part;
at a price of $0.01 per warrant;
upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrant holder; and
if, and only if, the reported last sale price of the ordinary shares equal or exceed $16.50 per share (as adjusted for share splits, share capitalizations, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date we send to the notice of redemption to the warrant holders.

If we call the warrants for redemption as described above, our management will have the option to require any holder that wishes to exercise his, her or its warrant to do so on a “cashless basis.” In determining whether to require all holders to exercise their warrants on a “cashless basis,” our management will consider, among other factors, our cash position, the number of warrants that are outstanding and the dilutive effect on our shareholders of issuing the maximum number of ordinary shares issuable upon the exercise of our warrants. If our management takes advantage of this option, all holders of warrants would pay the exercise price by surrendering their warrants for that number of ordinary shares equal to the quotient obtained by dividing (x) the product of the number of ordinary shares underlying the warrants, multiplied by the excess of the “fair market value” (defined below) over the exercise price of the warrants by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.


EX-10.1 3 grcyu-20221231xex10d1.htm EX-10.1

EXHIBIT 10.1

THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

THIRD AMENDED AND RESTATED PROMISSORY NOTE

Principal Amount:  Up to $800,000

Effective as of October 31, 2022

Greencity Acquisition Corporation, a Cayman Islands exempted company and blank check company (the “Maker”), promises to pay to the order of Cynthia Management Corporation, a British Virgin Islands business company, or its registered assigns or successors in interest (the “Payee”), or order, the principal sum of up to Five Hundred Thousand Dollars ($800,000) in lawful money of the United States of America, on the terms and conditions described below.  All payments on this Note shall be made by check or wire transfer of immediately available funds or as otherwise determined by the Maker to such account as the Payee may from time to time designate by written notice in accordance with the provisions of this Note. This Note hereby amends and restates the second amended and restated promissory note, dated July 28, 2020, issued by the Maker to the Payee.

1.Principal. The entire unpaid principal balance of this Note shall be payable by the Maker on the date on which Maker consummates its initial business combination (the “Maturity Date”). The principal balance may be prepaid at any time. Under no circumstances shall any individual, including but not limited to any officer, director, employee or shareholder of the Maker, be obligated personally for any obligations or liabilities of the Maker hereunder.

2.Interest. No interest shall accrue on the unpaid principal balance of this Note.

3.Drawdown Requests. Maker and Payee agree that Maker may request up to Eight Hundred Thousand Dollars ($800,000) for costs reasonably related to the Maker’s formation and the Maker’s initial public offering (the “IPO”). The principal of this Note may be drawn down from time to time prior to the Maturity Date (each, a “Drawdown Request”). Each Drawdown Request must state the amount to be drawn down, and must not be an amount less than Ten Thousand Dollars ($10,000) unless agreed upon by Maker and Payee. Payee shall fund each Drawdown Request no later than five (5) business days after receipt of a Drawdown Request; provided, however, that the maximum amount of drawdowns collectively under this Note is Eight Hundred Thousand Dollars ($800,000). Once an amount is drawn down under this Note, it shall not be available for future Drawdown Requests even if prepaid. No fees, payments or other amounts shall be due to Payee in connection with, or as a result of, any Drawdown Request by Maker. It is acknowledged that the Company may have received amounts in respect of drawdowns under this Note prior to the date hereof, and it is agreed that all such sums were received as drawdowns of principal hereunder in anticipation of the execution of this Note.

4.Application of Payments. All payments shall be applied first to payment in full of any costs incurred in the collection of any sum due under this Note, including (without limitation) reasonable attorney’s fees, then to the payment in full of any late charges and finally to the reduction of the unpaid principal balance of this Note.

5.Events of Default. The following shall constitute an event of default (“Event of Default”):

(a)Failure to Make Required Payments. Failure by Maker to pay the principal amount due pursuant to this Note within five (5) business days of the date specified above.

(b)Voluntary Bankruptcy, Etc. The commencement by Maker of a voluntary case under any applicable bankruptcy, insolvency, reorganization, rehabilitation or other similar law, or the consent by it to the appointment of or taking possession by a receiver, liquidator, assignee, trustee, custodian, sequestrator (or other similar official) of Maker or for any substantial part of its property, or the making by it of any assignment for the


benefit of creditors, or the failure of Maker generally to pay its debts as such debts become due, or the taking of corporate action by Maker in furtherance of any of the foregoing.

(c)Involuntary Bankruptcy, Etc. The entry of a decree or order for relief by a court having jurisdiction in the premises in respect of Maker in an involuntary case under any applicable bankruptcy, insolvency or other similar law, or appointing a receiver, liquidator, assignee, custodian, trustee, sequestrator (or similar official) of Maker or for any substantial part of its property, or ordering the winding-up or liquidation of its affairs, and the continuance of any such decree or order unstayed and in effect for a period of 60 consecutive days.

6.Remedies.

(a)Upon the occurrence of an Event of Default specified in Section 5(a) hereof, Payee may, by written notice to Maker, declare this Note to be due immediately and payable, whereupon the unpaid principal amount of this Note, and all other amounts payable hereunder, shall become immediately due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby expressly waived, anything contained herein or in the documents evidencing the same to the contrary notwithstanding.

(b)Upon the occurrence of an Event of Default specified in Sections 5(b) or 5(c), the unpaid principal balance of this Note, and all other sums payable with regard to this Note, shall automatically and immediately become due and payable, in all cases without any action on the part of Payee.

7.Waivers. Maker and all endorsers and guarantors of, and sureties for, this Note waive presentment for payment, demand, notice of dishonor, protest, and notice of protest with regard to the Note, all errors, defects and imperfections in any proceedings instituted by Payee under the terms of this Note, and all benefits that might accrue to Maker by virtue of any present or future laws exempting any property, real or personal, or any part of the proceeds arising from any sale of any such property, from attachment, levy or sale under execution, or providing for any stay of execution, exemption from civil process, or extension of time for payment; and Maker agrees that any real estate that may be levied upon pursuant to a judgment obtained by virtue hereof or any writ of execution issued hereon, may be sold upon any such writ in whole or in part in any order desired by Payee.

8.Unconditional Liability. Maker hereby waives all notices in connection with the delivery, acceptance, performance, default, or enforcement of the payment of this Note, and agrees that its liability shall be unconditional, without regard to the liability of any other party, and shall not be affected in any manner by any indulgence, extension of time, renewal, waiver or modification granted or consented to by Payee, and consents to any and all extensions of time, renewals, waivers, or modifications that may be granted by Payee with respect to the payment or other provisions of this Note, and agrees that additional makers, endorsers, guarantors, or sureties may become parties hereto without notice to Maker or affecting Maker’s liability hereunder.

9.Notices. All notices, statements or other documents which are required or contemplated by this Note shall be made in writing and delivered: (i) personally or sent by first class registered or certified mail, overnight courier service or facsimile or electronic transmission to the address designated in writing, (ii) by facsimile to the number most recently provided to such party or such other address or fax number as may be designated in writing by such party or (iii) by electronic mail, to the electronic mail address most recently provided to such party or such other electronic mail address as may be designated in writing by such party. Any notice or other communication so transmitted shall be deemed to have been given on the day of delivery, if delivered personally, on the business day following receipt of written confirmation, if sent by facsimile or electronic transmission, one (1) business day after delivery to an overnight courier service or five (5) days after mailing if sent by mail.

10.Construction. THIS NOTE SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICT OF LAW PROVISIONS THEREOF.

11.Severability. Any provision contained in this Note which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.


12.Trust Waiver.  Notwithstanding anything herein to the contrary, the Payee hereby waives any and all right, title, interest or claim of any kind (“Claim”) in or to any distribution of or from the trust account to be established in which the proceeds of the IPO (including the deferred underwriters discounts and commissions) and the proceeds of the sale of the warrants to be issued in a private placement to occur prior to the closing of the IPO are to be deposited, as described in greater detail in the registration statement and prospectus to be filed with the Securities and Exchange Commission in connection with the IPO, and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim against the trust account for any reason whatsoever.

13.Amendment; Waiver.  Any amendment hereto or waiver of any provision hereof may be made with, and only with, the written consent of the Maker and the Payee.

14.Assignment. No assignment or transfer of this Note or any rights or obligations hereunder may be made by any party hereto (by operation of law or otherwise) without the prior written consent of the other party hereto and any attempted assignment without the required consent shall be void.

[Signature page follows]


IN WITNESS WHEREOF, Maker, intending to be legally bound hereby, has caused this Note to be duly executed as deed by the undersigned on the day and year first above written.

GREENCITY ACQUISITION CORPORATION

By:

/s/ Panyan Yu

Name: Panyan Yu

Title: Chief Finance Officer


EX-10.2 4 grcyu-20221231xex10d2.htm EX-10.2

EXHIBIT 10.2

THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

PROMISSORY NOTE

Principal Amount: $2,016,863

Effective as of December 31, 2022

Greencity Acquisition Corporation, a Cayman Islands exempted company and blank check company (the “Maker”), promises to pay to the order of Cynthia Management Corporation, a British Virgin Islands business company, or its registered assigns or successors in interest (the “Payee”), or order, the principal sum of $2,016,863 in lawful money of the United States of America, on the terms and conditions described below.  All payments on this Note shall be made by check or wire transfer of immediately available funds or as otherwise determined by the Maker to such account as the Payee may from time to time designate by written notice in accordance with the provisions of this Note.

1.Principal. The principle balance of this Promissory Note (this “Note”) shall be payable promptly after the date on which the Maker consummates an initial business combination (a “Business Combination”) with a target business. In the event that a Business Combination does not close prior to July 28, 2023, this Note shall be deemed to be terminated and no amounts will thereafter be due from Maker to Payee under the terms hereof. The principle balance may not be prepaid without the consent of the Payee.

2.Interest. No interest shall accrue on the unpaid principal balance of this Note.

3.Application of Payments. All payments shall be applied first to payment in full of any costs incurred in the collection of any sum due under this Note, including (without limitation) reasonable attorney’s fees, then to the payment in full of any late charges and finally to the reduction of the unpaid principal balance of this Note.

4.Events of Default. The following shall constitute an event of default (“Event of Default”):

(a)Failure to Make Required Payments. Failure by Maker to pay the principal amount due pursuant to this Note within five (5) business days of the date specified above.

(b)Voluntary Bankruptcy, Etc. The commencement by Maker of a voluntary case under any applicable bankruptcy, insolvency, reorganization, rehabilitation or other similar law, or the consent by it to the appointment of or taking possession by a receiver, liquidator, assignee, trustee, custodian, sequestrator (or other


similar official) of Maker or for any substantial part of its property, or the making by it of any assignment for the benefit of creditors, or the failure of Maker generally to pay its debts as such debts become due, or the taking of corporate action by Maker in furtherance of any of the foregoing.

(c)Involuntary Bankruptcy, Etc. The entry of a decree or order for relief by a court having jurisdiction in the premises in respect of Maker in an involuntary case under any applicable bankruptcy, insolvency or other similar law, or appointing a receiver, liquidator, assignee, custodian, trustee, sequestrator (or similar official) of Maker or for any substantial part of its property, or ordering the winding-up or liquidation of its affairs, and the continuance of any such decree or order unstayed and in effect for a period of 60 consecutive days.

5.Remedies.

(a)Upon the occurrence of an Event of Default specified in Section 5(a) hereof, Payee may, by written notice to Maker, declare this Note to be due immediately and payable, whereupon the unpaid principal amount of this Note, and all other amounts payable hereunder, shall become immediately due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby expressly waived, anything contained herein or in the documents evidencing the same to the contrary notwithstanding.

(b)Upon the occurrence of an Event of Default specified in Sections 5(b) or 5(c), the unpaid principal balance of this Note, and all other sums payable with regard to this Note, shall automatically and immediately become due and payable, in all cases without any action on the part of Payee.

6.Waivers. Maker and all endorsers and guarantors of, and sureties for, this Note waive presentment for payment, demand, notice of dishonor, protest, and notice of protest with regard to the Note, all errors, defects and imperfections in any proceedings instituted by Payee under the terms of this Note, and all benefits that might accrue to Maker by virtue of any present or future laws exempting any property, real or personal, or any part of the proceeds arising from any sale of any such property, from attachment, levy or sale under execution, or providing for any stay of execution, exemption from civil process, or extension of time for payment; and Maker agrees that any real estate that may be levied upon pursuant to a judgment obtained by virtue hereof or any writ of execution issued hereon, may be sold upon any such writ in whole or in part in any order desired by Payee.

7.Unconditional Liability. Maker hereby waives all notices in connection with the delivery, acceptance, performance, default, or enforcement of the payment of this Note, and agrees that its liability shall be unconditional, without regard to the liability of any other party, and shall not be affected in any manner by any indulgence, extension of time, renewal, waiver or modification granted or consented to by Payee, and consents to any and all extensions of time, renewals, waivers, or modifications that may be granted by Payee with respect to the payment or other provisions of this Note, and agrees that additional makers, endorsers, guarantors, or sureties may become parties hereto without notice to Maker or affecting Maker’s liability hereunder.

8.Notices. All notices, statements or other documents which are required or contemplated by this Note shall be made in writing and delivered: (i) personally or sent by first class registered or certified mail, overnight courier service or facsimile or electronic transmission to the address designated in writing, (ii) by facsimile to the number most recently provided to such party or such other address or fax number as may be designated in writing by such party or (iii) by electronic mail, to the electronic mail address most recently provided to such party or such other electronic mail address as may be designated in writing by such party. Any notice or other communication so transmitted shall be deemed to have been given on the day of delivery, if delivered personally, on the business day following receipt of written confirmation, if sent by facsimile or electronic transmission, one (1) business day after delivery to an overnight courier service or five (5) days after mailing if sent by mail.

9.Construction. THIS NOTE SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICT OF LAW PROVISIONS THEREOF.

10.Severability. Any provision contained in this Note which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating


the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

11.Trust Waiver.  Notwithstanding anything herein to the contrary, the Payee hereby waives any and all right, title, interest or claim of any kind (“Claim”) in or to any distribution of or from the trust account to be established in which the proceeds of the IPO (including the deferred underwriters discounts and commissions) and the proceeds of the sale of the warrants to be issued in a private placement to occur prior to the closing of the IPO are to be deposited, as described in greater detail in the registration statement and prospectus to be filed with the Securities and Exchange Commission in connection with the IPO, and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim against the trust account for any reason whatsoever.

12.Amendment; Waiver.  Any amendment hereto or waiver of any provision hereof may be made with, and only with, the written consent of the Maker and the Payee.

13.Assignment. No assignment or transfer of this Note or any rights or obligations hereunder may be made by any party hereto (by operation of law or otherwise) without the prior written consent of the other party hereto and any attempted assignment without the required consent shall be void.

[Signature page follows]


IN WITNESS WHEREOF, Maker, intending to be legally bound hereby, has caused this Note to be duly executed as deed by the undersigned on the day and year first above written.

GREENCITY ACQUISITION CORPORATION

By:

/s/ Panyuan Yu

Name: Panyan Yu

Title: Chief Finance Officer


EX-21 5 grcyu-20221231xex21.htm EX-21

EXHIBIT 21

LIST OF SUBSIDIAIRIES OF GREENCITY ACQUISITION CORPORATION

None


EX-31.1 6 grcyu-20221231xex31d1.htm EX-31.1

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jinlong Liu, certify that:

1.I have reviewed this annual report on Form 10-K for the year ended December 31, 2022 of Greencity Acquisition Corporation.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 25, 2023

/s/ Jinlong Liu

Jinlong Liu

Chief Executive Officer

(Principal Executive Officer)


EX-31.2 7 grcyu-20221231xex31d2.htm EX-31.2

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Panyan Yu, certify that:

1.I have reviewed this annual report on Form 10-K for the year ended December 31, 2022 of Greencity Acquisition Corp.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 25, 2023

/s/ Panyan Yu

Panyan Yu

Chief Financial Officer

(Principal Financial and Accounting Officer)


EX-32.1 8 grcyu-20221231xex32d1.htm EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Greencity Acquisition Corp. (the “Company”) for the fiscal year ended December 31, 2022, as filed with the Securities and Exchange Commission (the “Report”), each of the undersigned, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Dated: May 25, 2023

/s/ Jinlong Liu

Jinlong Liu

Chief Executive Officer

(Principal Executive Officer)

/s/ Panyan Yu

Panyan Yu

Chief Financial Officer

(Principal Financial and Accounting Officer)


EX-101.SCH 9 grcyu-20221231.xsd EX-101.SCH 99900 - Disclosure - Standard And Custom Axis Domain Defaults link:presentationLink link:calculationLink link:definitionLink 00100 - Statement - BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - STATEMENTS OF INCOME link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - STATEMENT OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Summary of net loss per share presented in the statement of operations (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - INITIAL PUBLIC OFFERING - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - PRIVATE PLACEMENT - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - RELATED PARTY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional information (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - SHAREHOLDERS DEFICIT (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - WARRANTS - Warrants activity (Details) link:presentationLink link:calculationLink link:definitionLink 40802 - Disclosure - WARRANTS - Additional information (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - FAIR VALUE MEASUREMENTS - Fair value on a recurring basis (Details) link:presentationLink link:calculationLink link:definitionLink 40902 - Disclosure - FAIR VALUE MEASUREMENTS - Initial measurement (Details) link:presentationLink link:calculationLink link:definitionLink 40903 - Disclosure - FAIR VALUE MEASUREMENTS - Changes in the fair value of the warrant liability (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - INITIAL PUBLIC OFFERING link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - PRIVATE PLACEMENT link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - SHAREHOLDERS DEFICIT link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - WARRANTS link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - WARRANTS (Tables) link:presentationLink link:calculationLink link:definitionLink 30903 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 40904 - Disclosure - FAIR VALUE MEASUREMENTS - Additional information (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 grcyu-20221231_cal.xml EX-101.CAL EX-101.DEF 11 grcyu-20221231_def.xml EX-101.DEF EX-101.LAB 12 grcyu-20221231_lab.xml EX-101.LAB EX-101.PRE 13 grcyu-20221231_pre.xml EX-101.PRE XML 14 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document and Entity Information - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
May 25, 2023
Document Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2022    
Entity File Number 001-39404    
Entity Tax Identification Number 00-0000000    
Entity Registrant Name GREENCITY ACQUISITION CORPORATION    
Entity Incorporation, State or Country Code E9    
Entity Current Reporting Status No    
Entity Interactive Data Current No    
Entity Central Index Key 0001768910    
Current Fiscal Year End Date --12-31    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Amendment Flag false    
Entity Well-known Seasoned Issuer No    
Entity Address, Address Line One 505 Eshan Road, Floor 6    
Entity Address, Address Line Two Pudong New District    
Entity Address, City or Town Shanghai    
Entity Address, Country CN    
Entity Address, Postal Zip Code 200120    
City Area Code +86    
Local Phone Number 21-20257919    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
Entity Shell Company true    
Entity Common Stock, Shares Outstanding     1,465,047
Entity Voluntary Filers No    
Entity Public Float $ 41,258,914    
Auditor Name Marcum LLP Friedman LLP  
Auditor Firm ID 688 711  
Auditor Location Costa Mesa, CA New York, NY  
Ordinary shares      
Document Information [Line Items]      
Trading Symbol GRCY    
Title of 12(b) Security Ordinary Shares, Par Value $0.0001 Per Share    
Security Exchange Name. NASDAQ    
Redeemable warrants, each warrant exercisable for one-half ordinary share      
Document Information [Line Items]      
Trading Symbol GRCYW    
Title of 12(b) Security Redeemable Warrants Entitling the Holder to Purchase One-half (1/2) of One Ordinary Share    
Security Exchange Name. NASDAQ    
Units, each consisting of one Ordinary Share and one Warrant      
Document Information [Line Items]      
Trading Symbol GRCYU    
Title of 12(b) Security Units, Each Consisting of One Ordinary Share and One Warrant    
Security Exchange Name. NASDAQ    
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.23.1
BALANCE SHEETS - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash $ 6,918 $ 61,773
Prepaid expenses and other current assets 5,100 5,100
Total Current Assets 12,018 66,873
Marketable securities held in Trust Account 6,658,707 41,419,557
TOTAL ASSETS 6,670,725 41,486,430
Current liabilities:    
Accrued expenses 170,798 43,472
Amount due to related party 290,000 170,000
Extension loan payable - related party 2,016,863 800,004
Promissory note payable - related party 745,504 393,808
Total Current Liabilities 3,223,165 1,407,284
Deferred underwriting compensation 1,000,000 1,000,000
Warrant liabilities 63,134 950,000
TOTAL LIABILITIES 4,286,299 3,357,284
Commitments and contingencies
Ordinary shares, subject to possible redemption: 610,752 and 4,000,000 shares as of December 31, 2022 and 2021 (at redemption value of $10.90 and $10.35 per share) 6,658,707 41,400,004
Shareholders' Deficit:    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Ordinary shares, $0.0001 par value; 100,000,000 shares authorized; 1,260,000 shares issued and outstanding as at December 31, 2022 and 2021 126 126
Accumulated deficit (4,274,407) (3,270,984)
Total Shareholders' Deficit (4,274,281) (3,270,858)
TOTAL LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS' DEFICIT $ 6,670,725 $ 41,486,430
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.23.1
BALANCE SHEETS (Parenthetical) - $ / shares
Dec. 31, 2022
Dec. 31, 2021
Preferred stock, par or stated value per share $ 0.0001 $ 0.0001
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par or stated value per share $ 0.0001 $ 0.0001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares, issued 1,260,000 1,260,000
Common stock, shares, outstanding 1,260,000 1,260,000
Ordinary shares subject to possible redemption, shares 610,752 4,000,000
Common stock subject to possible redemption    
Ordinary shares subject to possible redemption, shares 610,752 4,000,000
Redemption price per share $ 10.90 $ 10.35
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.1
STATEMENTS OF INCOME - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
General and administrative expense $ 653,877 $ 638,533
Total operating expenses (653,877) (638,533)
Other income (expense):    
Change in fair value of warrant liabilities 886,866 1,980,000
Interest income earned from marketable securities held in Trust Account 378,536 4,341
Total other income, net 1,265,402 1,984,341
Income before income taxes 611,525 1,345,808
NET INCOME $ 611,525 $ 1,345,808
Common stock subject to possible redemption    
Other income (expense):    
Basic weighted average shares outstanding, ordinary shares attributable to Greencity Acquisition Corporation 3,392,094 4,000,000
Diluted weighted average shares outstanding, ordinary shares attributable to Greencity Acquisition Corporation 3,392,094 4,000,000
Basic net income (loss) per share, ordinary shares attributable to Greencity Acquisition Corporation $ 0.26 $ 0.30
Diluted net income (loss) per share, ordinary shares attributable to Greencity Acquisition Corporation $ 0.26 $ 0.30
Common stock not subject to possible redemption    
Other income (expense):    
Basic weighted average shares outstanding, ordinary shares attributable to Greencity Acquisition Corporation 1,260,000 1,260,000
Diluted weighted average shares outstanding, ordinary shares attributable to Greencity Acquisition Corporation 1,260,000 1,260,000
Basic net income (loss) per share, ordinary shares attributable to Greencity Acquisition Corporation $ (0.22) $ 0.10
Diluted net income (loss) per share, ordinary shares attributable to Greencity Acquisition Corporation $ (0.22) $ 0.10
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.23.1
STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($)
Ordinary shares
Accumulated deficit
Total
Balance at Dec. 31, 2020 $ 126 $ (3,816,788) $ (3,816,662)
Balance (in shares) at Dec. 31, 2020 1,260,000    
Accretion of carrying value to redemption value   (800,004) (800,004)
Net income (loss)   1,345,808 1,345,808
Balance at Dec. 31, 2021 $ 126 (3,270,984) (3,270,858)
Balance (in shares) at Dec. 31, 2021 1,260,000    
Accretion of carrying value to redemption value   (1,614,948) (1,614,948)
Net income (loss)   611,525 611,525
Balance at Dec. 31, 2022 $ 126 $ (4,274,407) $ (4,274,281)
Balance (in shares) at Dec. 31, 2022 1,260,000    
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.23.1
STATEMENT OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities    
Net income (loss) $ 611,525 $ 1,345,808
Adjustments to reconcile net income to net cash used in operating activities    
Interest income earned from marketable securities held in Trust Account (378,536) (4,341)
Change in fair value of warrant liabilities (886,866) (1,980,000)
Change in operating assets and liabilities:    
Prepaid expenses and other current assets   120,320
Accrued liabilities 127,326 16,823
Advances from a related party 120,000 120,000
Net cash used in operating activities (406,551) (381,390)
Cash flows from investing activities    
Cash withdrawn from trust account to pay redeeming shareholders 36,356,245  
Net cash provided by investing activities 36,356,245  
Cash flows from financing activities    
Payment of offering costs   (30,000)
Repayment of promissory note payable - related party   (782)
Proceeds from promissory note payable - related party 351,696  
Redemption of ordinary share (36,356,245)  
Net cash used in financing activities (36,004,549) (30,782)
NET CHANGE IN CASH (54,855) (412,172)
Cash, beginning of year 61,773 473,945
Cash, end of year 6,918 61,773
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Accretion of carrying value to redemption value of redeemable ordinary shares 1,614,948 800,004
Proceeds of extension loan payable - related party deposited in Trust Account by a founder shareholder $ 1,216,859 $ 800,004
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.1
ORGANIZATION AND BUSINESS BACKGROUND
12 Months Ended
Dec. 31, 2022
ORGANIZATION AND BUSINESS BACKGROUND  
ORGANIZATION AND BUSINESS BACKGROUND

NOTE 1 - ORGANIZATION AND BUSINESS BACKGROUND

Greencity Acquisition Corporation (the “Company”) is a blank check company incorporated in the Cayman Islands on May 14, 2018. The Company was formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses that have a connection to the Asia market.

The Company’s entire activity from inception up to July 23, 2020 was in preparation for the initial public offering. Since the initial public offering, the Company’s activity has been limited to the evaluation of business combination candidates. The Company has selected December 31 as its fiscal year end and tax year end.

Financing

The registration statement for the Company’s initial public offering (the “Public Offering”as described in Note 3) was declared effective by the SEC on July 23, 2020. The Company consummated the Public Offering on July 28, 2020, the Company consummated the Initial Public Offering of 4,000,000 units at $10.00 per unit (the “Public Units”) and sold to the Sponsor to purchase 260,000 units at $10 per unit, generating gross proceeds of $42,600,000.

The Company incurred $2,646,665 in initial public offering related costs, including $1,000,000 of underwriting fees, $1,000,000 of deferred underwriting fees and $646,665 of other offering costs.

Trust Account

Following the closing of the Initial Public Offering on July 28, 2020, an amount of $40,600,000 from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Units was placed in a trust account (the “Trust Account”) invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a 7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, upon the Company’s failure to consummate a Business Combination within 39 months from the closing of the Public Offering. Placing funds in the Trust Account may not protect those funds from third party claims against the Company. Although the Company will seek to have all vendors, service providers, prospective target businesses or other entities it engages, execute agreements with the Company waiving any claim of any kind in or to any monies held in the Trust Account, there is no guarantee that such persons will execute such agreements. The remaining net proceeds (not held in the Trust Account) may be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative expenses. Additionally, the interest earned on the Trust Account balance may be released to the Company to pay the Company’s tax obligations.

The Company timeframe to complete the initial business combination expired on April 28, 2022. On April 20, 2022, the Company held an Annual General Meeting of Shareholders. Among other things, shareholders approved the proposal to extend the time to complete the Company’s initial business company by six monthly extensions to October 28, 2022. In connection with the vote to approve the Extension Amendment, the holders of 78,050 shares of the Company’s ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.46 per share, for an aggregate redemption amount of $816,101.13. As a result, an amount of $41,008,428.63 remained in the trust account.

On October 28, 2022, the Company held an Extraordinary General Meeting of Shareholders. Shareholders approved the proposal to extend the time to complete our initial business company by six monthly extension to April 28, 2023. In connection with the vote to approve the Extension Amendment, the holders of 3,311,198 shares of the Company’s ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.73 per share, for an aggregate redemption amount of $35,540,143.87. As a result, an amount of $6,555,395.97 remained in the trust account.

On April 25, 2023, the Company held an Extraordinary General Meeting of Shareholders. Shareholders approved the proposal to extend the time to complete our initial business company by six monthly extension to October 28, 2023. In connection with the vote to approve the Extension Amendment, the holders of 405,705 shares of the Company’s ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $11.18 per share, for an aggregate redemption amount of $4,535,353.71. As a result, an amount of $2,292,209.07 remained in the trust account.

Business Combination

Subject to the requirements that funds held in trust pending liquidation or completion of a Business Combination the Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and sale of the Private Units following completion of a Business Combination, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Additionally, NASDAQ rules which are applicable to the company as its securities are listed on NASDAQ, provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (less any deferred underwriting commissions and taxes payable on interest earned) at the time of the signing of an agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target or assets sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.

The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek shareholder approval of a Business Combination at a meeting called for such purpose at which shareholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination.

If the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to 15% or more of the Public Shares without the Company’s prior written consent.

If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.

The shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.15 per Public Share, subject to increase of up to an additional $0.30 per Public Share in the event that the Sponsor elects to extend the period of time to consummate a Business Combination (see below), plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter (as discussed in Note 6). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.

The Sponsor and any of the Company’s officers or directors that may hold founder shares (the “initial shareholders”) will agree (a) to vote their founder shares, the ordinary shares included in the Private Units (the “Private Shares”) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association with respect to the Company’s pre-Business Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the founder shares) and Private Shares into the right to receive cash from the Trust Account in connection with a shareholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek shareholder approval in connection therewith) or a vote to amend the provisions of the Amended and Restated Memorandum and Articles of Association relating to shareholders’ rights of pre-Business Combination activity and (d) that the founder shares and Private Shares shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the initial shareholders will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination.

If the Company does not complete a business combination within 12 months from the consummation of the Public Offering, the Company will trigger an automatic winding up, dissolution and liquidation pursuant to the terms of the amended and restated memorandum and articles of association. As a result, this has the same effect as if the Company had formally gone through a voluntary liquidation procedure under the Companies Law. If the Company does not complete a business combination within 12 months from the consummation of the Public Offering, the Company will trigger an automatic winding up, dissolution and liquidation pursuant to the terms of the amended and restated memorandum and articles of association. As a result, this has the same effect as if the Company had formally gone through a voluntary liquidation procedure under the Companies Law. Accordingly, no vote would be required from our shareholders to commence such a voluntary winding up, dissolution and liquidation. However, if the Company anticipate that the Company may not be able to consummate its initial business combination within 12 months, the Company may, but are not obligated to, extend the period of time to consummate a business combination nine times, each by an additional month (the “Combination Period”). The Company has amended and restated memorandum and articles of association to extend the Combination Period from April 28, 2022 to October 28, 2023 (for a total of 39 months to complete a Business Combination). As of the date of this report, the Company has extended twenty-three times the period of time to consummate a Business Combination until June 28, 2023.

On each of July 27, 2021, August 27, 2021, September 27, 2021, October 27, 2021, November 27, 2021, December 27, 2021, January 27, 2022, February 27, 2022 and March 27, 2022, the Company obtained loan extension in an amount of $133,334 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until April 28, 2022. On each of April 27, 2022, May 27, 2022, June 27, 2022, July 27, 2022, August 27, 2022 and September 27, 2022, the Company obtained loan extension in an amount of $129,425 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until October 28, 2022. On each of October 27, 2022 and November 27, 2022, the Company obtained loan extension in an amount of $20,155 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until December 28, 2022. On each of January 4, 2023, January 31, 2023, February 28, 2023 and March 31, 2023, the Company obtained loan extension in an amount of $20,155 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until April 28, 2023. On each of April 30, 2023 and May 18, 2023, the Company obtained loan extension in an amount of $6,767 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until June 28, 2023. As of December 31, 2022, the Sponsor has deposited an additional $2,016,863 of funds to extend the time frame.

If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable and less interest to pay dissolution expenses up to $50,000), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).

The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor (other than the Company’s independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below (i) $10.15 per share or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Risks and Uncertainties

Results of operations and the Company’s ability to complete the initial Business Combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond its control. The business could be impacted by, among other things, downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence and spending, the ongoing effects of the COVID-19 pandemic, including resurgences and the emergence of new variants, and geopolitical instability, such as the military conflict in the Ukraine. The Company cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact our business and our ability to complete an initial business combination.

Liquidity and Going Concern

As of December 31, 2022, the Company had $6,918 in its operating bank accounts and working capital deficit of $3,211,147.

Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination.

To complete a Business Combination, the Company will need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.

In connection with the Company’s assessment of going concern in accordance with the authoritative guidance in ASU 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has concluded that the Company has incurred significant operating losses and determined that the mandatory liquidation and subsequent dissolution, should the Company be unable to raise additional funds to meet its obligations and complete a Business Combination, raises substantial doubt about the Company’s ability to continue as a going concern. The Company has until June 28, 2023 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date without an extension to the acquisition period, there will be a mandatory liquidation and subsequent dissolution. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after June 28, 2023.

XML 21 R8.htm IDEA: XBRL DOCUMENT v3.23.1
SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Dec. 31, 2022
SIGNIFICANT ACCOUNTING POLICIES  
SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation

The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the SEC.

Emerging growth company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Significant item subject to such estimates and assumptions includes the valuation of private warrants.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2022 and 2021.

Warrants

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC Topic 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations.

The Company accounts for the 4,260,000 Warrants issued with the Initial Public Offering as liabilities in accordance with ASC 480 and ASC 815-40.

Marketable Securities Held in Trust Account

As of December 31, 2022, $6,658,707 of the assets held in the Trust Account were held in money market funds, and consisted of U.S. Treasury securities carried at fair value.

Gains and losses resulting from the change in fair value of investments held in Trust Account are accounted as interest income in the accompanying statement of income. Interest income for the years ended December 31, 2022 and 2021 amounted to $378,536 and $4,341, respectively.

Ordinary Shares Subject to Possible Redemption

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are subject to occurrence of uncertain future events and are considered to be outside of the Company’s control. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets.

Income Taxes

The Company complies with the accounting and reporting requirements of ASC Topic 740, Income Taxes (“ASC 740”), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits as of December 31, 2022 and 2021 and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.

Net Income (Loss) Per Ordinary Share

The Company complies with accounting and disclosure requirements of ASC 260, Earnings Per Share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable common stock and non-redeemable common stock and the undistributed income (loss) is calculated using the total net income less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable common stock. Any remeasurement of the accretion to redemption value of the common stock subject to possible redemption was considered to be dividends paid to the public shareholders. As of December 31, 2022, the Company has not considered the effect of the warrants sold in the Initial Public Offering to purchase an aggregate of 2,130,000 shares in the calculation of diluted net income (loss) per share, since the exercise of the warrants is contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic (income) loss per share for the period presented.

The net income (loss) per share presented in the statement of income is based on the following:

    

For the

Years Ended

December 31,

    

2022

    

2021

Net income

$

611,525

$

1,345,808

Accretion of carrying value to redemption value

 

(1,614,948)

 

(800,004)

Undistributed income (loss)

$

(1,003,423)

$

545,804

For the years ended December 31,

2022

2021

Redeemable

Redeemable

Ordinary

Non-Redeemable

Ordinary

Non-Redeemable

    

Share

    

Ordinary Share

    

Share

    

Ordinary Share

Basic and diluted net income (loss) per share:

Numerators:

 

  

 

  

 

  

 

  

Allocation of undistributed income (loss)

$

(731,650)

$

(271,773)

$

415,060

$

130,744

Accretion of carrying value to redemption value of redeemable shares

 

1,614,948

 

 

800,004

 

Allocation of net income (loss)

$

883,298

$

(271,773)

$

1,215,064

$

130,744

Denominators:

 

 

 

 

Weighted-average shares outstanding

 

3,392,094

 

1,260,000

 

4,000,000

 

1,260,000

Basic and diluted net income (loss) per share

$

0.26

$

(0.22)

$

0.30

$

0.10

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Fair Value of Financial Instruments

ASC Topic 820 “Fair Value Measurements and Disclosures” (“ASC 820”) defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with the market approach, income approach and cost approach shall be used to measure fair value. ASC 820 establishes a fair value hierarchy for inputs, which represent the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances.

The fair value hierarchy is categorized into three levels based on the inputs as follows:

Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.

Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means.

Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

The fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC 820 approximates the carrying amounts represented in the balance sheet. The fair values of cash, and other current assets, accrued expenses, due to sponsor are estimated to approximate the carrying values as of December 31, 2022 and 2021, due to the short maturities of such instruments.

Convertible notes

The Company evaluates all convertible notes, to determine if such notes are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

Reclassification of Prior Year Presentation

Certain reclassifications have been made between accrued expenses and amount due to a related party, to conform to the current year presentation. The reclassifications did not impact previously reported total current liabilities, total liabilities, the net cash used in operating activities or net cash provided by financing activities.

Recently Issued Accounting Standards

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. The amendments are effective for smaller reporting companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying financial statements.

XML 22 R9.htm IDEA: XBRL DOCUMENT v3.23.1
INITIAL PUBLIC OFFERING
12 Months Ended
Dec. 31, 2022
INITIAL PUBLIC OFFERING  
INITIAL PUBLIC OFFERING

NOTE 3 - INITIAL PUBLIC OFFERING

Pursuant to the Initial Public Offering on July 28, 2020, the Company sold 4,000,000 Units at a purchase price of $10.00 per Unit. Each Unit consists of one ordinary share and one redeemable warrant (“Public Warrant”). Each Public Warrant will entitle the holder to purchase one-half of one ordinary share at an exercise price of $11.50 per whole share (see Note 8).

XML 23 R10.htm IDEA: XBRL DOCUMENT v3.23.1
PRIVATE PLACEMENT
12 Months Ended
Dec. 31, 2022
PRIVATE PLACEMENT.  
PRIVATE PLACEMENT

NOTE 4 - PRIVATE PLACEMENT

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 260,000 Private Units at a price of $10.00 per Private Unit, for an aggregate purchase price of $2,600,000. The proceeds from the Private Units were added to the net proceeds from the Initial Public Offering held in the Trust Account. The Private Units are identical to the Units sold in the Initial Public Offering, except for the private warrants (“Private Warrants”), as described in Note 8. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Units and underlying securities will be worthless.

XML 24 R11.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS
12 Months Ended
Dec. 31, 2022
RELATED PARTY TRANSACTIONS  
RELATED PARTY TRANSACTIONS

NOTE 5 - RELATED PARTY TRANSACTIONS

Founder Shares

In December 2018, the Company received $25,000 for the anticipated issuance of 1,150,000 founder shares to the Sponsor. As of December 31, 2018, one founder share was issued to the Sponsor. The remaining 1,149,999 founder shares were issued to the Sponsor on February 21, 2019.

The 1,150,000 founder shares included an aggregate of up to 150,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the Sponsor will collectively own 20% of the Company’s issued and outstanding shares after the Initial Public Offering. On September 10, 2020, the underwriter did not exercise their over-allotment option election, resulting in the forfeiture of 150,000 founder shares. Accordingly, there were 1,000,000 Founder Shares issued and outstanding.

The initial shareholders have agreed not to transfer, assign or sell any of the founder shares (except to certain permitted transferees) until, with respect to 50% of the founder shares, the earlier of (i) six months after the date of the consummation of a Business Combination, or (ii) the date on which the closing price of the Company’s ordinary shares equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after a Business Combination, with respect to the remaining 50% of the founder shares, upon six months after the date of the consummation of a Business Combination, or earlier, in each case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property.

Private placement

Pursuant to the Initial Public Offering on July 28, 2020, the Sponsor purchased an aggregate of 260,000 Private Units at a price of $10.00 per Private Unit, for an aggregate purchase price of $2,600,000. Each Unit consists of one ordinary share and one Private Warrant. Each Private Warrant will entitle the holder to purchase one-half of one ordinary share at an exercise price of $11.50 per whole share.

Administrative Services Arrangement

The Company entered into an agreement whereby, commencing on July 24, 2020, through the earlier of the Company’s consummation of a Business Combination and its liquidation, the Company will pay the Sponsor a total of $10,000 per month for certain general and administrative services, including office space, utilities and administrative services, as the Company may require from time to time. For the year ended December 31, 2022 and 2021, the Company incurred $120,000 and $120,000 in fees for these services, respectively. These amounts were unpaid during the years. As of December 31, 2022 and 2021, the balances due to related parties were $290,000 and $170,000, respectively.

Promissory Note Payable — Related Party

On February 21, 2019, the Company issued a non-interest bearing, unsecured promissory note to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. On June 30, 2019, the Company amended the promissory note such that the Company may borrow up to an aggregate total principal amount of $500,000 (the “Promissory Note”) and on June 20, 2020, the Company further amended the Promissory Note such that the Promissory Note is payable on the earlier of (i) December 31, 2020 or (ii) the consummation of the Initial Public Offering. In connection with the Promissory Note, the Company converted $24,995 in advances as of December 31, 2018 into amounts outstanding under the Promissory Note. On July 28, 2020, the Company amended the Promissory Note such that it is payable upon the consummation of a Business Combination. On October 31, 2022, the Company further amended the promissory note such that the Company may borrow up to an aggregate total principal amount of $800,000. At December 31, 2022 and 2021, there was $745,504 and $393,808, respectively, outstanding under the Promissory Note. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Promissory Note but no proceeds held in the Trust Account would be used to repay the Promissory Note.

Working Capital Loans

In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $2,500,000 of notes may be converted upon consummation of a Business Combination into additional Private Units at a price of $10.00 per Unit. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December 31, 2022 and 2021, there was no outstanding balance under the Working Capital Loans.

Extension Loans Payable — Related Party

As discussed in Note 1, the Company has extended twenty-three times the period of time to consummate a Business Combination until June 28, 2023. On each of July 27, 2021, August 27, 2021, September 27, 2021, October 27, 2021, November 27, 2021, December 27, 2021, January 27, 2022, February 27, 2022 and March 27, 2022, the Company obtained loan extension in an amount of $133,334 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until April 28, 2022. On each of April 27, 2022, May 27, 2022, June 27, 2022, July 27, 2022, August 27, 2022 and September 27, 2022, the Company obtained loan extension in an amount of $129,425 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until October 28, 2022. On each of October 27, 2022 and November 27, 2022, the Company obtained loan extension in an amount of $20,155 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until December 28, 2022. On each of January 4, 2023, January 31, 2023, February 28, 2023 and March 31, 2023, the Company obtained loan extension in an amount of $20,155 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until April 28, 2023. On each of April 30, 2023 and May 18, 2023, the Company obtained loan extension in an amount of $6,767 from the sponsor, total amounting to $2,111,017 pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until June 28, 2023. Any such payments would be made in the form of a loan. The notes would either be repaid upon consummation of a Business Combination, without interest. If the Company completes a Business Combination, the Company would repay such loaned amounts out of the proceeds of the Trust Account released to the Company. If the Company does not complete a Business Combination, the Company will not repay such loans. Furthermore, the letter agreement with the initial shareholders contains a provision pursuant to which the Sponsor has agreed to waive its right to be repaid for such loans in the event that the Company does not complete a Business Combination. The Sponsor and its affiliates or designees are not obligated to fund the Trust Account to extend the time for the Company to complete a Business Combination. As of December 31, 2022, the Company has extended seventeen times the period of time to consummate a Business Combination. The Company obtained loan extension from the Sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination. The Notes are non-interest bearing and is payable upon the closing of a business combination. As of December 31, 2022 and 2021, there were $2,016,863 and $800,004, respectively, outstanding under the note payable to related party in balance sheets.

XML 25 R12.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES
12 Months Ended
Dec. 31, 2022
COMMITMENTS AND CONTINGENCIES  
COMMITMENTS AND CONTINGENCIES

NOTE 6 – COMMITMENTS AND CONTINGENCIES

Registration Rights

Pursuant to a registration rights agreement entered into on July 23, 2020, the holders of the founder shares, Private Units (and their underlying securities), the shares underlying the warrants underlying the unit purchase option issued to the underwriters and any Units that may be issued upon conversion of the Working Capital Loans (and underlying securities) are entitled to registration rights. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. Notwithstanding the foregoing, the underwriters may not exercise their demand and “piggyback” registration rights after five (5) and seven (7) years after the effective date of the registration statement and may not exercise their demand rights on more than one occasion. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The underwriters were paid a cash underwriting discount of two and one-half percent (2.5%) of the gross proceeds of the Initial Public Offering, or $1,000,000. The underwriters are entitled to a deferred fee of two and one-half percent (2.5%) of the gross proceeds of the Initial Public Offering, or $1,000,000. The deferred fee will be paid in cash upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement.

XML 26 R13.htm IDEA: XBRL DOCUMENT v3.23.1
SHAREHOLDERS DEFICIT
12 Months Ended
Dec. 31, 2022
SHAREHOLDERS DEFICIT  
SHAREHOLDERS DEFICIT

NOTE 7 - SHAREHOLDERS’ DEFICIT

Preference Shares — On February 21, 2019, the Company filed an Amended and Restated Memorandum and Articles of Incorporation, pursuant to which the Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors. At December 31, 2022 and 2021, there were no preference shares designated, issued or outstanding.

Ordinary Shares — On February 21, 2019, the Company filed an Amended and Restated Memorandum and Articles of Incorporation, pursuant to which the Company is authorized to issue 100,000,000 ordinary shares, with a par value of $0.0001 per share. Holders of the ordinary shares are entitled to one vote for each ordinary share.

As of December 31, 2022, there were 1,260,000 ordinary shares issued and outstanding, excluding 610,752 ordinary shares subject to possible redemption, respectively.

As of December 31, 2021, there were 1,260,000 ordinary shares issued and outstanding, excluding 4,000,000 ordinary shares subject to possible redemption, respectively.

Unit Purchase Option

On July 28, 2020, the Company sold the underwriter (and/or its designees), for $100, an option to purchase up to 240,000 Units exercisable at $11.00 per Unit (or an aggregate exercise price of $2,640,000) commencing on the later of the consummation of a Business Combination and January 28, 2021. The unit purchase option may be exercised for cash or on a cashless basis, at the holder’s option, and expires five years from the effective date of the registration statement related to the Initial Public Offering. The Units issuable upon exercise of the option are identical to those offered in the Initial Public Offering. The Company accounted for the unit purchase option as liability classification. The unit purchase option is valued based on the fair value of the Units. These amounts are below the exercise price of the unit purchase option therefore the probability of exercise is low resulting in a de minimus value for the unit purchase option. The option and such units purchased pursuant to the option, as well as the ordinary shares underlying such units, the warrants included in such units, and the shares underlying such warrants, have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(g)(1) of FINRA’s NASDAQ Conduct Rules. Additionally, the option may not be sold, transferred, assigned, pledged or hypothecated for a one-year period (including the foregoing 180-day period) following July 28, 2020 except to any underwriter and selected dealer participating in the Initial Public Offering and their bona fide officers or partners. The option grants to holders demand and “piggy-back” rights for periods of five and seven years, respectively, from July 28, 2020 with respect to the registration under the Securities Act of the securities directly and indirectly issuable upon exercise of the option. The Company will bear all fees and expenses attendant to registering the securities, other than underwriting commissions which will be paid for by the holders themselves. The exercise price and number of units issuable upon exercise of the option may be adjusted in certain circumstances including in the event of a stock dividend, or the Company’s recapitalization, reorganization, merger or consolidation. However, the option will not be adjusted for issuances of ordinary shares at a price below its exercise price.

XML 27 R14.htm IDEA: XBRL DOCUMENT v3.23.1
WARRANTS
12 Months Ended
Dec. 31, 2022
WARRANTS.  
WARRANTS

NOTE 8 - WARRANTS

Warrants — Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) the consummation of a Business Combination or (b) 12 months from the effective date of the registration statement relating to the Initial Public Offering. No Public Warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to such ordinary shares. Notwithstanding the foregoing, if a registration statement covering the ordinary shares issuable upon the exercise of the Public Warrants is not effective within 60 days, the holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise the Public Warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act. If an exemption from registration is not available, holders will not be able to exercise their Public Warrants on a cashless basis. The Public Warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation.

Redemption of warrants when the price per share of ordinary shares equals or exceeds $16.50. Once the Public Warrants become exercisable, the Company may redeem the Public Warrants (except with respect to the Private Placement Warrants):

in whole and not in part,
at a price of $0.01 per warrant,
upon not less than 30 days’ prior written notice of redemption to each Public Warrant holder,
if, and only if, the reported last sale price of the ordinary shares equal or exceed $16.50 per share, (as adjusted for share splits, share capitalizations, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 trading day period ending on the third trading day prior to the notice of redemption to Public Warrant holders, and
if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless.

In addition, if (x) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $16.50 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 165% of the higher of the Market Value and the Newly Issued Price.

The Private Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Warrants and the ordinary shares issuable upon the exercise of the Private Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions and the Private Warrants underlying the Private Units issued to the underwriter may not be exercised after five years from the effective date of the Initial Public Offering. Additionally, the Private Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

A summary of warrants as of December 31, 2022 and 2021 is as follows:

    

Number of

    

Weighted

shares

Average life

Public warrants issued from the Company’s initial Public Offering in July 2020

4,000,000

  

Private warrants issued from the Company’s private placement in July 2020

 

260,000

 

  

Balance of warrants outstanding as of December 31, 2022 and 2021

 

4,260,000

 

5 years

XML 28 R15.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS
12 Months Ended
Dec. 31, 2022
FAIR VALUE MEASUREMENTS  
FAIR VALUE MEASUREMENTS

NOTE 9 - FAIR VALUE MEASUREMENTS

The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 1 — Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2 — Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

Level 3 — Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

The following tables present information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2022 and 2021, and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

Significant Other

Significant Other

Quoted Prices In

Observable

Unobservable

December 31,

Active Markets

Inputs

Inputs

Description

    

2022

    

(Level 1)

    

(Level 2)

    

(Level 3)

Assets:

 

  

  

  

  

U.S. Treasury Securities held in Trust Account*

$

6,658,707

$

6,658,707

$

$

Liabilities:

 

  

 

  

 

  

 

  

Derivative warrant liabilities – Public warrants

$

54,400

$

54,400

$

$

Derivative warrant liabilities – Private warrants

 

8,734

 

 

 

8,734

Total fair value

$

63,134

$

54,400

$

$

8,734

    

Quoted Prices In

Significant Other

Significant Other

Active Markets

Observable Inputs

Unobservable Inputs

Description

    

December 31, 2021

    

(Level 1)

    

(Level 2)

    

(Level 3)

Assets:

 

U.S. Treasury Securities held in Trust Account*

$

41,419,557

$

41,419,557

$

$

Liabilities:

 

 

 

 

Derivative warrant liabilities – Public warrants

$

840,000

$

840,000

$

$

Derivative warrant liabilities – Private warrants

 

110,000

 

 

 

110,000

Total fair value

$

950,000

$

840,000

$

$

110,000

*

included in marketable securities held in Trust Account on the Company’s balance sheets.

The warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on our balance sheets. At December 31, 2022 and 2021, the fair value of Public Warrants was measured using quoted prices in an active market (Level 1) and the fair value of Private Warrants was measured using Black-Scholes model. There were no transfers between Levels 1, 2 or 3 during the years ended December 31, 2022 and 2021.

The key inputs into Black-Scholes model for the Private Warrants were as follows at their measurement dates:

    

December 31,

December 31, 

 

    

2022

    

2021

 

Input

 

  

  

Share price

$

10.76

$

10.35

Risk-free interest rate

 

3.98

%

 

1.20

%

Volatility

 

1.00

%

 

12

%

Exercise price

$

11.50

$

11.50

Warrant life

 

5 years

 

5 years

The following table presents the changes in the fair value of warrant liabilities for the year ended December 31, 2022:

Public

    

Private

    

Total

    

Warrants

    

Warrants

    

Warrants

Fair Value at January 1, 2022

$

840,000

$

110,000

$

950,000

Change in fair value of public and private warrants

 

(785,600)

 

(101,266)

 

(886,866)

Fair Value at December 31, 2022

$

54,400

$

8,734

$

63,134

The following table presents the changes in the fair value of warrant liabilities for the year ended December 31, 2021:

Public

Private

Total

    

Warrants

    

Warrants

    

Warrants

Fair Value at January 1, 2021

$

2,740,000

$

190,000

$

2,930,000

Change in fair value of public and private warrants

(1,900,000)

(80,000)

(1,980,000)

Fair Value at December 31, 2021

$

840,000

$

110,000

$

950,000

XML 29 R16.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS
12 Months Ended
Dec. 31, 2022
SUBSEQUENT EVENTS  
SUBSEQUENT EVENTS

NOTE 11 - SUBSEQUENT EVENTS

In accordance with ASC 855, Subsequent Events, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before the consolidated financial statements are issued, the Company has evaluated all events or transactions that occurred after the balance sheet date, up through the date was the Company issued the financial statements.

On January 4, 2023, January 31, 2023, February 28, 2023 and March 31, 2023, the Company obtained extension loan in an amount of $20,155 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until April 28, 2023.

On April 30, 2023 and May 18, 2023, the Company obtained extension loan in an amount of $6,767 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until June 28, 2023.

On April 25, 2023 the Company amended and restated memorandum and articles of association to extend the date by which the Company has to consummate a business combination six (6) times for an additional one (1) month each time from April 28, 2023 to October 28, 2023 by amending the Amended and Restated Memorandum and Articles of Association by deleting the existing Section 48.7 thereof and replacing them with the new Section 48.7.

On April 25, 2023, 405,705 shares of common stock were presented for redemption in connection with the Extraordinary General Meeting.

XML 30 R17.htm IDEA: XBRL DOCUMENT v3.23.1
SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Dec. 31, 2022
SIGNIFICANT ACCOUNTING POLICIES  
Basis of presentation

Basis of presentation

The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the SEC.

Emerging growth company

Emerging growth company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

Use of Estimates

The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Significant item subject to such estimates and assumptions includes the valuation of private warrants.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2022 and 2021.

Warrants

Warrants

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC Topic 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations.

The Company accounts for the 4,260,000 Warrants issued with the Initial Public Offering as liabilities in accordance with ASC 480 and ASC 815-40.

Marketable Securities Held in Trust Account

Marketable Securities Held in Trust Account

As of December 31, 2022, $6,658,707 of the assets held in the Trust Account were held in money market funds, and consisted of U.S. Treasury securities carried at fair value.

Gains and losses resulting from the change in fair value of investments held in Trust Account are accounted as interest income in the accompanying statement of income. Interest income for the years ended December 31, 2022 and 2021 amounted to $378,536 and $4,341, respectively.

Ordinary Shares Subject to Possible Redemption

Ordinary Shares Subject to Possible Redemption

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are subject to occurrence of uncertain future events and are considered to be outside of the Company’s control. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets.

Income Taxes

Income Taxes

The Company complies with the accounting and reporting requirements of ASC Topic 740, Income Taxes (“ASC 740”), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits as of December 31, 2022 and 2021 and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.

Net Income (Loss) Per Ordinary Share

Net Income (Loss) Per Ordinary Share

The Company complies with accounting and disclosure requirements of ASC 260, Earnings Per Share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable common stock and non-redeemable common stock and the undistributed income (loss) is calculated using the total net income less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable common stock. Any remeasurement of the accretion to redemption value of the common stock subject to possible redemption was considered to be dividends paid to the public shareholders. As of December 31, 2022, the Company has not considered the effect of the warrants sold in the Initial Public Offering to purchase an aggregate of 2,130,000 shares in the calculation of diluted net income (loss) per share, since the exercise of the warrants is contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic (income) loss per share for the period presented.

The net income (loss) per share presented in the statement of income is based on the following:

    

For the

Years Ended

December 31,

    

2022

    

2021

Net income

$

611,525

$

1,345,808

Accretion of carrying value to redemption value

 

(1,614,948)

 

(800,004)

Undistributed income (loss)

$

(1,003,423)

$

545,804

For the years ended December 31,

2022

2021

Redeemable

Redeemable

Ordinary

Non-Redeemable

Ordinary

Non-Redeemable

    

Share

    

Ordinary Share

    

Share

    

Ordinary Share

Basic and diluted net income (loss) per share:

Numerators:

 

  

 

  

 

  

 

  

Allocation of undistributed income (loss)

$

(731,650)

$

(271,773)

$

415,060

$

130,744

Accretion of carrying value to redemption value of redeemable shares

 

1,614,948

 

 

800,004

 

Allocation of net income (loss)

$

883,298

$

(271,773)

$

1,215,064

$

130,744

Denominators:

 

 

 

 

Weighted-average shares outstanding

 

3,392,094

 

1,260,000

 

4,000,000

 

1,260,000

Basic and diluted net income (loss) per share

$

0.26

$

(0.22)

$

0.30

$

0.10

Concentration of Credit Risk

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

ASC Topic 820 “Fair Value Measurements and Disclosures” (“ASC 820”) defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with the market approach, income approach and cost approach shall be used to measure fair value. ASC 820 establishes a fair value hierarchy for inputs, which represent the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances.

The fair value hierarchy is categorized into three levels based on the inputs as follows:

Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.

Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means.

Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

The fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC 820 approximates the carrying amounts represented in the balance sheet. The fair values of cash, and other current assets, accrued expenses, due to sponsor are estimated to approximate the carrying values as of December 31, 2022 and 2021, due to the short maturities of such instruments.

Convertible notes

Convertible notes

The Company evaluates all convertible notes, to determine if such notes are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

Reclassification of Prior Year Presentation

Reclassification of Prior Year Presentation

Certain reclassifications have been made between accrued expenses and amount due to a related party, to conform to the current year presentation. The reclassifications did not impact previously reported total current liabilities, total liabilities, the net cash used in operating activities or net cash provided by financing activities.

Recently Issued Accounting Standards

Recently Issued Accounting Standards

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. The amendments are effective for smaller reporting companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying financial statements.

XML 31 R18.htm IDEA: XBRL DOCUMENT v3.23.1
SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2022
SIGNIFICANT ACCOUNTING POLICIES  
Schedule of net income (loss) per share presented in the statement of operations

    

For the

Years Ended

December 31,

    

2022

    

2021

Net income

$

611,525

$

1,345,808

Accretion of carrying value to redemption value

 

(1,614,948)

 

(800,004)

Undistributed income (loss)

$

(1,003,423)

$

545,804

For the years ended December 31,

2022

2021

Redeemable

Redeemable

Ordinary

Non-Redeemable

Ordinary

Non-Redeemable

    

Share

    

Ordinary Share

    

Share

    

Ordinary Share

Basic and diluted net income (loss) per share:

Numerators:

 

  

 

  

 

  

 

  

Allocation of undistributed income (loss)

$

(731,650)

$

(271,773)

$

415,060

$

130,744

Accretion of carrying value to redemption value of redeemable shares

 

1,614,948

 

 

800,004

 

Allocation of net income (loss)

$

883,298

$

(271,773)

$

1,215,064

$

130,744

Denominators:

 

 

 

 

Weighted-average shares outstanding

 

3,392,094

 

1,260,000

 

4,000,000

 

1,260,000

Basic and diluted net income (loss) per share

$

0.26

$

(0.22)

$

0.30

$

0.10

XML 32 R19.htm IDEA: XBRL DOCUMENT v3.23.1
WARRANTS (Tables)
12 Months Ended
Dec. 31, 2022
WARRANTS.  
Summary of warrants activity

    

Number of

    

Weighted

shares

Average life

Public warrants issued from the Company’s initial Public Offering in July 2020

4,000,000

  

Private warrants issued from the Company’s private placement in July 2020

 

260,000

 

  

Balance of warrants outstanding as of December 31, 2022 and 2021

 

4,260,000

 

5 years

XML 33 R20.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2022
FAIR VALUE MEASUREMENTS  
Schedule of company's asset measured at fair value on a recurring basis

Significant Other

Significant Other

Quoted Prices In

Observable

Unobservable

December 31,

Active Markets

Inputs

Inputs

Description

    

2022

    

(Level 1)

    

(Level 2)

    

(Level 3)

Assets:

 

  

  

  

  

U.S. Treasury Securities held in Trust Account*

$

6,658,707

$

6,658,707

$

$

Liabilities:

 

  

 

  

 

  

 

  

Derivative warrant liabilities – Public warrants

$

54,400

$

54,400

$

$

Derivative warrant liabilities – Private warrants

 

8,734

 

 

 

8,734

Total fair value

$

63,134

$

54,400

$

$

8,734

    

Quoted Prices In

Significant Other

Significant Other

Active Markets

Observable Inputs

Unobservable Inputs

Description

    

December 31, 2021

    

(Level 1)

    

(Level 2)

    

(Level 3)

Assets:

 

U.S. Treasury Securities held in Trust Account*

$

41,419,557

$

41,419,557

$

$

Liabilities:

 

 

 

 

Derivative warrant liabilities – Public warrants

$

840,000

$

840,000

$

$

Derivative warrant liabilities – Private warrants

 

110,000

 

 

 

110,000

Total fair value

$

950,000

$

840,000

$

$

110,000

*

included in marketable securities held in Trust Account on the Company’s balance sheets.

Schedule of initial measurement of key inputs

    

December 31,

December 31, 

 

    

2022

    

2021

 

Input

 

  

  

Share price

$

10.76

$

10.35

Risk-free interest rate

 

3.98

%

 

1.20

%

Volatility

 

1.00

%

 

12

%

Exercise price

$

11.50

$

11.50

Warrant life

 

5 years

 

5 years

Schedule of changes in the fair value of warrant liabilities

Public

    

Private

    

Total

    

Warrants

    

Warrants

    

Warrants

Fair Value at January 1, 2022

$

840,000

$

110,000

$

950,000

Change in fair value of public and private warrants

 

(785,600)

 

(101,266)

 

(886,866)

Fair Value at December 31, 2022

$

54,400

$

8,734

$

63,134

Public

Private

Total

    

Warrants

    

Warrants

    

Warrants

Fair Value at January 1, 2021

$

2,740,000

$

190,000

$

2,930,000

Change in fair value of public and private warrants

(1,900,000)

(80,000)

(1,980,000)

Fair Value at December 31, 2021

$

840,000

$

110,000

$

950,000

XML 34 R21.htm IDEA: XBRL DOCUMENT v3.23.1
ORGANIZATION AND BUSINESS BACKGROUND (Details)
12 Months Ended
May 18, 2023
USD ($)
Apr. 30, 2023
USD ($)
Apr. 25, 2023
USD ($)
$ / shares
shares
Mar. 31, 2023
USD ($)
Feb. 28, 2023
USD ($)
Jan. 31, 2023
USD ($)
Jan. 04, 2023
USD ($)
Nov. 27, 2022
USD ($)
Oct. 28, 2022
USD ($)
item
$ / shares
shares
Oct. 27, 2022
USD ($)
Sep. 27, 2022
USD ($)
Aug. 27, 2022
USD ($)
Jul. 27, 2022
USD ($)
Jun. 27, 2022
USD ($)
May 27, 2022
USD ($)
Apr. 27, 2022
USD ($)
Apr. 20, 2022
USD ($)
item
$ / shares
shares
Mar. 27, 2022
USD ($)
Feb. 27, 2022
USD ($)
Jan. 27, 2022
USD ($)
Dec. 27, 2021
USD ($)
Nov. 27, 2021
USD ($)
Oct. 27, 2021
USD ($)
Sep. 27, 2021
USD ($)
Aug. 27, 2021
USD ($)
Jul. 27, 2021
USD ($)
Jul. 28, 2020
USD ($)
$ / shares
shares
Jun. 28, 2020
$ / shares
shares
Feb. 21, 2019
$ / shares
shares
Dec. 31, 2022
USD ($)
item
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
Dec. 31, 2018
shares
Organization Consolidation And Presentation Of Financial Statements [Line Items]                                                                
Condition for future business combination number of businesses minimum | item                                                           1    
Deferred underwriting fee                                                           $ 1,000,000 $ 1,000,000  
Maximum maturity term of investments                                                           180 days    
Maximum period of time failure to consummate business combination from closing of public offering                                                           39 months    
Cash                                                           $ 6,918 $ 61,773  
Marketable securities held in Trust Account     $ 2,292,209.07           $ 6,555,395.97               $ 41,008,428.63                              
Working capital deficit                                                           $ 3,211,147    
Maximum threshold business days to redeem outstanding public shares                                                           10 days    
Business combination limit on net tangible assets                                                           $ 5,000,001    
Share redemption (as a percent)                                                           15.00%    
Threshold period from closing of public offering entity is obligated to complete business combination                                                           12 months    
Extension period of time to consummate a Business Combination                                                           39 months    
Percentage of shares of stock the Company is obligated to redeem without consummating a business combination                                                           100.00%    
Operating bank accounts                                                           $ 6,918    
Dissolution expenses                                                           $ 50,000    
Common stock, par or stated value per share | $ / shares                                                         $ 0.0001 $ 0.0001 $ 0.0001  
Related party transaction, Amount deposited into trust account by sponsor                                                           $ 1,216,859 $ 800,004  
Number of monthly extensions approved | item                 6               6                              
Holders of number of ordinary shares who exercised their right to redeem shares | shares     405,705           3,311,198               78,050                              
Redemption price | $ / shares     $ 11.18           $ 10.73               $ 10.46                              
Aggregate redemption amount     $ 4,535,353.71           $ 35,540,143.87               $ 816,101.13                              
Maximum [Member]                                                                
Organization Consolidation And Presentation Of Financial Statements [Line Items]                                                                
Redemption price per share | $ / shares                                                           $ 0.30    
Sponsor                                                                
Organization Consolidation And Presentation Of Financial Statements [Line Items]                                                                
Number of common stock issued (in shares) | shares                                                         1,149,999     1
Shares issued price per share | $ / shares                                                           $ 10.15    
Fair value on assets held In trust (as a percent)                                                           80.00%    
Proceeds from sponsor deposited into the Trust Account $ 6,767 $ 6,767   $ 20,155 $ 20,155 $ 20,155 $ 20,155 $ 20,155   $ 20,155 $ 129,425 $ 129,425 $ 129,425 $ 129,425 $ 129,425 $ 129,425   $ 133,334 $ 133,334 $ 133,334 $ 133,334 $ 133,334 $ 133,334 $ 133,334 $ 133,334 $ 133,334       $ 2,016,863    
Redemption price per share | $ / shares                                                           $ 10.15    
IPO                                                                
Organization Consolidation And Presentation Of Financial Statements [Line Items]                                                                
Number of common stock issued (in shares) | shares                                                     4,000,000          
Exercise price of warrants or rights | $ / shares                                                     $ 11.50          
Transaction cost                                                     $ 2,646,665          
Underwriting fees                                                     1,000,000          
Deferred underwriting fee                                                     1,000,000          
Other offering costs                                                     $ 646,665          
Shares issued price per share | $ / shares                                                     $ 10.00     $ 10.00    
Number of targeted business | item                                                           1    
Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination                                                           50    
Number of ordinary shares per unit | shares                                                     1          
Warrants exercise ratio | shares                                                     0.5          
IPO | Sponsor                                                                
Organization Consolidation And Presentation Of Financial Statements [Line Items]                                                                
Number of warrants issued (in shares) | shares                                                     260,000          
Exercise price of warrants or rights | $ / shares                                                     $ 10          
Gross proceeds from issuance of warrants                                                     $ 42,600,000          
Private placement                                                                
Organization Consolidation And Presentation Of Financial Statements [Line Items]                                                                
Number of common stock issued (in shares) | shares                                                       260,000   260,000    
Proceeds from issuance IPO                                                     $ 40,600,000          
Exercise price of warrants or rights | $ / shares                                                       $ 11.50        
Shares issued price per share | $ / shares                                                       $ 10.00   $ 10.00    
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.23.1
SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Significant Accounting Policies [Line Items]    
Marketable securities held in Trust Account $ 6,658,707 $ 41,419,557
Dividend income 378,536 4,341
Unrecognized Tax Benefits 0 0
Unrecognized tax benefits, interest and penalty accrued 0 $ 0
Tax provision $ 0  
IPO    
Significant Accounting Policies [Line Items]    
Warrants issued 42,600,000  
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.23.1
SIGNIFICANT ACCOUNTING POLICIES - Summary of net loss per share presented in the statement of operations (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Significant Accounting Policies [Line Items]    
Anti-dilutive securities attributable to warrants (in shares) 2,130,000  
Numerators:    
Net income (loss) $ 611,525 $ 1,345,808
Accretion of carrying value to redemption value (1,614,948) (800,004)
Undistributed income (loss) (1,003,423) 545,804
Redeemable Ordinary shares    
Numerators:    
Accretion of carrying value to redemption value 1,614,948 800,004
Allocation of undistributed income (loss) (731,650) 415,060
Allocation of net income (loss) 883,298 1,215,064
Non-Redeemable Ordinary shares    
Numerators:    
Allocation of undistributed income (loss) (271,773) 130,744
Allocation of net income (loss) $ (271,773) $ 130,744
Ordinary share subject to redemption    
Denominators:    
Basic weighted average shares outstanding, ordinary shares attributable to Greencity Acquisition Corporation 3,392,094 4,000,000
Diluted weighted average shares outstanding, ordinary shares attributable to Greencity Acquisition Corporation 3,392,094 4,000,000
Basic net income (loss) per ordinary share $ 0.26 $ 0.30
Diluted net income (loss) per ordinary share $ 0.26 $ 0.30
Ordinary share not subject to redemption    
Denominators:    
Basic weighted average shares outstanding, ordinary shares attributable to Greencity Acquisition Corporation 1,260,000 1,260,000
Diluted weighted average shares outstanding, ordinary shares attributable to Greencity Acquisition Corporation 1,260,000 1,260,000
Basic net income (loss) per ordinary share $ (0.22) $ 0.10
Diluted net income (loss) per ordinary share $ (0.22) $ 0.10
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.23.1
INITIAL PUBLIC OFFERING - Additional Information (Details) - IPO - $ / shares
Jul. 28, 2020
Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]    
Issuance of ordinary shares (in Shares) 4,000,000  
Unit price $ 10.00 $ 10.00
Number of ordinary shares per unit 1  
Number of public warrants per unit 1  
Warrants exercise ratio 0.5  
Warrants exercise price $ 11.50  
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.23.1
PRIVATE PLACEMENT - Additional Information (Details) - Private placement - USD ($)
12 Months Ended
Jun. 28, 2020
Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]    
Number of common stock issued (in shares) 260,000 260,000
Aggregate purchase price $ 2,600,000 $ 2,600,000
Shares issued price per share $ 10.00 $ 10.00
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
May 18, 2023
Apr. 30, 2023
Mar. 31, 2023
Feb. 28, 2023
Jan. 31, 2023
Jan. 04, 2023
Nov. 27, 2022
Oct. 27, 2022
Sep. 27, 2022
Aug. 27, 2022
Jul. 27, 2022
Jun. 27, 2022
May 27, 2022
Apr. 27, 2022
Mar. 27, 2022
Feb. 27, 2022
Jan. 27, 2022
Dec. 27, 2021
Nov. 27, 2021
Oct. 27, 2021
Sep. 27, 2021
Aug. 27, 2021
Jul. 27, 2021
Sep. 10, 2020
Jun. 28, 2020
Feb. 21, 2019
Dec. 31, 2022
Dec. 31, 2018
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2018
Dec. 31, 2023
Dec. 31, 2019
Jun. 30, 2019
RELATED PARTY TRANSACTIONS                                                                      
Common stock, shares, issued                                                     1,260,000     1,260,000 1,260,000        
Common stock, shares, outstanding                                                     1,260,000     1,260,000 1,260,000   1,260,000    
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination                                                       30 days              
Proceed held in trust account                                                     $ 0     $ 0          
General and administrative services expense per month                                                           10,000          
Related party transaction, converted notes upon consummation of a business combination                                                           $ 2,500,000          
Related party transaction, converted notes price per share upon consummation of a business combination                                                           $ 10.00          
Related party transaction general and administrative services expenses                                                           $ 120,000 $ 120,000        
Amount due to related party                                                     290,000     290,000 170,000        
Aggregate total principal amount                                                     800,000     $ 800,000          
Related party transaction, extension period of time to consummate a business combination                                                           39 months          
Related Party Loans                                                                      
RELATED PARTY TRANSACTIONS                                                                      
Proceed held in trust account                                                     $ 0     $ 0          
Private placement                                                                      
RELATED PARTY TRANSACTIONS                                                                      
Number of common stock issued (in shares)                                                 260,000         260,000          
Shares issued price per share                                                 $ 10.00   $ 10.00     $ 10.00          
Aggregate purchase price                                                 $ 2,600,000         $ 2,600,000          
Exercise price of warrants or rights                                                 $ 11.50                    
Sponsor                                                                      
RELATED PARTY TRANSACTIONS                                                                      
Proceeds from issuance of shares                                                       $ 25,000              
Anticipated issuance of founder shares to the Sponsor                                                       1,150,000              
Number of common stock issued (in shares)                                                   1,149,999           1      
Shares issued price per share                                                     $ 10.15     $ 10.15          
Weighted average number of shares, common stock subject to forfeiture                                               150,000       150,000              
Shares owned by sponsor (in percentage)                                                       20.00%              
Common stock, shares, issued                                               1,000,000                      
Common stock, shares, outstanding                                               1,000,000                      
Percentage of shares agreed not to transfer, assign or sell                                                       50.00%              
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)                                                       $ 12.50              
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination                                                       20 days              
Percentage of transfer of remaining founder shares based on certain exceptions                                                       50.00%              
Proceeds from sponsor deposited into the Trust Account $ 6,767 $ 6,767 $ 20,155 $ 20,155 $ 20,155 $ 20,155 $ 20,155 $ 20,155 $ 129,425 $ 129,425 $ 129,425 $ 129,425 $ 129,425 $ 129,425 $ 133,334 $ 133,334 $ 133,334 $ 133,334 $ 133,334 $ 133,334 $ 133,334 $ 133,334 $ 133,334             $ 2,016,863          
Sponsor | Extension Loans Payable - Related Party                                                                      
RELATED PARTY TRANSACTIONS                                                                      
Proceeds from sponsor deposited into the Trust Account $ 6,767 $ 6,767         $ 20,155 $ 20,155 $ 129,425 $ 129,425 $ 129,425 $ 129,425 $ 129,425 $ 129,425     $ 133,334 $ 133,334 $ 133,334 $ 133,334 $ 133,334 $ 133,334 $ 133,334       $ 2,111,017   $ 20,155 2,016,863 800,004        
Unsecured promissory note                                                                      
RELATED PARTY TRANSACTIONS                                                                      
Due to related parties                                                             $ 393,808        
Borrowings principal amount                                                   $ 300,000                  
Amount due to related party                                                     $ 745,504     $ 745,504          
Unsecured promissory note | Maximum                                                                      
RELATED PARTY TRANSACTIONS                                                                      
Borrowings principal amount                                                                     $ 500,000
Unsecured promissory note | Sponsor                                                                      
RELATED PARTY TRANSACTIONS                                                                      
Amount due to related party                                                                   $ 24,995  
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES - Additional information (Details) - Underwriting Agreement
12 Months Ended
Dec. 31, 2022
USD ($)
COMMITMENTS AND CONTINGENCIES  
Underwriter commission (in percentage) 2.50%
Proceeds from issuance of shares to underwriters $ 1,000,000
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.23.1
SHAREHOLDERS DEFICIT (Details)
12 Months Ended
Jul. 28, 2020
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
Vote
$ / shares
shares
Dec. 31, 2023
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Feb. 21, 2019
$ / shares
shares
WARRANTS          
Preferred stock, shares authorized   1,000,000   1,000,000 1,000,000
Preferred stock, par or stated value per share | $ / shares   $ 0.0001   $ 0.0001 $ 0.0001
Preferred stock, shares issued   0   0  
Preferred stock, shares outstanding   0   0  
Common stock, shares authorized   100,000,000   100,000,000 100,000,000
Common stock, par or stated value per share | $ / shares   $ 0.0001   $ 0.0001 $ 0.0001
Ordinary shares subject to possible redemption, shares   610,752   4,000,000  
Number of votes per share | Vote   1      
Common stock, shares, issued   1,260,000   1,260,000  
Common stock, shares, outstanding   1,260,000 1,260,000 1,260,000  
Common stock value | $   $ 126   $ 126  
Unit Purchase Option          
WARRANTS          
Common stock, shares, issued 240,000        
Unit price | $ / shares $ 11.00        
Underwriter commission | $ $ 100        
Common stock value | $ $ 2,640,000        
Expired period effective date of registration period of the initial public offering 5 years        
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.23.1
WARRANTS - Warrants activity (Details)
Dec. 31, 2022
USD ($)
WARRANTS  
Number of shares $ 4,260,000
Weighted average life 5 years
Public warrants  
WARRANTS  
Number of shares $ 4,000,000
Private warrants  
WARRANTS  
Number of shares $ 260,000
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.23.1
WARRANTS - Additional information (Details)
12 Months Ended
Dec. 31, 2022
$ / shares
WARRANTS  
Warrants redemption price $ 0.01
Sale price of the ordinary shares $ 16.50
Weighted average life 5 years
Maximum  
WARRANTS  
Written notice of redemption to each public warrant holder 30 days
Minimum  
WARRANTS  
Written notice of redemption to each public warrant holder 20 days
Closing of business combination  
WARRANTS  
Unit price $ 9.20
Percentage of gross proceeds on additional issuance of shares 60.00%
Period in private warrants 30 days
Closing of business combination | Market value below $ 9.20  
WARRANTS  
Exercise price of the warrants will be adjusted of the higher of the market value (in percentage) 115.00%
Closing of business combination | Market value $ 16.50  
WARRANTS  
Exercise price of the warrants will be adjusted of the higher of the market value (in percentage) 165.00%
Warrants  
WARRANTS  
Effective date of the registration 12 months
Maximum threshold period for registration statement to become effective after business combination 60 days
Sale price of the ordinary shares $ 16.50
Weighted average life 5 years
Warrants | Market value $ 16.50  
WARRANTS  
Sale price of the ordinary shares $ 16.50
Threshold consecutive trading days for redemption of public warrants 30 months
Warrants | Closing of business combination  
WARRANTS  
Weighted average life 5 years
Threshold trading days for redemption of public warrants 20 days
Warrants | Maximum | Market value $ 16.50  
WARRANTS  
Threshold consecutive trading days for redemption of public warrants 30 days
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS - Fair value on a recurring basis (Details) - USD ($)
Apr. 25, 2023
Dec. 31, 2022
Oct. 28, 2022
Apr. 20, 2022
Dec. 31, 2021
FAIR VALUE MEASUREMENTS          
Assets held in Trust Account $ 2,292,209.07   $ 6,555,395.97 $ 41,008,428.63  
Warrant liabilities   $ 63,134     $ 950,000
Recurring          
FAIR VALUE MEASUREMENTS          
Warrant liabilities   63,134     950,000
Recurring | Public warrants          
FAIR VALUE MEASUREMENTS          
Warrant liabilities   54,400     840,000
Recurring | Private warrants          
FAIR VALUE MEASUREMENTS          
Warrant liabilities   8,734     110,000
Recurring | Level 1          
FAIR VALUE MEASUREMENTS          
Warrant liabilities   54,400     840,000
Recurring | Level 1 | Public warrants          
FAIR VALUE MEASUREMENTS          
Warrant liabilities   54,400     840,000
Recurring | Level 3          
FAIR VALUE MEASUREMENTS          
Warrant liabilities   8,734     110,000
Recurring | Level 3 | Private warrants          
FAIR VALUE MEASUREMENTS          
Warrant liabilities   8,734     110,000
Recurring | U.S. Treasury Securities          
FAIR VALUE MEASUREMENTS          
Assets held in Trust Account   6,658,707     41,419,557
Recurring | U.S. Treasury Securities | Level 1          
FAIR VALUE MEASUREMENTS          
Assets held in Trust Account   $ 6,658,707     $ 41,419,557
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS - Initial measurement (Details)
Dec. 31, 2022
$ / shares
Y
Dec. 31, 2021
Y
$ / shares
Share price    
FAIR VALUE MEASUREMENTS    
Input 10.76 10.35
Risk-free interest rate    
FAIR VALUE MEASUREMENTS    
Input 0.0398 0.0120
Volatility    
FAIR VALUE MEASUREMENTS    
Input 0.0100 0.12
Exercise price    
FAIR VALUE MEASUREMENTS    
Input 11.50 11.50
Warrant life    
FAIR VALUE MEASUREMENTS    
Input | Y 5 5
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS - Changes in the fair value of the warrant liability (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
FAIR VALUE MEASUREMENTS    
Fair Value at Beginning $ 950,000 $ 2,930,000
Change in fair value of public and private warrants (886,866) (1,980,000)
Fair Value at Ending $ 63,134 $ 950,000
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Fair Value Adjustment of Warrants Fair Value Adjustment of Warrants
Public warrants    
FAIR VALUE MEASUREMENTS    
Fair Value at Beginning $ 840,000 $ 2,740,000
Change in fair value of public and private warrants (785,600) (1,900,000)
Fair Value at Ending 54,400 840,000
Private warrants    
FAIR VALUE MEASUREMENTS    
Fair Value at Beginning 110,000 190,000
Change in fair value of public and private warrants (101,266) (80,000)
Fair Value at Ending $ 8,734 $ 110,000
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS - Additional information (Details)
12 Months Ended
Dec. 31, 2022
USD ($)
FAIR VALUE MEASUREMENTS  
Transfers between Levels 1, 2 or 3 $ 0
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS (Details) - Subsequent event
May 18, 2023
USD ($)
Apr. 30, 2023
USD ($)
Apr. 25, 2023
item
shares
Mar. 31, 2023
USD ($)
Feb. 28, 2023
USD ($)
Jan. 31, 2023
USD ($)
Jan. 04, 2023
USD ($)
SUBSEQUENT EVENTS              
Extended number of times to consummate the business combination | item     6        
Extended to consummate a business combination each time     1 month        
Redemption of common shares | shares     405,705        
Unsecured promissory note | Sponsor              
SUBSEQUENT EVENTS              
Proceeds from issuance of promissory note deposited in Trust Account by a founder-shareholder | $ $ 6,767 $ 6,767   $ 20,155 $ 20,155 $ 20,155 $ 20,155
XML 49 grcyu-20221231x10k_htm.xml IDEA: XBRL DOCUMENT 0001768910 grcyu:SponsorMember 2020-09-10 2020-09-10 0001768910 grcyu:ClosingOfBusinessCombinationMember us-gaap:WarrantMember 2022-12-31 0001768910 us-gaap:MeasurementInputSharePriceMember 2022-12-31 0001768910 us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001768910 us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001768910 us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001768910 us-gaap:MeasurementInputExercisePriceMember 2022-12-31 0001768910 us-gaap:MeasurementInputSharePriceMember 2021-12-31 0001768910 us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001768910 us-gaap:MeasurementInputPriceVolatilityMember 2021-12-31 0001768910 us-gaap:MeasurementInputExpectedTermMember 2021-12-31 0001768910 us-gaap:MeasurementInputExercisePriceMember 2021-12-31 0001768910 srt:MaximumMember 2022-12-31 0001768910 grcyu:CommonStockSubjectToPossibleRedemptionMember 2022-12-31 0001768910 grcyu:CommonStockSubjectToPossibleRedemptionMember 2021-12-31 0001768910 grcyu:SponsorMember 2019-02-21 2019-02-21 0001768910 grcyu:SponsorMember 2018-01-01 2018-12-31 0001768910 us-gaap:RetainedEarningsMember 2022-12-31 0001768910 us-gaap:RetainedEarningsMember 2021-12-31 0001768910 us-gaap:RetainedEarningsMember 2020-12-31 0001768910 grcyu:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001768910 grcyu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001768910 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001768910 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001768910 grcyu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001768910 grcyu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001768910 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001768910 grcyu:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001768910 grcyu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001768910 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001768910 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001768910 grcyu:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001768910 grcyu:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001768910 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001768910 us-gaap:CommonStockMember 2022-12-31 0001768910 us-gaap:CommonStockMember 2021-12-31 0001768910 us-gaap:CommonStockMember 2020-12-31 0001768910 us-gaap:PrivatePlacementMember 2022-12-31 0001768910 grcyu:SponsorMember 2022-12-31 0001768910 grcyu:ClosingOfBusinessCombinationMember 2022-12-31 0001768910 grcyu:MarketValue16.50Member us-gaap:WarrantMember 2022-12-31 0001768910 us-gaap:WarrantMember 2022-12-31 0001768910 us-gaap:PrivatePlacementMember 2020-07-28 2020-07-28 0001768910 grcyu:PublicWarrantsMember 2022-12-31 0001768910 grcyu:PrivatePlacementWarrantsMember 2022-12-31 0001768910 grcyu:PublicWarrantsMember 2021-12-31 0001768910 grcyu:PrivatePlacementWarrantsMember 2021-12-31 0001768910 grcyu:PublicWarrantsMember 2020-12-31 0001768910 grcyu:PrivatePlacementWarrantsMember 2020-12-31 0001768910 grcyu:PublicWarrantsMember 2022-01-01 2022-12-31 0001768910 grcyu:PrivatePlacementWarrantsMember 2022-01-01 2022-12-31 0001768910 grcyu:PublicWarrantsMember 2021-01-01 2021-12-31 0001768910 grcyu:PrivatePlacementWarrantsMember 2021-01-01 2021-12-31 0001768910 grcyu:CommonStockSubjectToPossibleRedemptionMember 2022-01-01 2022-12-31 0001768910 grcyu:CommonStockNotSubjectToPossibleRedemptionMember 2022-01-01 2022-12-31 0001768910 grcyu:CommonSharesSubjectToRedemptionMember 2022-01-01 2022-12-31 0001768910 grcyu:CommonSharesNotSubjectToRedemptionMember 2022-01-01 2022-12-31 0001768910 grcyu:CommonStockSubjectToPossibleRedemptionMember 2021-01-01 2021-12-31 0001768910 grcyu:CommonStockNotSubjectToPossibleRedemptionMember 2021-01-01 2021-12-31 0001768910 grcyu:CommonSharesSubjectToRedemptionMember 2021-01-01 2021-12-31 0001768910 grcyu:CommonSharesNotSubjectToRedemptionMember 2021-01-01 2021-12-31 0001768910 us-gaap:UnsecuredDebtMember 2021-12-31 0001768910 us-gaap:UnsecuredDebtMember 2022-12-31 0001768910 us-gaap:UnsecuredDebtMember grcyu:SponsorMember 2019-12-31 0001768910 srt:MaximumMember us-gaap:UnsecuredDebtMember 2019-06-30 0001768910 us-gaap:UnsecuredDebtMember 2019-02-21 0001768910 2023-12-31 0001768910 grcyu:SponsorMember 2020-09-10 0001768910 2019-02-21 0001768910 us-gaap:IPOMember 2022-12-31 0001768910 grcyu:SponsorMember us-gaap:IPOMember 2020-07-28 0001768910 us-gaap:PrivatePlacementMember 2020-06-28 0001768910 2020-12-31 0001768910 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2022-12-31 0001768910 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2022-12-31 0001768910 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2021-12-31 0001768910 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2021-12-31 0001768910 grcyu:UnitPurchaseOptionMember 2020-07-28 0001768910 2018-12-01 2018-12-31 0001768910 us-gaap:UnsecuredDebtMember grcyu:SponsorMember us-gaap:SubsequentEventMember 2023-05-18 2023-05-18 0001768910 us-gaap:UnsecuredDebtMember grcyu:SponsorMember us-gaap:SubsequentEventMember 2023-04-30 2023-04-30 0001768910 us-gaap:UnsecuredDebtMember grcyu:SponsorMember us-gaap:SubsequentEventMember 2023-03-31 2023-03-31 0001768910 us-gaap:UnsecuredDebtMember grcyu:SponsorMember us-gaap:SubsequentEventMember 2023-02-28 2023-02-28 0001768910 us-gaap:UnsecuredDebtMember grcyu:SponsorMember us-gaap:SubsequentEventMember 2023-01-31 2023-01-31 0001768910 us-gaap:UnsecuredDebtMember grcyu:SponsorMember us-gaap:SubsequentEventMember 2023-01-04 2023-01-04 0001768910 grcyu:RelatedPartyLoansMember 2022-12-31 0001768910 grcyu:RelatedPartyExtensionLoansMember grcyu:SponsorMember 2023-05-18 2023-05-18 0001768910 grcyu:SponsorMember 2023-05-18 2023-05-18 0001768910 grcyu:RelatedPartyExtensionLoansMember grcyu:SponsorMember 2023-04-30 2023-04-30 0001768910 grcyu:SponsorMember 2023-04-30 2023-04-30 0001768910 grcyu:SponsorMember 2023-03-31 2023-03-31 0001768910 grcyu:SponsorMember 2023-02-28 2023-02-28 0001768910 grcyu:SponsorMember 2023-01-31 2023-01-31 0001768910 grcyu:RelatedPartyExtensionLoansMember grcyu:SponsorMember 2023-01-04 2023-03-31 0001768910 grcyu:SponsorMember 2023-01-04 2023-01-04 0001768910 grcyu:RelatedPartyExtensionLoansMember grcyu:SponsorMember 2022-12-01 2022-12-31 0001768910 grcyu:RelatedPartyExtensionLoansMember grcyu:SponsorMember 2022-11-27 2022-11-27 0001768910 grcyu:SponsorMember 2022-11-27 2022-11-27 0001768910 grcyu:RelatedPartyExtensionLoansMember grcyu:SponsorMember 2022-10-27 2022-10-27 0001768910 grcyu:SponsorMember 2022-10-27 2022-10-27 0001768910 grcyu:RelatedPartyExtensionLoansMember grcyu:SponsorMember 2022-09-27 2022-09-27 0001768910 grcyu:SponsorMember 2022-09-27 2022-09-27 0001768910 grcyu:RelatedPartyExtensionLoansMember grcyu:SponsorMember 2022-08-27 2022-08-27 0001768910 grcyu:SponsorMember 2022-08-27 2022-08-27 0001768910 grcyu:RelatedPartyExtensionLoansMember grcyu:SponsorMember 2022-07-27 2022-07-27 0001768910 grcyu:SponsorMember 2022-07-27 2022-07-27 0001768910 grcyu:RelatedPartyExtensionLoansMember grcyu:SponsorMember 2022-06-27 2022-06-27 0001768910 grcyu:SponsorMember 2022-06-27 2022-06-27 0001768910 grcyu:RelatedPartyExtensionLoansMember grcyu:SponsorMember 2022-05-27 2022-05-27 0001768910 grcyu:SponsorMember 2022-05-27 2022-05-27 0001768910 grcyu:RelatedPartyExtensionLoansMember grcyu:SponsorMember 2022-04-27 2022-04-27 0001768910 grcyu:SponsorMember 2022-04-27 2022-04-27 0001768910 grcyu:SponsorMember 2022-03-27 2022-03-27 0001768910 grcyu:SponsorMember 2022-02-27 2022-02-27 0001768910 grcyu:RelatedPartyExtensionLoansMember grcyu:SponsorMember 2022-01-27 2022-01-27 0001768910 grcyu:SponsorMember 2022-01-27 2022-01-27 0001768910 grcyu:RelatedPartyExtensionLoansMember grcyu:SponsorMember 2022-01-01 2022-12-31 0001768910 grcyu:RelatedPartyExtensionLoansMember grcyu:SponsorMember 2021-12-27 2021-12-27 0001768910 grcyu:SponsorMember 2021-12-27 2021-12-27 0001768910 grcyu:RelatedPartyExtensionLoansMember grcyu:SponsorMember 2021-11-27 2021-11-27 0001768910 grcyu:SponsorMember 2021-11-27 2021-11-27 0001768910 grcyu:RelatedPartyExtensionLoansMember grcyu:SponsorMember 2021-10-27 2021-10-27 0001768910 grcyu:SponsorMember 2021-10-27 2021-10-27 0001768910 grcyu:RelatedPartyExtensionLoansMember grcyu:SponsorMember 2021-09-27 2021-09-27 0001768910 grcyu:SponsorMember 2021-09-27 2021-09-27 0001768910 grcyu:RelatedPartyExtensionLoansMember grcyu:SponsorMember 2021-08-27 2021-08-27 0001768910 grcyu:SponsorMember 2021-08-27 2021-08-27 0001768910 grcyu:RelatedPartyExtensionLoansMember grcyu:SponsorMember 2021-07-27 2021-07-27 0001768910 grcyu:SponsorMember 2021-07-27 2021-07-27 0001768910 grcyu:RelatedPartyExtensionLoansMember grcyu:SponsorMember 2021-01-01 2021-12-31 0001768910 grcyu:UnderwritingAgreementMember 2022-01-01 2022-12-31 0001768910 grcyu:ClosingOfBusinessCombinationMember 2022-01-01 2022-12-31 0001768910 grcyu:SponsorMember us-gaap:IPOMember 2020-07-28 2020-07-28 0001768910 us-gaap:PrivatePlacementMember 2022-01-01 2022-12-31 0001768910 us-gaap:PrivatePlacementMember 2020-06-28 2020-06-28 0001768910 us-gaap:IPOMember 2020-07-28 2020-07-28 0001768910 srt:MinimumMember 2022-01-01 2022-12-31 0001768910 srt:MaximumMember 2022-01-01 2022-12-31 0001768910 2023-04-25 0001768910 2022-10-28 0001768910 2022-04-20 0001768910 us-gaap:SubsequentEventMember 2023-04-25 2023-04-25 0001768910 grcyu:UnitPurchaseOptionMember 2020-07-28 2020-07-28 0001768910 grcyu:MarketValueIsBelow9.2PerShareMember grcyu:ClosingOfBusinessCombinationMember 2022-01-01 2022-12-31 0001768910 grcyu:MarketValue16.50Member grcyu:ClosingOfBusinessCombinationMember 2022-01-01 2022-12-31 0001768910 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001768910 2021-12-31 0001768910 us-gaap:IPOMember 2020-07-28 0001768910 grcyu:ClosingOfBusinessCombinationMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001768910 srt:MaximumMember grcyu:MarketValue16.50Member us-gaap:WarrantMember 2022-01-01 2022-12-31 0001768910 grcyu:MarketValue16.50Member us-gaap:WarrantMember 2022-01-01 2022-12-31 0001768910 us-gaap:IPOMember 2022-01-01 2022-12-31 0001768910 2023-04-25 2023-04-25 0001768910 2022-10-28 2022-10-28 0001768910 2022-04-20 2022-04-20 0001768910 grcyu:SponsorMember 2022-01-01 2022-12-31 0001768910 grcyu:SponsorMember 2018-12-01 2018-12-31 0001768910 grcyu:CommonClassaNotSubjectToRedemptionMember 2022-01-01 2022-12-31 0001768910 grcyu:CommonClassaNotSubjectToRedemptionMember 2021-01-01 2021-12-31 0001768910 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001768910 grcyu:CommonClassaSubjectToRedemptionMember 2022-01-01 2022-12-31 0001768910 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001768910 grcyu:CommonClassaSubjectToRedemptionMember 2021-01-01 2021-12-31 0001768910 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001768910 grcyu:UnitsEachConsistingOfOneClassOrdinaryShareAndOneRedeemableWarrantMember 2022-01-01 2022-12-31 0001768910 grcyu:RedeemableWarrantsEachExercisableForOneHalfOfOneOrdinaryShareFor11.50PerShareMember 2022-01-01 2022-12-31 0001768910 2022-12-31 0001768910 2023-05-25 0001768910 2021-01-01 2021-12-31 0001768910 2022-01-01 2022-12-31 shares iso4217:USD pure grcyu:item iso4217:USD shares grcyu:Vote grcyu:Y 0001768910 --12-31 2022 FY false 0 0 1260000 1260000 0 0 3392094 1260000 4000000 1260000 00-0000000 P10D 42600000 0.26 -0.22 0.30 0.10 0.5 1000000 1260000 1260000 P30D P20D http://fasb.org/us-gaap/2021-01-31#FairValueAdjustmentOfWarrants http://fasb.org/us-gaap/2021-01-31#FairValueAdjustmentOfWarrants 10-K true 2022-12-31 false 001-39404 GREENCITY ACQUISITION CORPORATION E9 505 Eshan Road, Floor 6 Pudong New District Shanghai CN 200120 +86 21-20257919 Ordinary Shares, Par Value $0.0001 Per Share GRCY NASDAQ Redeemable Warrants Entitling the Holder to Purchase One-half (1/2) of One Ordinary Share GRCYW NASDAQ Units, Each Consisting of One Ordinary Share and One Warrant GRCYU NASDAQ No No No No Non-accelerated Filer true true false true 41258914 1465047 Marcum LLP 688 Friedman LLP 711 Costa Mesa, CA New York, NY 6918 61773 5100 5100 12018 66873 6658707 41419557 6670725 41486430 170798 43472 290000 170000 2016863 800004 745504 393808 3223165 1407284 1000000 1000000 63134 950000 4286299 3357284 610752 4000000 10.90 10.35 6658707 41400004 0.0001 0.0001 1000000 1000000 0 0 0.0001 0.0001 100000000 100000000 1260000 1260000 126 126 -4274407 -3270984 -4274281 -3270858 6670725 41486430 653877 638533 -653877 -638533 -886866 -1980000 378536 4341 1265402 1984341 611525 1345808 611525 1345808 3392094 3392094 4000000 4000000 0.26 0.26 0.30 0.30 1260000 1260000 1260000 1260000 -0.22 -0.22 0.10 0.10 1260000 126 -3270984 -3270858 -1614948 -1614948 611525 611525 1260000 126 -4274407 -4274281 1260000 126 -3816788 -3816662 -800004 -800004 1345808 1345808 1260000 126 -3270984 -3270858 611525 1345808 378536 4341 -886866 -1980000 -120320 127326 16823 120000 120000 -406551 -381390 36356245 36356245 30000 782 351696 36356245 -36004549 -30782 -54855 -412172 61773 473945 6918 61773 1614948 800004 1216859 800004 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 1 - ORGANIZATION AND BUSINESS BACKGROUND</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Greencity Acquisition Corporation (the “Company”) is a blank check company incorporated in the Cayman Islands on May 14, 2018. The Company was formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses that have a connection to the Asia market.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company’s entire activity from inception up to July 23, 2020 was in preparation for the initial public offering. Since the initial public offering, the Company’s activity has been limited to the evaluation of business combination candidates. The Company has selected December 31 as its fiscal year end and tax year end.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Financing</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The registration statement for the Company’s initial public offering (the “Public Offering”as described in Note 3) was declared effective by the SEC on July 23, 2020. The Company consummated the Public Offering on July 28, 2020, the Company consummated the Initial Public Offering of 4,000,000 units at $10.00 per unit (the “Public Units”) and sold to the Sponsor to purchase 260,000 units at $10 per unit, generating gross proceeds of $42,600,000.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company incurred $2,646,665 in initial public offering related costs, including $1,000,000 of underwriting fees, $1,000,000 of deferred underwriting fees and $646,665 of other offering costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Trust Account</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Following the closing of the Initial Public Offering on July 28, 2020, an amount of $40,600,000 from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Units was placed in a trust account (the “Trust Account”) invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a 7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, upon the Company’s failure to consummate a Business Combination within 39 months from the closing of the Public Offering. Placing funds in the Trust Account may not protect those funds from third party claims against the Company. Although the Company will seek to have all vendors, service providers, prospective target businesses or other entities it engages, execute agreements with the Company waiving any claim of any kind in or to any monies held in the Trust Account, there is no guarantee that such persons will execute such agreements. The remaining net proceeds (not held in the Trust Account) may be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative expenses. Additionally, the interest earned on the Trust Account balance may be released to the Company to pay the Company’s tax obligations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company timeframe to complete the initial business combination expired on April 28, 2022. On April 20, 2022, the Company held an Annual General Meeting of Shareholders. Among other things, shareholders approved the proposal to extend the time to complete the Company’s initial business company by six monthly extensions to October 28, 2022. In connection with the vote to approve the Extension Amendment, the holders of 78,050 shares of the Company’s ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.46 per share, for an aggregate redemption amount of $816,101.13. As a result, an amount of $41,008,428.63 remained in the trust account. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On October 28, 2022, the Company held an Extraordinary General Meeting of Shareholders. Shareholders approved the proposal to extend the time to complete our initial business company by six monthly extension to April 28, 2023. In connection with the vote to approve the Extension Amendment, the holders of 3,311,198 shares of the Company’s ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.73 per share, for an aggregate redemption amount of $35,540,143.87. As a result, an amount of $6,555,395.97 remained in the trust account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On April 25, 2023, the Company held an Extraordinary General Meeting of Shareholders. Shareholders approved the proposal to extend the time to complete our initial business company by six monthly extension to October 28, 2023. In connection with the vote to approve the Extension Amendment, the holders of 405,705 shares of the Company’s ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $11.18 per share, for an aggregate redemption amount of $4,535,353.71. As a result, an amount of $2,292,209.07 remained in the trust account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Business Combination</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Subject to the requirements that funds held in trust pending liquidation or completion of a Business Combination the Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and sale of the Private Units following completion of a Business Combination, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Additionally, NASDAQ rules which are applicable to the company as its securities are listed on NASDAQ, provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (less any deferred underwriting commissions and taxes payable on interest earned) at the time of the signing of an agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target or assets sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek shareholder approval of a Business Combination at a meeting called for such purpose at which shareholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to 15% or more of the Public Shares without the Company’s prior written consent.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.15 per Public Share, subject to increase of up to an additional $0.30 per Public Share in the event that the Sponsor elects to extend the period of time to consummate a Business Combination (see below), plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter (as discussed in Note 6). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Sponsor and any of the Company’s officers or directors that may hold founder shares (the “initial shareholders”) will agree (a) to vote their founder shares, the ordinary shares included in the Private Units (the “Private Shares”) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association with respect to the Company’s pre-Business Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the founder shares) and Private Shares into the right to receive cash from the Trust Account in connection with a shareholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek shareholder approval in connection therewith) or a vote to amend the provisions of the Amended and Restated Memorandum and Articles of Association relating to shareholders’ rights of pre-Business Combination activity and (d) that the founder shares and Private Shares shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the initial shareholders will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the Company does not complete a business combination within 12 months from the consummation of the Public Offering, the Company will trigger an automatic winding up, dissolution and liquidation pursuant to the terms of the amended and restated memorandum and articles of association. As a result, this has the same effect as if the Company had formally gone through a voluntary liquidation procedure under the Companies Law. If the Company does not complete a business combination within 12 months from the consummation of the Public Offering, the Company will trigger an automatic winding up, dissolution and liquidation pursuant to the terms of the amended and restated memorandum and articles of association. As a result, this has the same effect as if the Company had formally gone through a voluntary liquidation procedure under the Companies Law. Accordingly, no vote would be required from our shareholders to commence such a voluntary winding up, dissolution and liquidation. However, if the Company anticipate that the Company may not be able to consummate its initial business combination within 12 months, the Company may, but are not obligated to, extend the period of time to consummate a business combination nine times, each by an additional month (the “Combination Period”). The Company has amended and restated memorandum and articles of association to extend the Combination Period from April 28, 2022 to October 28, 2023 (for a total of 39 months to complete a Business Combination). As of the date of this report, the Company has extended twenty-three times the period of time to consummate a Business Combination until June 28, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On each of July 27, 2021, August 27, 2021, September 27, 2021, October 27, 2021, November 27, 2021, December 27, 2021, January 27, 2022, February 27, 2022 and March 27, 2022, the Company obtained loan extension in an amount of $133,334 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until April 28, 2022. On each of April 27, 2022, May 27, 2022, June 27, 2022, July 27, 2022, August 27, 2022 and September 27, 2022, the Company obtained loan extension in an amount of $129,425<span style="white-space:pre-wrap;"> from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until October 28, 2022. On each of October 27, 2022 and November 27, 2022, the Company obtained loan extension in an amount of </span>$20,155<span style="white-space:pre-wrap;"> from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until December 28, 2022. On each of January 4, 2023, January 31, 2023, February 28, 2023 and March 31, 2023, the Company obtained loan extension in an amount of </span>$20,155 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until April 28, 2023. On each of April 30, 2023 and May 18, 2023, the Company obtained loan extension in an amount of $6,767 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until June 28, 2023. As of December 31, 2022, the Sponsor has deposited an additional $2,016,863 of funds to extend the time frame.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than <span style="-sec-ix-hidden:Hidden_wNyFHoWdd0Ki2C9nygGnPA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ten</span></span> business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable and less interest to pay dissolution expenses up to $50,000), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor (other than the Company’s independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below (i) $10.15 per share or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Risks and Uncertainties </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Results of operations and the Company’s ability to complete the initial Business Combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond its control. The business could be impacted by, among other things, downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence and spending, the ongoing effects of the COVID-19 pandemic, including resurgences and the emergence of new variants, and geopolitical instability, such as the military conflict in the Ukraine. The Company cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact our business and our ability to complete an initial business combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Liquidity and Going Concern</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022, the Company had $6,918 in its operating bank accounts and working capital deficit of $3,211,147. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To complete a Business Combination, the Company will need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In connection with the Company’s assessment of going concern in accordance with the authoritative guidance in ASU 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has concluded that the Company has incurred significant operating losses and determined that the mandatory liquidation and subsequent dissolution, should the Company be unable to raise additional funds to meet its obligations and complete a Business Combination, raises substantial doubt about the Company’s ability to continue as a going concern. The Company has until June 28, 2023 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date without an extension to the acquisition period, there will be a mandatory liquidation and subsequent dissolution. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after June 28, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> 1 4000000 10.00 260000 10 42600000 2646665 1000000 1000000 646665 40600000 P180D P39M 6 78050 10.46 816101.13 41008428.63 6 3311198 10.73 35540143.87 6555395.97 405705 11.18 4535353.71 2292209.07 1 0.80 50 5000001 0.15 10.15 0.30 P12M P12M P39M 133334 133334 133334 133334 133334 133334 133334 133334 133334 129425 129425 129425 129425 129425 129425 20155 20155 20155 20155 20155 20155 6767 6767 2016863 1 50000 10.00 10.15 6918 3211147 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Basis of presentation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the SEC.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Emerging growth company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Significant item subject to such estimates and assumptions includes the valuation of private warrants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Cash and Cash Equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2022 and 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Warrants</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, <i style="font-style:italic;">Distinguishing Liabilities from Equity</i> (“ASC 480”) and ASC Topic 815, <i style="font-style:italic;">Derivatives and Hedging</i> (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for the <span style="-sec-ix-hidden:Hidden_cH3yWHktVkmdpYCG83ZY2g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4,260,000</span></span> Warrants issued with the Initial Public Offering as liabilities in accordance with ASC 480 and ASC 815-40.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Marketable Securities Held in Trust Account</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022, $6,658,707 of the assets held in the Trust Account were held in money market funds, and consisted of U.S. Treasury securities carried at fair value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Gains and losses resulting from the change in fair value of investments held in Trust Account are accounted as interest income in the accompanying statement of income. Interest income for the years ended December 31, 2022 and 2021 amounted to $378,536 and $4,341, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Ordinary Shares Subject to Possible Redemption</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are subject to occurrence of uncertain future events and are considered to be outside of the Company’s control. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Income Taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company complies with the accounting and reporting requirements of ASC Topic 740,<i style="font-style:italic;"> Income Taxes</i> (“ASC 740”), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits as of December 31, 2022 and 2021 and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Net Income (Loss) Per Ordinary Share </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company complies with accounting and disclosure requirements of ASC 260, <i style="font-style:italic;">Earnings Per Share</i>. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable common stock and non-redeemable common stock and the undistributed income (loss) is calculated using the total net income less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable common stock. Any remeasurement of the accretion to redemption value of the common stock subject to possible redemption was considered to be dividends paid to the public shareholders. As of December 31, 2022, the Company has not considered the effect of the warrants sold in the Initial Public Offering to purchase an aggregate of 2,130,000 shares in the calculation of diluted net income (loss) per share, since the exercise of the warrants is contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic (income) loss per share for the period presented.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The net income (loss) per share presented in the statement of income is based on the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Years Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 611,525</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,345,808</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accretion of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,614,948)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (800,004)</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Undistributed income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,003,423)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 545,804</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:45.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the years ended December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:22.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ordinary</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-Redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ordinary</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-Redeemable</b></p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="font-size:8pt;font-weight:bold;margin-left:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ordinary Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ordinary Share</b></p></td></tr><tr><td style="vertical-align:bottom;width:53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per share:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Numerators:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Allocation of undistributed income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (731,650)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (271,773)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 415,060</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 130,744</p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accretion of carrying value to redemption value of redeemable shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,614,948</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 800,004</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Allocation of net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 883,298</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (271,773)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,215,064</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 130,744</p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Denominators:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted-average shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,392,094</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,260,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,000,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,260,000</p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden__a8GlZMMTkK3gQdeYqQdiQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_2e0Xc14Z2E2xUWysJxXx9w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.22)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_fiN8b7Q1WEqFMC9KpEgqUA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_VzCa-922l06E59kcSxbD2g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.10</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Fair Value of Financial Instruments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ASC Topic 820 “<i style="font-style:italic;">Fair Value Measurements and Disclosures</i>” (“ASC 820”) defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with the market approach, income approach and cost approach shall be used to measure fair value. ASC 820 establishes a fair value hierarchy for inputs, which represent the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The fair value hierarchy is categorized into three levels based on the inputs as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 12pt 18pt;">Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 12pt 18pt;">Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 12pt 18pt;">Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC 820 approximates the carrying amounts represented in the balance sheet. The fair values of cash, and other current assets, accrued expenses, due to sponsor are estimated to approximate the carrying values as of December 31, 2022 and 2021, due to the short maturities of such instruments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Convertible notes</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company evaluates all convertible notes, to determine if such notes are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Reclassification of Prior Year Presentation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Certain reclassifications have been made between accrued expenses and amount due to a related party, to conform to the current year presentation. The reclassifications did not impact previously reported total current liabilities, total liabilities, the net cash used in operating activities or net cash provided by financing activities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Recently Issued Accounting Standards</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. The amendments are effective for smaller reporting companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying financial statements.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Basis of presentation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the SEC.</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Emerging growth company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Significant item subject to such estimates and assumptions includes the valuation of private warrants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Cash and Cash Equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2022 and 2021.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Warrants</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, <i style="font-style:italic;">Distinguishing Liabilities from Equity</i> (“ASC 480”) and ASC Topic 815, <i style="font-style:italic;">Derivatives and Hedging</i> (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for the <span style="-sec-ix-hidden:Hidden_cH3yWHktVkmdpYCG83ZY2g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4,260,000</span></span> Warrants issued with the Initial Public Offering as liabilities in accordance with ASC 480 and ASC 815-40.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Marketable Securities Held in Trust Account</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022, $6,658,707 of the assets held in the Trust Account were held in money market funds, and consisted of U.S. Treasury securities carried at fair value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Gains and losses resulting from the change in fair value of investments held in Trust Account are accounted as interest income in the accompanying statement of income. Interest income for the years ended December 31, 2022 and 2021 amounted to $378,536 and $4,341, respectively.</p> 6658707 378536 4341 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Ordinary Shares Subject to Possible Redemption</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are subject to occurrence of uncertain future events and are considered to be outside of the Company’s control. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets.</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Income Taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company complies with the accounting and reporting requirements of ASC Topic 740,<i style="font-style:italic;"> Income Taxes</i> (“ASC 740”), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits as of December 31, 2022 and 2021 and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.</p> 0 0 0 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Net Income (Loss) Per Ordinary Share </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company complies with accounting and disclosure requirements of ASC 260, <i style="font-style:italic;">Earnings Per Share</i>. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable common stock and non-redeemable common stock and the undistributed income (loss) is calculated using the total net income less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable common stock. Any remeasurement of the accretion to redemption value of the common stock subject to possible redemption was considered to be dividends paid to the public shareholders. As of December 31, 2022, the Company has not considered the effect of the warrants sold in the Initial Public Offering to purchase an aggregate of 2,130,000 shares in the calculation of diluted net income (loss) per share, since the exercise of the warrants is contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic (income) loss per share for the period presented.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The net income (loss) per share presented in the statement of income is based on the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Years Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 611,525</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,345,808</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accretion of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,614,948)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (800,004)</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Undistributed income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,003,423)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 545,804</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:45.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the years ended December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:22.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ordinary</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-Redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ordinary</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-Redeemable</b></p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="font-size:8pt;font-weight:bold;margin-left:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ordinary Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ordinary Share</b></p></td></tr><tr><td style="vertical-align:bottom;width:53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per share:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Numerators:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Allocation of undistributed income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (731,650)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (271,773)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 415,060</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 130,744</p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accretion of carrying value to redemption value of redeemable shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,614,948</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 800,004</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Allocation of net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 883,298</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (271,773)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,215,064</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 130,744</p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Denominators:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted-average shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,392,094</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,260,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,000,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,260,000</p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden__a8GlZMMTkK3gQdeYqQdiQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_2e0Xc14Z2E2xUWysJxXx9w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.22)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_fiN8b7Q1WEqFMC9KpEgqUA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_VzCa-922l06E59kcSxbD2g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.10</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p> 2130000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Years Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 611,525</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,345,808</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accretion of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,614,948)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (800,004)</p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Undistributed income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,003,423)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 545,804</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:45.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the years ended December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:22.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ordinary</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-Redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ordinary</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-Redeemable</b></p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="font-size:8pt;font-weight:bold;margin-left:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ordinary Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ordinary Share</b></p></td></tr><tr><td style="vertical-align:bottom;width:53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per share:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Numerators:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Allocation of undistributed income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (731,650)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (271,773)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 415,060</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 130,744</p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accretion of carrying value to redemption value of redeemable shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,614,948</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 800,004</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Allocation of net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 883,298</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (271,773)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,215,064</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 130,744</p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Denominators:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted-average shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,392,094</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,260,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,000,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,260,000</p></td></tr><tr><td style="vertical-align:bottom;width:53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted net income (loss) per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden__a8GlZMMTkK3gQdeYqQdiQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.71%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_2e0Xc14Z2E2xUWysJxXx9w;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.22)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_fiN8b7Q1WEqFMC9KpEgqUA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_VzCa-922l06E59kcSxbD2g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.10</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p> 611525 1345808 -1614948 -800004 -1003423 545804 -731650 -271773 415060 130744 1614948 800004 883298 -271773 1215064 130744 3392094 1260000 4000000 1260000 0.26 -0.22 0.30 0.10 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Fair Value of Financial Instruments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ASC Topic 820 “<i style="font-style:italic;">Fair Value Measurements and Disclosures</i>” (“ASC 820”) defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with the market approach, income approach and cost approach shall be used to measure fair value. ASC 820 establishes a fair value hierarchy for inputs, which represent the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The fair value hierarchy is categorized into three levels based on the inputs as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 12pt 18pt;">Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 12pt 18pt;">Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 12pt 18pt;">Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC 820 approximates the carrying amounts represented in the balance sheet. The fair values of cash, and other current assets, accrued expenses, due to sponsor are estimated to approximate the carrying values as of December 31, 2022 and 2021, due to the short maturities of such instruments.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Convertible notes</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company evaluates all convertible notes, to determine if such notes are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Reclassification of Prior Year Presentation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Certain reclassifications have been made between accrued expenses and amount due to a related party, to conform to the current year presentation. The reclassifications did not impact previously reported total current liabilities, total liabilities, the net cash used in operating activities or net cash provided by financing activities.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Recently Issued Accounting Standards</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. The amendments are effective for smaller reporting companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying financial statements.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 3 - INITIAL PUBLIC OFFERING</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Pursuant to the Initial Public Offering on July 28, 2020, the Company sold 4,000,000 Units at a purchase price of $10.00 per Unit. Each Unit consists of one ordinary share and one redeemable warrant (“Public Warrant”). Each Public Warrant will entitle the holder to purchase <span style="-sec-ix-hidden:Hidden_OzWSk7tZgUOPKzNHO_SAbQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span>-half of one ordinary share at an exercise price of $11.50 per whole share (see Note 8).</p> 4000000 10.00 1 1 11.50 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 4 - PRIVATE PLACEMENT</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 260,000 Private Units at a price of $10.00 per Private Unit, for an aggregate purchase price of $2,600,000. The proceeds from the Private Units were added to the net proceeds from the Initial Public Offering held in the Trust Account. The Private Units are identical to the Units sold in the Initial Public Offering, except for the private warrants (“Private Warrants”), as described in Note 8. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Units and underlying securities will be worthless.</p> 260000 10.00 2600000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 5 - RELATED PARTY TRANSACTIONS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Founder Shares</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December 2018, the Company received $25,000 for the anticipated issuance of 1,150,000 founder shares to the Sponsor. As of December 31, 2018, one founder share was issued to the Sponsor. The remaining 1,149,999 founder shares were issued to the Sponsor on February 21, 2019.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The 1,150,000 founder shares included an aggregate of up to 150,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the Sponsor will collectively own 20% of the Company’s issued and outstanding shares after the Initial Public Offering. On September 10, 2020, the underwriter did not exercise their over-allotment option election, resulting in the forfeiture of 150,000 founder shares. Accordingly, there were 1,000,000 Founder Shares issued and <span style="-sec-ix-hidden:Hidden_8x6I_WAQfkmGih9NPLasbw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">outstanding</span></span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The initial shareholders have agreed not to transfer, assign or sell any of the founder shares (except to certain permitted transferees) until, with respect to 50% of the founder shares, the earlier of (i) six months after the date of the consummation of a Business Combination, or (ii) the date on which the closing price of the Company’s ordinary shares equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after a Business Combination, with respect to the remaining 50% of the founder shares, upon six months after the date of the consummation of a Business Combination, or earlier, in each case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Private placement </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the Initial Public Offering on July 28, 2020, the Sponsor purchased an aggregate of 260,000 Private Units at a price of $10.00 per Private Unit, for an aggregate purchase price of $2,600,000. Each Unit consists of one ordinary share and one Private Warrant. Each Private Warrant will entitle the holder to purchase one-half of one ordinary share at an exercise price of $11.50 per whole share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Administrative Services Arrangement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company entered into an agreement whereby, commencing on July 24, 2020, through the earlier of the Company’s consummation of a Business Combination and its liquidation, the Company will pay the Sponsor a total of $10,000 per month for certain general and administrative services, including office space, utilities and administrative services, as the Company may require from time to time. For the year ended December 31, 2022 and 2021, the Company incurred $120,000 and $120,000 in fees for these services, respectively. These amounts were unpaid during the years. As of December 31, 2022 and 2021, the balances due to related parties were $290,000 and $170,000, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Promissory Note Payable — Related Party</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On February 21, 2019, the Company issued a non-interest bearing, unsecured promissory note to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. On June 30, 2019, the Company amended the promissory note such that the Company may borrow up to an aggregate total principal amount of $500,000 (the “Promissory Note”) and on June 20, 2020, the Company further amended the Promissory Note such that the Promissory Note is payable on the earlier of (i) December 31, 2020 or (ii) the consummation of the Initial Public Offering. In connection with the Promissory Note, the Company converted $24,995 in advances as of December 31, 2018 into amounts outstanding under the Promissory Note. On July 28, 2020, the Company amended the Promissory Note such that it is payable upon the consummation of a Business Combination. On October 31, 2022, the Company further amended the promissory note such that the Company may borrow up to an aggregate total principal amount of $800,000. At December 31, 2022 and 2021, there was $745,504 and $393,808, respectively, outstanding under the Promissory Note. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Promissory Note but no proceeds held in the Trust Account would be used to repay the Promissory Note.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Working Capital Loans</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $2,500,000 of notes may be converted upon consummation of a Business Combination into additional Private Units at a price of $10.00 per Unit. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December 31, 2022 and 2021, there was no outstanding balance under the Working Capital Loans.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Extension Loans Payable — Related Party</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As discussed in Note 1, the Company has extended twenty-three times the period of time to consummate a Business Combination until June 28, 2023. On each of July 27, 2021, August 27, 2021, September 27, 2021, October 27, 2021, November 27, 2021, December 27, 2021, January 27, 2022, February 27, 2022 and March 27, 2022, the Company obtained loan extension in an amount of $133,334 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until April 28, 2022. On each of April 27, 2022, May 27, 2022, June 27, 2022, July 27, 2022, August 27, 2022 and September 27, 2022, the Company obtained loan extension in an amount of $129,425 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until October 28, 2022. On each of October 27, 2022 and November 27, 2022, the Company obtained loan extension in an amount of $20,155 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until December 28, 2022. On each of January 4, 2023, January 31, 2023, February 28, 2023 and March 31, 2023, the Company obtained loan extension in an amount of $20,155 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until April 28, 2023. On each of April 30, 2023 and May 18, 2023, the Company obtained loan extension in an amount of $6,767 from the sponsor, total amounting to $2,111,017 pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until June 28, 2023. Any such payments would be made in the form of a loan. The notes would either be repaid upon consummation of a Business Combination, without interest. If the Company completes a Business Combination, the Company would repay such loaned amounts out of the proceeds of the Trust Account released to the Company. If the Company does not complete a Business Combination, the Company will not repay such loans. Furthermore, the letter agreement with the initial shareholders contains a provision pursuant to which the Sponsor has agreed to waive its right to be repaid for such loans in the event that the Company does not complete a Business Combination. The Sponsor and its affiliates or designees are not obligated to fund the Trust Account to extend the time for the Company to complete a Business Combination. As of December 31, 2022, the Company has extended seventeen times the period of time to consummate a Business Combination. The Company obtained loan extension from the Sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination. The Notes are non-interest bearing and is payable upon the closing of a business combination. As of December 31, 2022 and 2021, there were $2,016,863 and $800,004, respectively, outstanding under the note payable to related party in balance sheets.</p> 25000 1150000 1 1149999 1150000 150000 0.20 150000 1000000 0.50 12.50 P20D P30D 0.50 260000 10.00 2600000 11.50 10000 120000 120000 290000 170000 300000 500000 24995 800000 745504 393808 0 2500000 10.00 0 133334 133334 133334 133334 133334 133334 133334 129425 129425 129425 129425 129425 129425 20155 20155 20155 6767 6767 2111017 2016863 800004 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 6 – COMMITMENTS AND CONTINGENCIES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Registration Rights</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to a registration rights agreement entered into on July 23, 2020, the holders of the founder shares, Private Units (and their underlying securities), the shares underlying the warrants underlying the unit purchase option issued to the underwriters and any Units that may be issued upon conversion of the Working Capital Loans (and underlying securities) are entitled to registration rights. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. Notwithstanding the foregoing, the underwriters may not exercise their demand and “piggyback” registration rights after five (5) and seven (7) years after the effective date of the registration statement and may not exercise their demand rights on more than one occasion. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Underwriting Agreement</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The underwriters were paid a cash underwriting discount of two and one-half percent (2.5%) of the gross proceeds of the Initial Public Offering, or $1,000,000. The underwriters are entitled to a deferred fee of two and one-half percent (2.5%) of the gross proceeds of the Initial Public Offering, or $1,000,000. The deferred fee will be paid in cash upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement.</p> 0.025 1000000 0.025 1000000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 7 - SHAREHOLDERS’ DEFICIT</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Preference Shares</i><span style="font-style:italic;font-weight:bold;"> </span>— On February 21, 2019, the Company filed an Amended and Restated Memorandum and Articles of Incorporation, pursuant to which the Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors. At December 31, 2022 and 2021, there were no preference shares designated, issued or outstanding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Ordinary Shares</i><span style="font-style:italic;font-weight:bold;"> </span>— On February 21, 2019, the Company filed an Amended and Restated Memorandum and Articles of Incorporation, pursuant to which the Company is authorized to issue 100,000,000 ordinary shares, with a par value of $0.0001 per share. Holders of the ordinary shares are entitled to one vote for each ordinary share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022, there were 1,260,000 ordinary shares issued and <span style="-sec-ix-hidden:Hidden_jol4ZINH5Ee27e7qNyVwAg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">outstanding</span></span>, excluding 610,752 ordinary shares subject to possible redemption, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2021, there were 1,260,000 ordinary shares <span style="-sec-ix-hidden:Hidden_0Eq-EPMAhU6htKu4fezstg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">issued</span></span> and outstanding, excluding 4,000,000 ordinary shares subject to possible redemption, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Unit Purchase Option</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">On July 28, 2020, the Company sold the underwriter (and/or its designees), for $100, an option to purchase up to 240,000 Units exercisable at $11.00 per Unit (or an aggregate exercise price of $2,640,000) commencing on the later of the consummation of a Business Combination and January 28, 2021. The unit purchase option may be exercised for cash or on a cashless basis, at the holder’s option, and expires five years from the effective date of the registration statement related to the Initial Public Offering. The Units issuable upon exercise of the option are identical to those offered in the Initial Public Offering. The Company accounted for the unit purchase option as liability classification. The unit purchase option is valued based on the fair value of the Units. These amounts are below the exercise price of the unit purchase option therefore the probability of exercise is low resulting in a de minimus value for the unit purchase option. The option and such units purchased pursuant to the option, as well as the ordinary shares underlying such units, the warrants included in such units, and the shares underlying such warrants, have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(g)(1) of FINRA’s NASDAQ Conduct Rules. Additionally, the option may not be sold, transferred, assigned, pledged or hypothecated for a one-year period (including the foregoing 180-day period) following July 28, 2020 except to any underwriter and selected dealer participating in the Initial Public Offering and their bona fide officers or partners. The option grants to holders demand and “piggy-back” rights for periods of five and seven years, respectively, from July 28, 2020 with respect to the registration under the Securities Act of the securities directly and indirectly issuable upon exercise of the option. The Company will bear all fees and expenses attendant to registering the securities, other than underwriting commissions which will be paid for by the holders themselves. The exercise price and number of units issuable upon exercise of the option may be adjusted in certain circumstances including in the event of a stock dividend, or the Company’s recapitalization, reorganization, merger or consolidation. However, the option will not be adjusted for issuances of ordinary shares at a price below its exercise price.</p> 1000000 0.0001 0 0 100000000 0.0001 1 1260000 610752 1260000 4000000 100 240000 11.00 2640000 P5Y <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 8 - WARRANTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Warrants</i><span style="font-style:italic;font-weight:bold;"> </span>— Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) the consummation of a Business Combination or (b) 12 months from the effective date of the registration statement relating to the Initial Public Offering. No Public Warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to such ordinary shares. Notwithstanding the foregoing, if a registration statement covering the ordinary shares issuable upon the exercise of the Public Warrants is not effective within 60 days, the holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise the Public Warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act. If an exemption from registration is not available, holders will not be able to exercise their Public Warrants on a cashless basis. The Public Warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Redemption of warrants when the price per share of ordinary shares equals or exceeds $16.50. Once the Public Warrants become exercisable, the Company may redeem the Public Warrants (except with respect to the Private Placement Warrants):</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">in whole and not in part,</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">at a price of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$0.01</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per warrant,</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">upon not less than </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> days’ prior written notice of redemption to each Public Warrant holder,</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if, and only if, the reported last sale price of the ordinary shares equal or exceed </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$16.50</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> per share, (as adjusted for share splits, share capitalizations, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> trading days within a </span><span style="-sec-ix-hidden:Hidden_1sWCmO_CqUu66Rm3CfcvjA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> trading day period ending on the third trading day prior to the notice of redemption to Public Warrant holders, and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants at the time of redemption and for the entire </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">-day trading period referred to above and continuing each day thereafter until the date of redemption.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, if (x) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the ordinary shares during the <span style="-sec-ix-hidden:Hidden_XB8pxZSY5km6t3gBaUEkQQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">20</span></span> trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $16.50 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 165% of the higher of the Market Value and the Newly Issued Price.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Private Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Warrants and the ordinary shares issuable upon the exercise of the Private Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions and the Private Warrants underlying the Private Units issued to the underwriter may not be exercised after five years from the effective date of the Initial Public Offering. Additionally, the Private Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A summary of warrants as of December 31, 2022 and 2021 is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average life</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Public warrants issued from the Company’s initial Public Offering in July 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,000,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Private warrants issued from the Company’s private placement in July 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 260,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance of warrants outstanding as of December 31, 2022 and 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,260,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5 years</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> P12M P60D P5Y 16.50 0.01 P30D 16.50 P20D P30M 9.20 0.60 9.20 1.15 16.50 1.65 P30D P5Y <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average life</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Public warrants issued from the Company’s initial Public Offering in July 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,000,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Private warrants issued from the Company’s private placement in July 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 260,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:73.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance of warrants outstanding as of December 31, 2022 and 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,260,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5 years</p></td></tr></table> 4000000 260000 4260000 P5Y <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 9 - FAIR VALUE MEASUREMENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 18pt;">Level 1 — Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 18pt;">Level 2 — Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 18pt;">Level 3 — Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following tables present information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2022 and 2021, and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.00925827%;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted Prices In</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable</b></p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level 1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level 2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level 3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Assets:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">U.S. Treasury Securities held in Trust Account*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,658,707</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,658,707</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Derivative warrant liabilities – Public warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 54,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 54,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Derivative warrant liabilities – Private warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,734</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,734</p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total fair value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 63,134</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 54,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,734</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted Prices In</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">Description</p></td><td style="vertical-align:bottom;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level 1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level 2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level 3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Assets:</p></td><td style="vertical-align:bottom;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">U.S. Treasury Securities held in Trust Account*</p></td><td style="vertical-align:bottom;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 41,419,557</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 41,419,557</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Liabilities:</p></td><td style="vertical-align:bottom;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Derivative warrant liabilities – Public warrants</p></td><td style="vertical-align:bottom;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 840,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 840,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Derivative warrant liabilities – Private warrants</p></td><td style="vertical-align:bottom;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 110,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 110,000</p></td></tr><tr><td style="vertical-align:bottom;width:39.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total fair value</p></td><td style="vertical-align:bottom;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 950,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 840,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 110,000</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">*</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">included in marketable securities held in Trust Account on the Company’s balance sheets.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on our balance sheets. At December 31, 2022 and 2021, the fair value of Public Warrants was measured using quoted prices in an active market (Level 1) and the fair value of Private Warrants was measured using Black-Scholes model. There were no transfers between Levels 1, 2 or 3 during the years ended December 31, 2022 and 2021. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The key inputs into Black-Scholes model for the Private Warrants were as follows at their measurement dates:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:58.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:58.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Input</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.35</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.98</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:58.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:58.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercise price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Warrant life</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The following table presents the changes in the fair value of warrant liabilities for the year ended December 31, 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:52.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:52.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Public</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Private</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair Value at January 1, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 840,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 110,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 950,000</p></td></tr><tr><td style="vertical-align:bottom;width:52.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_ELI_LpeNEEi5Bjtti81Q8Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in fair value of public and private warrants</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (785,600)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (101,266)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (886,866)</p></td></tr><tr><td style="vertical-align:bottom;width:52.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair Value at December 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 54,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,734</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 63,134</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The following table presents the changes in the fair value of warrant liabilities for the year ended December 31, 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Public</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Private</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair Value at January 1, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,740,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 190,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,930,000</p></td></tr><tr><td style="vertical-align:bottom;width:66.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden__ENRbRm4YEezNgIAajTQlw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in fair value of public and private warrants</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,900,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (80,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,980,000)</p></td></tr><tr><td style="vertical-align:bottom;width:66.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair Value at December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 840,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 110,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.38%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 950,000</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.00925827%;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted Prices In</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable</b></p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level 1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level 2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level 3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Assets:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">U.S. Treasury Securities held in Trust Account*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,658,707</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,658,707</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Liabilities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Derivative warrant liabilities – Public warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 54,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 54,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Derivative warrant liabilities – Private warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,734</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,734</p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total fair value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 63,134</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 54,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.11%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.06%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,734</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quoted Prices In</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant Other</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Significant Other</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Active Markets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Observable Inputs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unobservable Inputs</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">Description</p></td><td style="vertical-align:bottom;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level 1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level 2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Level 3)</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Assets:</p></td><td style="vertical-align:bottom;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">U.S. Treasury Securities held in Trust Account*</p></td><td style="vertical-align:bottom;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 41,419,557</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 41,419,557</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Liabilities:</p></td><td style="vertical-align:bottom;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Derivative warrant liabilities – Public warrants</p></td><td style="vertical-align:bottom;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 840,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 840,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Derivative warrant liabilities – Private warrants</p></td><td style="vertical-align:bottom;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 110,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 110,000</p></td></tr><tr><td style="vertical-align:bottom;width:39.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total fair value</p></td><td style="vertical-align:bottom;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 950,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 840,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.63%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 110,000</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">*</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;">included in marketable securities held in Trust Account on the Company’s balance sheets.</p></td></tr></table> 6658707 6658707 54400 54400 8734 8734 63134 54400 8734 41419557 41419557 840000 840000 110000 110000 950000 840000 110000 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:58.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:58.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Input</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.35</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.98</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:58.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:58.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercise price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Warrant life</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p> 10.76 10.35 0.0398 0.0120 0.0100 0.12 11.50 11.50 5 5 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:52.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:52.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Public</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Private</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair Value at January 1, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 840,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 110,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 950,000</p></td></tr><tr><td style="vertical-align:bottom;width:52.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_ELI_LpeNEEi5Bjtti81Q8Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in fair value of public and private warrants</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (785,600)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (101,266)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (886,866)</p></td></tr><tr><td style="vertical-align:bottom;width:52.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair Value at December 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 54,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,734</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 63,134</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Public</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Private</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair Value at January 1, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,740,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 190,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,930,000</p></td></tr><tr><td style="vertical-align:bottom;width:66.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden__ENRbRm4YEezNgIAajTQlw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in fair value of public and private warrants</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,900,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (80,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,980,000)</p></td></tr><tr><td style="vertical-align:bottom;width:66.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair Value at December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 840,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 110,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.38%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 950,000</p></td></tr></table> 840000 110000 950000 -785600 -101266 -886866 54400 8734 63134 2740000 190000 2930000 -1900000 -80000 -1980000 840000 110000 950000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 11 - SUBSEQUENT EVENTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In accordance with ASC 855, Subsequent Events, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before the consolidated financial statements are issued, the Company has evaluated all events or transactions that occurred after the balance sheet date, up through the date was the Company issued the financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On January 4, 2023, January 31, 2023, February 28, 2023 and March 31, 2023, the Company obtained extension loan in an amount of $20,155 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until April 28, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On April 30, 2023 and May 18, 2023, the Company obtained extension loan in an amount of $6,767 from the sponsor, pursuant to which such amount had been deposited into the Trust Account in order to extend the amount of available time to complete a business combination until June 28, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On April 25, 2023 the Company amended and restated memorandum and articles of association to extend the date by which the Company has to consummate a business combination six (6) times for an additional one (1) month each time from April 28, 2023 to October 28, 2023 by amending the Amended and Restated Memorandum and Articles of Association by deleting the existing Section 48.7 thereof and replacing them with the new Section 48.7.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">On April 25, 2023, 405,705 shares of common stock were presented for redemption in connection with the Extraordinary General Meeting.</p> 20155 20155 20155 20155 6767 6767 6 P1M 405705 EXCEL 50 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( $FJN58'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " !)JKE6%ES;_N\ K @ $0 &1O8U!R;W!S+V-O&ULS9+/ M3L,P#(=?!>7>NG^T(:(N%Q GD)"8!.(6.=X6K6FCQ*C=V].&K1."!^ 8^Y?/ MGR4WZ"7V@5Y"[RFPI7@SNK:+$OU&')B]!(AX(*=C/B6ZJ;GK@],\/<,>O,:C MWA-41;$&1ZR-9@TS,/,+4:C&H,1 FOMPQAM<\/XSM EF$*@E1QU'*/,2A)HG M^M/8-G %S#"FX.)W@&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW A(5M>5 TR M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04 M" !)JKE63/(KTR0) "300 & 'AL+W=OSVD2'SMMI[NS'Q108J: O$+4 MR7^_$F#+](@7Z,K]T/CV/H8?0N_SQEE:T9P6!0E\(Q"3@4@*+/S^( M3^)8*HGE^&\E.MA]IRSIW.Y+ MSL2[D:CC5U,:Y&(SEM-,@;3OHCJ9\E0G=D(1U@9%8SMW".MN%O79 Q2D)CI%K'R''U0>I"Z0OGXMB8Z;'"Y M;0W_T/$!J_KR,216XS/>\1EWXS-)TQS':$'6E'$=*%B'LUR'UP>K^H(R)%8# M=;(#==)Q(#$L6ENQ2S;#@K6><9QI:8%E?6D9$JO1.MW1.NU&:TY81&7[")%H M0MH]L$5I.S,WSNQ@?5]HAL1JT,YVT,[ 5:UZ[&T4$W2?)T^$Z7#!&I9E#]US MS_)TI,#2OJ0,B=5(G>](G7::'!BO=4 M"PTLZ@W-D%H=FLH&-NB7U:CCA)716'96O*6HA08K-D SF@%,J=6AJ11@PSY^ M.]($("9<[DRDSE?T!WG3TH*E1(NP3T_.SFUMIX"+>U,[1#2P53:P85._W3%O MHRP0U+X1S$ GUR(W'-K.T-7%:Q^N[(WM$$'!5DG![A@5]KG=BA?U,QHLUN1Z MX;+>Q X1%FR5%NR.<:$B5J6&9F:PW.TW+3&C0<&46IV8B@HV[/,G E=8(HOQ MBY81+-"80>&ZWI@.$1-LE1/L3D'A*XGCX?>4;E*T)#BC*0G1+,MR?5)HT6QH MET8S@BFU^K%4%1*<3B%A$H9"/3O:/D#%((BHX*BHXG:+"#J,OGXD!]"CV:2U"6&XI!N++"D=:;D;3@BFU.C>5 M%IQ.:4%Q*T.I%AFLY&L#/5S4&]8A4H*C4H+3*27L8,UIQH4;^5>T;@SQ+8J. M" N.-BC A;W!'2(H."HH."U!H<#&"&[F! O\XTS?"8S& E-J=4@J%CBPD_]$ M"VN[$NX#.$S9(N+80Y$(QJ?GMO;P$%S=&]@A4H&C4H$#V_B]X^$,^2)SOM"& MF0O6N:?I$ @T MG=F#RWK#.D1.<%1.<#KEA)N$L!=Y /*C4. K,9LE:YSJQQPLV$C-:$PPI5:_ M2D'%!+=33+AYW3\I6F9W[14*L%IC(H7K>E^-<(@\X*H\X';* \N5B*30^&J1 M:1I?<%EO5HZ<7HAP[8WG5#G=S^%QH+EX]9U3NULWZ+DOX@ M!US4F\,AW+ZKW+[;R>W/\Z5*IG.QM+<]VQF?GMK?;7!4=HY;> ME%J=CK+T+NS()WD8<1&PF\X.MY3?81;D"?KT::X=1W#Q+8M(F."TH7P*E_\J M&F7D7=B#;]'<1BQ!LZF6#JQPVT ],M"DY M'6=%[](2,NFF?:-J4U-J=7K*F[NEBS5[-:Q)G^T;59N:4JM?$*M"T"'Q>^]@0;7-;[JMA#^'1/^70/-MB/$8\)HL_(=MX]O4=+ M$N1,V 4M+EAIM_>7SO4(S3%#7W"<$_2;=2PO)Y"9J7Q7B]6HI3>E5L>J++W7 MNFU.K E*7W8".^("$A"7X2 M@W&#F;Q@3XP@@H/5]BDBKX0%459\1$R0B*9DN,+Q,Z*UMJ-%;/2F :-J4U-J M=>Y[]PUXYKN.9S(!^$;5IJ;4ZCQ5GO!@3]^AZ\ "LNM\U6(R>I+ E%H=D\H6 M'NSQ^[0=6&EOXOA:31SE75RQW Q\1=#O- Y%X^%49& F9N.L.+=?SAWO[)'S M7B['@SSC7^M@VFU@]+R#*;7Z-E")QH/31)\>U9)+FGN4T5,-IM3JP%2^\>!\ M\SF-=ETIH&D69<55O&+TT+^,GN)N0OER-2BU5(V&(:-J4U-J==0J#'D'"$.> MT3!D5&UJ2JU^]YL*0^/_-PRU",BV]%F'":[K?>O;(=+06*6AL;$TU*)4S14W MP,SFHY&>W>K MRU.QQ5W_F>@I>\%WK^Y^66!2W$__T^O7]@>__'T )5/^7,$=EF=X,Q23 M9R%I'9\*O\?*7P HGW"Z+NZ)?Z*YW&*[^ M!U!+ P04 " !)JKE6^GS"?9T% "7%0 & 'AL+W=O;28,EOZ>$&4+HA)FTR05ZG7X46 1? M;8M*OKB/']9*?]$?#C;T@O7ZQ_+)P'9Q94LC%/OL:16E_T@AZ*V(KFB;KGVVNV M<\C5]I8\D<5_M-W)6CVTS*7BZ4X9$*1Q5G[2IUT@]A2PTZ) =@KDM0KV3L$N M'"V1%6Y=446' \&W2&AIL*8OBM@4VN!-G.G7.%,"GL:@IX:7HYO1Y_$$S:XG MD_D,O4=?9E?HW M!Y\JQTCE&"GLV2WVQKD0+%.(2LF4/#?Y4QIPS 9T_9S+#5VRBQX4B&3BD?6& MO_^&/>N#R;LW,G;@JUWY:G=9'XZI7)L<++6\0DO7\^/0"W$PZ#_N S<(8=^W M*ZD#1$Z%R.E$="?8AL818D_0;R23B&81XFK-!"3U_HLQP2Y-NWN(7&Q91[!_ M(G2 VJU0NYVHYUS1!+UDSJ@5H-OX;4RL1F";4IX7M 76JR!ZG1 _4?&=*;I( M&)(,0AFK&**[9DF$X@S-!70,-%HN>9XI$W+/@,D-?,L_PMZ4<["#0]?US?#] M"K[?'>';^>@&C68S:#8F?+X!'Z C[A&^IAS@"SS';LF H,(7O*IK)#%=Q$D1 M7&/K"-ZR=;R1L0.'P\KAL/.%0*Z(G-6%:G(V;*8[O)/P.-^;8H[M^,3\0K!5 M$Y35C3#5R8RBG"'%87)(J *\&RK4LY&DK 8,$EI6HW\8Y, KJZV%X#U"Q9UX M)T]J-^4DG&8 ]+FHUO>O@(Z;T"WL!9Y]C+TI&&CH3@OVFC-Q)TU!V^9I+"47 MSRCCBOT2>-+ Y#NNNX=IA[TI9X=V8 4MV&L.Q-TD>-B\;^H"-J*UFR@(L;%W MW&@,@MB!AA2TQ;IF2-Q-D5=LQ0!KA/(L8F*K.WGV@)8\U85(]8QK!-[D/6Q9 MIOS^N> A\)HD<3=+?J5"T,,>:41JX#\;VXU\:(J%;@?,FBAQ-U.65',S'5U. M;Z;SZ<3(-]A ="3P2!@>PVP*VK;;D0 M4;5G#3W2!,@$5$ZP=19:A9R^M%VT ?W"JGD!"EXY/AD$83[I:M$U7^.P F"A@'8)1<&JG#FQ MSB"@6%-2^4H_(-Q(C5RMN8C_9=$'8+2,(6 W/>X4ZTBNI((+*#;C=M@)Z!?* M[ T,'0:M'D5(]RC2*#-3R,J M04-GQ+OX*$Y@+H&H88@XEW5$H_ M$3J,S-[A0/>@ V-OGN;E2!.5-61$V!Q6WCO$=YQ&Q9LD;>);81M!D'JP(:\9 M;(QU;\3;DCW<-,@WU,TGWRZN[T?W7]#D[^^ M3.??T.CS%9I=C^XGU[ Y8WBF^(@;<&5XFEQN6847H@6@.RX/Q>3S[Y8\/21!""I[0$QD*OU/![* M])ML,UO7-8BWEHI'N3,21"S.KO0AWX@]![M[PL')'9QS'3JY0[IS9D:6AG5- M%9V,!-\2H:U130_2O4F],1H6ZV.<*X%W&?JIR=7EY\NOTQLRO[VY^3XG;V=4 M0*P"4,RCX3ORGKPF)I$!KLJ1J?"!VLWTI<)^> M[VZ7W4T,LXC5*6)U4KWN";T99@@( 3[!;?7N6R2A@G#,:445+FYHN :2@,CB MK0HWT^^G^OH'LIE8;P1RB%IG48)T"TCW69#XVL/+WUCGB>(DX5*R10C8,_@0);KVM^H*DG7$V+.MONLLK[@N>JW/FN1[;U9_K8_6UZ\OO7<%)$L&\AC=M+C8HO9#:PT/:2JN.>\!J M[O5WNKG^0L6*Q9*$L$0_J]W'<$76KV83Q9.TY5MPA0UD.@RPQP>A#?#^DG.U MF^@NLOC7,/D/4$L#!!0 ( $FJN5;MKF5/SP0 +X5 8 >&PO=V]R M:W-H965T&ULQ5C;R8LL0:#=)[ M3V(TX"L5L02>!)*K.*;BUS5$?#.TL+6]\9W-%\K#)9W#,Z@?RR>AK^PB M2LAB2"3C"1(P&UI7^'),B'%(+?YBL)$[Y\A0F7+^8B[NPJ'E&$000:!,"*H/ M:QA#%)E(&L?//*A5O-,X[IYOHW])R6LR4RIAS*._6:@60\NW4 @SNHK4=[[Y M!CFAKHD7\$BF_VB3VSH6"E92\3AWU@ABEF1'^IHG8LPT.)'<@APZ=!@'^+SM&/YQOTZ??/ UOI=QA+.\CC76?Q2$,\3- ]3]1"HMLD MA' _@*W!%0C)%N$U:8UX \$%@-[O4NEQLSUNZY; MF.U![A20.ZV0)UQIP'KE&YS)?(M3U@'-(G5W$)S7(JVS:X':+:!V4T>W >JC M6H! + EX#.A3#O3S91W2;AMG4_TNY9(&,+1T>9,@UF"-_O@->\Z?=7/H2,'V M.'L%9Z]U>,8+FLQ!DT8SR@1:TV@%B,_0A@I!$X4B1JNQ8J=L-DXKVH?;2=YC:CN+4RU_=?!J[-KQ[31#W+X4>1QK M;:&[;O"BE&@%22Z U^D=KTK&B[>>"E+D@QRK% M>:1C\3Y2M'W>97_'[0W^FDH6H$VJ_W0EHVO=-G5YE@NJWX:T$I9*]W[=1\\0 M%_JHQ>_V(55*L.DJ*WEZVGP5 $G U"]=YGZNF&2I2F%3=,(K=:]]P^ MPX3G-)QZ5>P.V"X89%*\/]A$FHZHN&)%0-VY-0*A':"K M?K$&(ET%/B,MHS*J_Q?U#):_P\BY((==K]:J07SA4HG@=BFR'?@3L/;>Q;K. MJHEU*6%PNX;9J_H)5_^E\K>^X<,5\$C1]O-1BA_L'ZWRM^JH#_,^4K1]WJ64 MPNU:ZN25OT9W$6^OEN5Y>MMP_U.[%&BD7:"=OO+G -].PCL,]Y-0JD#2K@)/ M5?ES6+O5[5P7P<,OB1HSYZ+A,X*4CNX?XTOQ]E68ADFV]F\IV+.$HDBF.F0SD5/ST"1 M;19F%XHOT_VV*5>*Q^GI F@(PACHYS/.U?;"O*#8LAW]"U!+ P04 " !) MJKE6R%^_C&0# #.#0 & 'AL+W=OW?SW;2C(0DA;;C M _'CWG-SCGUO[.Z6LI]\B;$ OY,XY3UC*<3JS#1YM,0)XJ=TA5,Y,Z 8W' M@3NR6 HU8/:[*[3 $RSN5[=,]LP"9482G')"4\#PO&<,X-D(:@=M\9W@+=]I M T7E@=*?JG,UZQF6>B,F35*W[1# Y2Z2?Z$^F@^GXV_AZ.@$W%V!X.;C^,IZ JVLP MN1S3<$)N)^,P(>W'[NFD-$5AAGED!"Y#-4KD[/DKT*P-;JJ;F=\A2+< M,V3YXIAML-%_]P;ZUN>Z-7XEL))0;B&4VRJ4W(8,ZYI%YR!"C/TAZ0)L4+S& M0%!9"VEY/5:G66N ([48NGL+6 ':XQ]; EX++5/+ MW#D[JYO.-\06).4@QG,);YT&DA[++@]91]"5/DX_4"$/Y[JYE!7.'Z?P%02P,$% @ 2:JY5HU%0M$:!@ AAD !@ !X;"]W M;W)K2. MF1QA KG[+&P1W+,M*@D(_[Z2[-@8"X=<:3X$OZP>/[M:K1ZOK[>4_>1+0@1X M3>*4W[260JRNVFT>+$F"^6>Z(JF\LZ LP4*>LIGVI@5;;Q>>HI>E4!?:O>L5?B%3(IY7 M$R;/V@5*&"4DY1%- 2.+FU8?7@U01PW0%M\CLN5[QT"Y,J?TISH9A3E,W/,R8#&/Z)0+&]:?@N$ M9('7L7BBVZ\D=\A5> &-N?X/MKFMU0+!F@N:Y(,E@R1*LU_\F@=B;P#TC@Q M^0!T., Y,L#.!]C:T8R9=NL."]R[9G0+F+*6:.I QT:/EMY$J9K&J6#R;B3' MB=YTUI\-OPW',_!X#P;]Z5=P__#X8PHNP?/T#GSZ_<_KMI"/4<;M((>\S2#1 M$4B(P#>:BB4'PS0D816@+?D5)-$;R5O4B'A'@L_ AA< 60@9" U.'PX;Z-A% MS&R-9Q_!&V"^! NY #A8,)H N:88%E'ZDB5E)"+"36'+4!TSJEJO5WR% W+3 MD@N2$[8AK=X?OT'/^LOD\IG *@%PB@ X3>B]L2PO41K0A(!/,>71>MS?[?M3-H.VXON47=A6*;D'1;9RC?OBW7#RRW@@.!)4%)Z!I M$,4$I"5W>5V=!6HZUYR$\OK)<^F>,D6#,=#; DL0[5C,D(@WX0T'4J3#'*'NSN3>VEW?%=VSM( M 8.=8SO0G "=PJ].HU^#)4Y?B.*YP!$#&QRO": +L,6,X52 .,+S*#XZOYTZ M)]_W?.^0N\$.=GU+_IGI^P5]O[G&%/3W,I)S(M,9I^$^^RL3??^ MEA4UQD+27F$F=D;"T!2P_861$W[7KLH8E8S1N[O4+]7V'+=:D"S/=>$A=8.A M[4.[>XQ[J3#@QR1&E&YDC3Z!^EDUQKG0JD$H509LEADZ"-M(+$.&MVD6"*$W M'9QM.FH'7^&=S,60D$1%AR\Q(TL:AX29X^/49LSV;-=#SJ$N:>;VJ[Z7\@4V M;OIE\JX8W4121H/Y[O0L<$_V\O^0'K#4'M#[4)HOHE06F1,<;-0T'T[S,Z%5 M@U *%=BL5"9XIW2J$B=TL2!,N1]0;M[2FK$^[+E!OM@-M;=4+[!1%/2>Y*Y= M>"53.(DXIVP'4BJ(6K):4UZ>L(F<5![&H4&A(1Y#O\7 M;^L:PW:AUZWM\6<2-M67\5*QH&;%\B3+;;+271B5LRR4JU9ZJVNOR2U4ER27 M1^I1\Y-_U;-2Y*!FD5.3#*<6)%07,=)%RW)1K%TCX<%.QS[D6C=S.G9W+[NJ5$L%@MY7(!> J%>.!I)U3>%UH7_( MT6!5<:5*L10*J+G1,7V>3!YT!Z__ .Y&T\'#X_3Y::C:>>/'\:5NZ8W&WX?3 MV6C\!?3'=^!^-.Z/!_IL,!M]'\U&PZGQ)1*=M"5)OZ"B]B<%"'DHMO:^KC;YWZET\ M)%\[W5KQJQL:?6_O=;03PEYTHY\#S2SK&Q=7BX\)?=U"/[A^"Z\&V2>!$B;[ M0O$-,UF!.(C)0D):GSMR0EC6],].!%WIOOF<"D$3?;@D6$9 &/J=KG\S+Y[JI"U7)3R:Q35D*LWTE"[UY<30Y\A<^J^6JQ@NG+Y^O MQ5+>ROK+^I.!;Z=AE%R5LK)*5XF1BQ='UY.?7IWA_73#OY3YD+*V]T M\=\JKUF-*Z>2):Y6M1BY?/C=XD!N^&T? #;96>AL6I"IER M6QOX5<%S]?WCW/]>_O?OX(;G^\#IY]>7VW8.7 M#Z^?G]8P$]Y_FKE17_&HTSVC3J;)>UW5*YN\J7*9=PT;CS?[D??.H9\.CH@;]9-))/D:?*8X9.W1LHJ4_4VN<[^:)15 MI%LWVJRU$?3YN%[)Y.]_NYI.QS_?Z'(MJBU]F_Q\DBB;B&1>B.HN >N2P5^^ M(5%5YH:0.7Q)<(P;L2U%E;RS<']N$QCZO=@FDS.4@E&E4MTT162[&$3SB)2.Q*&)G(K]E*5$N9NN]&9KJR MM6F$QBV.)HD@T6KJYK455*_B^Y8L+6HJP5M:P M@P7.7TO#\]<:ME_5!@Q3(XI$&(.+ (,'M_(4,&9GO;!1#>/!3*I4A0![U,#\ MTEJDXUQ5[?* 6A(?+S7LQ]\E+8]8 ]/@\[%CTBL_R$T[B.?8*+DNZI5NEBMF MB6>732I=)P4L QD&.Q')6IA:90TN2U4Y6"ZSQ>F64B^-6*\4R*)PYK"XL"T0OF8,NQDS M!^2]*!I> ]!V4$ RD&B5@ZK9KA+AD.PO83@PN+*<@ZS-)@EN#X1RH6P&Z]Q* M@5*4DV+4XFNX,$I^@2G .@ ?<5SD-X@!3PJ:49-P!]+TM[:'#AV#\HE_^^A^ MF_V]NDK?KHKIOVGW[G][8RR2,[2\7B,_Y*F0DJ# #^9C$?P?0TFBR?&')Y- M!9BN >!@-D;1:A92PJW=&P!Z29IVYTXBQ1._%+B5C698 S!@I,"-9;H! MJ?Q%%P!0\6@Y^,N@?*N@%0]M<%0)&<75U-NQ5NM[$T=>C0NNKJ7EKGC;^, M;D?)4M]+4Y$&6PD<)R>2DK=QBRVEJ'!QX.Q0R<$+P0^WSOQ.C\7)\>3BI"4I MCD_#>4&ZSHAJDV=G2$A@(_P*Z+&SV.''_*IY.0D:^!I7N*7QKL9)+K;D_ JP MA>17O3N%X.8ISZ+:D3TJ84\".D7V3Q8@24U-*P/'6LFM\R/) D00=B_K(#X: M+"QNFSC\N0$F345R>7COM.=< CX G \+J8!LO3*%(HG]*CM6) MG])Y4;;\PXX4MWZLW",Y6F VW$J2OJR'.KO3--F$F))(T0-IFK:O! MVQ9"%0WX548]SC#N6Z43JMDSI#.&$4%[>HK9TXM1\@E$GNS _GV4@"(1O8 2 MUB"<< ?"1'[ S:-,3G@&C'@A5 D,7T)\:^MX9WN@T48![K-2WN%.&87 A7N0 M,8WTP9A @>.'R>\5DPP^VK5S3;4P2Q"H+F)C\Q5P&S@#0H6H??(KJ"+2<0FX MO(6.W14)0 QD,]QV2#S@RQW@-"01.PF\ M3&&5:RR =I1PX.F$CX+UDV@'8 MBTE6%-MD*W0F%L6>R.!71[^T2QPY=( Y UQ8QR(>(VOV+N"$N#>726,9\JSA M*P(*3[$45'R):!KQ"3^#4^0-BGNAP,,!\775(;IH(QGV'0C+5=60'R27Z,;+ M03$=HKG'L &,AT40=9VSMB/N3QVF S4&'4=515W60X(X%Q#9P'+EDV[4]Z5- M.]8D$6M4$P>?X".$## >[$9^Q0B +N,N=S:X#UK&&Z8E@XVUZBM;&?#C-*XE M.8 A/V:U1@3<$N!=%4<40=/N$6^B"O%ZZ=H;/Q1L$]:*@L_4\IL#I>/S M,>\Y8('^VK4!="0@F'*W(1VDH<5*DRG+Y%$F,9B PF4 ]T#3W%7W%.I()NP* M09^@.TJ.9X"?&0?)N/BO"LTR#([P\^R"L"&-D-((B&Z6H,=+M-W1(!'DN9I< MI)/Q9#29 8,MS66;HMY!1HCEKM*SZ=7H8N9L01OZ=\ *R5V?%\.2!T0W(A#L M00&\_6%ATXWY=N'"$3JJ-?O3)6N6SB:3=/+LZM]6N"YGWR%3I[=CYZ=OD(\7+L.&=V_-6%JZST>7DH&Q-T^DS^#=^-AH_*%N#\/:VF?].R),=O9&8GG3P MC: 4@]& @FA( !L4)A<*[LX#FG?2NBQ"*/V9SP!V/P_8O-">F)Z M37;9M3:HIOL+1=$W[)P'3'W(P!*" PRRND19@2WM9(%W0PL>2,-51& N8PIQ MFO%Q+:82 >?^T;"M@KL1H=;)U?@_/&4]AAV,M(XQW*; 8CA9 Q0HE;4!=P.< M13,AMD0F7?5A]$GB=DZFTN=.U+)R!IB4W$499%SQ<!)C+M8$9XMRML:8 MOY6&,A[54(*$N'D@I4'T#?$B3-\8P6EOT8FEF?2HB$X_(&+,@*:+!G61,[>/ M9Z%7%-*JV L'OZ?7:VUJ3'IN([?CRC@BP1];RP;ZX.S7+7NDD.-XE.V5BM0+ M\S1JUPN+>(4AAY3!4EQ=)?+,!Q,Z@ N[>G!17*,%/@ZG-P$UO)#JO"E,.H($7A! --!@86L%E) M%T;*+:,:G >9Z1(WWR(\Z"8\E89ICC9"=4 /^5!T,Z#)2X52'(I^K=U\X4P,_"41(S(],J\']B/M+PGI9P=YEE**]'?M4Z1],^2@ M%Q(R)V_$GT!^%^(>";O8*Y @;8]=Q>'MH%W*M>1*(R94&[ !+7*S*$"V$6UB M,I9Y=K_#);1KEU;&.3Y+JDOE ./!),.5IJ3KUUC++-C\7ENK,R4A4U_9Y?P9/[I9Z7+W=L5%0"X) UTR M:9QQA_6X+/G2Z&;MDN+),:65%P12V6#[G/QDYCEYVSJ<-ZX:WJ;C9V=[T_'Q MS3X)3UEX-N?HA@"E(X$ILXJRP#6@ , )^]L=M#DYW_&372.,#V V?HC#K$F( M,D F2(,D8O%WBYZY)4/A:MG!\?G2BI??((,Y8-^)/4A/'2@_JRH DX#R!P3\-G>NLX;@&$8K+]W9A.I>Q2H20W&-&^@\,U@U0>2Y=A=#7L3#4VT;5Y.#3 ML9P;3*CWS =0.UK^'CI@H:5$>^$A4.1ZN@*X8*A@X"91]S&##Q?A8[4'&[O( MWJ5#)N<4L<93I$@H'R<"$5""2!FX!0'!;@@\DB?CT6R\,X2?6MX3(O:HRY>& MJ=9O>VD(&$/IG/81$A(/U6N.0;&!=!"U@22LBX9!?Z#-GFQX+\K=(1&*%!=J MY+W2C052/9 C1^WIY<1/F-.PJZ?,Y0W WE,!XR*X\K [RG\0%ET=V#KQ3 M6[)[.-K9P;Z4X><]A8<0-:+MAIB\L39J;;@X\<#:RVRE!VSJM^'4H7B_;U@W MU*3D*SA>C*@V4@4@L9,&PFB#$D=@#\#$9K4VSH$BRB-CNM#LF1SPB%V,SX#% MO E5:MH_Q7Q JA-<-J>TB%_=0=GR]G-2L7'9S41TFB[<+\S^3ML%;KXK'+[C M(D_RACL%@$R+.@1+PVF1&%_M2W8G7*IN'^=^!/0\1C) 1XPI*1MK7/]^'IU4Q'$C_4E8#!0#'3L2+E='/9@M#>DTXRH?F^J.%)"#$L% M3$]C@%198(*/':L@4L=M2PM9N8X4LL!T98DS%)0);!.AF<0:(R4^0_&[:QX? MC";[V=U]QIN98B6J4A5I1B^.')[P4'YD!T+M#R*[8R-NDCC!"0?D82=E\%(H M!-9W6."5'Y%PZDDBAND=.P/B[0TJ//60G&]IGN/\I/6V/=LVP'_XQ?D2;J)4 M:_S1M:B$?"^6L:..#6??-XI#-@ %:J\6J1!%^8ZT4?(/O0%88'R]>M?(#@*B M_:O9(Z5]X_&GVU43]!^/RI C8+,D/7;VU@+3)E,=[M2>L8L"E<^ M#K5S,FF!>,NEY-I$4VM\/(OXF9*!TT43(N(X];^+Z$UI6_39ZH+QNE!V=4%$ MNB!:7>A5/F#'EG(; :;[;)S=S8!0=JX=42RR"5@V(AC L!-G$":YL=8\.J6U)_ M#KO;:"&/)'1DU'K[Q6C3F=6=W+/O!XO2SU'$P\V8!_IE^I*VDSI-X;F:LF@X MBPM-R)JFWQ!W#7$AKZI_)",]_HCG;9O_?5MV$Y@_( M9B^JW)V5Y:#;8C14O$Z..=*N=N)7KFIOQVVN!3.'*!\!XO9M"$W][Z5=1-:A2[LHT37Z1<].Y1&Q]+\ K M1W?%=-+SFFO>A195U'I B"6NE$]FLW0V.VN-K^60L9OSLXMRS,YX[(!ALCC0]<6O7(.X!&;!>]_LK]B@5KBH'ITDV/46 Y , M*ZH9Y42I<+N6?-((33@>UAHZ"!CC"*J:"NI**M=U07T8G*2'!6^QMF^ICH?. M&\ ,]U"L8+=84XC37^0H,065,[90=8B<"A4W?-SX3GX,U*KVQ!92LV[;LRUY M<=V)'$UB :H@&_KXT]X2HKMYKCKA"Q8=[5X&ZQD&8[1X7" MPGQ*>U\_NJ]+H5+T'6>;INR><<2C)Z*RPAVF]/T9J4N:1CJQ_]P!I9:)X5&N MG-.YOOY-.HJY(@3I+(\[V? #J>8!D""[K5:+@<>PK9QS0'Q6-.R .V=\[P:W MA%$]./72*:R/AF.FQTKOJ.-4KX1/J@"G=RJ$V319>CE425J+84 M.=M;BNS>WF+:=SLE$+)@CJZ.J@I+I+(,#6'@P[$:!>:%2OFAB2#B3]HII72K M >1+5*3Z3L<=\_Q^MVTW! W\-#YS,M";$#5$>,UA,\6#[=1WZ"'JZZ(*$C%R ML=TOQTX8\$PN3$&F!,42:8UI:9<@^S\YU++'L%"\WY[M^-;C+J0=P"A,7Z5M M&0K;)O MQV=%1 Y2:[%K1%"(S[6G>V&P3I8L1%1CR2@ ST0#+A /MNL2-+0)ZV93 J$V MC$_+<5M>\%%>#"&I&1"H7[HB3]O4.)=;39T:UG>@L=1&X,47<6'O;IDIVN>= M@Q^YWE1U8UH3NK, =VPO[*$]9)>&\B@]K57!S<'TPZ)PE9/./4$6\)4#*,+- M>HV-?RLT4^#*3+-V0^,!8MR,2U%#J">QZ[9:@*1CLH)Z65USKJLQ54N-$LC9 ME[8]^N._WKU^.GD&Y@-5466Q"<00A,CY)_DGOW.?NWQ+,; M:JBI7-8@.@0_>.Q$X#GC]-GDBD0*6;WV!ZCG^)(+UP;.Z\37TW CW%IA*@-[ M"I.FX#10@)[L'W9_L7 M"6!U;?BP7/0B@13!%B84'SQLM^,,4JQ]TY%-E 4#SJ7@HW7 F8;JMNX=/FX_ M?4B*0(8;85DM^,4=#>=Q07QTK5S[=M7KY\;1]O2&/!BM#%"]DJYG1%!S;IN# M\PSW*5:,H;@KN+VG;:YUJ6J4IEL?DG;/V/J">MJ6TU-6) ].5._5#CNU^.A1 M3D$XQ/! NI*BOT[9!84K=4&T"V*Y.=M0]Z<[AHB6#C0;QKEOX3GI.!5/0]CE M&U:PSU,7,CJ.D))GQK=4#;G2OFHA*VPO(?U RILW9 Q9X/(CM1U*Z0N*(5_$O$^N(5B MR_&F?Q=(F@ :AAU11W@+1M W>&?E@V/;L!'"'B:TPF@PHY M==E?@)PT%G!P M)44>'7\=<""^!9O/-W3:OM&1!=*VC=]M+@2;X!+NH2_QG! ?YL@P<.$;L'K" M072-.'3OZ:8=P(7FQI8.B+./SIR]1]:3M-!"PQ"BJ5?8)W M7_ ]1&=/)^>I#T%>@[@6FKD),W3!(?C$AF*/-XAYH\Z,UG7=\+ECR;V<'8>4 M^F[.WK$=7#\WL.S4-5;T5AKW;@XZ)0&ZCWFMUDG!8JT#'-&+!\)(,!=8=]VK M!)&1;>869!I7$=5CT%"1G,;+H&AJK[*P=_*Z32ZT[=UR)OL!0TQCVKBK$,!D M,Z\=Q1^$WC'-.T*Q6P\92.0_J@( (EJSU?"1\(,G(!ZN*E"SF0-IKKGUD<7_ M\"@E.WPG;2>QY^+6V-NOVT1XON0"@3AE,"QTL%[ "X TY-"+N#1\>CR_(@#5/^EUFMZ4=]?#J!3][7[UZH9NZ4*5\7R6F62Y%M7XM"_WX\F!T MX!]\4/-%30].7KU8B;F\E_6GU?L*WTX"E%PM96F4+I-*SEX>7(U^?CVA];S@ M3R4?3?0Y(4JF6G^A+[?YRX,A(20+F=4$0>#?@[R614& @,97!_,@'$D;X\\> M^ENF';1,A9'7NOA+Y?7BY<'E09++F6B*^H-^_%4Z>LX(7J8+PW^31[OV='R0 M9(VI]=)M!@9+5=K_XLGQ(=IP.=RQ8>PVC!EO>Q!C^4;4XM6+2C\F%:T&-/K MI/)N(*=*$LI]7>&MPK[ZU?WM+^]NW]Y>7[W[F%Q=7]]]>O?Q]MTOR?N[WV^O M;V_N7YS4.(26GF0.X&L+<+P#X&B<_*'+>F&2FS*7>1? "; +*(X]BJ_'>R&^ MD=D@.1VER7@X'N^!=QI(/F5XI_\O/KW MOT;GP^=[T)T$="?[H/\WZ.X'^.[NXTTR3HZ3;T!.7@NC3*)G"5-5UH+MZ.-" MPI8RO5R)3)3I2@S)8K$8(F$Q=8F$97TVV2>J#+Y-+@?)+DN"E'A;9DG M"_$@DZF4):U;83TO(\A5#G@2AE O^'M3UG3.JE(X9E5(D\QE*2M1%&MZ+U?N MB!J8?2H5?;LG3!CWJZ6L5":2PW__ZW(\'CYG/'ZYNGK/WT?/CQB955.91I1U M4FL&$QU+KW-ELD*;!D15#2% #RLY;PKF"1]$V^YOK@?)#4Z13U1*5T8\"TE:Z8 MKY7\VJC*J4N]$#7KC%BM"HAK6D@2A08B%80SQ3/'%J(QK"YUG6SG'BV#NA1- MCE=I,FUJ7ERH)>M'K5/^/I41*O28MT.O6/F(#0I>#!$P!YHD<65J22L=3I&> MS%2U3$0-M7.&TB$0K/&"FPPG06ZBF@K(X?CNJ9!K*SM ;S+9T3F-L^9.TX"# MJ(@H8G'64$QCG!$G[;%@OL*!*Z@]5"!S'+A1(>8!01&4"!0"+G2#W 8 $S6,*?'\ .B M$MFB :B56-N3249P#P^D.V3MO%'F@^1M4Y%NI(&KH^'X<'IT. HVX177D6?V M* I3O5\52N07NDH(%8.WK<^+- !\+7,(QR3TH""']0!.1P<=LN8J\+U>:".M M(K,C)$(7(@=_N[;L=*ZRC R2@T/("O:9KEV@/!5)%AA6'BF!1FI M<%.2+(A5-T_90I0P8!QXQ(:USR)^B!4#=GM!%B0^E0<3#KXQ@S?D3(VM?@57 MU-1>D/*I)OL#+I5 ,LB,L-K-BM5';XM?6=&"FGA3'N_6 O(1A(MILD42TL8( M'SAM58%LS?YIT''H"[A6Y0?%[ '$=C(1QO3 M8'/$>>>(Z6CX^AF$6M;>@3+TG(,@,G?OKNA37RE3YIJC@T,'R6)'2&)!B9Q( MVZ(* 5UA7]=(W[=8P3?W$VM!,468)448WEK!U91>)QRZ%)1&%\_-MAS$Y0_E MEABR=@S'&:54_'XWS1#GWM<6% E!0@/]GM-P9"8#4@;;69EE4.!WMK]@;0 MF2ZIY%.U,ZV0-WD#(_F4B/K,:Z@[2TJ&XT@YX7X:'UFL);*S$DD ML)_">NDB5:'$5!769_4R,,HR-!/-^KYCCSV%+& OI;1O%SK('S04V(9(BF: MF\.1.KFVJ8R5YB"Y5_,225=&B232C"7L?OK9.37K G:RQ^8J[!@EDJ6B"4+R M]O,H*N@/*O#D#_&%XW\ MD,B"'Q5!L-*3(37YR:?TX)!#8PJI# 4: 0, M#)YMG00]9*&Q#KNS@D^V@B29D3!RUNH4!]4><13^DA=DJLJ:):EGYOV^?*(8 ME'^OD%+O'UOJ<*9!''%% RDJI^+@"N4^'ENX*]T4"!$VNKD2H90"84\B6\L; MFV66'#R7&LHU:VK2,=)^Y'/,Y@?)7+_BR@1/BG7J:@006X!O!@9LW%'60&.. M@Y\NJZ*('X0V2*Z%6; >\(<;B!!R9Z6, XNG%)(JBF2AY@L +!16$^D/@&<5 M&14,R"0OZOP>2%+P5\ 0YU'X7UL>5U*"5*[0071!10!X, 7-A(9LT>@&N%SE M46[!(;N[G"('#D"U+I=3L,!7[$PB/HP&R5].A3N G0^S<>:Y*)$J-9<>46<&Y)[L(8UAOG):Y8T+X,"N9D;A8+9QQMH6( M:" [,%!PFC4'Y[D^A3J]#=IZU7KB^^")7VL*AK[R?'MU_SH4G5O77W/-YH*W MWW9U?QUV?=0K(#FY'*;)&Y@0=C?*+ C([Y'O8W6[8;9!'.P^@+@EZU>90U,ZQ+0,3 $^PJ*Q<$L]_BW4:L]=LI))3^DIF1,9O M7/X'\[.2<1#CY(&\L*'*/$.^]5TXNQ0XH/[_@?=FH%' K%0%1]D36;2E2\ M_"H+=LX?JP;1Q>E[>(I<9%\X./2H"^L1C JOX=(D MI8N$"KQXF;OBEOTG1QN Y23F(T6Z!E5K5!9EX)ZR$:EE+?(=L,OE%IJFVM?EMR% 0RGL;O8S6 MDKIM-OO<[9A=SF-5_=GIQ65Z=GK.;Y]-TM/)B'H2Y"')BQ3K07)'85" @?=4 MTYODOLURWOO,X8/,75-AMQ91J-8>EK&PHHPI9"%5"VM+AY#HC'TR_"5YR C- M3=!+\K@U=2XBV"2.*)JPX80X$P47&QZP>,EZM*DUUSXAX@XEG2"7;!U]8@]# MAVKC%?NRF120^C$&%U(5VJ[P_IUF#O\: LSH;7(EXE$ZX&14;G@PA20NX?) M]OFP"2=J)!EW;H#X<0M*?8B>J9Z^/V7I+Y@[;1;;F+.GYGO=(6*:1]U':SE_QE7#GVB>C$,D-.B7W11_$D^RGM M$KD5'@;[[;7;=S2)J9L/X[9)T,4$25#G"'J'I\P#1/PI:8^/A+:5@]S7$&E6 M3MY^K4W7-;90[]'[SFTMA1@:P8@A$%?$$TE&N8H7!3$'6RH>LSKH@GU.GHPW M5!(:5-KLQM8(4UG*&3G'-O.PP3QU6_P9R9+"R51RZ7)&*FNPQ72;/=B*+2*Y>4)#/$4!Y>BS56)+<& M&I!3JVJK@NBRH C]F0@%%9\1?$VN6*>ZN4:@V)!F5 WG]B["<1M;PK6Z=F8A M'&>;,LIZ"+YG8YHH;C.G-L2RQM![5]/ST3 =SB;*/7"^6>#P!T#P+02/.\>Z MK?@/^I="ULE0S4@2%(_"]COL6V2^QG5MJ6,F'ZT ;.%I,Q-2J[C:]XWTU"(C M"B[Z*(>LN)T$,%87.)WA>P.G6UW4J!4WE5T/Y'M2/94"M1(8;%&MD,\@ 8OZ M*S59+Q]GY':PMA7H6B3)UX;R8%WZ/@PBAW<DT=9 O MSL.M5%\=3=M95FVF$5&6%.+Q.TQ%2QLXK0=H[:76-?7+ [:[=>Y1%460%]3" M99OZP;7N01= /LKBP5?UFSK5#T;"7\_)O&^YH:G)=Q[4^R_+MA%.;URT%D^< MT<1,L_UHXV.0T^%(96)Y<\.SM<49DJR^N_FC9V#Y!UJ"!=;#G]'J#U*WH/H;MZ[)Z3MN3W> M$L^HC$IN1$4*;?B@%GXI0TY_6# B*^HN+3:NUSN%7*3G*FJ%<%331:$?<=+/ M?,$[/'W^/_]_Z_C8?_Y_7'SP%,C&NXX3]0_9F;(C?=>2[5\^2\Y'H_1L?!8] M&:$Z.4LOAY>4-R&.NN2$BCFNE6S6T\UW[3,/XW"4GH\FZ4^3RZ/VV>60ZMK) M$90LI[LWS@ORGAQ:+ !C.#Q-)^/3^.D98S;YQ[C\OTIG9RG8W\!2B+Z,-E9\ M:"N:;YW^ TO]_V!E_L$[71YO@?.]ZZPQ]6QWZT.:=\FGL!\9^?#3O/QA>C].*BH\F3T5DZ/!_&=G=XG?E%F+^.7E:3K^Z?(;!(_2 M,9,\V4+R&UEJ3DN^2RS?^O\7#PW*_%@@GM,$C>,)U634%29V^K6GZ>E/XW3X MTR3BF._ ^2<3^M9YTJ[Y(>V.*!\.QNR;F\< MKR%_52W3"EW=*D9P4FG?,JDM%>$;Z&Z%;:\D9PC4_?HMD14YP3Q M6CL)XL1GXS-F^>:$@,\%*T6=A-!5Y-BL3,"12\LVC9Q*I!8/LE-4\=VUA::- MS>SBO)^8P'#YVM'!18U)7:H_O2VV KB-!-"6V)"AGP*+=_[1%KTV3WX3\AM; MYT=]T(4"5ZIL81-1I"=SU )_VWI.N\NH K05O31%E:O&5EPV88&M_4[+DE&P M^C_])6FTM2E%_KGA;N_71M._5:7"73E?W]@.L6M TE07&%;X7G-TLQ3FS.J> M#+F"<4U!RHDSP$<&&M!)+ HM>Z;P3E\X"71EH1MMJ]7JZY[(I:X6W14M8 0U,H MD6+EJ?X:F&KIE"O#G > IB 2$[W;Q8*#:^R1^-:&QLR755ZJBON M8$S#Y06L0C?S!;^61;A.MYCQC)!G^>E>EO=1:4H]I>%D>Z=)(WF17-W<*WNQ MHG.)%?6X!GWSWM7.=,W174*TU_E?&U&HV9J-?&LHL*T.\D?DB7CV[\E-/'"C MVR<-VYYK8%($$WKJBI3QV,X=M',NLN1+2+[XW1P>^B W47Z/5Q47TO@8S>!? MA[N+[AX33=4O14Z?ZD?ZTM?BN%OFM$V$9NI*5$2$3;)HML8KH[<-JB4[/PJP M+-_$Q@^-*"ABUIGD#?-6MA7F(7?1Z(IS2T: ;&;J[LB9/0"X_""0L M=%.G[&2=J^DL9N;;EM6MG2_8.IYQ6R97S9Q:[C#3H47FOY\ 47M.^K3B48!6 MP3^%;73T\? \A0.9UL[]TT?;>;*.P/ANW!VK\YV;,3N\;Z:UG2"Y&!Z/A_:G M#WN,#*"OZ68*G.(P>P,\Z];-WSV6?LRD!0U#/)X =(2[QSG0P,DJ-DW!31YZR^FHZ:DS6UBXG+2)Z)JAEPO%*(; M51K%!OIYQ).+>\0&6=>%^R7/7E1C00K S!W?7&DJ?3NTK4@]WV*'W9OWYFL@ M8Z.NFAT[DB3=T]4+;2]B^B&PHU[$0,:F_1%3.U_/Z>D2^_G^Q;OOZ%<$>#\# M5\%=J03R$.Q)_&I/ %D5J&;G2X9*<;P1AL;RPGMU/',3^A M-[^)LJ'&ELTM1N WK8LN;VE]SSOOGZOV]T)I&'CL# MQ8D#6,Z-JC694-V]! M7!WKE,?>\UFO:WUA^S.=-3QW8'RZ=?5]TR M4+-MXG2P[7=[)]&O+&D6G']+RG.?96U_AI^K7ME?:;;+[6]=_Q T2HX, M0LZP=3BX.#NPPP?^"WPI_V9SJNM:+_GC J6>K&@!WL\TLC/WA0X(/^)]]1]0 M2P,$% @ 2:JY5J;!%UVC @ UP4 !@ !X;"]W;W)KI("+1#+2 52C>F_D&T75^;Y$*L.G9F M.Z7]]CL[(:-2BS3M!<0^/_?SAV:4B-+?5(APCB*3L*"<1F,ASZVT..AJJS@$A<:3%443+]. M4*C-*.@&V\"2KW/K N%X6+(UWJ%]*!>:=F%+27F!TG E06,V"LZ[IY.^TWO! M+XX;L[,&5\E*J2>WF:>C('*&4&!B'8'1XQFG*(0#D8W?#3-HKW2)N^LM_=+7 M3K6LF,&I$H\\M?DH& 208L8J89=J\P.;>HX=+U'"^'_8U-JX'T!2&:N*)ID< M%%S63_;2O(>=A$'T04+<),3>=WV1=WG!+!L/M=J =FJBN84OU6>3.2[=1[FS MFDXYY=GQ_&9^/S^_@L7#Y&H^A=O+R]ER?O-]&%J".TF8-*!)#8H_ '5CN%;2 MY@9F,L7T+2 D5ZVU>&MM$N\E7F#2@5[W".(HCO?P>FVI/<_K_7^I-:C_/LCU MR:DI68*C@!K!H'[&8'QXT#V)SO;8[+8)@LK@4S?JD*9$[74=F+$D]TM(%#6ZH522 M*4EJG7))8P),SC0"DZD/:TR1QM)*(&R8UL[]Y\.#01Q'9XWMQSKL@]VS+\T= M;P^IR80 E)9; KEJ]]SG"GV0K4:S]2#/FOI*W[KHVV4^N\ M;M:_\GKD73.]YM* P(Q2H\ZWXP!T/4;JC56E;]V5LC0(_#*GR8O:">@\4\IN M-^Z"=I:/_P!02P,$% @ 2:JY5BV6=!UP P S0< !D !X;"]W;W)K M&ULC55M;]LX#/XKA'<8;D N=MRTUVN3 $G7806N M7=!TVV=9IFW=9,F3Y+K]]T?)3IIV;; OB<67AP\IBIQUVORP%:*#AUHJ.X\J MYYJS.+:\PIK9L6Y0D:;0IF:.CJ:,;6.0Y<&IEG&:)"=QS82*%K,@6YO%3+=. M"H5K [:M:V8>5RAU-X\FT59P*\K*>4&\F#6LQ VZK\W:T"G>H>2B1F6%5F"P MF$?+R=EJZNV#P3>!G=W[!I])IO4/?[C*YU'B":%$[CP"H[][O$ I/1#1^#E@ M1KN0WG'_>XO^*>1.N63,XH66WT7NJGET&D&.!6NEN]7=9QSR.?9X7$L;?J'K M;2?_1,!;ZW0].!.#6JC^GST,==AS.$W><$@'AS3P[@,%EA^98XN9T1T8;TUH M_B.D&KR)G%#^4C;.D%:0GUNL;Z^^+>\N8?WO\N+R^O+F;A8[@O7*F \0JQXB M?0-BDL*U5JZR<*ERS)\#Q,1G1RK=DEJE!Q$_(A_#T60$:9*F!_".=DD>!;RC MWTUR_%J6/<;T=0S_.,YLPSC.(^I^B^8>H\7[=Y.3Y/P P^F.X?00^N]=PV&( MFR_D/X6_X!'+^803,TC2R MW(@,0[@;36:G8[CJ+_="UPU3CY!KM*"T TX"B63#8-52&Z"UWB@3BH5YZ;MD M8+TO7A-AG8\&EB]K:9G$;3N]N TA)60(K>WOHVA5'LP,YE@W 7OKV!=G4U%1 M*7/;9O_1#-\6U>#/5ABDQ4"HY,&:AJQ91H$EZSY0%^6OA/=2BHA&/OJ[M!3\1H>[A*4A7&K[WG>&_$UFC*L$@LA'[HI^U.NMM5RWY$/YGWB^Z:F5(H M"Q(+)P &0 'AL+W=O9]G1GJY4_J3V0AAV9'&=ALQ!*QXF5J/ZC= MS\++,T=ZL4H-_64[MS8Z';&X-%9E?C-PD,G<_>=?O!Y:&\[" QLBOR$BOMU! MQ.5/W/++EUKMF,;50 U_D*BT&YB3.1KEUFIX*F&?O?QP]>OB[NHG=K/X'WW]OWU[Z=RNS'L*D]$TB5P#(S5 MW$45=Z^B!RG^).(QFTX"%H51] "]:2WME.A-OXFTCM9LF!9&RW-3\%ASAZC_24X?IG7]_NZ*S=DS=I@H>Z-*L)EFMQL. MPK"W.0/=BVP)MZ)PU "X^NU%FM0 TI3%DB]VN57FW+Y.R0F? +*6PEI2V!FN>]PX9D2 M7ZS(8>F&6[JF8W=:6J'-CS^<19/3%TQMA7[&TU39#-=*PW)E8:?0L31HC9RM MRC1E0!5^%ES;@!G5T*R.W$E8!$F%LN96I'NF=CF(_R^4I.4#_MS:!#Q/&.1\ M8^$'*MV+R5? ).U[FTLK>@QTDM.M#D*8IZ!**], S&LWJ)/"^]Z\ M,6R7M#. X#J5< ^6',FGS,@O+',9OC%LXMTXFV&.A&) M84\FT7@>HD)\QCB"C,&3WZ&H@G8P94%UC3\Q4Z32@L#N*I%;F8@\,>@[ '9X M+O]+7!LR+J0^7DC+T^KN4Z*$)HI"5#F9/>%[0[H&@^"C:?BL]0A9DBH!;67@ MM#'>=>H\I*Z^U6PGOSU@PQ*B^IM:S3M$@-$D.-@K!D0$5ZL ,YH!(U"F4@=I MM,M(?2XFBO;^5'XN9>)W9$*O\41G'C#NAN=K@%GBO;A&LSFGMC8(3EPW'[ J= 7>25:6Q M5,BQ:G?UY3(DW*Y.^\@U&,YZ"KV[KAR!KJ1-2?_,&0HU5O,#U)YM>+HZ=*!% M.>JRT9)\4J6''5 5;CFD_@1@-@B@.19 J$UZ"SL,6R!':V>YNY87PS7D6*RP MZ/:Y2^JT:H=U8PD%I!7HM2UGC2VU*M>;?KX=W Z9NLUPQA%T@C1@SY56&;/0&%+8P/\QU&*7U/:@/[ '@K >A(PB.@]^ M3+JJ #Y+C>:#:N&$QG7U!<(FX8,089V'IH6>8%!]22 ME+K**P1D][!O3VD>[ !RR9])\G]CV1*$ T'! MQCEE0F2U.3C'@[LH.\ 8KC-@4__;5E\JC9V3P]#=? 2'8:^1>J63XTZK?/0> MXPR2P30<$H!GSDOP7I]'4Q(;'A<_CA<7.8,/$)JJ/ H?-&S!]V=O'CJ M_RH= 7M\MPPY:ZZ>@!Z$]=)&P M/O<#&$(Q RS= P4 Z2TUES/HVN94OI.M"P4^W!_ZY.N#KPW '1X:.-6[R+VR M.N0BAS4L;5NA!+<>CZB(A?>Q5>TD\,?V_IL=]JP*H87]HQ3EN_ GI[-Y, ]G M+@=-SZ?!67C6S4'!8XWRUOODMNYX#Q2Y1 G7XV*WT/,AE+W$;,P*I2L;@-I< M7[ 1J6O2 .?3MCL-+0&U?*5+15I4Q;%O^65IX= >+=]9=LGL5 F/E@(921XD M.F8?E?Z$>GGM6@OVJP(HBZH *./ S@K$QEE*&^3&RCAPVX^Q1V#O&E+4 P^' M]J!6I[+5&M29VE?8>UT8%7?MJGD"Y1F\&:[ 'I"@$8&DE!9EA3C;$J8"G( MUW-S:+@PN,EK157K$W;D,^:@AJJ\.6:W& +#6JSM(*BOBX'H-F._33 M[Q"2 H^8H3).P?W85@GM "[&JN*("@R8#]$48UG7.DRDB;5P^URH K"NR@:< MX;CRFFG2XY_@QZ?'))%XA9GZ<1T!/O[N0G+8S-\D, =)/Q*N^5P(/+0SG<=P MK8QWX(PKG/'1FPXGS\,0;>&\IC1^M$>YJ8=LH3=RDT.J&SLPWOX9]!I"$&AV M^-H/(C#8/:!N>O)#5J9)DL<>@56ZO:>E)+[&I 1Y251&T' M&MVT"^-D.@VFTYEO0#;8TAR$L523_=X-1W<3$!^B4$;:JE>\[YJRE?&=Z=Q4 MO>:!;[E,R2\:>V5%*LA:R\I:\3UK+2"ZT\I<4<=<_E&MFG>\K4YGYM9EVG[: MM:U3]3WS?K6ZH_-@%LW_B>JNW7E(X3U?=UKKN_O7*@U0[&3^C]19$]U#2JL" MW4U-IDWD^V0\;4>^STJMR&]6_9]IM1/XTX' =_UQK:P]FYS])56=!*GW[\>>^5N 2HA#@$YX*BO!3,SGHC6NZ;,H3)4V]^- M,0&I=<:&M6CF4=-XQY(#0R0;\HQ3GJ:KKKJ"&F7YZZX1M$@%-\T[57_ /?8: MN-B8X!%LXNP2=_4X!0SUQC7+F=(>? )1>JW23&2K$<3@.SE0/'JY(32LMI(\ M?'A$5;5-"++\6SQ\SG&*B9"Z?GG0V)9>.-7<5B[20M5?HQOG4_4(UP]^ZS:. M7D0D M\FXA1SJ!NCWFL8<[]$SS-X![/P 5#6D$@SWOX13QYTA M_:'\52>J!T:2WTLJ$^&472@3J=9\_ MU7?KC\<6[INI9KG[\@PPPAK#/A4KV!J.3^,D,Y&A+IX0,Y'J?%7L=J\B2D61"_GUW9<<$".ETIM,/ 5O:??3LLR_6V=+8 M!YG@NE';G4>Y]>=+KN23'0KBN*5'33F9L(3R]VD7/E19%&IP*U8O[_:-> M(:2.1F=A;6I'9Z;R2FJ<6G!540B[ND1EEN?1(%HOW,E%[GFA-SHKQ0+OT7\O MIY;>>BU**@O43AH-%K/SZ&)PH_\28J=8YL+AV*@?,O7Y>70<08J9J)2_ M,\O?L(GGD/$2HUSX"\O:=MB/(*F<-T7C3 P*J>O_XKG1837Z\FX^NK^[.>IR/8L)]$_(9)%X:##L3].-Z!-VP#'@:\X7\5< UWL!V.>^;$E2+!\XB:PJ%] MPFCT^=/@J'^Z@^Q!2_9@%_J_)[L;;G([NX(C^/SI.!X,3F$G.MSA0CIO16B> MT*P.II5UE= >O %!/;EA86L+L;"(U+0>Z(<64Y":C,G@]TJM(!Z&1/8[X'.$ MW*@4K0.3A=?,5%0T-#%R05)V8&KED_ (W[4DY#VA4S:3%H*96DF] (=)9:67 MZ/9KS-IYTX17E\):XOUNO2)H*"N;Y-398,H0BG2N(N)$NS8ACR6=P4R9@]"K MAI+/A:=F7,$#% 4+*'T MJJ:R1>PNS-Z)2%&\H+P#*<0#!536H5&B:'X5Q(&TQN=$56D@D1OK@!F)-0^%8#KJ>V2^XJ,C@8 M'-9I#FCW+Y87B>_"Q'B.D +1Z;HN"1T7AMXZ[VN0"TX;:K!GM(ETV#1%G:P0 MQ::Z_R2NR$(T]&F$OF&48/J.0& GD5)D@M*#^:<)-$-)QIW7SN M0]$$*:5B53GO!!)R]4$!=:FM&YW9XZ(=9;.W*5C29(-22)(;B&K^LLN.J70) MC3(?]%F:( 2%]247*H.2A&#,O;A[^//^6L*%-52-I34)8MH.Q&N:,I*FQ;2: M*YG +:EO0TU0[?TTZ/3[??YUW_-[V_>"+RH85,H0_U=>KPYN4EA+Q_D*VO'( M#'VJC%NG:GN+9M84P504+# -%50!B-=FEJY+U%)!^P[/@;^:@<&[I$O1!O J M7>TGJ[OMB]W;N%L5:!?A!ND@'%)?L]K5]I)Z4=_-7LSK&^Z-L M)8U]A1J[] M[M?#J&Z!]8LW9;BIS8VG>U]XS.FBC98-:#\SQJ]?^(#VZC[Z&U!+ P04 M" !)JKE6NP-W!U & #S#@ &0 'AL+W=O\\]]Y(\6ECWX"LI WNJM?''HRJ$YOUDXLM*UMSOVD8: MC,RLJWE T\TGOG&2B[BHUI,\R_8G-5=F='(4^V[=R9%M@U9&WCKFV[KF;GDF MM5T5)8^T"-:W$\RL@@J649"('CYU&>2ZT)"&;\V6&.ABUIX>IW MC_XA^@Y?"N[EN=5_*!&JX]'!B DYXZT.=W9Q)3M_WA)>:;6/_]DBS<$#/SER=L$&\&/]]$O#?_ MT\^$LO=C%,J0][[AI3P>(06\=(]R=/+ZE^E^=KC!QKW!QKU-Z#]MXV:4SS=? M+MD[ML-6X5[_LGR@PB914AV;NN&&P!8+6)'"WFZA5,!NV_!J(EU M3 6///9J;J3TVV.&2L=>33- <,-L@@^6-?V.;4/-?"\92=9X)I^D*Y7GA9:, M!RR?[F*LP2[1VBU HS/YT[.>9#]?,D:IQ #D/(J'^\GR&U6VAIUKR3&:&_8 MK3E9C&G4**V)-31:AC[.SEH/%7A/#A?@+!4\D/^1FY88[&B9[K(OD078-/C3 MN5CS)2N>+1.1AY+["G$@,WAL:-H%95#Y,3E*YE0@5[I.8;Z#&\?MY5.C*'(S M5%ZVE-SAT]DZ+I.SF8PEF0EBI/,-_"@?7/( N@D23 1T$P."B*=9UW! <0T5 M%%J5[ 90#FPE[U)$2"PQ'&T#I('O;IO.9\B**8$-5 FT"&[C)$H.P93Y]]UZ MB?&RM*T)'6_A)9:Y9UKQ0FD5EJS4W'LUP^8TMB$VRK-'KDG\= *)7A4SKEP: MZ/V*OD<@+.8U6>2CEP4=OXGW?TCO16-C5L(=&:50.K>DW=G]7 M-F+.ZR59]@R;ZL.".\>)(F5*W8H4\M5)9 M-? &J7S]F%7\DDJ6!XY"LH!S& MQ:W MTVFV-=_>FFY3""+FD'B?3^\O3G^#((UH 4CS(853(139P+5>CE>U3_EN;*"< MI_*(,;CB(6THGSB-!1%?C99B3IISK%HV%@@E[V7.H42Y0XE-M4Y9P;82D\10 M5"A=L8T5 -C:S5;^VMU,K(4N^]EV8(M10IQ&8!.9B@S-'^F7*X7O(5"RA44 M>DB+S7!V]B4?LJ=&"-*(3KS)W!2&=8O&C"1%UG/S'&Z:1Z<@S,+&R.]*4;JE M+1$HE?2'O'H^@6+VUU#(H^Q"^%VI(_-,&V\>\*O]^6.B.QJY^(8+>2H2T$S@ M]*MC8=WW)1,G M.^](2P?'RAVG8W/W1Q?>R?IZ3GXB;NY M0N2UG&%IMOON[2AE5=\(MHG/FL(&/)+B9X57J70T >,S:T/?H V&=^[)WU!+ M P04 " !)JKE6GDJ'U)$( "^%@ &0 'AL+W=O7O';GKB]M'8PN MU9T3OEZMI-O<*F/75X/IH%FXUXMEH(7Q]64E%^JK"G]4=PZ_QJV67*]4Z;4M MA5/%U>!F>GY[2N?YP'^T6OO.=T&>S*W]03\^Y5>#"1FDC,H":9#X>% ?E#&D M"&;\E70.VBM)L/N]T?XK^PY?YM*K#]9\UWE87@W>#42N"EF;<&_7OZGDSQO2 MEUGC^;]8Q[/3DX'(:A_L*@G#@I4NXZ=\3''H"+R;/",P2P(SMCM>Q%9^E$%> M7SJ[%HY.0QM]85=9&L;IDI+R-3CL:LB%Z^\W]_@!M>O7DS/)A<'##MM#3L]I/U@ MT ]+?O[R[1?Q3KP6C0KQ73HGR^#%OC-9"2^E) E+7?UW.AL>^M< M97:E<%ZY3'LY-VK(YS[8527+#:"Z0>WF2JWVBA_1154 Z,,2YWR%8A7!QK-. M/\B 3X,\@ ="*W9\+EZ]>'_V]OV%T"4\M$8)6>:BM($6*NG"L#TA@Y#)>;C\ M+=;/KV@K0@-FNG0U!\-"EU MV]##=B6SY8ZC B;FRFWOTL60+;:EV? /=&VS ME9*U3?%0'$DO9/XG: 3;8/"4>E\9'?PP_]&GMA[PZ!0-X]&F?.3U'<'1$4XJ\ MD NGV,Z1^+94VSMCX3&IU*LY K6'+KE P'B1.5K15*UM;HD"YVI;A[ @4RY( M^M0NJU= $Y49-C)3J! @A],I4J%6&.LACB-F2_-:A9%YR&?C'NUBN2 MH]R"/'($#F^-SF5,]V]VC2O=4"16[@5N3@/!6"43V+GT!: M4U%R$B&)5E89A3*0XK;V:+V $@[.83VC-O%5DF^7[V+]-9S7J#8:-E%5Q9(I M4/Q>+)5I,?C-(6#B)LML37VH*8)>]VX"C*PJS26]H0/,'E'C'M[1;7<#T974 MLE+(-CT].1&:GM?L1.'LJFM^ZGG(ED<CW"Y$JHTP/#NP7W9P9R^>X(/<"A)!=1LN: MUNU2?Z"@]S:*SISQ\OUH%AMWWP=QQ)=S)/^15H0=U9 #PPX/"Y%L%A;@+"0I MFF_VIGAN)5HK+,J1@RQ8QPU\V. 4Q<3V4M1;4V09KZ,#7ROB$684*F59%-IH M OZ0@P?4B"!_1&*CYI0 0_I^M=P3Q=>8,D99LK*CE6_MJJ6YIL(4D\6)LYT$ M>N8=BR/2DYK#9[5&=_]$P&6'KH307+VB:IN#T1X2@\C(BK! MG'H1FPMA6,8$QXDK/5F(.(7%W''S.9@YGL3_3/S:#!%&KS3E*#K=&[^?&+L3 MTF8_AE;'VDC9X*/TK /[B*&3BTT\\F1Z012T4=+Y;0O9>\Y,TY^_9&/'9_3PT#Y.CYU\DF,B<;"9>EC$R3T=9E&)\O0 +(ER,YQ[XB- MM"(F#13?)KE*;<>(O^1HN:M76\ZD3RL?,1(P2-R\^J&[\67J8@:"VLPY?ES9N+) MR<7__/FY'<&_-X2T>R35;_/S)O&5T47K36MVPOFS$X_>#U1BG7_7AAYC06O- M3:?#R61"?^U*DZA_?%^5!*KV14?OIME9U'\+ BDCZ[:J:2##TP-S\D^S<3IL M5+U)%9M,WO=*:]QYI\@/#/3FU ONW/'U8KO:OIR]B>\DM\?CF]W?I5MHL))1 M!40GH[=O!O$=0_,CV(K?4,YM"';%7Y=* J)T /N%M:'Y01>TKZRO_PM02P,$ M% @ 2:JY5KF*''?S!P SAT !D !X;"]W;W)K&ULU5E;<]NV$OXK&/6T$W=DB:0D6[[.R(XSS9FD<2T[>89(2,28!!@ MM*+^^NX")$6)E.RTQSWMBR@ NXN]?8L%>;Z4ZE''C!GR+4V$ONC$QF2G_;X. M8Y92W9,9$[ RERJE!H9JT=>98C2R3&G2#SSOJ)]2+CJ7YW;N5EV>R]PD7+!; M172>IE2MKE@BEQ<=OU-.W/%%;'"B?WF>T06;,O.0W2H8]2LI$4^9T%P*HMC\ MHC/Q3Z^&2&\)/G.VU+7_!"V92?F(@_?11<=#A5C"0H,2*#R>V#5+$A0$:GPM M9':J+9&Q_K^4_L[:#K;,J&;7,OG"(Q-?=,8=$K$YS1-S)Y>_L,*>$#(2@8 JNWV\AJ^98:>GFNY)(H MI 9I^,>::KE!.2XP*%.C8)4#G[E\-WE_1SY//CSD3&A,R*%@11B&40A1E;,E-;%DT32I%"W4@1AGE.SF,HD+/F2JY MZIH#"Q4@(&(J63E*ZMAGS"P9$V"2>H1#(J,0I9"#MFB_T[YP.II+(C"Q1]XW M-7!$&<#9F5KM+NQONT8P]@M\M^97*)R+AO!%SF!^S@5:NFVM=$I^<">6$)\8G,^."._Y1+1 M9ZUU*6;/X,(QVA45# $/UYB"N9K0'IELL5DNR%5+7J>V3J$E%>RVC#D4EEHN MNQTK"S:991CFRJ6JSN=SB!CFQERQKSD3X%-,7VI=V#RNZ'EE2K,A2 M:+?1VM:2=76KT&7WV TL1"MH5$:E/=3; #.HBR;V+!=F(Y0.S&UG0>&-RN;U MP;-QUJ ,+.6Y4E4R( DT-RR=0;S+!L>Z'_[X[N"#^@1.-VR[6*XK0.$%B2Z)IUHV%WZ'G[)G9[Y*6;6RK6W!U\/QANF+3MY_K84=]+ _6] M5F5JX1QT_9J\%YG25.&?\-P)\->H)COP7JLE6]#?*"DM=6#[O/!?N2B\7M$8 M^MVA?](=C8Z?F]P-DN^"\ZO#?3STNMX&)IHSKP=XW]_4?9;K5F-+&O(^Q;+NVZM\H-V'M1QX]W.[P;Z,;- M%M:5>Z5A^WO[4L,?'0X]VVNAB*+Y Q%(@9>'EE@4'>JV/I/][5SSNENDTI?2 MAB6H7/6/N<9&L=G.;U^#UOBWU];F)D7"[-OE*J'AX^$TC"4VP*F,6&+="PY9 M,MO(5R\-=/4BP.ZK"1J*;?6 1.MK_8I1H,1[=;3')RZ$CVRUOL1 @]JB3'5? M:QJ#ZE%=O;=R;R+ _NUW$:]0 UL[O-9):[6MUK:D/RMY&KM.C MS?%@5(WON'X\A&LJ7GR@PV> )X6N*M<'O9,Q^9'XO<"#QV>94.,NO%5!Z'FX MX@?P<_.-J9#K%AW\WLC;.?Y2@66^9AH5V;!K7#Y;+F,E'-UM)H0K\<*AH)GF M;3@MLP;WVY6,?]^MIT![F<*N[FYY3K?\>8=V?B[?6/Z7BIS"45MB:5]MWCX2 MUA7]VKH2/;GIQV; MM6!/1[G9/S9ZT/]+OOA_>[Y4PR(>E?G_B_SQ:^X-NL?-##K9G@FZ)X._GD/K MS.F>>%;<07-MO&L!F,JU_>E5-^][X%',M'W%Z=>^L:5,+>R71$ULX^$^MU6S MU;"=& M9AMP4G=K@31IG'2?*>EL$:%(E:1BY]_O2,F*O"7&@'X:8,CB\>ZYYX['T\UV M2C^: M'"OA32S(/"VNHB#$U68,G,4%4H:6>C=,DL+?4V-)5&EGNC4H1)%)V% M)>,R6,R\[%8O9JJV@DN\U6#JLF3Z^1*%VLV#.#@([OBVL$X0+F85V^(:[4-U MJVD5=B@Y+U$:KB1HW,R#97QQ.7;Z7N$[QYWIO8.+)%7JT2T^Y_,@)D2QC]AU^C&I)S5QJJR-28&)9?-/]NW>>@93*,W#)+6(/&\&T>> MY4=FV6*FU0ZTTR8T]^)#]=9$CDMW*&NK:9>3G5VL'R[7JV\/JZ_WL/I.S_4L MM 3K-L.LA;AL()(W(.($KI6TA8&5S#$_!@B)3THG#!:__A*?1;^?(#CN"(Y/ MH?\W@JJ*G&<"NX%D!:"Q+!:?2,K!%B9H)()',FCRP!;.@LJPFG8U%30*DFR0\F:;SY,R2J+:0(D&AU\B4-$IPMY7#ADM2 MYPT%BZ4'9J3)C:DQ'WB+*U563#Y#P0SY9J+VIDR( Q-B:363AOF.T&>FG>() M<@.H*]K2JMX67L4SWC%SY+@AXT6O$1["C80O3-;4_6#LJWLTZ 1MO9/D$Z;: MBY)I(_*YO6::3N5%J^]8I9;Z+[G&O6T;IE!, J>#IU_ISLF=R+LD&L23"6RT M*CV J5R6]0"J6IN:D995[?F;FAZM:<%R.AJ4U.\J9;A+*Y>DZ2#N-74I6#;% MX#Q2G;D\JH9,DXX7"NR)<4&%18=,S=VI912$0$HGHQ(P%(8Q3I92!GWC=C4F M8%EI>AXRXE/9B$;149*>(9[^5(K.!N=GY__'#'VI);Z6H&32)JB?#D85F;NB M)_<:?8WF4&*IZ'[D=>GE3%N>"6PNNS&*RMF[.R;>W-WG-B?_O(>>O?2?_+?Y M&[Z']VJ',%E+_B[0_#7Q\$O>\$O>\$35DXSA3U@X9X;OUBW<\9X.CQW.QI= MVGQZ*\&R5K]LVJ^SE#2R](U>.;(!C*/)X#R:4"NB;N?)4.)*ES.KLD?8D1OP M'R3IVR2ECEH9EI5'I5*CY,O61^=XM:P:WX M% %4, !D !X;"]W;W)K&ULM5QI<]NVUOXK M'-_.'7N&MB597M(FF7&_WQ\;+*E7 ESI->RQ).YKE:B MQF6U.#;K2HJ<%ZV*X\EH=':\$JK<>_Z4[[VMGC_535VH4KZM$M.L5J+:O)"% MOG^V-][S-]ZIQ;*F&\?/GZ[%0M[*^L/Z;86KXP E5RM9&J7+I)+S9WN7XY]? MC,]I ;_QEY+W)OJ=T%%F6G^BB^O\V=Z(,)*%S&H"(?#?G;R214&0@,=G!W0O M[$D+X]\>^FL^/ XS$T9>Z>)OE=?+9WL7>TDNYZ(IZG?Z_C?I#G1*\#)=&/XW MN;?O3L_WDJPQM5ZYQ9]<7EW=?'CS_OK- MK\G;FS^NKZY?W2;[;W6A,B7-P=/C&OO1JN/,P7YA84]VP!Y/DC]U62]-\JK, M9=X%< Q$ [83C^V+R2#$ES([2D[&:3(9328#\$["Z4\8WLGWG;[OR!;@M!\@ MZ=#/9BTR^6P/2F)D=2?WGO_W/^.ST2\#Z$X#NM,AZ,]?"*-,HN<)PRYK08+= MA^1W@$G>+R5T)-.KM2@WJEPDD5#%VB2BDGZ9S!-5)A^.;H^2 M7!>%J/"TS).EN)/)3,J2WEOC?7Z-(%+WDZZ:L:9]UI;#-NI F6Y\IDA38-#E4UA #=K.2B*9@FO!$MNWUU=33 O]/ MO]-!PK\"S@O:>X&%(((C=A\'OPL0\_#*_59TFL111_8O2!VQ$F'(E&$7)OBM M,YF3?7$02""SIE(U+$%RF=4IK5CI7,T5ELPV_,KOS6H-4:GJY*:IDA>- 3QC MB&=5W:QY'4&;C& 8]FF!0^[WFQ>W]-!S+F4VJ!IV#H#%)[ MOP,3X25H?2:K M&NXFD0]RM;9LFE=ZE=R)2NG&@']K73&+*_FY4963W'HI:A9?L5[#I(E9(4DJ M-!"I(" WF2R(_X:>RV"+U<.T"X% G>,,P\TX*,1+@IB1=$JE,"*-:01 MWT2*(S9[@1?$/I4'%0ZV,8,UY&"0M7X-4]34GI'RH2;] RZ50,#)A+#2S8*U MC5Z/75G3"S71ICS<+05D(P@7TV3+)$2F$3XPVJK"L37;IZ..05_"Y/(:X$DL MZ![#@MQ]CONEP@LKB?L6Y?LE]$$$,O+6QC18'%'>&6+:&K9^#J:6M3>@##UG M?XSLP)LK^K4ME"E3S9V#70?Q8H=+8D:)G([6(PH!76$?UT@1>K3@B^N)M#@Q M>9@5>1A>6L'4E%XF'+KDE,;GOYB^<,B%,F6/#]DX@F./4BI^OOO,8.?@8PN* MF* Y)G(L)P>[^)+\$MM4AAR%J*!6:VV,(M&;"1!*DO$OHV"*PQ-O"T NK.UQO,XGB9+BFU M5;53[Q!&>B4G&2D1>3"_H7(L+3)L1PH"$]AX[V:M 1M,9RK(-9(FK8B,;"OQ MOG3>LE!BI@IK-[<"4HIT-!.>=6['&KL+:>'@26G=+G00PV@HD773Y%$!-X"FK(=U&5,I!5RO1,28-S;2 M+=F!KS2$:][4)&,D_8@IF.VLD8BICCH MZ2([BCH"TX:LQ'FP$N>#.GXES)(EB7^\@A! <@C;/G/QG: ZGM:3'6)3%,E2 M+98X7:'P-O'A#H>S6H7L$C0GM^(< >BK8,!!+AR>XJ&-97@E)>C.I1!PH*"L M" R9@0&$AFS1Z'K\7.51L,4Q3/=UV^D@SDW2\>K-(4>6-KTDDCF;U[FO2D2MC67% MC-G B0#;2F-8@9RZN6V"+S=KF9'!;C.=0OHU>N@ MMI>M6[P-;O&%ILC$5R1>7]Z^",6(WO>O.(%VD91?=GE[%5:]UVL@.;T8IO>*R0918#L*Q.VQ?I,Y1Q2OR?N'\"YD[H'^;+!65 8F MD7=DRT $P!/,*LN7Q-/?8IW&Y#6/XOH979(](2MH7# ..V0YXR#&D1RY(T,5 MFPS![U?A[/*1@/K_!]Z//:X"9J7B>&DN<$&NC-/3V-#[D[@4&(DGQ+1@6;(5 M=WZ1A%Z*.1 ^2J[8@AMOPKT5S3N;S/MPSS0L\3^>S)2%L*U84*&$]$=3FF:A M1F$!8&EX=9OW'^U64UHV32=GHW0T&@V8E"?!I#P9- Q_BNJ3K%G9HEST-UFP MGWM?-7#43F/ZK,X/ YY<]MO/-/GI+#T[O4C/1^>>X"X"6SHX=*L+ZQY\#(]A M[26E%H0*O&V9NT((NQ:."@"6@\WW%)$TU29.H3,P5]G(H>4\XE)PT\6 FFR< M<\I<&O)5E38(Z,I,[+>6O;3@VIC];>5(E93%XPT7(;I3=XK$;2X4(DF$7%L+ MO0AM)!6);::RVV>YV-1JXD\GYQ?IZ:&0AX!)MQ2#]D[HI8O:V0'[G!;DVDN$][6,;"BL+O M$-)6+:R>ZCLQ(_9K\#GD98Z2F]V@5^2U:BK%1;!)9B*/S,8G^.K(05L7BY=7 M+.R/1?O*1]=<_:<=Y(I5>/NP^Z'D^N@1^X.Y%!S:1DA6U)F+2KHNT"!*.)&F M1*O2P>^Y&B(%]^WY(X#-VIE2G4%E.5?F?+P,I>F[4%HTNI"N=N0VVRXLN,T/ M>H@)U4+R14>T7@SAN7/0? )RF; KVW1X#">JC!JW;X#XO@>E;8B>J/Y\ \2- M*+:+.B[Y<$3RDA'E.M8#ZZ:F&[OJ,8YL6QG+-^I&MYTEZOB9-9T]7$BW4=M- M7C+J<1EB^Q"=>& P61I''=WQH*FYMD;WO7CH+ZA\P_*MK&B%$!DW@PG9ZJ;M M:+Q0LP[VQ<:RYU/$LITMZ!GN,AL0N,U(@'U 8\NC2)\,4=>*BC22S*FB>+636I#$988>NYJ5+PUM)>CKG( SA=S9/X!"+XDYG%G=]N+_]%VH]7: M.:J!$ ?%O;#U._L4"8QQG1"J0LM[RP!;2+$1'(E57+WRS:G4(B,*KAM0*E!Q MB19@K"QPV,>]."=;7=2HO#V372/HZ[Q;(H732F#0(UHA[D.@&M4+:])>WL[( M?K"VO.Y*?LGGAM(97?JZ(IR7-QR6\@0[I\XDKTU=$>NAZ10I$5?.&,<1I5]4,$Y[[0Z;3&KF\038 M/=3X'UGI8.AM-=JT[GO0>TY:[SD9=']OD*\Y_[3_!R*&@^0M"-<-WWN]ZK\' M.^!M!^96>EPM)>K)*U&1KAG>J(5?RI"6[1>,R)H*N/O^_W'^R,-DCYYU[+N_R7:>;?R;]MC^X4_) MV7B0)=_B0XL%8(Q&)^ETT% MS(7H8OSHC7=MOO>EW;_A5?]_T#)_XXTN#WO@?.U[5IFV=+?W)DW:94YC"V;Y M@/K]./W9]?\;Y.(5Y?#FRWM=0JNST)UKODYNS\'^L]-1Y][D?)R>GW3H^ M34=GHUCO3D;I^73ZS5J'MZ):@/GK>/?QCGK6(7UR< MI),G%U\X\#B=\)&G/4=^*4O-$=-7L>5+___-8\@R/Q0(-6A@SM&$,E;J.Q Y M_;LGZ^2;JCDX^.)F@\/QEU+L?A M=7&K%A6;<# E>0(54G[Y3YU.O:OQ]'TE79"A1U_FIRR%#R>4?*1RDH#P]8Z%I8^/@.$LB(C!<'CIP< >CP';0>CP\ M(OV:2I-_>1/3,O&Z96*OI/QKJ%&I! +O)V23:.6?;?'"YCLO0S!HZS51W7^I MP*\J6]J$ K'< CG=/S8OUZXO78#JQ59,I\IU8S-G&]W!,/U!KR7C8"+_\L,; MT=*F%/G'AKL;GQM-_ZTK%>:(N)MJ.R*NEDT3KV!EX7LK4:,WS.#66]+%F:BK M+U-NDP$^,HF 3F)1:,DS@RG_Q!&S2^_=4*\=QN2VK^2A%I+PN_94]%XX6?3,OCKX*I88).4XQ(YQHQ1P^@!Y")VA:0>]R^A'6S!(P'02 MY])49,M;N_BLKU=2J.P+.'NRKCKLZ^BXEVS.AS(PHUW["2]SHI6[(B>T26B.>B']PD%O=,?'3F MZV:5?)0_=LK;V^A;?P:W93NCEL"NDA:DPQ?C_&1:ZJ>9S!K4IK')*NZ3DT5H M$>WBZ3;]4CDP[& K^[JJ_3"/LBBSMXD(->AQVD]#QL.?=""* /-K;E! ?7:4 M[K\11LG,H4I,Q5<^J(43=,F-EK#ZE+:;8WM#3M(CJ2+Z MYI0<1@O3SA!WDT7#DD M2^U4[7AX*/:=?'SLMP!?<04%/X>_'OMQT).KT##LKC'19V(KD=.O^IXNMO4] MK@\[O12A?; 6%9'9!LHT'>G5UEL1*E%TOG*S0O$8&S]IIZ J6>=[D# Q:XN_ M'G+'H-I'W5NNU,9A.8U+DTETLS9D,\DY!I$)+[IO%]@=.:/<>7E0/-IQRO'P M$"08: N]UW:XJF\VK5& MA0+H*^I4@XD<*[T"GG7KJV_N2S^ZUX*&%3N< G2$N\=3\3( M,OL^>Y];/THB:(FDK]7*UJ<[Z5[IG'("MNBNP(P8-9ZIMYT.!IYUZ<6"'-T+ M_H'CKMCMQ*;5!D1\'N60B0PU8O>UY#35%G_"[,K:'I5[2KI_U,\/T@<.4!^E MRP0-)L3C$/3-2/NA26&H!U)7FCZ:HT]+_*!*5(:W 6I\N)SDB4XU1\ >2B^/ MB@#D6.G[OP<7O! 99%T7[JO9051C1@K S!W=7#%&^@9 6X/Q=(N]W=8'3=R3 M-39T4O-#=R1)3?-ZJ6U7=#M^Z(@7$9"Q:3\8;C\@XQQCA?7<#/6^+_I,#L_G MH"J(:\O+,PE%8O[RB&0;MU%\@,.?Q$?A;JU:A=90&+JA]GP,=FO4,;>?U<3T MA-S\+LJ&2KDV0!R#WO1>-,Q![V\YCN$/AWR3-@W3])T!3(ZJ2'OFE'+3!Q"/ M6Y*N3.*$QS;=K=6UMK#]#G4#IQ((G_9^Q\,M]K9W[>B !('#'/>)7^@Z^X\A M>J8 ^SYGZ/55Q]%?*J"/G?CO,?!'!65M_VA!N!O^YL.E_4L'[>OV#T;\*>A; M*81?FB]A!N9A?:M0"FJ4-"M Z$P* MHF#1]X;AU2BV]L[@]PPVNO%.;"9S*;];89+V/6H#@AP28Q$X+H\PACRW0!C& MGUM,KS[2.C;?=^B?7>Z8RYQK&,O\6Y::5=_K>B2%!2]S%&=>^3PHG^7^[&4*\#X.* ET)5>\P3Z'C)$@WH$;_#^ M7=BF'T^$&]?AQJ?0!S,D9%KF0.2""*1K)A)9 #G+I=;G9 U(M1570-S1PD"* M%L2L@&C##2"1C/5$.BMN":&/Y7AWV*MAB;TH[CE=VF7#)-$@?LP8%$2 MKM13)I;DD>Y-"L7;[E6Z'<1;Z[3#V+^/N^5[7I=2G-#XG#R+-M%'9 MO*SJW^S0/@K$H#3R8Q8UM2T76?S3U?VONO/DN@&N&T>K?]"%AA ^L[C#:N+/ M!+\D+Y[^!M/=>J/23. ?I59,I?AP!.>U=C-'H]JZ$H\J1UQG">$B)6F6NY:? M(.;5_]ZY:5E8L':S8*AS,X/]B-Z((:U>.PW&32F&[S? M2S?#:9+(4IAJT*FU]9@XK*:CO7DU8W[E:ID)37)8H"N]Z+0\HJJYK1*,7+M9 M:2X-3E[N=86C+BAK@/L+*I1IEVP>([^,A*370S(,$#^,H M.@\%93)()MZWT,E$598S"0M-3"4$U;LY<%5/@V'0.99L4UCG")-)23>P ONC M7&BTPIXE8P*D84H2#?DTF VOYF.7[Q-^,JC-WIJX2M9*/3GC:S8-(B<(.*36 M,5!\;.$&.'=$*.-7RQGT6SK@_KIC_^QKQUK6U,"-XH\LL\4TN Q(!CFMN%VJ M^@NT]9PYOE1QX_])W>3&'P.25L8JT8)1@6"R>=+G]CWL 2ZC-P!Q"XB][F8C MK_*66II,M*J)=MG(YA:^5(]&<4RZ0UE9C5&&.)L\SI;+V?W#BKQ_H&L.YL,D MM$CK@F':4LP;BO@-BF%,[I2TA2&?9 ;9:X(0]?2BXD[4/#[*> OI@(R&IR2. MXO@(WZ@O'M!YG.WEW&4>C:_*_S_M*K$$[$8_^$D/V M1XHI*%;?F[,M:&Q9PED.9%&M.4M?"F#&5$B1:R6(+8#<*%%2N7/8X<4UQB6S MC/(.]SW/03.Y03_Y5O&=._2HWVE\&D61^_6>A69;:N'?]RM;0,GQ&'&>V-<[ MQ><-_YQR*E-X=18XQ8RE,G/RJ'$AO)K@WU9W/0F&W6*(4CNJ,[(#JLVA"Q+N MM:H O?$#R9!45=(V7=M[^YDW:UK]);T9F'=4;Y@TA$..T&AP<180W0RAQK"J M](V_5A;'B%\6.+=!NP2,YTK9SG ;]%^"Y#=02P,$% @ 2:JY5D&ULU1AK<^(V\*]H MN-XUN7'!-L^\F"$)F::3]-*0Y#X+LX FMD0E.23_OBL9&P/&Y*['3?L%:7>U MJWVSUNEN0<;B31,511.7;.81B?E;Q*BGBGDVFVB!J MW=,9G< ]./L3B)4RZ2,6 1<,<&)A/%9I><=G[?,>7O@B<%(4-E?,D_.MOT*"6*E1;1@1@TBQI.5OB[\ MD&/HN%L8_ 6#;_5.+K):7E)-NZ=2S(DTIU&:V5A3+3>K=//;);;\W>+SOW_;_?!B0@P3 M6\'U5)$^'\%H54 -U:%AC";R'3%Y(5HB#>;!$Z1/=N+R"V5SZ!5AK[FLW@3O 052#:S38[OQL5S\D/9,@ZOB[O?E8'53)@[0)]D8&)IF89NB$*80CPCC2L"VA"8&( MN?Z<\?U"6DZKV7':;GL'SNP\_Z0$L^_UAM$A"ZU9NQUU"9*]4!NP.972Y%*X MY$]T]T[(73P,69 >43GKF@VGX;IEB.T>>>_E]A1LWHZ^KS=63%KWLE?Y*2RGH RM=!9N"M^>F ML+^FT?":D/( ^5T!.+"0N_/[1!/\,;DDP=%LU3Y>)_=+$5CA2%2#LN MV/9@>\A.R8,IE4!FIB?F(^E6VZU5N-[,X'NFGG\;2P#TCP8<@S61)C-3>KUZ MU"$?B5?U75R>1(C)CC@59ON5OAK5BGC)5.3 MO &5:BN\6$ORIY7E3^O]D_J4\@FF-$N2-S^-#N-)V6ZQXN,9[K.7ZKE<-T.BVG8S"KVJ__S^;UWQA]5@>=C6'I)\$?$D;2.\9VC^K^/Y3*"SI%KQ1UNTCK;",B4TLK#G#?O M&]*TJ)74&ULQ=U[;Z-HFL;AKX*RHU6W-%LQ=IQ#;W6DM\J L8W!QN?6_$%LDJ"R309( M5=>H/_R"#[%Q' ZS/VEJI>T+H,7P+766Q66BTOJY7*]>7*\=87 M]Y\W'[."^\_^:[3TUJX52.'K:N4$/[^X2__'[Q?RQ?X#?>_I.4H^<'G_^<5Y MY9NR\%;N.O3\M12XC[]?"/DWH=5ODS4VBXP\]T=X]+:4?"T/ MOO\M>4=?_'Y127;)7;KS*#&<^#_?W:_NO&TT6?'X[;VN;K[Z M^*MY<$+WJ[\<>XOH^?>+VPMIX3XZK\NH[_]HNKNOJ)YXO="M=%5[C9K7!3=(7;W0JW15>XVZUP=_I=JG]TX"K[ M(UL0_7F5_R.7"QUS>'W3YW5'_Z"=7 MWA]VN?!QE_<'7CX]\A\?E_VAEPL?>WE_\.73H__A*M7]T:\6/OK5_=&O%C[Z MU;=?]L)'O[H_^M7"1[^Z/_K5PD>_NC_ZU<*_\]7]T:\6/OK5_=&OOCOZ'_WM MJNZ/?O7TZ-<^W,K^Z%=/C_Z'J]3V1[]V>O0__+&L[8]^[?3HUVH?K;(_^K5W M1_^C7[':VQ_[S=&_W.;0)L0:3N37MTY2VXZ" M^+->O%YT;_8UT=5G8J";74ET&]*7H:UW%=N6OHBO;:UO#N./_=)P(\=;AK]^ MOHSB;29K7L[WOK+=0/6##N%NT@+E_'>ONUR=;_+7ZJ9HN'\ ME.3;OTO52K4F#>UX]_YV;L>^9BOB)?@DU2JY3*, 4ZVG&>EOTJ44/CN!&^[^ M%#F"[B)Z_DYULQG9?"C%&SL_IZU,AIIMS %^7 MA1@SCUD78JS\OP0%E%Z17^%\IE^$J?R[/TUV@3\'!79R4.3/03XS+/![7( 9 M93,-=_[&R!G,N/B?@RQF4OP7-HN9%O^%S6)FQ7]ALQ@ABO_&9CHYJ;MUMG\L M*Z6"3N0D\?:/P5XN).:$\O:G?)-6\ETQ,2>--S^IN_S[-WZY14Y*'_/RF6_N M.3(GL8](^?8LDRI?M;>^6-NPM8]^28(G9^W]R]F<5_S[5 $FN0F$)B*HEI)-8D,9W$6B36 M)K$.B1DDUB4QD\0L$NN16)_$;!(;D-B0Q$8D-B:Q"8E-26Q&8D*@&IKI @UU M@::Z0&-=H+DNJ&!/-<>KM^9XE:7?QV5QX6UZX:,?2(^OT6O@2@^O8;Q8&$IS M?_40=\7-Y]>OJPGVC)2^U^GXO?[[\GNJ"Z :IM$YUP?I;%ZQG M=L&&^^@&@;N07M<+-_@1Q+UP_20]NNZY7I=)E>UU)-8@,87$5!+32*Q)8CJ) MM4BL36(=$C-(K$MB)HE9)-8CL3Z)V20V(+$AB8U(;$QB$Q*;DMB,Q$1VH)?N M=:B&AKI 4UWL8OWZN-=5-O].VUW1!:DX3A6WZ[?B=IU9W SGS\U9N)43O<:M M[:<4N<$J.5/GK;^[8;2YOGNNPV6J93LJM]-H>KWX@:>OT@Z7^2M7.G1\9;) ME=S(E^;^>G/S9_3!==W'P%])\Z4?)B?[XO5?7A^6WCQ^ZS$FUT_G>F/F+I7M MC236(#&%Q%02TTBL26(ZB;5(K$UB'1(S2*Q+8B:)6236([$^B=DD-B"Q(8F- M2&Q,8A,2FY+8C,1$=C$HW1M1#0UU@::ZR([U^]J=M-K<&7NV.*)[0L5XJCC> MOA7'V\RO\ZL3/I_K=IEKE>UV)-8@,87$5!+32*Q)8CJ)M4BL36(=$C-(K$MB M)HE9)-8CL3Z)V20V(+$AB8U(;$QB$Q*;DMB,Q$1V=I?N=JB&AKI 4UWL8OWX ME'WS%+RS4WM])(NM&NI>G;W5L_N_2]KU;OJM7*W:?*3?H M*.1V51+32*Q)8CJ)M=X?J^MZO5Z[JW^Z.SE6;7*['1(S2*Q+8B:)6236(['^ M^Y^B*[E2N;VJWGZZ/OF;:Y,;'I#8D,1&)#8FL0F)34EL1F(B.WU+%RQ40_-6 M-% -S62!AK*@4CG5U^3*6V%+GCR:T=C&?O MN80Z=UZ\R%DFSZCUYM[9=I8M ME:UGJ-9 -0755%334*V):CJJM5"MC6H=5#-0K8MJ)JI9J-9#M3ZJV:@V0+4A MJHU0;8QJ$U2;HMH,U41.T)'%]LEKT),7H@7N O774G^:Q1&SGJ1=,7= M:^T^?)S@E^RMEFZ*I-9 -0755%334*V):CJJM5"MC6H=5#-0K8MJ)JI9J-9# MM3ZJV:@V0+4AJHU0;8QJ$U2;HMH,U41.*2C?%%&.C7O!YKW("?Q[.>/V#79/ ML'A/5\?JH3I6,[_2+^?NREAZ*R^2DL?NN9$4U\4G+[D4[(2A>_Y6WNQME"Z* MI-9 -0755%334*V):CJJM5"MC6H=5#-0K8MJ)JI9J-9#M3ZJV:@V0+4AJHU0 M;8QJ$U2;HMH,U41.!2A?%%&.C7O!YKW8!_[Q*<7ZYA$L[Q[%QVX82_-T+SS, M]) S'_Q\;R=G!3=G#5FQ7S)%DNW0'1*!ZHIJ*:B MFH9J35334:V%:FU4ZZ":@6I=5#-1S4*U'JKU4P')OW8A_X=T/=\EYV$M4EP,D^?_>:'DQY]XY 3^O5S->OX+NR]8P*?KY6'>AYP]\$/Y M,W+787)J\>3Q@>G'!CK2VR7JKSFU$9T*@FH-5%-0344U#=6:J*:C6@O5VJC6 M034#U;JH9J*:A6H]5.NCFHUJ U0;HMH(U<:H-D&U*:K-4$WDU('RM9&=%\)R M;-Z+G,#/>6P@NR]8P*=KXV':B)S]:&UK>P7:>7*3PKB]>67S5N3/OTG1LYO4 MQ!=G_?X\Y.X6F!]>].R_1H>.F9RZ=(J?G$3GEJ!: ]445%-134.U)JKIJ-9" MM3:J=5#-0+4NJIFH9J%:#]7ZJ&:CV@#5AJ@V0K4QJDU0;8IJ,U03.>VA?,MD M)YJP')OW8A_XQU>YW[_*D9U>0G'I,GF87R)G/V_;?'&#;0%\<-;?)&?[3,/S M][B@KGZ'"21R M]@B2AA>&_O)U+NPX_> @..I,$U1JHIJ":BFH:JC5134>U%JJU4:V# M:@:J=5'-1#4+U7JHUD+_RZ].('D!_%[FZO$ MWYWEJYN\'G%[85GZ2_J;=)GUA$1TU FJ-5!-0345U314:Z*:CFHM5&NC6@?5 M#%3KHIJ):A:J]5"MCVHVJ@U0;8AJ(U0;H]H$U::H-D,UD=,$RI=#=M(*R^WS M_N:HS54^G7E0C5)T0;7H@E@ IQI=]3#\I)H]_*3O+C?M+>YRT4\I"IQUZ,R3 M$WM_E\0JN: K+=P7/_229;QUY,>+)!/L=E=[I8>?4OCBKT,_.%?QLK==MN*A M6@/5%%1344U#M2:JZ:C60K4VJG50S4"U+JJ9J&:A6@_5^JAFH]H U8:H-D*U M,:I-4&V*:C-4$SG5H'3%8SDV[@6;]V(?^,?G_^2J?'U;OSMM@F>6O$W.%%Z= M-D%J#]--\# (I9K]W.[NZ^K!#9+;03;WPRQ_2N[^+N-0 O][W '_DN(J MN#I;]M"))ZC60#4%U514TU"MB6HZJK5V6OWXE1#G_G;@'\]^7/S<8.Z%R:V_ MSZX72('W]!P=W0:\6_2OC*N[V;M2N@VB8TUVVO$?_:M*_:9R\DQ*!=VJBFH: MJC5134>UUIFC5:O)LGQW>]KVT%DDJ&:@6A?53%2S4*V':OTS/THWMY5ZY;3Q MH4-&4&V(:B-4&Z/:!-6FJ#9#-9&3V^4;'SMDA.4:+,>&M&!36F QG6Y\ATDD MU>Q))/W##)*7P)OGOR@OVRM=V] Y)#OM]OB4J_SI]%X;!=VHBFH:JC5134>U MUKF#5?ET4SOM;.CD$%0S4*V+:B:J6:C60[7^^1^DJW=GZ="1(*@V1+41JHU1 M;8)J4U2;H9K(2=[RG8T="<)R#99C(UJP&2VPD$YWML/HD/C-K,XFGIX"-WGP MWO$$.6?S6KRSC2U3*]W82*VQTX[_=E_5:\G_?;J13VL;N645U314:Z*:CFJM M,T>L5J]?5>2KVJ?;F]/R1FZZ@VH&JG51S40U"]5ZJ-8_\^-T*U_+E?A_MM5. M"QRYX0&J#5%MA&IC5)N@VA359J@FXP MG*.:_41IP_G36[VNI#\,-[G(^H^SK0V=MX%J#5134$U%-0W5FJBFHUH+U=JH MUD$U ]6ZJ&:BFH5J/53KHYJ-:@-4&Z+:"-7&J#9!M2FJS5!-Y"1\^6[(SMM@ M.3;O!1OX@DU\@45^NAL>)G!4MP]EKGW0#="Z8].C$IZ_&YXOENB4S90K8%J M"JJIJ*:A6A/5=%1KH5H;U3JH9J!:%]5,5+-0K8=J?52S46V :D-4&Z':&-4F MJ#9%M1FJ"<%R;-H+-NX%F_>"#7S!)K[ (C_=+0\#.:K9 SG>O=BO^+/XLN72 ME1$=T(%J"JJIJ*:A6A/5=%1KH5H;U3JH9J!:%]5,5+-0K8=J?52S46V :D-4 M&Z':&-4FJ#9%M1FJB9S@+U\9V0$=+,?FO=@'_O%+4"J?:N\>TL+.YZ"X=!,\ MS.>H9L_GL#,>R8>.Y$"U!JHIJ*:BFH9J35334:V%:FU4ZZ":@6I=5#-1S4*U M'JKU4X;(X68Z->['/^^,'A/L*TFWO,">D MECTGQ-X^_'G7[LJ^TC ;+]WRT"DAJ*:@FHIJ&JHU44U'M1:JM5&M@VH&JG51 MS40U"]5ZJ-9'-1O5!J@V1+41JHU1;8)J4U2;H9K(R?[R+8^=/<)R;-Z+?>"? M/*E4KI^^UI#=+);EZ3I8/=3![*$BJN,%TG=G^>I*R7,*P]"-0NG972XD?;T; M%OR+$TI.TA'G[CKZ]6PK1*>%H%H#U1144U%-0[4FJNFHUD*U-JIU4,U M2ZJ MF:AFH5H/U?JH9J/: -6&J#9"M3&J35!MBFHS5!,Y%:!\*V3GD[ GGQ]+&<47*Y;<#FSX')6P>5Z M!9?KH]]D^]Q6:_&_DV'B@X++#0LN-RJXW+C@WU^]NE&0WK%%<.J@.LQ;B-[."ZO_QR(QLN?0I"U)KH)J" M:BJJ::C61#4=U5JHUD:U#JH9J-9%-1/5+%3KH5H?U6Q4&Z#:$-5&J#9&M0FJ M35%MAFHB)_C+G[) .3;N!9OW8A_X^1>RT,UB69[N@H>Q#;7LL0VZ99[M>>BD M!E1KH)J":BJJ::C61#4=U5JHUD:U#JH9J-9%-1/5+%3KH5H?U6Q4&Z#:$-5& MJ#9&M0FJ35%MAFHB)]3+]SQV4@/+L7DOV, 7;.(++/+3=? PJ:'VGY_44$,G M-:!: ]445%-134.U)JKIJ-9"M3:J=5#-0+4NJIFH9J%:#]7ZJ&:CV@#5AJ@V M0K4QJDU0;8IJ,U03@N78M!=LW LV[P4;^()-?(%%?KI;'B8UU+(G-4 /S$"' M-J!: ]445%-134.U)JKIJ-9"M3:J=5#-0+4NJIFH9J%:#]7ZJ&:CV@#5AJ@V M0K4QJDU0;8IJ,U03.1V@?'O</UCIRJP')OE@@US@:5YJO9=':8J7&5/51BN%V[P(_ B;_TD/;KGS_5E&V5[ M'ZHU4$U!-175-%1KHIJ.:BU4:Z-:!]4,5.NBFHEJ%JKU4*V/:C:J#5!MB&HC M5!NCV@35IJ@V0S61$_&E>]_5FCTI@&?['SI. =4:J*:@FHIJ&JHU44U'M1:JM5&M@VH&JG51 MS40U"]5ZJ-9'-1O5!J@V1+41JHU1;8)J4U2;H9K(B?KR_4\NW/_820DLQV:Y M8,-<8&F>[G_50__+'JA@1L^;>T/B%I@4O^2*[_E3?^C,!%1KH)J":BJJ::C6 M1#4=U5JHUD:U#JH9J-9%-1/5+%3KH5H?U6Q4&Z#:$-5&J#9&M0FJ35%MAFHB M)^7+5[_JNTN^YZ_XLMMEDURP42[8+!=8F*>;WV%LPE7VV(3_WV35;+QT'R2U M!JHIJ*:BFH9J35334:V%:FU4ZZ":@6I=5#-1S4*U'JKU4:]V =^ZHKVNPJ(;A++\70%/(P9N,S)XCM5G?[E(3NW-DT=(/VT> M].*_1F'DK!?)-=_O_N8U?Z$[?TU>_N>&F\;X[.Y:HQ3YTH,K.?-_OGK)"P4? M?DHO?AC]3Y2Z47CUXJQ_)HLF;R[CKGFHFO%''KSUYMG59_LF.O($U1JHIJ": MBFH:JC5134>U%JJU4:V#:@:J=5'-1#4+U7JHUD[Y.#;# M!1OB@DUQP<:XP'(\W04/@T>NL@>/C/=/DW;W#YH.DK. V040'3.":@U44U!- M134-U9JHIJ-:"]7:J-9!-0/5NJAFHIJ%:CU4ZZ.:C6H#5!NBV@C5QJ@V0;4I MJLU03>0D?OD"N.7DRE$#K+Q_G#2[53;'!1OD@DUR@45YN@,>9HQ<9<\8T2TS M[GOV2S+2.#A;^-#Y(:C60#4%U514TU"MB6HZJK50K8UJ'50S4*V+:B:J6:C6 M0[4^JMFH-D"U(:J-4&V,:A-4FZ+:#-5$3KR7+WPHQ\:]8/->L($OV,076.2G MB^%ASLC5]H'6M0^*H1D\.6OO7YN7!4I?DWJX]!;;]\1Z(5G)-M?1]@/FHZ1Z M:V<]]YRE9, ML'$OV+P7;. +-O$%%OFI;ED_##.I9P\S.;P(\6V@\>XQ-[]XZ]W%YU\S+T-G M;Z!LJO51S4:U :H-46V$:F-4FZ#:%-5F MJ"9R(KY\\4,Y-NX%F_>"#7S!)K[ (C]=#@_#5.(W$_\_>;_*;A>H;DEJ#513 M4$U%-0W5FJBFHUH+U=JHUD$U ]6ZJ&:BFH5J/53KHYJ-:@-4&Z+:"-7&J#9! MM2FJS5!-")9CTUZP<2_8O!=LX LV\046^>EN>9C24L^>TG*X7V7NKU9Q@0PC M?_ZM]#TKZ" 55&N@FH)J*JIIJ-9$-1W56JC61K4.JAFHUD4U$]4L5.NA6A_5 M;%0;H-H0U4:H-D:U":I-46V&:B*G Y1OC^P@E?K[425G;X%ADUPH1;?+IK3 M8CK=^ YC4NK98U*L\R\ZU"WS;+-#IZ*@6@/5%%1344U#M2:JZ:C60K4VJG50 MS4"U+JJ9J&:A6@_5^JAFH]H U8:H-D*U,:I-4&V*:C-4$SE97[[9;;G4BPTK M'[S8D!V.PG)LF LVS046Y^D&>!B.4L\>CL+O'4H+=W'&*U\NJE?;$\0[M^)_)??+^0+Z<&/ M(G^U>?/9=19ND"P0?_[1]Z/].\D&?OC!M\V.W_\?4$L#!!0 ( $FJN5;4 MY&PO=V]R:W-H965TWUQZ@N3#&"M8U/;P/8^?6TG9($- MN?:TQPL2.S/_^_X^)>K@ 4>B@HDP-GI=3ZRG5EMH("RPN^!J:?++@H ML-)#L73E6@#.K5-!W<#S(K? A#E)W\Y-1=+G&T4)@ZE 6[@>,[ M^XDO9+E29L)-^FN\A!FHN_54Z)%;J^2D "8)9TC 8N ,_:NQ;QVLQ5\$=O+@ M'IE4YIS?FT&:#QS/$ &%3!D)K"];& .E1DES?*]$G3JF<3R\WZM_L,GK9.98 MPIC3KR17JX'3,0U@YA#;1DLRF-<$*)WW!=T@8:ZUF;FQMK+?. MAC#S&F=*Z*=$^ZEDEGZ\3C^DX^'U+1J.QS=WU[?I]4G FNA^@SYRI ME43O60[YL8"K4ZGS"?;YC()6Q0ED%RCTWZ# "X(&H/&ON_LM.&%=WM#JA>?* M2Y:,+$B&F4+#+.,;I@A;HBFG)",@T=^?M -*%13R6U/Y2O5.L[KYQ*_D&F

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end XML 51 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 52 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 53 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 170 210 1 false 38 0 false 7 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - BALANCE SHEETS Sheet http://www.deitaxonomy.com/role/StatementBalanceSheets BALANCE SHEETS Statements 2 false false R3.htm 00105 - Statement - BALANCE SHEETS (Parenthetical) Sheet http://www.deitaxonomy.com/role/StatementBalanceSheetsParenthetical BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - STATEMENTS OF INCOME Sheet http://www.deitaxonomy.com/role/StatementStatementsOfIncome STATEMENTS OF INCOME Statements 4 false false R5.htm 00300 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT Sheet http://www.deitaxonomy.com/role/StatementStatementsOfChangesInShareholdersDeficit STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT Statements 5 false false R6.htm 00400 - Statement - STATEMENT OF CASH FLOWS Sheet http://www.deitaxonomy.com/role/StatementStatementOfCashFlows STATEMENT OF CASH FLOWS Statements 6 false false R7.htm 10101 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND Sheet http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackground ORGANIZATION AND BUSINESS BACKGROUND Notes 7 false false R8.htm 10201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPolicies SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 10301 - Disclosure - INITIAL PUBLIC OFFERING Sheet http://www.deitaxonomy.com/role/DisclosureInitialPublicOffering INITIAL PUBLIC OFFERING Notes 9 false false R10.htm 10401 - Disclosure - PRIVATE PLACEMENT Sheet http://www.deitaxonomy.com/role/DisclosurePrivatePlacement PRIVATE PLACEMENT Notes 10 false false R11.htm 10501 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 11 false false R12.htm 10601 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.deitaxonomy.com/role/DisclosureCommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 12 false false R13.htm 10701 - Disclosure - SHAREHOLDERS DEFICIT Sheet http://www.deitaxonomy.com/role/DisclosureShareholdersDeficit SHAREHOLDERS DEFICIT Notes 13 false false R14.htm 10801 - Disclosure - WARRANTS Sheet http://www.deitaxonomy.com/role/DisclosureWarrants WARRANTS Notes 14 false false R15.htm 10901 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.deitaxonomy.com/role/DisclosureFairValueMeasurements FAIR VALUE MEASUREMENTS Notes 15 false false R16.htm 11001 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.deitaxonomy.com/role/DisclosureSubsequentEvents SUBSEQUENT EVENTS Notes 16 false false R17.htm 20202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesPolicies SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 17 false false R18.htm 30203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesTables SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPolicies 18 false false R19.htm 30803 - Disclosure - WARRANTS (Tables) Sheet http://www.deitaxonomy.com/role/DisclosureWarrantsTables WARRANTS (Tables) Tables http://www.deitaxonomy.com/role/DisclosureWarrants 19 false false R20.htm 30903 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://www.deitaxonomy.com/role/DisclosureFairValueMeasurements 20 false false R21.htm 40101 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details) Sheet http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails ORGANIZATION AND BUSINESS BACKGROUND (Details) Details http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackground 21 false false R22.htm 40201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) Sheet http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) Details 22 false false R23.htm 40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Summary of net loss per share presented in the statement of operations (Details) Sheet http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails SIGNIFICANT ACCOUNTING POLICIES - Summary of net loss per share presented in the statement of operations (Details) Details 23 false false R24.htm 40301 - Disclosure - INITIAL PUBLIC OFFERING - Additional Information (Details) Sheet http://www.deitaxonomy.com/role/DisclosureInitialPublicOfferingAdditionalInformationDetails INITIAL PUBLIC OFFERING - Additional Information (Details) Details 24 false false R25.htm 40401 - Disclosure - PRIVATE PLACEMENT - Additional Information (Details) Sheet http://www.deitaxonomy.com/role/DisclosurePrivatePlacementAdditionalInformationDetails PRIVATE PLACEMENT - Additional Information (Details) Details 25 false false R26.htm 40501 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails RELATED PARTY TRANSACTIONS (Details) Details http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactions 26 false false R27.htm 40601 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional information (Details) Sheet http://www.deitaxonomy.com/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails COMMITMENTS AND CONTINGENCIES - Additional information (Details) Details 27 false false R28.htm 40701 - Disclosure - SHAREHOLDERS DEFICIT (Details) Sheet http://www.deitaxonomy.com/role/DisclosureShareholdersDeficitDetails SHAREHOLDERS DEFICIT (Details) Details http://www.deitaxonomy.com/role/DisclosureShareholdersDeficit 28 false false R29.htm 40801 - Disclosure - WARRANTS - Warrants activity (Details) Sheet http://www.deitaxonomy.com/role/DisclosureWarrantsWarrantsActivityDetails WARRANTS - Warrants activity (Details) Details 29 false false R30.htm 40802 - Disclosure - WARRANTS - Additional information (Details) Sheet http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails WARRANTS - Additional information (Details) Details 30 false false R31.htm 40901 - Disclosure - FAIR VALUE MEASUREMENTS - Fair value on a recurring basis (Details) Sheet http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsFairValueOnRecurringBasisDetails FAIR VALUE MEASUREMENTS - Fair value on a recurring basis (Details) Details 31 false false R32.htm 40902 - Disclosure - FAIR VALUE MEASUREMENTS - Initial measurement (Details) Sheet http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsInitialMeasurementDetails FAIR VALUE MEASUREMENTS - Initial measurement (Details) Details 32 false false R33.htm 40903 - Disclosure - FAIR VALUE MEASUREMENTS - Changes in the fair value of the warrant liability (Details) Sheet http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfWarrantLiabilityDetails FAIR VALUE MEASUREMENTS - Changes in the fair value of the warrant liability (Details) Details 33 false false R34.htm 40904 - Disclosure - FAIR VALUE MEASUREMENTS - Additional information (Details) Sheet http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails FAIR VALUE MEASUREMENTS - Additional information (Details) Details 34 false false R35.htm 41101 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.deitaxonomy.com/role/DisclosureSubsequentEventsDetails SUBSEQUENT EVENTS (Details) Details http://www.deitaxonomy.com/role/DisclosureSubsequentEvents 35 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept DueToOtherRelatedPartiesClassifiedCurrent in us-gaap/2021 used in 4 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. grcyu-20221231x10k.htm 77, 90 [dq-0542-Deprecated-Concept] Concept NotesPayableRelatedPartiesClassifiedCurrent in us-gaap/2021 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. grcyu-20221231x10k.htm 77 [dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesCurrent in us-gaap/2021 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. grcyu-20221231x10k.htm 90 [dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesCurrentAndNoncurrent in us-gaap/2021 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. grcyu-20221231x10k.htm 90 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 23 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate, grcyu:Classofwarrantorrightredemptionofwarrantsorrightsthresholdconsecutivetradingdays, grcyu:Classofwarrantorrightredemptionofwarrantsorrightsthresholdtradingdays, grcyu:MaximumThresholdBusinessDaysToRedeemOutstandingPublicShares, us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight, us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights, us-gaap:CommonStockSharesOutstanding, us-gaap:EarningsPerShareDiluted, us-gaap:PreferredStockSharesOutstanding, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding - grcyu-20221231x10k.htm 9 [ix-0514-Hidden-Fact-Not-Referenced] WARN: 2 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:CommitmentsAndContingencies - grcyu-20221231x10k.htm 9 [dqc-0033-Document-Period-End-Date-Context] The ending date of 2021-12-31 used for AuditorFirmId must be the same as the Document Period End Date, 2022-12-31. The properties of this AuditorFirmId fact are Context: Duration_1_1_2021_To_12_31_2021_gE9SUDFw50yBBXybqOQaCg, Unit: (none), Rule Element Id: 2. grcyu-20221231x10k.htm 74 [dqc-0033-Document-Period-End-Date-Context] The ending date of 2021-12-31 used for AuditorLocation must be the same as the Document Period End Date, 2022-12-31. The properties of this AuditorLocation fact are Context: Duration_1_1_2021_To_12_31_2021_gE9SUDFw50yBBXybqOQaCg, Unit: (none), Rule Element Id: 2. grcyu-20221231x10k.htm 76 [dqc-0033-Document-Period-End-Date-Context] The ending date of 2021-12-31 used for AuditorName must be the same as the Document Period End Date, 2022-12-31. The properties of this AuditorName fact are Context: Duration_1_1_2021_To_12_31_2021_gE9SUDFw50yBBXybqOQaCg, Unit: (none), Rule Element Id: 2. grcyu-20221231x10k.htm 74 grcyu-20221231x10k.htm grcyu-20221231.xsd grcyu-20221231_cal.xml grcyu-20221231_def.xml grcyu-20221231_lab.xml grcyu-20221231_pre.xml grcyu-20221231xex10d1.htm grcyu-20221231xex10d2.htm grcyu-20221231xex21.htm grcyu-20221231xex31d1.htm grcyu-20221231xex31d2.htm grcyu-20221231xex32d1.htm grcyu-20221231xex4d2.htm http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true JSON 56 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "grcyu-20221231x10k.htm": { "axisCustom": 0, "axisStandard": 16, "baseTaxonomies": { "http://fasb.org/us-gaap/2021-01-31": 293, "http://xbrl.sec.gov/dei/2021q4": 46 }, "contextCount": 170, "dts": { "calculationLink": { "local": [ "grcyu-20221231_cal.xml" ] }, "definitionLink": { "local": [ "grcyu-20221231_def.xml" ] }, "inline": { "local": [ "grcyu-20221231x10k.htm" ] }, "labelLink": { "local": [ "grcyu-20221231_lab.xml" ] }, "presentationLink": { "local": [ "grcyu-20221231_pre.xml" ] }, "schema": { "local": [ "grcyu-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 332, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 25, "http://www.deitaxonomy.com/20221231": 3, "http://xbrl.sec.gov/dei/2021q4": 6, "total": 34 }, "keyCustom": 76, "keyStandard": 134, "memberCustom": 18, "memberStandard": 18, "nsprefix": "grcyu", "nsuri": "http://www.deitaxonomy.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "grcyu:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10401 - Disclosure - PRIVATE PLACEMENT", "menuCat": "Notes", "order": "10", "role": "http://www.deitaxonomy.com/role/DisclosurePrivatePlacement", "shortName": "PRIVATE PLACEMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "grcyu:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10501 - Disclosure - RELATED PARTY TRANSACTIONS", "menuCat": "Notes", "order": "11", "role": "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10601 - Disclosure - COMMITMENTS AND CONTINGENCIES", "menuCat": "Notes", "order": "12", "role": "http://www.deitaxonomy.com/role/DisclosureCommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10701 - Disclosure - SHAREHOLDERS DEFICIT", "menuCat": "Notes", "order": "13", "role": "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficit", "shortName": "SHAREHOLDERS DEFICIT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "grcyu:WarrantLiabilityDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10801 - Disclosure - WARRANTS", "menuCat": "Notes", "order": "14", "role": "http://www.deitaxonomy.com/role/DisclosureWarrants", "shortName": "WARRANTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "grcyu:WarrantLiabilityDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativesAndFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10901 - Disclosure - FAIR VALUE MEASUREMENTS", "menuCat": "Notes", "order": "15", "role": "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurements", "shortName": "FAIR VALUE MEASUREMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativesAndFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11001 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "16", "role": "http://www.deitaxonomy.com/role/DisclosureSubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "20202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "17", "role": "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesPolicies", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "18", "role": "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesTables", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "grcyu:SummaryOfWarrantsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30803 - Disclosure - WARRANTS (Tables)", "menuCat": "Tables", "order": "19", "role": "http://www.deitaxonomy.com/role/DisclosureWarrantsTables", "shortName": "WARRANTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "grcyu:SummaryOfWarrantsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "As_Of_12_31_2022_QSA6znOC8ECoQDqRvs2q6g", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "Unit_Standard_USD_-gXyktSl3UySiRtICm6A0w", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00100 - Statement - BALANCE SHEETS", "menuCat": "Statements", "order": "2", "role": "http://www.deitaxonomy.com/role/StatementBalanceSheets", "shortName": "BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "As_Of_12_31_2022_QSA6znOC8ECoQDqRvs2q6g", "decimals": "0", "lang": null, "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-gXyktSl3UySiRtICm6A0w", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30903 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)", "menuCat": "Tables", "order": "20", "role": "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsTables", "shortName": "FAIR VALUE MEASUREMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": "INF", "first": true, "lang": null, "name": "grcyu:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_item_1hyxT2FwAUaiBxEmIReSgw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40101 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details)", "menuCat": "Details", "order": "21", "role": "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails", "shortName": "ORGANIZATION AND BUSINESS BACKGROUND (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": "INF", "first": true, "lang": null, "name": "grcyu:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_item_1hyxT2FwAUaiBxEmIReSgw", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "As_Of_12_31_2022_QSA6znOC8ECoQDqRvs2q6g", "decimals": "0", "first": true, "lang": null, "name": "grcyu:MarketableSecuritiesHeldInTrustAccountNoncurrent", "reportCount": 1, "unitRef": "Unit_Standard_USD_-gXyktSl3UySiRtICm6A0w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)", "menuCat": "Details", "order": "22", "role": "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:UnrecognizedTaxBenefits", "p", "us-gaap:IncomeTaxPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "As_Of_12_31_2022_QSA6znOC8ECoQDqRvs2q6g", "decimals": "0", "lang": null, "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-gXyktSl3UySiRtICm6A0w", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "p", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_KUByKpVXJkiE8bchsOXqOg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Summary of net loss per share presented in the statement of operations (Details)", "menuCat": "Details", "order": "23", "role": "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Summary of net loss per share presented in the statement of operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_KUByKpVXJkiE8bchsOXqOg", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_7_28_2020_To_7_28_2020_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_OAdu7NxPmkmrFxlYE-kPlw", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unitRef": "Unit_Standard_shares_KUByKpVXJkiE8bchsOXqOg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40301 - Disclosure - INITIAL PUBLIC OFFERING - Additional Information (Details)", "menuCat": "Details", "order": "24", "role": "http://www.deitaxonomy.com/role/DisclosureInitialPublicOfferingAdditionalInformationDetails", "shortName": "INITIAL PUBLIC OFFERING - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "grcyu:InitialPublicOfferingTextBlock", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_7_28_2020_To_7_28_2020_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_OAdu7NxPmkmrFxlYE-kPlw", "decimals": "0", "lang": null, "name": "grcyu:NumberOfPublicWarrantsPerUnit", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_KUByKpVXJkiE8bchsOXqOg", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_6_28_2020_To_6_28_2020_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_PrivatePlacementMember_lRGp_PmZwk680ICr5JtTeQ", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unitRef": "Unit_Standard_shares_KUByKpVXJkiE8bchsOXqOg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40401 - Disclosure - PRIVATE PLACEMENT - Additional Information (Details)", "menuCat": "Details", "order": "25", "role": "http://www.deitaxonomy.com/role/DisclosurePrivatePlacementAdditionalInformationDetails", "shortName": "PRIVATE PLACEMENT - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockSharesIssued", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "As_Of_12_31_2022_QSA6znOC8ECoQDqRvs2q6g", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unitRef": "Unit_Standard_shares_KUByKpVXJkiE8bchsOXqOg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40501 - Disclosure - RELATED PARTY TRANSACTIONS (Details)", "menuCat": "Details", "order": "26", "role": "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails", "shortName": "RELATED PARTY TRANSACTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_12_1_2018_To_12_31_2018_E40MXz9WcUWY3yWoyp8OpA", "decimals": null, "lang": "en-US", "name": "grcyu:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_us-gaap_TypeOfArrangementAxis_grcyu_UnderwritingAgreementMember_9uuXN0cg9Emy-CVa9ocryg", "decimals": "3", "first": true, "lang": null, "name": "grcyu:PercentageOfUnderwritingCommissionOnGrossProceeds", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_HWl3Yagk7UGLKYF2Mus4dw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40601 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional information (Details)", "menuCat": "Details", "order": "27", "role": "http://www.deitaxonomy.com/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "shortName": "COMMITMENTS AND CONTINGENCIES - Additional information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_us-gaap_TypeOfArrangementAxis_grcyu_UnderwritingAgreementMember_9uuXN0cg9Emy-CVa9ocryg", "decimals": "3", "first": true, "lang": null, "name": "grcyu:PercentageOfUnderwritingCommissionOnGrossProceeds", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_HWl3Yagk7UGLKYF2Mus4dw", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockSharesAuthorized", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "As_Of_12_31_2022_QSA6znOC8ECoQDqRvs2q6g", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Unit_Standard_shares_KUByKpVXJkiE8bchsOXqOg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40701 - Disclosure - SHAREHOLDERS DEFICIT (Details)", "menuCat": "Details", "order": "28", "role": "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficitDetails", "shortName": "SHAREHOLDERS DEFICIT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "As_Of_2_21_2019_ORy_GXyDw0GEYrZWZgwZ6g", "decimals": "INF", "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_KUByKpVXJkiE8bchsOXqOg", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "grcyu:SummaryOfWarrantsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "As_Of_12_31_2022_QSA6znOC8ECoQDqRvs2q6g", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-gXyktSl3UySiRtICm6A0w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40801 - Disclosure - WARRANTS - Warrants activity (Details)", "menuCat": "Details", "order": "29", "role": "http://www.deitaxonomy.com/role/DisclosureWarrantsWarrantsActivityDetails", "shortName": "WARRANTS - Warrants activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "grcyu:SummaryOfWarrantsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "As_Of_12_31_2022_QSA6znOC8ECoQDqRvs2q6g", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-gXyktSl3UySiRtICm6A0w", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "As_Of_12_31_2022_QSA6znOC8ECoQDqRvs2q6g", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_Divide_USD_shares_0Aqybw46tU6JchxBt02dQw", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00105 - Statement - BALANCE SHEETS (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://www.deitaxonomy.com/role/StatementBalanceSheetsParenthetical", "shortName": "BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "As_Of_12_31_2022_us-gaap_StatementClassOfStockAxis_grcyu_CommonStockSubjectToPossibleRedemptionMember_W5iH0KAxT0iIYVeJnhlzbA", "decimals": "INF", "lang": null, "name": "us-gaap:TemporaryEquitySharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_KUByKpVXJkiE8bchsOXqOg", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "grcyu:WarrantLiabilityDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": "2", "first": true, "lang": null, "name": "grcyu:ClassOfWarrantOrRightRedemptionPricePerRight", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_0Aqybw46tU6JchxBt02dQw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40802 - Disclosure - WARRANTS - Additional information (Details)", "menuCat": "Details", "order": "30", "role": "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails", "shortName": "WARRANTS - Additional information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "grcyu:WarrantLiabilityDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": "2", "first": true, "lang": null, "name": "grcyu:ClassOfWarrantOrRightRedemptionPricePerRight", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_0Aqybw46tU6JchxBt02dQw", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "As_Of_4_25_2023_mXjb04uKW0m-c0jpPwT-ZA", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:AssetsHeldInTrustNoncurrent", "reportCount": 1, "unitRef": "Unit_Standard_USD_-gXyktSl3UySiRtICm6A0w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40901 - Disclosure - FAIR VALUE MEASUREMENTS - Fair value on a recurring basis (Details)", "menuCat": "Details", "order": "31", "role": "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsFairValueOnRecurringBasisDetails", "shortName": "FAIR VALUE MEASUREMENTS - Fair value on a recurring basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "As_Of_12_31_2022_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_vH9bNUaE502Wbw-TNdBUiA", "decimals": "0", "lang": null, "name": "us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-gXyktSl3UySiRtICm6A0w", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "As_Of_12_31_2022_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember_2AD2AKWTN0qWkO2ACZ3ryQ", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_0Aqybw46tU6JchxBt02dQw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40902 - Disclosure - FAIR VALUE MEASUREMENTS - Initial measurement (Details)", "menuCat": "Details", "order": "32", "role": "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsInitialMeasurementDetails", "shortName": "FAIR VALUE MEASUREMENTS - Initial measurement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "As_Of_12_31_2022_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember_2AD2AKWTN0qWkO2ACZ3ryQ", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_0Aqybw46tU6JchxBt02dQw", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "As_Of_12_31_2021_1VUOWqSgeEyFdi7dEY_8dA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unitRef": "Unit_Standard_USD_-gXyktSl3UySiRtICm6A0w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40903 - Disclosure - FAIR VALUE MEASUREMENTS - Changes in the fair value of the warrant liability (Details)", "menuCat": "Details", "order": "33", "role": "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfWarrantLiabilityDetails", "shortName": "FAIR VALUE MEASUREMENTS - Changes in the fair value of the warrant liability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "As_Of_12_31_2020_-CCYwnHi3UOpNbI7pyjgoA", "decimals": "0", "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-gXyktSl3UySiRtICm6A0w", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": "0", "first": true, "lang": null, "name": "grcyu:FairValueAssetsLiabilitiesTransfersBetweenLevelsAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-gXyktSl3UySiRtICm6A0w", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40904 - Disclosure - FAIR VALUE MEASUREMENTS - Additional information (Details)", "menuCat": "Details", "order": "34", "role": "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "shortName": "FAIR VALUE MEASUREMENTS - Additional information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": "0", "first": true, "lang": null, "name": "grcyu:FairValueAssetsLiabilitiesTransfersBetweenLevelsAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-gXyktSl3UySiRtICm6A0w", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_4_25_2023_To_4_25_2023_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_K9pcjGqq7UyVLmyp5uhZSw", "decimals": "INF", "first": true, "lang": null, "name": "grcyu:ExtensionPeriodToConsummateBusinessCombination", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_item_1hyxT2FwAUaiBxEmIReSgw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41101 - Disclosure - SUBSEQUENT EVENTS (Details)", "menuCat": "Details", "order": "35", "role": "http://www.deitaxonomy.com/role/DisclosureSubsequentEventsDetails", "shortName": "SUBSEQUENT EVENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_4_25_2023_To_4_25_2023_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_K9pcjGqq7UyVLmyp5uhZSw", "decimals": "INF", "first": true, "lang": null, "name": "grcyu:ExtensionPeriodToConsummateBusinessCombination", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_item_1hyxT2FwAUaiBxEmIReSgw", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-gXyktSl3UySiRtICm6A0w", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00200 - Statement - STATEMENTS OF INCOME", "menuCat": "Statements", "order": "4", "role": "http://www.deitaxonomy.com/role/StatementStatementsOfIncome", "shortName": "STATEMENTS OF INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-gXyktSl3UySiRtICm6A0w", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ExztFjsvCUK7wa9_2UWoeg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-gXyktSl3UySiRtICm6A0w", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00300 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT", "menuCat": "Statements", "order": "5", "role": "http://www.deitaxonomy.com/role/StatementStatementsOfChangesInShareholdersDeficit", "shortName": "STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ExztFjsvCUK7wa9_2UWoeg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-gXyktSl3UySiRtICm6A0w", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_Standard_USD_-gXyktSl3UySiRtICm6A0w", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00400 - Statement - STATEMENT OF CASH FLOWS", "menuCat": "Statements", "order": "6", "role": "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows", "shortName": "STATEMENT OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": "0", "lang": null, "name": "us-gaap:FairValueAdjustmentOfWarrants", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-gXyktSl3UySiRtICm6A0w", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10101 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND", "menuCat": "Notes", "order": "7", "role": "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackground", "shortName": "ORGANIZATION AND BUSINESS BACKGROUND", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "8", "role": "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPolicies", "shortName": "SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "grcyu:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10301 - Disclosure - INITIAL PUBLIC OFFERING", "menuCat": "Notes", "order": "9", "role": "http://www.deitaxonomy.com/role/DisclosureInitialPublicOffering", "shortName": "INITIAL PUBLIC OFFERING", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "grcyu-20221231x10k.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_C4NtmxqaJEOzx0oW5mLmuQ", "decimals": null, "first": true, "lang": "en-US", "name": "grcyu:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 38, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r354", "r355", "r356" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r354", "r355", "r356" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r354", "r355", "r356" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Document and Entity Information [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r354", "r355", "r356" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r357" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r360" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r359" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r353" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name." } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "grcyu_AccretionOfCarryingValueToRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount represent the accretion of carrying value to redemption value.", "label": "Accretion of Carrying Value To Redemption Value", "terseLabel": "Accretion of carrying value to redemption value" } } }, "localname": "AccretionOfCarryingValueToRedemptionValue", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails", "http://www.deitaxonomy.com/role/StatementStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "monetaryItemType" }, "grcyu_AggregateTotalPrincipalAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of aggregate total principal amount.", "label": "Aggregate Total Principal Amount", "terseLabel": "Aggregate total principal amount" } } }, "localname": "AggregateTotalPrincipalAmount", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "grcyu_AllocationOfUndistributedIncomeLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of allocation of undistributed income (loss).", "label": "Allocation Of Undistributed Income Loss", "terseLabel": "Allocation of undistributed income (loss)" } } }, "localname": "AllocationOfUndistributedIncomeLoss", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "grcyu_AnticipatedStockIssuance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Anticipated stock issuance to sponsor.", "label": "Anticipated Stock Issuance", "terseLabel": "Anticipated issuance of founder shares to the Sponsor" } } }, "localname": "AnticipatedStockIssuance", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "sharesItemType" }, "grcyu_BusinessCombinationAggregateFairMarketValueOnAssetsHeldInTrustPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of aggregate fair value of business combination to assets held in trust.", "label": "Business Combination Aggregate Fair Market Value On Assets Held In Trust Percentage", "terseLabel": "Fair value on assets held In trust (as a percent)" } } }, "localname": "BusinessCombinationAggregateFairMarketValueOnAssetsHeldInTrustPercentage", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "percentItemType" }, "grcyu_BusinessCombinationAggregateRedemptionAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the aggregate redemption amount.", "label": "Business Combination, Aggregate Redemption Amount", "terseLabel": "Aggregate redemption amount" } } }, "localname": "BusinessCombinationAggregateRedemptionAmount", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "monetaryItemType" }, "grcyu_BusinessCombinationLimitOnNetTangibleAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum percentage of ordinary shares issued for redemption.", "label": "Business Combination Limit On Net Tangible Assets", "terseLabel": "Share redemption (as a percent)" } } }, "localname": "BusinessCombinationLimitOnNetTangibleAssets", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "percentItemType" }, "grcyu_BusinessCombinationNumberOfTargetedBusiness": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents the information pertaining to business combination, number of targeted business.", "label": "Business Combination, Number of Targeted Business", "terseLabel": "Number of targeted business" } } }, "localname": "BusinessCombinationNumberOfTargetedBusiness", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "integerItemType" }, "grcyu_BusinessCombinationRedemptionPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the redemption price of common stock.", "label": "Business Combination, Redemption Price", "terseLabel": "Redemption price" } } }, "localname": "BusinessCombinationRedemptionPrice", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "perShareItemType" }, "grcyu_CashWithdrawnFromTrustAccountToPayRedeemingShareholders": { "auth_ref": [], "calculation": { "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash withdrawn from trust account to pay redeeming shareholders.", "label": "Cash Withdrawn From Trust Account To Pay Redeeming Shareholders", "terseLabel": "Cash withdrawn from trust account to pay redeeming shareholders" } } }, "localname": "CashWithdrawnFromTrustAccountToPayRedeemingShareholders", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "grcyu_ChangeInFairValueAdjustmentOfWarrants": { "auth_ref": [], "calculation": { "http://www.deitaxonomy.com/role/StatementStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_OtherNonoperatingIncome", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of fair value adjustment of warrants.", "label": "Change In Fair Value Adjustment Of Warrants", "negatedLabel": "Change in fair value of warrant liabilities" } } }, "localname": "ChangeInFairValueAdjustmentOfWarrants", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "grcyu_ClassOfWarrantOrRightRedemptionPricePerRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the redemption price per right.", "label": "Class Of Warrant Or Right Redemption Price Per Right", "terseLabel": "Warrants redemption price" } } }, "localname": "ClassOfWarrantOrRightRedemptionPricePerRight", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "grcyu_Classofwarrantorrightredemptionofwarrantsorrightsthresholdconsecutivetradingdays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.", "label": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays", "terseLabel": "Threshold consecutive trading days for redemption of public warrants" } } }, "localname": "Classofwarrantorrightredemptionofwarrantsorrightsthresholdconsecutivetradingdays", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "grcyu_Classofwarrantorrightredemptionofwarrantsorrightsthresholdtradingdays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days for stock price trigger considered for redemption of warrants.", "label": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays", "terseLabel": "Threshold trading days for redemption of public warrants" } } }, "localname": "Classofwarrantorrightredemptionofwarrantsorrightsthresholdtradingdays", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "grcyu_ClosingOfBusinessCombinationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It stands for Closing of business combination .", "label": "Closing of business combination [Member]", "terseLabel": "Closing of business combination" } } }, "localname": "ClosingOfBusinessCombinationMember", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "grcyu_CommonClassaNotSubjectToRedemptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for common class a not subject to redemption.", "label": "Non-Redeemable Ordinary shares" } } }, "localname": "CommonClassaNotSubjectToRedemptionMember", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails" ], "xbrltype": "domainItemType" }, "grcyu_CommonClassaSubjectToRedemptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing subject to possible redemption.", "label": "Redeemable Ordinary shares" } } }, "localname": "CommonClassaSubjectToRedemptionMember", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails" ], "xbrltype": "domainItemType" }, "grcyu_CommonSharesNotSubjectToRedemptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing not subject to possible redemption.", "label": "Ordinary share not subject to redemption" } } }, "localname": "CommonSharesNotSubjectToRedemptionMember", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails" ], "xbrltype": "domainItemType" }, "grcyu_CommonSharesSubjectToRedemptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing subject to possible redemption.", "label": "Ordinary share subject to redemption" } } }, "localname": "CommonSharesSubjectToRedemptionMember", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails" ], "xbrltype": "domainItemType" }, "grcyu_CommonStockNotSubjectToPossibleRedemptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for common not stock subject to possible redemption.", "label": "Common Stock Not Subject To Possible Redemption [Member]", "terseLabel": "Common stock not subject to possible redemption" } } }, "localname": "CommonStockNotSubjectToPossibleRedemptionMember", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementsOfIncome" ], "xbrltype": "domainItemType" }, "grcyu_CommonStockSubjectToPossibleRedemptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for common stock subject to possible redemption.", "label": "Common Stock Subject To Possible Redemption [Member]", "terseLabel": "Common stock subject to possible redemption" } } }, "localname": "CommonStockSubjectToPossibleRedemptionMember", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheetsParenthetical", "http://www.deitaxonomy.com/role/StatementStatementsOfIncome" ], "xbrltype": "domainItemType" }, "grcyu_CommonStockSubjectToPossibleRedemptionPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the accounting policy on common stock subject to possible redemption.", "label": "Common Stock Subject To Possible Redemption, Policy [Policy Text Block]", "terseLabel": "Ordinary Shares Subject to Possible Redemption" } } }, "localname": "CommonStockSubjectToPossibleRedemptionPolicyTextBlock", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "grcyu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum number of businesses which the reporting entity must acquire with the net proceeds of the offering.", "label": "Condition For Future Business Combination Number Of Businesses Minimum", "terseLabel": "Condition for future business combination number of businesses minimum" } } }, "localname": "ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "integerItemType" }, "grcyu_ConvertibleNotesPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for Convertible notes.", "label": "Convertible notes, Policy [Policy Text Block]", "terseLabel": "Convertible notes" } } }, "localname": "ConvertibleNotesPolicyPolicyTextBlock", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "grcyu_DeferredUnderwritingFeesPayable": { "auth_ref": [], "calculation": { "http://www.deitaxonomy.com/role/StatementBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of deferred underwriting fee payable.", "label": "Deferred Underwriting Fees Payable", "terseLabel": "Deferred underwriting fee", "verboseLabel": "Deferred underwriting compensation" } } }, "localname": "DeferredUnderwritingFeesPayable", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails", "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "grcyu_DissolutionExpensesPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of dissolution expenses payable.", "label": "Dissolution Expenses Payable", "terseLabel": "Dissolution expenses" } } }, "localname": "DissolutionExpensesPayable", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "monetaryItemType" }, "grcyu_DueToOtherRelatedPartiesCurrent": { "auth_ref": [], "calculation": { "http://www.deitaxonomy.com/role/StatementBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due To Other Related Parties Current", "terseLabel": "Promissory note payable - related party" } } }, "localname": "DueToOtherRelatedPartiesCurrent", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "grcyu_EffectiveDateOfRegistrationPeriodInitialPublicOffering": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period of warrants of the company, effective date of registration period of the initial business combination.", "label": "Effective Date Of Registration Period, Initial Public Offering", "terseLabel": "Effective date of the registration" } } }, "localname": "EffectiveDateOfRegistrationPeriodInitialPublicOffering", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "grcyu_EmergingGrowthCompanyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for Emerging growth company.", "label": "Emerging Growth Company, Policy [Policy Text Block]", "terseLabel": "Emerging growth company" } } }, "localname": "EmergingGrowthCompanyPolicyTextBlock", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "grcyu_ExercisePriceOfWarrantsWillBeAdjustedOfHigherOfMarketValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents the exercise price of the warrants will be adjusted higher of the market value.", "label": "Exercise Price of the warrants will be adjusted Of The Higher Of Market Value", "terseLabel": "Exercise price of the warrants will be adjusted of the higher of the market value (in percentage)" } } }, "localname": "ExercisePriceOfWarrantsWillBeAdjustedOfHigherOfMarketValue", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "grcyu_ExpiresPeriodEffectiveDateOfRegistrationPeriodInitialPublicOffering": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period of warrants of the company, expired period effective date of registration period of the initial business combination.", "label": "Expires Period, Effective Date Of Registration Period, Initial Public Offering", "terseLabel": "Expired period effective date of registration period of the initial public offering" } } }, "localname": "ExpiresPeriodEffectiveDateOfRegistrationPeriodInitialPublicOffering", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficitDetails" ], "xbrltype": "durationItemType" }, "grcyu_ExtensionPeriodToConsummateBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of times extended to consummate a business combination.", "label": "Extension Period to Consummate Business Combination", "terseLabel": "Extended number of times to consummate the business combination" } } }, "localname": "ExtensionPeriodToConsummateBusinessCombination", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "integerItemType" }, "grcyu_ExtensionPeriodToConsummateBusinessCombinationForEachTime": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of months extended to consummate a business combination each time.", "label": "Extension Period to Consummate Business Combination For Each Time", "terseLabel": "Extended to consummate a business combination each time" } } }, "localname": "ExtensionPeriodToConsummateBusinessCombinationForEachTime", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "durationItemType" }, "grcyu_FairValueAssetsLiabilitiesTransfersBetweenLevelsAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of financial instrument classified as a liability into level 3 of the fair value hierarchy.", "label": "Fair Value Assets (Liabilities), Transfers Between Levels, Amount", "terseLabel": "Transfers between Levels 1, 2 or 3" } } }, "localname": "FairValueAssetsLiabilitiesTransfersBetweenLevelsAmount", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "grcyu_HoldersOfNumberOfSharesWhoExercisedTheirRightToRedeemShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the holders of number of shares who exercised their right to redeem shares.", "label": "Holders Of Number Of Shares Who Exercised Their Right To Redeem Shares", "terseLabel": "Holders of number of ordinary shares who exercised their right to redeem shares" } } }, "localname": "HoldersOfNumberOfSharesWhoExercisedTheirRightToRedeemShares", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "sharesItemType" }, "grcyu_IncreaseDecreaseInAdvancesFromRelatedParty": { "auth_ref": [], "calculation": { "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of from advances from related parties.", "label": "Increase Decrease In Advances From Related Party", "terseLabel": "Advances from a related party" } } }, "localname": "IncreaseDecreaseInAdvancesFromRelatedParty", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "grcyu_InitialPublicOfferingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for Initial public offering of the reporting entity.", "label": "INITIAL PUBLIC OFFERING" } } }, "localname": "InitialPublicOfferingAbstract", "nsuri": "http://www.deitaxonomy.com/20221231", "xbrltype": "stringItemType" }, "grcyu_InitialPublicOfferingTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Initial public offering.", "label": "Initial Public Offering [Text Block]", "terseLabel": "INITIAL PUBLIC OFFERING" } } }, "localname": "InitialPublicOfferingTextBlock", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureInitialPublicOffering" ], "xbrltype": "textBlockItemType" }, "grcyu_InvestmentsMaximumMaturityTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum maturity term of investments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Investments Maximum Maturity Term", "terseLabel": "Maximum maturity term of investments" } } }, "localname": "InvestmentsMaximumMaturityTerm", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "durationItemType" }, "grcyu_MarketValue16.50Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It stands for market value is $16.50 per share.", "label": "Market value $ 16.50", "terseLabel": "Market value $ 16.50" } } }, "localname": "MarketValue16.50Member", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "grcyu_MarketValueIsBelow9.2PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It stands for market value below $9.20 per share.", "label": "Market value below $ 9.20", "terseLabel": "Market value below $ 9.20" } } }, "localname": "MarketValueIsBelow9.2PerShareMember", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "grcyu_MarketableSecuritiesHeldInTrustAccountNoncurrent": { "auth_ref": [], "calculation": { "http://www.deitaxonomy.com/role/StatementBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of marketable securities held in trust account noncurrent.", "label": "Marketable Securities Held in Trust Account Noncurrent", "terseLabel": "Marketable securities held in Trust Account", "verboseLabel": "Marketable securities held in Trust Account" } } }, "localname": "MarketableSecuritiesHeldInTrustAccountNoncurrent", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "grcyu_MaximumPeriodFailureToConsummateBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum period of time failure to consummate business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Maximum Period Failure To Consummate Business Combination", "terseLabel": "Maximum period of time failure to consummate business combination from closing of public offering" } } }, "localname": "MaximumPeriodFailureToConsummateBusinessCombination", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "durationItemType" }, "grcyu_MaximumThresholdBusinessDaysToRedeemOutstandingPublicShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum Threshold Business Days To Redeem Outstanding Public Shares.", "label": "Maximum Threshold Business Days To Redeem Outstanding Public Shares", "terseLabel": "Maximum threshold business days to redeem outstanding public shares" } } }, "localname": "MaximumThresholdBusinessDaysToRedeemOutstandingPublicShares", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "durationItemType" }, "grcyu_MaximumThresholdPeriodForRegistrationStatementToBecomeEffectiveAfterBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum threshold period for registration statement to become effective after business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Maximum Threshold Period For Registration Statement To Become Effective After Business Combination", "terseLabel": "Maximum threshold period for registration statement to become effective after business combination" } } }, "localname": "MaximumThresholdPeriodForRegistrationStatementToBecomeEffectiveAfterBusinessCombination", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "grcyu_NoticePeriodForRedemptionToEachPublicWarrantHolder": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the written notice of redemption to each Public Warrant holder.", "label": "Notice Period For Redemption To Each Public Warrant Holder", "terseLabel": "Written notice of redemption to each public warrant holder" } } }, "localname": "NoticePeriodForRedemptionToEachPublicWarrantHolder", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "grcyu_NumberOfMonthlyExtensionsApprovedForCompleteBusinessCombinmation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of monthly extensions approved to complete Business Combination.", "label": "Number of Monthly Extensions Approved for Complete the Business Combinmation", "terseLabel": "Number of monthly extensions approved" } } }, "localname": "NumberOfMonthlyExtensionsApprovedForCompleteBusinessCombinmation", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "integerItemType" }, "grcyu_NumberOfOrdinarySharesPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents number of ordinary shares consist unit.", "label": "Number Of Ordinary Shares Per Unit", "terseLabel": "Number of ordinary shares per unit" } } }, "localname": "NumberOfOrdinarySharesPerUnit", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureInitialPublicOfferingAdditionalInformationDetails", "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "sharesItemType" }, "grcyu_NumberOfPublicWarrantsPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents number of public warrants per unit.", "label": "Number of public warrants per unit", "terseLabel": "Number of public warrants per unit" } } }, "localname": "NumberOfPublicWarrantsPerUnit", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureInitialPublicOfferingAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "grcyu_NumberOfSharesSponsorAggregateToPurchasePrice": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount represent number of shares sponsor aggregate to purchase price.", "label": "Number Of Shares Sponsor Aggregate To Purchase Price", "terseLabel": "Aggregate purchase price" } } }, "localname": "NumberOfSharesSponsorAggregateToPurchasePrice", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosurePrivatePlacementAdditionalInformationDetails", "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "grcyu_NumberOfVotesPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents the information pertaining to number of votes per share.", "label": "Number Of Votes Per Share", "terseLabel": "Number of votes per share" } } }, "localname": "NumberOfVotesPerShare", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficitDetails" ], "xbrltype": "integerItemType" }, "grcyu_NumberOfWarrantsIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of warrants issued during the period.", "label": "Number Of Warrants Issued", "terseLabel": "Number of warrants issued (in shares)" } } }, "localname": "NumberOfWarrantsIssued", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "sharesItemType" }, "grcyu_ObligationToRedeemPercentageOfCommonStockWithRespectToAnyOtherMaterialProvisionRelatingToStockholdersRightsOrPreInitialBusinessCombinationActivity": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the Company's obligation to redeem a specified percentage of the shares of Class A common stock sold in the Company's Initial Public Offering if the Company has not consummated a Business Combination within 24 months of the closing of its Initial Public Offering.", "label": "Obligation To Redeem Percentage Of Common Stock With Respect To Any Other Material Provision Relating To Stockholders Rights Or Pre-initial Business Combination Activity", "terseLabel": "Percentage of shares of stock the Company is obligated to redeem without consummating a business combination" } } }, "localname": "ObligationToRedeemPercentageOfCommonStockWithRespectToAnyOtherMaterialProvisionRelatingToStockholdersRightsOrPreInitialBusinessCombinationActivity", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "percentItemType" }, "grcyu_OperatingBankAccounts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount in operating bank accounts.", "label": "Operating Bank Accounts", "terseLabel": "Operating bank accounts" } } }, "localname": "OperatingBankAccounts", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "monetaryItemType" }, "grcyu_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "n/a", "label": "Organization Consolidation And Presentation Of Financial Statements [Line Items]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "stringItemType" }, "grcyu_OrganizationConsolidationAndPresentationOfFinancialStatementsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "n/a", "label": "Organization Consolidation And Presentation Of Financial Statements [Table]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsTable", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "stringItemType" }, "grcyu_OtherCostsRelatedToIssuanceOfCommonStock": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of other costs incurred during the issuance of stock.", "label": "Other Costs Related To Issuance Of Common Stock", "terseLabel": "Other offering costs" } } }, "localname": "OtherCostsRelatedToIssuanceOfCommonStock", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "monetaryItemType" }, "grcyu_PercentageOfGrossProceedsOnAdditionalIssuanceOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents the information pertaining to percentage of gross proceeds on additional issuance of shares", "label": "Percentage of Gross proceeds On Additional Issuance Of Shares", "terseLabel": "Percentage of gross proceeds on additional issuance of shares" } } }, "localname": "PercentageOfGrossProceedsOnAdditionalIssuanceOfShares", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "grcyu_PercentageOfSharesOwnedBySponsorAfterInitialPublicOffering": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents the information pertaining to percentage of shares owned by the sponsor after initial public offering.", "label": "Percentage of Shares owned By The Sponsor After Initial Public Offering", "terseLabel": "Shares owned by sponsor (in percentage)" } } }, "localname": "PercentageOfSharesOwnedBySponsorAfterInitialPublicOffering", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "percentItemType" }, "grcyu_PercentageOfTransferOfRemainingFounderSharesWithCertainExceptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of percentage of transfer of remaining founder shares based on certain exceptions.", "label": "Percentage Of Transfer Of Remaining Founder Shares With Certain Exceptions", "terseLabel": "Percentage of transfer of remaining founder shares based on certain exceptions" } } }, "localname": "PercentageOfTransferOfRemainingFounderSharesWithCertainExceptions", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "percentItemType" }, "grcyu_PercentageOfUnderwritingCommissionOnGrossProceeds": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents the information pertaining to underwriter commission based on gross proceeds in percentage", "label": "Percentage of Underwriting Commission on Gross proceeds", "terseLabel": "Underwriter commission (in percentage)" } } }, "localname": "PercentageOfUnderwritingCommissionOnGrossProceeds", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "grcyu_PeriodInWhichPrivateWarrantsWillNotBeTransferable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents the period in which Private Warrants will not be transferable", "label": "Period In Which Private Warrants will not Be Transferable", "terseLabel": "Period in private warrants" } } }, "localname": "PeriodInWhichPrivateWarrantsWillNotBeTransferable", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "grcyu_PrivatePlacementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "PRIVATE PLACEMENT." } } }, "localname": "PrivatePlacementAbstract", "nsuri": "http://www.deitaxonomy.com/20221231", "xbrltype": "stringItemType" }, "grcyu_PrivatePlacementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for private placement of the reporting entity.", "label": "PRIVATE PLACEMENT [Text Block]", "terseLabel": "PRIVATE PLACEMENT" } } }, "localname": "PrivatePlacementTextBlock", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosurePrivatePlacement" ], "xbrltype": "textBlockItemType" }, "grcyu_PrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents a redeemable warrant (Private Placement Warrant) that entitles the holder to purchase shares of common stock if the underwriter's option is exercised in full.", "label": "Private Placement Warrants [Member]", "terseLabel": "Private Placement Warrants", "verboseLabel": "Private warrants" } } }, "localname": "PrivatePlacementWarrantsMember", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfWarrantLiabilityDetails", "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsFairValueOnRecurringBasisDetails", "http://www.deitaxonomy.com/role/DisclosureWarrantsWarrantsActivityDetails" ], "xbrltype": "domainItemType" }, "grcyu_ProceedFromSponsorAmountsDepositedIntoTrustAccountBySponsor": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of proceeds from sponsor, deposited in trust account by sponsor.", "label": "Proceed From Sponsor, Amounts Deposited Into Trust Account By Sponsor", "terseLabel": "Proceeds from sponsor deposited into the Trust Account" } } }, "localname": "ProceedFromSponsorAmountsDepositedIntoTrustAccountBySponsor", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails", "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "grcyu_ProceedHeldInTrustAccountRelatedParties": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash proceed from a loan, supported by a promissory note, granted to related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.", "label": "Proceed Held In Trust Account, Related Parties", "terseLabel": "Proceed held in trust account" } } }, "localname": "ProceedHeldInTrustAccountRelatedParties", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "grcyu_ProceedsUnsecuredPromissoryNoteIssuedToSponsorAmountDepositedIntoTrustAccountBySponsor": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unsecured promissory note to sponsor.", "label": "Proceeds Unsecured Promissory Note Issued To Sponsor Amount Deposited Into Trust Account By Sponsor", "terseLabel": "Proceeds from issuance of promissory note deposited in Trust Account by a founder-shareholder" } } }, "localname": "ProceedsUnsecuredPromissoryNoteIssuedToSponsorAmountDepositedIntoTrustAccountBySponsor", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "grcyu_PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents a redeemable warrant (Public Warrant) that entitles the holder to purchase shares of common stock subject to adjustment.", "label": "Public Warrants [Member]", "terseLabel": "Public warrants" } } }, "localname": "PublicWarrantsMember", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfWarrantLiabilityDetails", "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsFairValueOnRecurringBasisDetails", "http://www.deitaxonomy.com/role/DisclosureWarrantsWarrantsActivityDetails" ], "xbrltype": "domainItemType" }, "grcyu_ReclassificationOfPriorYearPresentationPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for Reclassification of Prior Year Presentation.", "label": "Reclassification of Prior Year Presentation, Policy [Policy Text Block]", "terseLabel": "Reclassification of Prior Year Presentation" } } }, "localname": "ReclassificationOfPriorYearPresentationPolicyPolicyTextBlock", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "grcyu_RedeemableWarrantsEachExercisableForOneHalfOfOneOrdinaryShareFor11.50PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "N/A.", "label": "Redeemable warrants, each warrant exercisable for one-half ordinary share" } } }, "localname": "RedeemableWarrantsEachExercisableForOneHalfOfOneOrdinaryShareFor11.50PerShareMember", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "grcyu_RedemptionOfCommonShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption of common shares.", "label": "Redemption Of Common Shares", "terseLabel": "Redemption of common shares" } } }, "localname": "RedemptionOfCommonShares", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "grcyu_RelatedPartyExtensionLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for related party extension loans member.", "label": "Related Party Extension Loans [Member]", "terseLabel": "Extension Loans Payable - Related Party" } } }, "localname": "RelatedPartyExtensionLoansMember", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "grcyu_RelatedPartyLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for related party loans.", "label": "Related Party Loans", "terseLabel": "Related Party Loans" } } }, "localname": "RelatedPartyLoansMember", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "grcyu_RelatedPartyTransactionAmountDepositedIntoTrustAccountBySponsor": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount deposited into trust account by the sponsor.", "label": "Related party transaction, Amount Deposited Into Trust Account By Sponsor", "terseLabel": "Related party transaction, Amount deposited into trust account by sponsor", "verboseLabel": "Proceeds of extension loan payable - related party deposited in Trust Account by a founder shareholder" } } }, "localname": "RelatedPartyTransactionAmountDepositedIntoTrustAccountBySponsor", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails", "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "grcyu_RelatedPartyTransactionExtendPeriodOfTimeToConsummateBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of extension Period of time to consummate a Business Combination .", "label": "Related Party Transaction, Extend period of Time To Consummate A Business Combination", "terseLabel": "Related party transaction, extension period of time to consummate a business combination", "verboseLabel": "Extension period of time to consummate a Business Combination" } } }, "localname": "RelatedPartyTransactionExtendPeriodOfTimeToConsummateBusinessCombination", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails", "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "durationItemType" }, "grcyu_RelatedPartyTransactionGeneralAndAdministrativeServicesExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "It represents the information pertaining to general and administrative services expenses.", "label": "Related Party Transaction General And Administrative Services Expense", "terseLabel": "Related party transaction general and administrative services expenses" } } }, "localname": "RelatedPartyTransactionGeneralAndAdministrativeServicesExpense", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "grcyu_RelatedPartyTransactionGeneralAndAdministrativeServicesExpensePerMonth": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "It represents the information pertaining to general and administrative services expense per month.", "label": "Related Party Transaction General And Administrative Services Expense per Month", "terseLabel": "General and administrative services expense per month" } } }, "localname": "RelatedPartyTransactionGeneralAndAdministrativeServicesExpensePerMonth", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "grcyu_RelatedPartyTransactionNotesMayBeConvertedUponConsummationOfBusinessCombination": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of notes may be converted upon consummation of a Business Combination .", "label": "Related Party Transaction Notes May Be converted Upon Consummation Of A Business Combination", "terseLabel": "Related party transaction, converted notes upon consummation of a business combination" } } }, "localname": "RelatedPartyTransactionNotesMayBeConvertedUponConsummationOfBusinessCombination", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "grcyu_RelatedPartyTransactionPercentageOfSharesAgreedNotToTransferAssignOrSell": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents the information pertaining percentage of shares agreed not to transfer, assign or sell .", "label": "Related Party Transaction, Percentage of Shares Agreed Not To Transfer, Assign or sell", "terseLabel": "Percentage of shares agreed not to transfer, assign or sell" } } }, "localname": "RelatedPartyTransactionPercentageOfSharesAgreedNotToTransferAssignOrSell", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "percentItemType" }, "grcyu_RelatedPartyTransactionPricePerUnitUponConsummationOfBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It stands for notes may be converted upon consummation of a Business Combination price per unit.", "label": "Related Party Transaction , Price per Unit Upon Consummation Of A Business Combination", "verboseLabel": "Related party transaction, converted notes price per share upon consummation of a business combination" } } }, "localname": "RelatedPartyTransactionPricePerUnitUponConsummationOfBusinessCombination", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "perShareItemType" }, "grcyu_SignificantAccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "-US\nLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Significant Accounting Policies [Line Items]" } } }, "localname": "SignificantAccountingPoliciesLineItems", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails" ], "xbrltype": "stringItemType" }, "grcyu_SignificantAccountingPoliciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a significant accounting policies.", "label": "Significant Accounting Policies [Table]" } } }, "localname": "SignificantAccountingPoliciesTable", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails" ], "xbrltype": "stringItemType" }, "grcyu_SponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information about sponsors.", "label": "Sponsor [Member]", "terseLabel": "Sponsor" } } }, "localname": "SponsorMember", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails", "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.deitaxonomy.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "grcyu_SummaryOfWarrantsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants activity", "label": "Summary of Warrants Activity [Table Text Block]", "terseLabel": "Summary of warrants activity" } } }, "localname": "SummaryOfWarrantsActivityTableTextBlock", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsTables" ], "xbrltype": "textBlockItemType" }, "grcyu_ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompaniesPriorWrittenConsent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of threshold percentage of public shares subject to redemption Without companies prior written consent", "label": "Threshold Percentage Of Public Shares Subject To Redemption Without Companies Prior Written Consent", "terseLabel": "Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination" } } }, "localname": "ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompaniesPriorWrittenConsent", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "pureItemType" }, "grcyu_ThresholdPeriodFromClosingOfPublicOfferingEntityIsObligatedToCompleteBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the threshold period from closing of public offering the company is obligated to complete business combination.", "label": "Threshold Period From Closing Of Public Offering Entity Is Obligated To Complete Business Combination", "terseLabel": "Threshold period from closing of public offering entity is obligated to complete business combination" } } }, "localname": "ThresholdPeriodFromClosingOfPublicOfferingEntityIsObligatedToCompleteBusinessCombination", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "durationItemType" }, "grcyu_TransactionCostRelatedToIssuanceOfCommonStock": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount represents cost incurred for a stock issuance.", "label": "Transaction Cost Related To Issuance Of Common Stock", "terseLabel": "Transaction cost" } } }, "localname": "TransactionCostRelatedToIssuanceOfCommonStock", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "monetaryItemType" }, "grcyu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of the entity's common stock which would be required to be attained to trigger the transfer, assign or sale of any shares or warrants of the company, after the completion of the initial business combination.", "label": "Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination Stock Price Trigger", "terseLabel": "Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)" } } }, "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "perShareItemType" }, "grcyu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period of specified consecutive trading days for stock price trigger considered for the transfer, assigning or sale of any shares or warrants of the company, after the completion of the initial business combination.", "label": "Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination Threshold Consecutive Trading Days", "terseLabel": "Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination" } } }, "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "durationItemType" }, "grcyu_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days for stock price trigger considered for the transfer, assigning or sale of any shares or warrants of the company, after the completion of the initial business combination.", "label": "Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination Threshold Trading Days", "terseLabel": "Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination" } } }, "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "durationItemType" }, "grcyu_UnderwriterCommission": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "It represents the information pertaining to under writer commission.", "label": "Underwriter Commission", "terseLabel": "Underwriter commission" } } }, "localname": "UnderwriterCommission", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficitDetails" ], "xbrltype": "monetaryItemType" }, "grcyu_UnderwritingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It stands for underwriting agreement.", "label": "Underwriting Agreement" } } }, "localname": "UnderwritingAgreementMember", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "grcyu_UnderwritingFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of underwriting fees incurred for stock issuance.", "label": "Underwriting Fees", "terseLabel": "Underwriting fees" } } }, "localname": "UnderwritingFees", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "monetaryItemType" }, "grcyu_UndistributedIncomeLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of undistributed income (loss).", "label": "Undistributed Income Loss", "terseLabel": "Undistributed income (loss)" } } }, "localname": "UndistributedIncomeLoss", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "grcyu_UnitPurchaseOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It stands for Unit Purchase Option.", "label": "Unit Purchase Option" } } }, "localname": "UnitPurchaseOptionMember", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficitDetails" ], "xbrltype": "domainItemType" }, "grcyu_UnitsEachConsistingOfOneClassOrdinaryShareAndOneRedeemableWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Units, each consisting of one Class A ordinary share and one Redeemable Warrant.", "label": "Units, each consisting of one Ordinary Share and one Warrant" } } }, "localname": "UnitsEachConsistingOfOneClassOrdinaryShareAndOneRedeemableWarrantMember", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "grcyu_WarrantLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "WARRANTS." } } }, "localname": "WarrantLiabilityAbstract", "nsuri": "http://www.deitaxonomy.com/20221231", "xbrltype": "stringItemType" }, "grcyu_WarrantLiabilityDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of warrant liability.", "label": "Warrant Liability Disclosure [Text Block]", "verboseLabel": "WARRANTS" } } }, "localname": "WarrantLiabilityDisclosureTextBlock", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrants" ], "xbrltype": "textBlockItemType" }, "grcyu_WarrantPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for warrant", "label": "Warrant, Policy [Policy Text Block]", "terseLabel": "Warrants" } } }, "localname": "WarrantPolicyTextBlock", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "grcyu_WorkingCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Current Assets less Current Liabilities.", "label": "Working Capital", "terseLabel": "Working capital deficit" } } }, "localname": "WorkingCapital", "nsuri": "http://www.deitaxonomy.com/20221231", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "monetaryItemType" }, "srt_MaximumMember": { "auth_ref": [ "r224", "r305", "r322", "r331", "r332", "r342", "r348", "r350", "r379", "r388", "r389", "r390", "r391", "r392", "r393" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails", "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r224", "r305", "r322", "r331", "r332", "r342", "r348", "r350", "r379", "r388", "r389", "r390", "r391", "r392", "r393" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r216", "r224", "r281", "r305", "r322", "r331", "r332", "r342", "r348", "r350", "r379", "r389", "r390", "r391", "r392", "r393" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails", "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r216", "r224", "r281", "r305", "r322", "r331", "r332", "r342", "r348", "r350", "r379", "r389", "r390", "r391", "r392", "r393" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails", "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r143", "r225", "r370" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r143", "r225", "r362", "r363", "r370" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r19" ], "calculation": { "http://www.deitaxonomy.com/role/StatementBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Adjustments to reconcile net income to net cash used in operating activities" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r154" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Anti-dilutive securities attributable to warrants (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r99", "r109", "r129", "r165", "r167", "r169", "r173", "r185", "r186", "r188", "r189", "r190", "r191", "r192", "r194", "r195", "r242", "r244", "r258", "r349", "r377", "r378", "r386" ], "calculation": { "http://www.deitaxonomy.com/role/StatementBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets.", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r1", "r2", "r26", "r129", "r173", "r185", "r186", "r188", "r189", "r190", "r191", "r192", "r194", "r195", "r242", "r244", "r258", "r349", "r377", "r378", "r386" ], "calculation": { "http://www.deitaxonomy.com/role/StatementBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "verboseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldInTrustNoncurrent": { "auth_ref": [ "r364" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Cash and investments held in trust account", "terseLabel": "Assets held in Trust Account", "verboseLabel": "Marketable securities held in Trust Account" } } }, "localname": "AssetsHeldInTrustNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsFairValueOnRecurringBasisDetails", "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r346", "r347" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r81", "r82", "r346", "r347" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r83" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "terseLabel": "Business combination limit on net tangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Cash": { "auth_ref": [ "r16", "r328", "r329", "r349" ], "calculation": { "http://www.deitaxonomy.com/role/StatementBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "verboseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails", "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r4", "r42" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r36", "r41", "r43" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash, end of year", "periodStartLabel": "Cash, beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r36", "r94" ], "calculation": { "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "NET CHANGE IN CASH" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r129", "r147", "r148", "r151", "r153", "r157", "r158", "r173", "r185", "r188", "r189", "r190", "r194", "r195", "r199", "r200", "r203", "r207", "r258", "r333", "r361", "r365", "r371" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails", "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation", "http://www.deitaxonomy.com/role/StatementBalanceSheetsParenthetical", "http://www.deitaxonomy.com/role/StatementStatementsOfIncome" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "WARRANTS" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficitDetails", "http://www.deitaxonomy.com/role/DisclosureWarrantsWarrantsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r78", "r80" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfWarrantLiabilityDetails", "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsFairValueOnRecurringBasisDetails", "http://www.deitaxonomy.com/role/DisclosureWarrantsWarrantsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfWarrantLiabilityDetails", "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsFairValueOnRecurringBasisDetails", "http://www.deitaxonomy.com/role/DisclosureWarrantsWarrantsActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r214" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price of warrants or rights", "verboseLabel": "Warrants exercise price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureInitialPublicOfferingAdditionalInformationDetails", "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails", "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]", "terseLabel": "WARRANTS" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "Warrants exercise ratio" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureInitialPublicOfferingAdditionalInformationDetails", "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r214" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Warrants issued" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r78", "r80" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r23", "r53", "r103", "r112" ], "calculation": { "http://www.deitaxonomy.com/role/StatementBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies.", "verboseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r52", "r60", "r183", "r184", "r330" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r368", "r369", "r381" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Ordinary shares" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation", "http://www.deitaxonomy.com/role/StatementStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par or stated value per share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails", "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficitDetails", "http://www.deitaxonomy.com/role/StatementBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficitDetails", "http://www.deitaxonomy.com/role/StatementBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares, issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficitDetails", "http://www.deitaxonomy.com/role/StatementBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r9", "r70" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficitDetails", "http://www.deitaxonomy.com/role/StatementBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r9", "r349" ], "calculation": { "http://www.deitaxonomy.com/role/StatementBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Ordinary shares, $0.0001 par value; 100,000,000 shares authorized; 1,260,000 shares issued and outstanding as at December 31, 2022 and 2021", "verboseLabel": "Common stock value" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficitDetails", "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r107", "r161" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "verboseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r5", "r100", "r108", "r198" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "verboseLabel": "Borrowings principal amount" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesAndFairValueTextBlock": { "auth_ref": [ "r85", "r92" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "FAIR VALUE MEASUREMENTS" } } }, "localname": "DerivativesAndFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_DueToOtherRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r18", "r95", "r367" ], "calculation": { "http://www.deitaxonomy.com/role/StatementBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount payable to related parties classified as other, due within one year or the normal operating cycle, if longer.", "label": "Due to Other Related Parties, Current", "terseLabel": "Amount due to related party" } } }, "localname": "DueToOtherRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r18", "r187", "r188", "r189", "r193", "r194", "r195", "r269", "r367" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties, Current", "verboseLabel": "Amount due to related party" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r102", "r113", "r187", "r188", "r189", "r193", "r194", "r195", "r269", "r367" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.", "label": "Due to Related Parties", "verboseLabel": "Due to related parties" } } }, "localname": "DueToRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Basic and diluted net income (loss) per share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r124", "r135", "r136", "r137", "r138", "r139", "r144", "r147", "r151", "r152", "r153", "r155", "r248", "r249", "r319", "r321", "r336" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic net income (loss) per share, ordinary shares attributable to Greencity Acquisition Corporation", "verboseLabel": "Basic net income (loss) per ordinary share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails", "http://www.deitaxonomy.com/role/StatementStatementsOfIncome" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r124", "r135", "r136", "r137", "r138", "r139", "r147", "r151", "r152", "r153", "r155", "r248", "r249", "r319", "r321", "r336" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted net income (loss) per share, ordinary shares attributable to Greencity Acquisition Corporation", "verboseLabel": "Diluted net income (loss) per ordinary share" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails", "http://www.deitaxonomy.com/role/StatementStatementsOfIncome" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r46", "r47" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "verboseLabel": "Net Income (Loss) Per Ordinary Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r70", "r116", "r121", "r122", "r123", "r130", "r131", "r132", "r134", "r140", "r142", "r156", "r174", "r215", "r226", "r227", "r228", "r240", "r241", "r247", "r259", "r260", "r261", "r262", "r263", "r264", "r323", "r324", "r325", "r334" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r39", "r64" ], "calculation": { "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "terseLabel": "Change in fair value of warrant liabilities" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]", "terseLabel": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsFairValueOnRecurringBasisDetails", "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsInitialMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r88" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsFairValueOnRecurringBasisDetails", "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsInitialMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r88" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "verboseLabel": "Schedule of initial measurement of key inputs" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r196", "r217", "r218", "r219", "r220", "r221", "r222", "r251", "r278", "r279", "r280", "r340", "r341", "r343", "r344", "r345" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r250", "r251", "r253", "r254", "r257" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r196", "r217", "r222", "r251", "r278", "r343", "r344", "r345" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value Inputs Level 1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r196", "r217", "r218", "r219", "r220", "r221", "r222", "r251", "r280", "r340", "r341", "r343", "r344", "r345" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Inputs Level 3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r86", "r87" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of company's asset measured at fair value on a recurring basis" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "terseLabel": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfWarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r89", "r90" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfWarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r89", "r90" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of changes in the fair value of warrant liabilities" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r255" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "terseLabel": "Change in fair value of public and private warrants" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfWarrantLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r89" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Fair Value at Ending", "periodStartLabel": "Fair Value at Beginning" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfWarrantLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r196", "r217", "r218", "r219", "r220", "r221", "r222", "r278", "r279", "r280", "r340", "r341", "r343", "r344", "r345" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r256", "r257" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value Measurements Recurring [Member]", "terseLabel": "Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r91", "r93" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "verboseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList": { "auth_ref": [ "r255" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).", "label": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]" } } }, "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfWarrantLiabilityDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r171", "r172", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r197", "r212", "r246", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r339", "r373", "r374", "r375", "r395", "r396", "r397", "r398", "r399", "r400", "r401" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsFairValueOnRecurringBasisDetails", "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r29" ], "calculation": { "http://www.deitaxonomy.com/role/StatementStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative expense" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureInitialPublicOfferingAdditionalInformationDetails", "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails", "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r27", "r98", "r104", "r115", "r165", "r166", "r168", "r170", "r320", "r338" ], "calculation": { "http://www.deitaxonomy.com/role/StatementStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STATEMENTS OF INCOME" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r120", "r231", "r232", "r236", "r237", "r238", "r239" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r233" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "verboseLabel": "Tax provision" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r38" ], "calculation": { "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "verboseLabel": "Accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Change in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r38" ], "calculation": { "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r30", "r164" ], "calculation": { "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.deitaxonomy.com/role/StatementStatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_OtherNonoperatingIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "negatedTerseLabel": "Interest income earned from marketable securities held in Trust Account", "terseLabel": "Interest income earned from marketable securities held in Trust Account", "verboseLabel": "Dividend income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails", "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows", "http://www.deitaxonomy.com/role/StatementStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r20", "r129", "r173", "r185", "r186", "r188", "r189", "r190", "r191", "r192", "r194", "r195", "r243", "r244", "r245", "r258", "r337", "r377", "r386", "r387" ], "calculation": { "http://www.deitaxonomy.com/role/StatementBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r13", "r101", "r111", "r349", "r366", "r376", "r384" ], "calculation": { "http://www.deitaxonomy.com/role/StatementBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS' DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS' DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r21", "r129", "r173", "r185", "r186", "r188", "r189", "r190", "r191", "r192", "r194", "r195", "r243", "r244", "r245", "r258", "r349", "r377", "r386", "r387" ], "calculation": { "http://www.deitaxonomy.com/role/StatementBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities", "verboseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.deitaxonomy.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r22", "r63" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.deitaxonomy.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r53", "r54", "r55", "r56", "r57", "r58", "r59", "r61", "r62" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MarketableSecuritiesPolicy": { "auth_ref": [ "r106" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment classified as marketable security.", "label": "Marketable Securities, Policy [Policy Text Block]", "terseLabel": "Marketable Securities Held in Trust Account" } } }, "localname": "MarketableSecuritiesPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_MeasurementInputExercisePriceMember": { "auth_ref": [ "r382" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using agreed upon price for exchange of underlying asset.", "label": "Measurement Input Exercise Price [Member]", "terseLabel": "Exercise price" } } }, "localname": "MeasurementInputExercisePriceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsInitialMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r382" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input Expected Term [Member]", "terseLabel": "Warrant life" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsInitialMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r382" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input Price Volatility [Member]", "terseLabel": "Volatility" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsInitialMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r382" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input Risk Free Interest Rate [Member]", "terseLabel": "Risk-free interest rate" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsInitialMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputSharePriceMember": { "auth_ref": [ "r382" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using share price of saleable stock.", "label": "Measurement Input Share Price [Member]", "terseLabel": "Share price" } } }, "localname": "MeasurementInputSharePriceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsInitialMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsInitialMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsInitialMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r126" ], "calculation": { "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "verboseLabel": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r126" ], "calculation": { "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "verboseLabel": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r36", "r37", "r40" ], "calculation": { "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r28", "r40", "r105", "r114", "r117", "r118", "r119", "r123", "r129", "r133", "r135", "r136", "r137", "r138", "r141", "r142", "r149", "r165", "r166", "r168", "r170", "r173", "r185", "r186", "r188", "r189", "r190", "r191", "r192", "r194", "r195", "r249", "r258", "r338", "r377" ], "calculation": { "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.deitaxonomy.com/role/StatementStatementsOfIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income (loss)", "totalLabel": "NET INCOME" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails", "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows", "http://www.deitaxonomy.com/role/StatementStatementsOfChangesInShareholdersDeficit", "http://www.deitaxonomy.com/role/StatementStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r135", "r136", "r137", "r138", "r144", "r145", "r150", "r153", "r165", "r166", "r168", "r170", "r338" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "terseLabel": "Allocation of net income (loss)" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Numerator:", "terseLabel": "Numerators:" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Issued Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "verboseLabel": "SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementsOfIncome" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r17", "r96", "r367" ], "calculation": { "http://www.deitaxonomy.com/role/StatementBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Notes Payable, Related Parties, Current", "verboseLabel": "Extension loan payable - related party" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r165", "r166", "r168", "r170", "r338" ], "calculation": { "http://www.deitaxonomy.com/role/StatementStatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ORGANIZATION AND BUSINESS BACKGROUND" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r0", "r84" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "verboseLabel": "ORGANIZATION AND BUSINESS BACKGROUND" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackground" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r125" ], "calculation": { "http://www.deitaxonomy.com/role/StatementStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income", "totalLabel": "Total other income, net" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r33" ], "calculation": { "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Redemption of ordinary share" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r35" ], "calculation": { "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedLabel": "Payment of offering costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r8", "r199" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par or stated value per share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficitDetails", "http://www.deitaxonomy.com/role/StatementBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficitDetails", "http://www.deitaxonomy.com/role/StatementBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r8", "r199" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficitDetails", "http://www.deitaxonomy.com/role/StatementBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficitDetails", "http://www.deitaxonomy.com/role/StatementBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r8", "r349" ], "calculation": { "http://www.deitaxonomy.com/role/StatementBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r1", "r14", "r15" ], "calculation": { "http://www.deitaxonomy.com/role/StatementBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "verboseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private placement" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails", "http://www.deitaxonomy.com/role/DisclosurePrivatePlacementAdditionalInformationDetails", "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r31" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "verboseLabel": "Proceeds from issuance IPO" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r31" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "verboseLabel": "Gross proceeds from issuance of warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r32" ], "calculation": { "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from Related Party Debt", "terseLabel": "Proceeds from promissory note payable - related party" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r223", "r268", "r269" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails", "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.deitaxonomy.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r223", "r268", "r269", "r385" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "RELATED PARTY TRANSACTIONS.", "terseLabel": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r223", "r268", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r385" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails", "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.deitaxonomy.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r266", "r267", "r269", "r270", "r271" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "verboseLabel": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r34" ], "calculation": { "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of Related Party Debt", "negatedTerseLabel": "Repayment of promissory note payable - related party" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r10", "r77", "r110", "r229", "r326", "r327", "r349" ], "calculation": { "http://www.deitaxonomy.com/role/StatementBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r116", "r130", "r131", "r132", "r134", "r140", "r142", "r174", "r226", "r227", "r228", "r240", "r241", "r247", "r323", "r325" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureInitialPublicOfferingAdditionalInformationDetails", "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails", "http://www.deitaxonomy.com/role/DisclosurePrivatePlacementAdditionalInformationDetails", "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficitDetails", "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Sale price of the ordinary shares" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r372" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of net income (loss) per share presented in the statement of operations" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r96", "r97" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r24", "r66", "r68", "r69", "r71", "r72", "r73", "r74", "r75", "r76", "r77", "r157", "r199", "r200", "r201", "r203", "r207", "r212", "r342", "r361", "r365" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficitDetails", "http://www.deitaxonomy.com/role/DisclosureWarrantsWarrantsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Unit price", "verboseLabel": "Shares issued price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureInitialPublicOfferingAdditionalInformationDetails", "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails", "http://www.deitaxonomy.com/role/DisclosurePrivatePlacementAdditionalInformationDetails", "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficitDetails", "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance (in shares)", "periodStartLabel": "Balance (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares": { "auth_ref": [ "r65" ], "calculation": { "http://www.deitaxonomy.com/role/StatementBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of shares that would be issued, determined under the conditions specified in the contract if the settlement were to occur at the reporting date.", "label": "Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares", "verboseLabel": "Warrant liabilities" } } }, "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsFairValueOnRecurringBasisDetails", "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r44", "r127" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "verboseLabel": "SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r7", "r8", "r9", "r70", "r129", "r147", "r148", "r151", "r153", "r157", "r158", "r173", "r185", "r188", "r189", "r190", "r194", "r195", "r199", "r200", "r203", "r207", "r258", "r333", "r361", "r365", "r371" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails", "http://www.deitaxonomy.com/role/DocumentDocumentAndEntityInformation", "http://www.deitaxonomy.com/role/StatementBalanceSheetsParenthetical", "http://www.deitaxonomy.com/role/StatementStatementsOfIncome" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r25", "r70", "r116", "r121", "r122", "r123", "r130", "r131", "r132", "r134", "r140", "r142", "r156", "r174", "r215", "r226", "r227", "r228", "r240", "r241", "r247", "r259", "r260", "r261", "r262", "r263", "r264", "r323", "r324", "r325", "r334" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheetsParenthetical", "http://www.deitaxonomy.com/role/StatementStatementsOfChangesInShareholdersDeficit", "http://www.deitaxonomy.com/role/StatementStatementsOfIncome" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STATEMENTS OF CASH FLOWS" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BALANCE SHEETS" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r130", "r131", "r132", "r156", "r306" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheetsParenthetical", "http://www.deitaxonomy.com/role/StatementStatementsOfChangesInShareholdersDeficit", "http://www.deitaxonomy.com/role/StatementStatementsOfIncome" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r8", "r9", "r70", "r77" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Number of common stock issued (in shares)", "verboseLabel": "Issuance of ordinary shares (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureInitialPublicOfferingAdditionalInformationDetails", "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails", "http://www.deitaxonomy.com/role/DisclosurePrivatePlacementAdditionalInformationDetails", "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "terseLabel": "Proceeds from issuance of shares to underwriters", "verboseLabel": "Proceeds from issuance of shares" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r9", "r11", "r12", "r51", "r349", "r366", "r376", "r384" ], "calculation": { "http://www.deitaxonomy.com/role/StatementBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total Shareholders' Deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheets", "http://www.deitaxonomy.com/role/StatementStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shareholder's Deficit", "verboseLabel": "Shareholders' Deficit:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SHAREHOLDERS DEFICIT" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r79", "r128", "r200", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r213", "r215" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "SHAREHOLDERS DEFICIT" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficit" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r265", "r273" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r265", "r273" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r265", "r273" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r265", "r273" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r272", "r274" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureInitialPublicOfferingAdditionalInformationDetails", "http://www.deitaxonomy.com/role/DisclosurePrivatePlacementAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureInitialPublicOfferingAdditionalInformationDetails", "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails", "http://www.deitaxonomy.com/role/DisclosurePrivatePlacementAdditionalInformationDetails", "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficitDetails", "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureInitialPublicOfferingAdditionalInformationDetails", "http://www.deitaxonomy.com/role/DisclosurePrivatePlacementAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.", "label": "Temporary Equity, Accretion to Redemption Value, Adjustment", "terseLabel": "Accretion of carrying value to redemption value of redeemable ordinary shares" } } }, "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r185", "r188", "r189", "r190", "r194", "r195" ], "calculation": { "http://www.deitaxonomy.com/role/StatementBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "terseLabel": "Ordinary shares, subject to possible redemption: 610,752 and 4,000,000 shares as of December 31, 2022 and 2021 (at redemption value of $10.90 and $10.35 per share)" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/StatementBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityRedemptionPricePerShare": { "auth_ref": [ "r3", "r67" ], "lang": { "en-us": { "role": { "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Redemption Price Per Share", "verboseLabel": "Redemption price per share" } } }, "localname": "TemporaryEquityRedemptionPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureOrganizationAndBusinessBackgroundDetails", "http://www.deitaxonomy.com/role/StatementBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "verboseLabel": "Ordinary shares subject to possible redemption, shares" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureShareholdersDeficitDetails", "http://www.deitaxonomy.com/role/StatementBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r171", "r172", "r197", "r212", "r246", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r373", "r374", "r375", "r395", "r396", "r397", "r398", "r399", "r400", "r401" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsFairValueOnRecurringBasisDetails", "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r380" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_USTreasurySecuritiesMember": { "auth_ref": [ "r335", "r343", "r345", "r394" ], "lang": { "en-us": { "role": { "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).", "label": "U.S. Treasury Securities [Member]", "terseLabel": "U.S. Treasury Securities" } } }, "localname": "USTreasurySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r230", "r235" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r234" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "verboseLabel": "Unrecognized tax benefits, interest and penalty accrued" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnsecuredDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.", "label": "Unsecured Debt [Member]", "terseLabel": "Unsecured promissory note" } } }, "localname": "UnsecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.deitaxonomy.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r48", "r49", "r50", "r159", "r160", "r162", "r163" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrants [Member]", "terseLabel": "Warrants" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.", "label": "Warrants and Rights Outstanding", "verboseLabel": "Number of shares" } } }, "localname": "WarrantsAndRightsOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsWarrantsActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "auth_ref": [ "r254" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.", "label": "Warrants and Rights Outstanding, Measurement Input", "verboseLabel": "Input" } } }, "localname": "WarrantsAndRightsOutstandingMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureFairValueMeasurementsInitialMeasurementDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r383" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "verboseLabel": "Weighted average life" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureWarrantsAdditionalInformationDetails", "http://www.deitaxonomy.com/role/DisclosureWarrantsWarrantsActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r146", "r153" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted weighted average shares outstanding, ordinary shares attributable to Greencity Acquisition Corporation" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails", "http://www.deitaxonomy.com/role/StatementStatementsOfIncome" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation": { "auth_ref": [ "r45" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock subject to repurchase or cancellation determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period. Common stock subject to repurchase are outstanding common shares that are contingently returnable (that is, subject to recall).", "label": "Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation", "verboseLabel": "Weighted average number of shares, common stock subject to forfeiture" } } }, "localname": "WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Denominators:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r144", "r153" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic weighted average shares outstanding, ordinary shares attributable to Greencity Acquisition Corporation" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.deitaxonomy.com/role/DisclosureSignificantAccountingPoliciesSummaryOfNetLossPerSharePresentedInStatementOfOperationsDetails", "http://www.deitaxonomy.com/role/StatementStatementsOfIncome" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(3),(4))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62652-112803", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r351": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r352": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r353": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r354": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r355": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r356": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r357": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r358": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r359": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(b))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r395": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r396": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r397": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r398": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r399": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r401": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r44": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2646-109256", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "820", "URI": "http://asc.fasb.org/topic&trid=2155941", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 57 0001410578-23-001371-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001410578-23-001371-xbrl.zip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

3EQ+(SS-&/2U8E1A.C/Q%>0CB9,&-%!3)!4KBW2 MPX\/)V/AL5_B[E=9M9/ F !2.NQTNG=7BC&'4795-DX/U1#VG6^.!;%$%UTRT:>PKOK,H1=;E;R_AQK( M)*9@HDQ!3?4)0RNT@(QUDM!E W0?&,CEQ,B6PXKG0!8JF05L;JCDD)%K$U " MGDJP"&]$YT(S#3?E!B#E%#NT)Y@.P-+$N9"9S*0\H6OKD-/"%+>QTFYR8Z6_ M0A>0>4,[M<<4*RP!:\NZU=*FWVJ)7]\R[9:_ JU%*M/((OPE3@?3LI*/^;43 MTXP4Y*X;]M47VWGU@/N&!IMH\0YTQ]9AK:@'T^R^<'J-O+:0=<=%I$(D=J$+ MBAR7B0DBD975P%H\7KCV[4SB&.KY*.C W-%HZF6Z&.GZ8R[Q>MM+^;_BJG M*2^K*B^KV-T"O"@3N]!WJ=P-R'PD= 7A"N8TZ&_"=.(S7W/]D^\1&!U^@6/Q MD^-Y0UNW @,80WN@N38L5CI6B'[_KYXCB]*%CBQ-G?90<621Y23_Z720"AKF M%.,2C2T#VZA_2R/O'L&(U(%1V=V8.EY ^X)N3$7[&YX)JS^97JG#7NC+?XTI M4FB<4]R/)=5] JF+TNR%XZ[#E[!N^%W3;_CMW]ZI>[ M9(WWP/\)@!WF'O)Z:R?('46NTY2\-JIDPXV[T,>YWEVPK9@%T)RB)-3^X V9 M"2:+<'F9OUUD]G(_&_SW"[0"K<&WT!:<2I<_5$5)=\<7;^9X>/9S2'OP146E MZ]9E:&3.6=,*)/%NYZ$,Y,.&F-)9H6^@T#=2H8A'IAQ4DHBGA2MQ#QM;7GIL M20!1P4N04Z[C@0??3HRA+RQ["E@2T"A%DR!EXQO>G#CPY-A+^!'K!_!:9JR+ MBDK/ 9+32T?)T^M)1'L1%M>7%@ZZ*GQ*X>^B@D_'?!?PHLIX9 M (RY$_,^V@]X !O',WT4FN([84;2GJZC!_?;N!PF/EK$JV0G&)DEA_;EB#HZ MS@9.;8+&.]:./0EC,N9.'XH4K-?0>M\''E2NY_6=]:MIAQ@7$H^M";4(Q4%V MH1%F31'ET7$'FKZ:F^O#?:*:K9TS?74M,C R,C$R,S%X,3!K+FAT;>R]Z7+B2M8V^O^+ M./>@4]WOVU5Q#"4)Q."]>W_!( S&9L: _Q")E @9#: !D*_^9*8&!,8VML$6 M+CJB=QF0+T?RBH";HH:])__]/ME&*9 M__S??_X/A?Y'_D-1?_^_L1@E]_.M&TK4!5N%FD4)!@06%*FE;$TNJ8X^FP&- MNH6&(2L*E3=D48+>*PP=9^-V(A MNB+::N:E;<8D &;__3&QK-GE[]]C8([BNB']]G[ $V%B-!-+,#^\5Q19FP;/ M+Y?+^&ID*.0=EJ83O_'/(T0Q_W')$!Q[XWD1RA98Z9JN.G%!5W$7+,.N.UB9 M\L;SRX3?.O.[?WO3%B90!3%9,RV@"4$_>!2B%;P8'A3WV_W1?U1>63$3"AN= MH,]Q25_\EC4T 8@I_=LR@&:.=4,%%EH=U!##Q>A,B!*F83TE'/IR!]'DU7,D M8Q*A/OW'#3A^EL2IW^C7\*SE%U9CFTJ(]ILD\N>-?B##GB>#(9MZDF72+S7N M/N&]L&O-F&PV^WN%\18,^ E\-A[%OZYQ\ X8H+7=/>+7%I:-L:D-+,D[L91R ML23_^.?O"03B/W^KT *4H&L6$C;__6'!E?7;G2]^.0;GMKSX[P_O]YCES-!( M?__SMR5;"OSG[]_^OVY;(UUT_OE;E!>4:3D*_.\/%1B2K,4L?7:9H&?67ZC7 MW^CGC6=$V9PIP+G4= WB!^35)6X-&NZ?LBA"C?R)'B@90,!SIFQ-MEH89%WT MQ["-2"@"0QQVV\5A3.H[4ZNM)+I.6VY9E8*:RM%+1!KS4I,5-$7#1G,@,UJY M;>3,87T\9-AA@AEB9AXVV[G4HU8O9/B"WBS.6PN3G:>D'Y0&5#1@3[1<%G15 ME2TLI,V<)A90@TBP(P$O0_,')8O__5$F8Q^N;D6A)O-&>0I8$?2$6;/L#'.8 M%)N3^M1),D/FKEOOS=L2Y)V2**=%?C#,B+GW3G)>MNKBXJ$WI0M]JZ\UN+)I M2S?M)O567A@D\YEB,89&,_M0!%SV[9#WB$OK&#,9[-2D)CB%4B]TV MN,JUM68R6^*D81*/%W?QA8-MH!YT<7.X4[; -E>KC97*[G8?JPO3VFV6$GHVAY35=7NLC$:5"W$ M;L5B)YC(QY&/#7#^7UF^51>HU,.\]X2$W MF.42)4N87C7EBI@:L,WJ4OK""7\"]S[ !I @TE&HH?JX*"LV^O9EP@YNV8SRL,Q!?C[,"PW#:MWW!60V M)Q)9ELXF3Y2\-=UZGL+7];15+H\4>VH+]\:RK2:OQT;S:!2>&E6ND71HD>ZU M^,'=K-?FAG>?*IRV*K*1T M1KFWIFQ]G.13RQ6K:TC9)6GZA,G[(H %08++95N&?*QF6/-*.CD2M-S1*%S1 MY&ZVJLQI6N7NFH7N="P9R]?-B6/ZGAVPJJ"A6?)8%DB#[H0VAFV8RQE89.> MCLD5>21W,\8DCPT^.D9O8N.-1OVGAC\VE>0=4&RX.F'2DFT9"66,=@A4I3^]1P!^',RUNPDE5;[4P0ETQT M1D\4Z:K,%K*:(UUI#:1L M&PQ=_'0/,Z19[9$IBS(PG#908%@P^4]4&G5/]L!F:MBQ;[)FMW==65K=09YO M<W"3AD(YX?3* M4^MNJHJS0>$JD[@?L$B=)EUI]%:!7Y07L@@)[#U2TKFY,UHF4U8W=2U,5GF+ M9L7F,MHF(;M-<1X8&D*BV8 &:=T3])M>$\A<*?>WMYUI-2$U13B8-T49>Q!Q M-G4T*IJRI/WW1RSR)N"[*,I"NB\PR7N69U?=GF->K_JK[))0E/T27'ZUI?X(&'3O(N3=8P'$LBRKT"F>RTZ% M]FI4Q**2CC.?%R5(#]D,)AO]+G73'LX[EC!&?K_:NYLJ_7XA,[C9@!CS067# M V&R^>P&#>N/O?8T;=U+W7JC^E@KUX?MW(@(2>[32)@=,O0F"5M0P9D$#6 @ M6QCO4[H]FGDG_$L(BNT9^E4W/*H61MSRH9&Q.;I=OS$ZA?%BQ?4.%G[,K%*5 M82_7'$_5*WF2K35N@#G"_L*G>62?'&]]T)7D?:56YGC(IF%Z7G/NEKD3##_N M/6&:G\?XQFUNTDU-K*J=',-'TWI]PN\QSTW#&K: )D$"9OS),\8]*.-O CG< M%J &#%D/ ?\6&%-H$=>"2<4YVGO-9Z22K %-D/$VIHG<&MS(AB3R)(/W5FF" MO,ATL]&B4\+=8%"Z7=:[V#$*^PI$_.CCI?NB;AA8I!B!Q ]^,;V?3,OW*A!9 M3"2>+'D!+0-@HHO(O]@@/&/V"FI]6)AW[52JI28*8V'Q@!V(Q+,.Q'N)_A)1 M"XJ.'""I/O8=(82<$:)D2*6]C\!6)5^]YKFFS,?:5DXL:+%QZ?%@!'Z.JOU\ M9K:Z;P^XJ9JR$E(>=/DILF/^:; 'I>K+GJ;/A"4@&P2N+:RJ##3>/#!ELZOI M(Q,:"S!28$6;V:A+U+<@*S+I\T8&(_2WY5P!6;O133-8OOJXH@FZ"OF5!353 M1J_?R.:FCN-O*L.;&:SQO,SE'RQ+SC#-#)K_Z]E>_PI&FQ,?;--R._3]MP_0 M;MODDOALNULL+3G:R>?[SFA>;X+"DV#)%]!NR-=:HY::'/#PL295R+?34C& M&&&CF)]/%U^9(HZH;#;B]A?NA'PT==L@GTA&V:6W@H0>P0JNK16TA :!/]Z9U-E>X3QA.Y##EK]IS\UVOZVL3_G.6NB6;TY(! MD>5@(65H6BW$DMZBQVPS7;O*W ^ZSK):FC=*?"-3^D:+_OS4_YSE)YB_TY&V M)C:BM_)]^QJPB_I\Q-MJ.=8WR_K@L1]9,^3M*[]SUG_.HO.K&120>=:!AA]H MR$]6Y/O3M6QN,8++SC1;]T\VW""[_;O,M+^<:";%1+D[GF5)6 MM^[-I2J?S;?OLN@[S+/W3S+=(+O=3\RU_ MRR>N"X5ZDD\MP+5BWZK)=/];K?=GF6_'6O#7]W8[PFWZ>MQ9#.D8URFUIG1Q M,+ CMX8X3AO,XL<_^./&-$[,JGYSMAU)%_!3FQJZ2?;)GJ0X]3BY3%=SJPXM M5P9W\%J;*(^CR&K<9Z<>Q-[?,/<3 \";\]OV T#2Z#NQ+BN7^;HXJC3G2R-A M]2/K3Y\" XFF(.M6W;(8@@P6;QUN_YPH*W;)F-*0R.3[7:O2L.^WKGK)#0Z M"QFDLLS0-X&D Q.+Z'W DAF4X(<<&__B0KAYS:N&:*KB 80ESD)&_0M M: %9@Z*?U.SAH5B:0;79%FM=]7Z4B)ET5:U$-^3^XE37AOSNN9Z^C?">!;ZA M+7708F[ZZ/O[9>,Q R<&$UF-$,4%/I9S1A]F@6?\=:NLC>A2MS<83!YK=W;& MOCDO\!L6F#ZZF[?SO$1(1[NG&?V\Q.W$*S^',>\$?Y;1(@!#F#@W< &5#9@$ MSY 8ADD>8)YO,A3T*!EP;D--<':W%WK2#)(__3,D5:$\X&=TL@MC69V_?FCT MF4%DS8IGE\.W(G:MQ[/@V[O;_19RS00OK.1!!_,.Q:>+8;'K5<:Z&L7;G:NJDU#1G5]/S:Q#9"-'K;/KBRD2#81-G MACTTPYX"IY7NN%Y"4\ML=YYF8;]4=_2.$EF%> ;Z=P7ZT2T_K6[>/ZC#>;K+ M&E7+:L$RA$)D5\[@ZYV9 M,W@/[#\0N=,*NAK9P%"4C/T_'- '1^*BG!W5NH#G M:+8W6L8Z-3'?C6XJX)\.!.;/"5O6ZLE5ENZK^2ED.U.Q MID:@EK/[AG#E1';G-$K&_A\.Z,.[G<-&-7L]N*-YL%@T2_?CYD2*;NFA/QT( M;TV(#YTN\M8[N>*F*>ZAH/-JZV'6O*Z"P0)&-LRP9R;MDVF>;#3ZOK]& N"MUJ>@FR0[;;T\_< MNN>R'C_E_?4;"+8M(V]=Y4R[=-,RA@,^I239T>1V^=#O1M8S?W::ZS7=/<\3 M$\/KA?W@ <0A-YFF)]/,]126;\NU!!A5>S>1-:HB= #Q4Q?9+W>;$Y"X,F4\ MY[=5#9:R)6F52CZ6NW.A?U>J2(OQM1!9I?O,= ]0!3BJ"_VI=SHX+8;AJX5: MB;]BK%:BLQC==+7(B?17BT'OILD!7/@_HP#TVS"3SG3STCU?8J97LI1.] MZP0763WQO98PJ$6POEBJH[_KEJEG;+S*/>2L&[M1I.?7=YF:LLK%EJ7HVNY1 ML/&V[Q9(Q]A,T,[+=PN$'SU"_8%W[8(\"K%R/:D!=>HHL".G.[E*,AU9^^"P MFQ41X?)C)32S,>OVVH*Y--TK5D%V]#BM3@>1E=S'"N!'8S-&V+W M.MV-E6TA5RZN%A,SLG([2EP;^?V\>O\6@:X#K&FAYF3G>DRFI^437MJOX-KC M!TO?Q;6ZE"P_S%IVAHX5L[%48M%IY+(G+) _CVN/%29]PX*^S+52HLD6S+HI M3.MT:9BH])CA]>S,M5^SR/M>L?TN)F8&69G-V0R2S_HRQQKF5;LZ/S/Q7NX2 MNW>YMFW#ZV#U_-X/AI<%P/)&O9W%V!3334VRU=RTF:\;A1.&Q:<)@,@!Y+D; MT-\E+;*-R32IBXO:E-65Y21E,+?G6Z_CI//2=7E>87?.@7[4Z5J$ZEQ.1]4[>@I]]IG^&T/,0 MPE=EF0$%GP"G,2XEI,Y5XO *7,,\]07]KT#QG!!_4QA&!RXLVCB!(<+ELRY"/U0QK M7DDG1T+TTBA/Q\;Y"M \NWU_HVN2!0VU"$=/;V/L:B8^FP=%_*M_3N)>J.J= MVTQS&LOU1_QJDBZDNI'-H-HUO77ZW([YG=@6/?O^A;SA[F;I:XUKT.U1KQ(; M70^E2C.RSFY4%O)(&5*AJ]C>O) '.B'3C-7ZBT+'%NFY=7,K.[(T[0W_ ,;> MN\M('LIALH<%9&J8H%T\OG:%Z[OQ*I4>:JVT>#>@4_E',9NO3>5Z]*Z&>O?= MKZ+OEFA)2T6E/M&OD%SRYBKN")*JWG*&5WVGN*2O^(%QW[N7 MEO>IHR].--C[+6?G*XVZ!V?83 T[]DW6[/:N*TNK.\CSK>B>D]OC*%4PM=-P M')Z>BON@?'H/".8+[='B\V-I6N>5UK(YN7O,M_\XF79**-PZEO=Q;^%@9S,? M'A=6SV9G-=XIVW=E(7W;O9M'-\H8A;.9F^N:.N"ZADX,Q J%P5(KRXEN?58; M5=(SYT'2(V;[';^LS"G4EMWWP'NWW3%(,TX;MR!;,O03-JTZP/-(. TCZ#,ND3D 5SF59GMY.TC.^&JF5A]+ M52NS<")K)IV!'(F#TG^(QBGQY6LM?74MT* VN1,>"J7;^^.'ELX:YT]AU!.L M_WL KFKT9[U&OA_"!G-FKVG*L>QU=+=\V;*B/$NM&MG/Z"Y^X&?9Z;9]0C,NN\,)8DAC&9 M<&(8^L0GZ=O^8[8G='N#A-/3G5FF/HN")Q_.CF(R&.=[94>YCQXTI8X;,AEW MRPN1;OWAJU,SPBQ*A*+%+]!_G@QAZW?O;4U*W60TQNEUZX5.LMV+)>[54F3Y M\QLE=KQ))NU8U_6T=R[L(0721H)B(D9S,6:O,F];CQZ !9-N HK+@NL/I\V" M\R%?ZZKW[0S=RXJICEE7YUPYLKME9Q:, @LF0SDYK[!@^-$#L& B2/Q ++C^ M<-HL:-;,J5ZN5-I3>PHR8Q8J*R6ZET&?63 *+)@(69>OL&#BL(8HZ[EGA 77 M'TZ;!>G4PBZ,0';958?=&=NS9^EL,;)Q\#,+1H$%V3WK#6\]>I#C52$MR'P3 M+5B24J7T3>^*H2%=:.9KI94CWI^UX)D%7V!!9G\MR!SZA&,RQ(')[\" "K.< M,-6)4N!3AM O6LK,7AAG'7AFP!<9D$[NS8#K1X]0<_^9Q0GQ2OB)&QT]X>-^ M-KBZZF>S4UY-WS>68J)H#N3(XOZ%>?JH>V:B4<\WV#?4_;:5YE>62\+PDA]( MWBY:BU%>4'.0KS_TI5RN^'!_V_@NR-E%N.C*T),.++\/\/NB]#;+:95)IFEW MJQU@)_74()\N1C;">P;(VW<>HB,1*Q9;GS>-CD;7KWMTL36Y'63N(NO$G25B M5./\[P/\OBA=,M.8T2]5LM-ZO= KU*J,D(ENH:$S0-Z^$?1!@' EY^&NX4R5 MKE..-0<3O<8,5J=FV$4!()'=IO@@0))R+)?C.O15MSYN9R>C]KB1RY^:GHL" M0"(;1/\@0,:/>CU;Y3JE::HU$95:IZ\6E#- W@Z0:(1X]]8P7V!SYY5:"8K) M>8>/&9564JA62Y7HGG<_V]P'BZ@>6&.^N*7Q08S6&^:TJO:,+A_3\)^?"C7PCY M?7%:325NU;M,Y[9K.\854X8/@RLYL@<^SA#9!1%Z R)TA*5BQW"J-\M'OLG7 MAU*B,*O);)L[-:OS+!4]'-/[0YZ.!N3W]N"=[D,U*90M.C5N7Z5;U[6F7#TU M#_[/AD@VC)!LA&4B-V_FN6NM$ILZ[8K>;?;TP-^X]$O M _R^*,T.ED8&W)DJ7T]S#4VJ6SGQZM3\F3\;()DP0#(1EHC2=,8)^=$U2\>2 M0% =N\6DRF>)>** S^P/^$P4 +^WYYS+B)F[ZE"=VK5N@GML2,U1]M10^F<# M)!T&2#K"$I&SNG2Y.#$5OKIDR]>E>N6^Q9R:/W*6B!Z*T_L#/AT%P.\=\U:7 MS8DPF5S1A16]D)H/0H&_.DO$4P)(*@R05(0EXB-L-F[++:CR[5Q#F-XQ@^[P MX=3\D;-$]%"\6PG@:TWHWM:Y2FX#!62*>$D"X,$"X M"$O$[CBC2)F8LIK&9+Y0NI$[N9OKLT0\4BP+@]T5IZ>[.+%9C*8Z' MPX1L5<&B_6B=&DK_;( DPP!)1E@BII*W,Y"9W=SR]6NGP:E7"SLU.C7M>Y:( M'HJ3^P,^&07 [[W7+/6UXOQ^J-(%H5@U;CAYMIJ>)>(I 201!DCBT "1DJ/B MK++L9:;VK"W++=O)%1Y.38Q% 2")_0&2."Q V#! V$,#I-/B'MIW6G,^K7,) MN:5RO?M5ZPR0MP.$W1\@[($3FC;RF2)L4\E2<2#EZE7(5VE1OBE5:YW,ZKP3 M<:* WS]I=>/1+P/\WH<]\\,N-^[/ZC1L-;/%J\=Z.Q'="R+/ -D)D!,YW%2[ MRZJ]9EN.357)&F9SY07LGEQ$XRP1 Q1_V>$FWRYD/,C[GZ('^7+V=I6K@U:= MGR^6OI*=U6NWQ62J>*.3WM7R9XQWY M?"/D]RZ5-..X6E4L5[J@EKH?#-.C5/;D#-8_'"+T!D3H"$O%;#:UNNTF)_J8HQWY M?!O@][Z\9-$;*(MV;4SWIH7'ZEU-4BJ]LT0\)8!DP@#)1%@BYJ4A<[\T[@1: MSF<:US17ZJ_NSE;BB0)^WQ-]S-&.?+X-\'M[SIGK=C%]E9[1]KC"R;%!OV#0 M9XEX2@!)AP&2CK!$5.OR0T^*W2]X>7 -P=6=E,\.SA+Q1 &_[XD^YFA'/M\& M^'U1>B_7KWL#N]Q!-N(POTQVTZB/RHG#G+'T0O##-;YI[\S(D M\K8I:] T<\+X(D[=U90WN6E/?A4-$VKQE\8ZPLRL!PVD!!+-JV M=&%*WO*?J#3J?AZ6T&7F:1N1L7#3NRV 6/_[!'S>F\3U% M_/Y+"E:A)5WR#_=L.\/KW4+?+-9ZJX90?#B))0U/XULM:X" 'G7@>F M]A]&=-*N]F@U)M /L\:R$[L_^A+M02E90_1 5&6]RV99+FC(^^6]D\>Y7QD7 MP+?WZG1E/>;K?"PF0X9]&%<>ED[>T?>90L\?7P+F3'TC7C8I4OL_Q MW+YQ]G MP;8MU#:>4EN &D MA\!P"XPIM.Z 8L.*F8>*OLS&V08TVA-@P*TPW8=#PEPS M=Y];W,P?NKUI5K"G+3YS+44.8-B8VDDR'UA[T.SC@;MS0/I(,&=2<8X^-+*+ MF1OV>I8?2S1H&?<@H;$=91*YN,];D!TBTQG,7[,%5T(DT 09*!5D0AIVL"_K M_]X#>"LS"#W23N]>5N"O%,2Y;3(#X89,6+^[%9*PD<]NH]%5]O#><<2QK3<57MW4Z7?+V0& M-Y&3ME\=70VMWI:Y>0"7])UZ> ]5^C[I9U7RU6N>:\I\K&WEQ((6&Y<>(^?- MOJJ /Z )SZ+W^,'A#YJ9;X-T:2)W,^EFHT6GA+O!H'2[K'?I2$+Z79'HZ%JK M9P8YEI_U-@:X3IGC>2>3+-&R*"JQ 3TI.L/(J?DS3*,'T_<8E3H]KI1 ]K[/ MI_2:*)6N'-.)12XX]=5&9726_IE-D<$-E[R_LKL96HX]#C*.?#T=CZ.P0Q2= M_8/09J)75L+[Q#:77%50FP.^B1SMMC877[]B^Y!A]O56I(LZ M[P-WGTG3JVMI.+5;=&Q^,^_&G.-'MM_!K^&=R=<+QM.?)ZH_F$K,=Y.K 3MZ M-*=VR538;,D$G69DHU]1/:/RU<5 ,2:83!@AZ-.A[HJZOT$&9.7V;EJ_ZR?; M-.BG.F9D]7M$$<)D\++OA1#WT4^U]GPKO* TWRZ\5W05577R(^@IEO(A'J M@M716U"$:G@C?" HK?N981A350>*6AI-BFHBEZW&9[N+6%UR%K*1'[\'N+DK(!V*J#WR))DS)X(@^ON M:LB0*BN80ULGSLB1Y7U3OKAIS.&4;Z>PLURK$G.A6 MZ8ZX+(D"7-ZN>OPG7-J1[SUPY$NM0;^ST@ /A]WDTI)*[85ZBHK&?^3)%+^U M6GFO%8*SHTT>")."CDAL6B3KH*Y!]W%#E#6\MX S6G.:B+['_ 55,%+@YB:= M7&F:V@HRS6G[]I'K*2HMY^S(AE5>E2T'(LL9&B7/T5FYZ9J2SK5S2G-!RK/\(96Z96O+1-X">@]\12/2M MH+B5.\D.F^U1KND+F37+#7F9_U[R?& M[76#;W-UL],;)Y?M5<0FGR!WL1_@(.1K)K/$9]O=8FG)T4X^WW=&\WH3%*) MC,A;CX5DS5)79)GT)7KE QW.T//#O M;JJ#$GMKFTGQ:8\>,=&?'^A01OIPR$R<58(W MWMYA45X@\!&">BM)Y^;.:)E,6=W4M3!9Y2V:%4/U>T3R0KBQFJU"Q$BZ\4[2 M/WD??UF$FJ[B!-^GS>Z+H8TF?F^.?O^%N-,M.,PT4A.VG,Z4NW9Q?I]R'ISL ME?W<0N W/K#R@^&UT.194&_":>S1N+[)5&]-YB;W3&^#E[OZ+:\N$9UTVQ"@ MZ7Z<0" 208.(\<_?Z#^4:3D*DE)T ?_ZL=6J(!]I\+]QOTKXFDU/@_?Y&G3?D1HH90FVXO ME^A/"O\_X?V!.P#4Q(#C__[X5Z=>0!_-&= VNB1_7VJZH0+%;78)R?R\KW[\ MT\$6)J6/J0(6B#F1 M131"U.3__BO#THF_@@68'8IXKU-FGZEQAYT:(/)AF*9'"3H[!D,ZQ26'R11- M#P$SR@[95$)@16&-'R9&^AVT&&UT&I[ZCW^ZM4J'+U+M3J[#M__^ M/3K0FNT>YO[#:O.%;JO2J?!M*E?2 .4$,;NG:!56,%^(42W/)[.'&_B[>&#UEC.PNQOCQ3ZG>NOW? M?S$I^B\R9*2=-%TC!H$L4)X!VL+"^YVV.J4!;(F+4+XLZ@+)!<J+L4WQO]%Z'D-,3]QWCU5U^"O M+T;);@F:")X[#5U F#6U9M9-"(^Q"6']]X>,7D<^(%H#71D!1=&MD;[Z<22$ MYS3-!DH+SG3#"B']#G!WKSP9%YJD0NR3A?#IUH:2#JENA6H[ M*D+/-BKQ"F33R=1Z!;;P/WI/JSL@2Q&D[F#(9Y[/U6K=W W5XAOU5H=J=%OM M;J[6H3IU"HG]#I+MKLAA$E2]13'<3_&7^T6]1'7*/!72#8%>R!4Z%/J9R2:2 M7\@VVV#;GR0EW:"L":3&LBD A7*0>4HA_Q^*U [!&T+MI8@CLZB]B0@<_!;4 MC@7;!@D_\&Y0(H3; ;3N3>M6*O.PF1K=K7A JX_/2.AG9E^$@AM[3C 7%![6 M\<3U^]8T$RD!0A)KB9?R5(C4:@MN6&HU^2NN]-"FE]-2RY8^+D22D1,BG5:N MUJY@:1%]07),"].7'%8 "LH-%%)C0U=#QMOSC9"!B%#078#&!%W1C4O?9=S^ M59$U>&GC:P?P7T]^=MUUXG42\.#^C_W?5^;WXQ]+_X,($0TYN3\GX\0'V<0[ MCE1)5B"%1 O2!9>?Y'?P))"/.W;[#0G3?%EIS#HF3W>O6"ET4H09#G@Q!/>- MCC#L3.O#[J)WS_+JC<9!A5:F8ZXY9(>T]Z1% F/>6+W($,*T@F8"+_T_PHN. MPW\3=P(X+B:X\33?X">11F!;NO^%&VY3A SVR&$(@>%=T15?O(K(%@47B.\ M%[!>-0J85'L&!;R!*U*R1E4LDRI,@(&:_+4U_=]$9'XF\R;>'&ZFTQQ@Q2P8 M0H&AATDFR0Y!AF&&J0R72J>37%I(I+=5Q4 &D_M.)HU,7K:TR+2B69B6>9XXNW0\MSC-P]9L?&F=2W MG1Q>.O8T9_<6F>LA]+4=P&@KZ.V "10E8,P,?2'HMF89SN'C5ZX2KVA(:ZQ PMN4;E"Z-8$&]6 ; MLBG*I H!,@L_;7=;#LL;,AQ# IK\2#[_^B;L_P%F/PDL5>*M>#M.\>I,T1V< MDOY)X*EX^::"BYZ:'O^U3? C>"N?OQT<;5J^ M:S#63?$.M@)_>A3%4=F9@0QC>084"JZ@8./M%?0ULG2@^8OZB:A-87+_BES: M6T""XT3N?_I6T3'AC>5@SH!@"]!7)0"TA\<^F-:=\;@YS2O7_-7.E)'/H,3_ METD]EVGR)>/Y17W&TMSHB*\;$UU[N@E]/6&KM\DTVZ,+LV9O6I)RG=[UERT/ MR\30E+ATELD^MTQG%^4/DP$=7JHCPK5BFC8T\+(RZ;],RH(*G&$NHS3" M9A<4TD:*C:E! 209$5>+D-H=,8OTSN#7J/AUIFL;Z7)#MF34G4'V7:$!16IF M&Z:--V MG4)/D%@&P_X<_<*6 ,Y9XU<"MJ$AE<-.16B'$V28C"!DANE,-C-, M)I.C87:$!&D6)EDF!1(9"(3M?4MF;L[Z$N0SW0*HV..K^K70:_O;\1M/ZA*G M7=\JBUH7/BXY932XOH-U"8ON[2=5(5T#N52)[;8'56-Z0Z>N>0FWF=Q^4NDJ M2<@.VE.Z.FIT)8MI5/(3:<@^?;+0D_6RDV7&TQ2X'[,S"=JW?'.8>/KD -B- M<;O2$[O.\NZ>MP5MV"\NA\G@R6C+IC?NQ+JRV8\5TO%T-CH[>D]L^(-L8&[, MF(VG,W_4A)E,G(O0EO3G+/&?A>D$%Z>_RQ*_[H_O$F!?N+-YZ'-I'=ER#UGC MRCX4*004!%.C).<./>^MQ.JW2[COA $#$%O9/=3QSN4_K@R,SO)[TN\;+;^? M6DDD0&"[(Z.^-Y'1-ZW \M\DUSM%)Q"FDJ$C3^_R7X( X7C\95O'G[P'=X2J MF*%0D^>J.0P[(B(]R'V:C!;<3-K.578! MF] /S=G*N8&C:2]A)N_$ E35I9\?O3^;7+4*@T/ ?[>D_*[P7T_=UZXGCOTW MG'>=P'TVBB%2R^_9)?X,;#>N#-&2/0Q';CPS+#<=T_>9V-2\NEHF\];8] MU1HP13#_Z!8SF17EWGQY0=W<% YAR40-<\>4MY]>,7EIED:MI^ M;%E&[H;OQF@<%>5/BR(I PKVB7 \NXP>1+:-I5,-VT!(-R$NY!*; MH'E2/YG?+ E\HV^H32/I0&;0=Q7Z7Q$V///42S;0U6RL@]1-I<07M&GV=@"< MA<9(B*&>L8$RS]M O0,90=\5_$\LGJ@A_X0LF"@HIVMF6I!S[/3JOG?MP*5X-;Z6 MALDW&D)D)A?>1D PF=VV#04TD7SM3>(<\CE2R.?,4,=CJ-U6D*TO8XV'?KLW M+3B]T57[JI2,)7!^QMLC0=US*.@8H:"H\<3)V4J?K[.>L8\J4WD(FR,#\M5. M>53MS>LE^XU%!C_//OK34P43J>UAORD_4 KR T.OA5,%+ZE:O<9_VAF!I]-Y M9A78X+DOKHW[CL,-/_ZI:"(^< JID4,)$XA0KN)*Q+*[%,:ZG(YL4H!:0D6) M335]B=J#P-0U7%J'9-M>X'H[(AS+FEMMIV4KD$K2W(Y%16L9IP;H#Y\.!ZM2 M^=)$/R6CWSU+U$-4JF(BM3T:N0G)X1-ZH\']J-ZI9[M7J^*T/Z8JM6 ]RT M%V-;=[-T57E<+<^\>N;57;RZG$!2@62+87\ROZ@)TI"82T4**$K JF$>'D'O M =3F-MN^SK64B+[U]J1F!A0@R=IC6(I4"C>IGZ@=Y$I0IBU,*'.BXTIX?M5@ M:P*L[3$O@?E4PI"7O;'_NB!QGI^L.[<112]A$?AM8.=#I,, M@@P2F!:5I2D1."81.9M,_REFP685H\^2-@7;,! IW$+>.,: /#([+'3N.Z,Y M>STH3J=V?L4E.$.4'OK'$3H')7H$),\?)ULP[R&V4V7+0HP*%<1^AJ[AH(GB M4' !#8>J8/<&".3@=1%8P"VYO"5ZUFV$S8>P(=^"DJVXU6G:L0[U$T,G[3$/ MFV#C@;V/[!,DEV:XU.:QI9([ZD#80/.7:[T<"=;1DR6AM<5+ZXF6L+.A%MB; MM"ETN[ MMJI-Y7KQ(.2B+TN2$>')+Y8EZ=>&_39I0?QX!;T/*2 (2%H@%"). MPJR#G7AMY[?(V]!B.W\P521F4"^&K\H0QE4T>><"FRVH.:3S\5@E2C+TI37Q M?XXC*P:2L9&@ :FM36I%8!*R]%_/C9#\S/SE/_;J \^/SW\0FS#>P\^,U7_2 M#VLP["C&[CK-&J=^%L@"(*?_U^618+MW8.H['X%_XS'3T(Y)*IY*1.=TVJ$+ M_B;C;/+[SHZ+9TZTXN\^LTO$V0B=%#U6/>/C,^"K"O-FMV[QC)>W1:F>V"G1 M8=57Z9#[8@I\#CM_J$XUL; );;"%)>G'*U5-XHX%KY.0]PPU[[OH#Q5Q?&.^L>?9)&]%[WO]P].2LJ_ M%\F?0)ZH2S?^.9\X4K+-'^45&63!'6-(QG4DL5J>2TJ2+C!%LU/6Z?2B=]1K M=O^DY*"/AKO'+P2*<+6V/7?%<2"^*'$6-GU;KZV;=*X##!@,-.HK1'C_0/3Z5F6J5=J:;/^IU MLWMMFI^CQ(>+$H?VJCV[%E?\P*%28%D0X9YP$,*X;)FH(0U(9&\WJ+D(3!,9 MF?@K/TX*QV-(-BDTKR@P?E/&>Q<:8BJ,84-7*'P_8XC7UB8UJ?U(F=ZF>)). MA@H*MH$Q JC96'VE0(=LA?]D.*H;;\<+<2K-IG#UP5]XXNM9>JF((P7Q5XBC MQ[*ANMM.,]0WP \A(4!2W$0R8F"+LN6-*WX8?_F,V61V>"NW7I)?0"&0$($1; 9C26E MH)/]=B00%<>473FGX>QB)/AB(X M"6QK0,UT)2C>$$<_D8R?H/U5\B*73]UDUOS/WZ5"^ MVHOF94T_?";L'\TSKTII? S*+=6-46R2BF*N[2E)B!TPOZCD* ZU(!7&T$," M*4^#1H;/Z2!8$8%*DA;&6$^C5[!-ZC.%@A,/1UXD%*GPN4TN%J:6R#2A$A=9EKG((P)O6=J=56$EVG+;>L2D%-Y>CECS!S7B+*B+HE0D%6 M@?*#PMVCQ: W631G#NOC,$\VV[G4HU8O9/B"WBS.6PN3G:>D'Y37CDE:V&;0 M!K&/2XH.POE$G7:R4J@FS-$4SBK*33HW%Q.QYH]_DLP%RV4NLDS29S!_RO]@ MM3ESS7_%B9_A?\CSD[E&XZ92R.5O>*I>NQE0G7IP^3=/M?BK2KO3RM4Z[6-< M@G6BE'_5/+1V22#=MDC QSOU#O%!^.?EAJ 0'Q@_H?MGXTVO.&)8$F%O&KD' MF%$$DG(CHJ\NJ;I&W2*YQ'(7%.+?!'X8218B7O:4)VYGPVHW[U1G=_WKJG=(H4;LAR6*(EA?M:_GQBWUPV^S=7-3F^<7+97&Q*E4BOM2'U> M%Q)S:T76UV0-"1FIQ>J,Z-S//5WK<,W2Y H)&>8BF>(NZ&3ZJ8S9(O/V M>FVNTUD('50(%>N%[BV/I Q5J072ITCE!T@"E?@67ROP9_GS>F(* B>%&=V- M=I$H@XY,\"6&L*@+MNMVRL2I]"Z:=7U' X[1:\C3)"8'?K$!C"#V5D*\3C%T MK$K]A'$I?N'^6/'_17] 2XC_PN$X'3D?N*PORL2.1[C#$\]L//@Z/AUW M3=?@5Q,I&0'/V$_D#.I@K[]R*W7NF-MFZ>Q$'+6S5>']]__Y/W^C?X(,Y*#. MQ]9-48("@8'+Y4S\[&.6H$R"L9$!P11Y@$BU70)E"1S3VW3/,J$B[9Z-5LK(8UXFG2<^'WCIV[VND@]N<_@;4Q,"&WK\Z]<+.M<1_[[IZWOL*.>[$ M@$5*IZ"3Y&\S6%H07M[0E$.KMTW37<3R;HIBLHS( 0B&*9@>#9-09(<9D('# M,:"3HW$6TIE4XH?;ZV>4BF R;["5CGCO6<=U DO(_ZMU^".Y?&^APA,(A0EQ M/IJPE0J$I%+FQ52@$-^$&L?A_C&R$7V2^9]C2P/,+ET9N$1$>E7\!+^#$4*4 M;2&X(4ET?$%TF#STM>+8._3T<[%P MVC<;,!]:]P@*A+517+&@RN2[[4J-;[>'',/0;/)]5C)NB6+BE)^*_\1(/HSZ M^A( )$^-\3^.B5RKTJZ69IDDR]$?P44N3K5DP'%M@7&8[S]@3WC89KF,AS[$:3DX]2Z<8JT3OG-?RN9DO[C MA K;,/09GA?)!K$0>&(D;* $%+2>B/F[)'&92 MB023_@ \$G&*-$J%6CV+CY,6'\E;9%BVP1A:3E$V!44W;9P*D.*X;/HCQDDR M3N&6*;=I*M3V6:REC4XTE&IX'2@3#K]M"S[ M5?:/DU_IVUPM=\63%-=BI5WHMMN5 M.L)*$7U],VA7VO52Z0- 26/Y]>00-?:O;-.4O9/7N="APE)P>K2@:Z);S\ 5 M:*:MN,=7ZS/H9HE\>^?L8W",-O80.M*Y)C[!*5LDBP"M,OJH>)]\%_PCV,O% MJ7 '!$>A+L)N/I4;Z;;EZUJ\3_&=Y!J7^+/D&EK]3"!(@DO!3+3^;7LV4\@G M8#@?P%8F'I)4ZQX(Q$)]**0H^3<74Q]$5^2AE"V0@\8F7F\1R0P@&=!=;EQ3 M)T=J;'P 2MDXY76 #SIC &WTX1;N<7NQR"7M2"/FUH4]\ MK**Y%VEE^G;3\ MRN9PJK&A*UAJD0T,D82Z,XD41R<^ C>D%?VF"7C6C9_EU&G+J7P='Z:L:.X) M2%+'@$XPW$?VT++Y.$5:I4+-?BO1POUYHJ6PUA(M* %\NE0JZ09:?^W:-F13 ME(6/0*80#ZDA*NB!\KJ@_#[L]-BX5:1%QWF,[2XY/RC6EBY463_*0 M^3Y?Z'8J=WR]5*H4^%8[5RN2L@P?R3>EL<&"B^'IWNX8'Y2DJ_LEZ;R" ^O= MM^]NGWP[X;.%*2: 4J%^V^!K[5RG4J\-TUPVS7$?01,3#^&G$*J)^*W5C^"&C?M;[PY57VI( MZ$SD&3ESCH@)9(W*0PTB:83#?.[O1%:MM]>^NT3ZSGOU&%\);Z%)[@9V@='Z MX^B?E\N!ZY9_!%^)>("DC1XV\D5(<71P \\:N#YPW;V,9Z2#4/6!'D&E/7N M00E"L@T&C06R:\R/X"F)3U]X'83V)RC52ZMN=#3V[:6LU0()M3)RZS4=G&+S[_4[0T5FHX]J#<5BGJNXE]8[A^MY.'39?9F MQ2:]*HAT4 21_<0JE)D,N1IT9Q5*4C"26O^)J7&N0KF?//JL*I0@DQC1J00[ MY$ Z,4S"$3O$=RX/DV)ZG$HGF22 V*+'O;IOE.JM7JY5O*G7JY7:5;N3Z[@' M"H8I-I-*?F'%2K((V.[R%^&E\E;>+"AO&M1Z'D>L\+U5(7=[P)V);%(Y3;.1 MM=(*KJM;ZR-<\1'(FHF/ARV!(<8479]Z-SA:H012[VHO%0+-JQKOWRS&IG/! M=7/K*\GP57/H6R:;2%Q0WLDS+ 19^J_-IR[(M\Q?7L3':Y/A=[09OK'':SRY MW7CX&:_E.(6O30G-QYNS?V$9(I!WD1]))<)W6>$[,FFX^B:N42YA2JZ;)Y74;0O--4Y5- I+ M1?S"!;ESZ^F%7F/H7=JF/WAI5A=XRE ID4ZT4FN'UH#?/D N\C\/H?>]U0 M)%&+/"O(AF"K^"8" 9+18OJX*ZVA>_,H,$U;G7F]O;8(>*UQE4G31P0^ MOX%CC!;JP\>:]Q,AU )N?XWQ(6OVCN]M1=S^$IJ6K*+&GWQ/5F;[6[(BXI.! MJ,!Y\A66+-M?SA2@/?E.-Y&]H3P9P$PGBP^4)S\8$"?//1F$MZC;7YN37=-> MXB_#K&LB("O P(@T(#F:A:^_=)!XQZ,8.R\LFLL1&(E@9))2_2[OF_Y*BCK" M+.86+'X\+EV_CXOPXQ^W.B!6]_.\Z#+^6A"2L?HF\Z:^QA1(#^> M." ?&O6V]X+U%7%A)DC8Q9#-(6!#!=>%]<>:>>+*_.^_LJET]J_M<6WY.\]> M//;6(>]I0@'7LL="T+_QBLAF69,QKZWOSD*_CF2-2+^UV?_$03HCZ(]#D&DC M4]@D(LB V XA6A[?IRT8MHR/Y!";1O".] 27:,I(*1-CP,LHNJ"FT*$@PJ#N MX!TS](X8)"&M+T^\KOJ?8M-R3:1B@ 3#QE=+("IV16^/W0"^Y M,0Q?+XL/=^.V@SMZ'(J8*/C/X#)98BYK)K[M2E9'MF&Z:OW, F<66+- @%XJ MI.OU$TQ$NL0$6K09S>\@#3@4E84 M:H1+@@4;/BK$ZR=1DJ$OK0GQ"8'F^'LDZXN+K^OY-MZ>/ /P#, U &T3>DXA MOFK W=&:0,7;HT8H-&S30H87.2:![2FP +)"<(+L?AM96X:NKD-K^%9J%1MH M.UX> 05ON?Z%6HD0!.DS K\6@>,@K74*K!V_%;NXD[([!NDX!%GC/Q\#B MST-M=XH5$4E!P(X=DO96,4Q1&P$2_(?;#5$,FAX%][@TE@^U7 M+U,#MX;\>;(3Y&5)B' !%7VV+@KHQMW7AC V2EK ?=IFH,^LB6YZ[Z EG0!2]=)/H!!)/^:+A)&U!;YV:2, M8$ TZ.IHJ(9GK;_Y:>XZA+!!W?'C'7@!8 M;@+!POE-AE_BU=A ,!*/:&(X1\-P]R1$&Z4O;P%O&@&):LSM#!H M?1PO#^&EC),V29#8\(6#_ 4R<_SUYMS]P2!@DLT^-\>"Y+UX(9[P;/%F""02 MW<"AGHOM^6)"+'!2,8*BWS+^<48 $IJCE^'A@_:UB?6@:[588$HPI2/O3"+H M)2IG)N) $]FY7,AX%;27DSR6$^@MY,:.C8:X5U[7!KMXFB=$UG^)NKA JR1 MQ*+ G?0(KK='7?L*S-#"":[J6B>.*6!IQD\QZ39Q3KH])]WNF72;Y$:,,,XR M0R;)PF$RE1D/,UE&'-))(2T"&F3&3&8CZ?:9>SL/G&F[\\S F])J@UM!O:$> M,9GVM>Q?>+$ M4XC4$WK(?Q/;*!MO^_=-S&STE>OU%7'1M%),:! MIB5" =$3K:*W9,C^<&VA<#ZV6^G(VR/ =XC(;DE^'9=H1'86F[A &)I8DGX M6^3BBWT'KV;\5RO:2R]8+2XGRALB5L*- E= MO#M2L*D"L?FG!X#%C<4F0!GO[H]0AYC?V.67\;TJR&9S2VB@"7L;*.X6C.;E MQQ-(XUX1&QJ";/H6IS\T9+SEUE868JI@S-XP51P/"%[VWR(&)'I!GBGNC2[6 M4@]^O"#$#9.4B7,TMK21Q:9X T7,:H^PC8D) ,0'V]MM)) R!4,>N7(%+ZF_ M_XV\#Y%(#$#ZW( ._@X+4W$]Y;< ,.FC:&/=/%^'!$@\&K@ZV@V6X$(FAD]0 M#[:DU3'&UDO,3@;$L$C*:-;$L[RWIJ.);O?(W< ;:&/,60Y2]]@=L[P X9OZ M)/X#:@#Y*\C+F.D:P:WK.L2_1O94GF)U+Q9.7B#;%?_?9>8+?S?;"ZJ:YCHZ MAO&7I/WGD0\F8]P"#>JVB>@=@ 47D?4X'7^L-.H7F"]-?*N#*^PA+D*RP)Y, M0P&"*R&[1);X=QM1.;^6.I:!KMMN+9&*)6\70OJ/;#"@)3!UI-@*#@*!#$+U ME394\,_PB1CW'2]4_ OS:QY#W)Q0=S*F&FV,O M4OXJ=UY8+2RYW;,&^*B.UX[[DQ=!)8OO.9 D@!">S 0;.7B=12*&\?NXDM$8 MFRC(),%EA[&= 1'K>@-["3H__6YTRG/[,3U4V2*+Y#4,H?F+PD7X%>1Q(!'H M/"\#0C0)COZ\;'74=-:":P/9SP[]R5QSD7XA,]MD(YSFGP)+_@2_?K*_ M7CM=AE<.]2]"\8OD7:CF%9H(/@@%5$QK- MY1I#;)QN/B!B"S4(=82?),+GWUXOQ,H@@9; #"*#0B8!&@Z^4L03GAY;71"L M&3()?:%?$IEPIZY$\;C3"R415J)^>G$[,E7_Z(RY-6;\<#!<: 3@#>;BX_*7 M.X> V9_T[7WVI=H+"+P@$)SA+PF< -6-M^,Q-R*[L1-R@8 J^\!#LKU #GZY M]ZZTB=/1\7B5^E^@SOY"'_';!5\( \^9,=UF(<2%(@CC;_-2L"^#-+7F!H;= MDW=8J._$8N;T?Z'A^J@^XA MB2>F!W"?]@S?A6Z1B#"1&#N[\&0)P2->,F*:JA!YCN@;6R7? [P'Y-G(2#OH M@AR$17_F?B'[3\0GW@A>[9%[P)&<4T5NJLOZ>,DVPZFNMT'A,,]^DY=Q*^NC M<4$*LJOQ7C!2O>.\B<2&G?J-':@J/J :9)Z%TCJ01)BB/TU' M'>F*;U)?M0J#KI\"\HQ;BD?G6P;F,S&)3= '(0K/HT5F[=.XA)^^\N[ Q)-. MGW/_EZ@+Z ](-C4QQOHBMVS+1%,B-=&4O]BA?:2_HEB),QTW=T$LP)-H^Q:B*[7$0Y M>XK#;SBXI,S3U-BD"37HG.2>7?*\9W?>LWMMSRY2&VPMB$&-#(IU0WI*\34+&Z?JP5>T^Q6).A(S"('#V^*Y M(F$I9 = Z+OHH>O/L0.-[$'),WNQB2B9%QN&KG=P-0C$Z6CMW6 4FK_O;_A' M9U\M'T"4+O)*37GE&J+(="#MN)(8-5$7+!U;@.MY[@B]XCX#K\<='_F.]YM" MTT)CP\M^$3(8B"62SES02,G[ASAV6][;ZCKPROS]!3]YB8B0D*_C?NN]A6U) M8K82,R-D[P<6!QG\BA1;08WC,&,R1>P/;^2.(Z1N4BRF7@J@9Y10]E>6U[RLV0/5NMB,S2,,XPLLB."- J) M]"@ZP*W;)O5O.DXCSX-4(,%&7=BO<8,"7KD3EXCNMLD3>."PD%N0:!W@%/U> M2"&G76]XF:3$WL+)8D1TO?8"GMEFT" 45 '61E#%]3%>#ZULL0RQ*+9%P4X1 ML(LIODB.:4]&LB%S$/L9(&"=5T5/^VO$#&YA0Y8F#BYC$A<)AKE@LIG(BAGD M-;]=S"2X"RY)7S#)1#R3?E'2I"XXCKM(9+EX-ATI08/#J)\B:8BGL*>X>1JC M_%IQL\4=7R-L>H%<<8V33>$2DAUK 1,81)P[\O4)J;"D01,D?!TD\X2$S=%" MJ-M+@8134-8C6#+L ),UTDQ<4O?9O',BUWZF?A&!: ;,^K:XF LVK#+WVI!MFFV<965)+F+M(T%Y+^.,1# M,I8PW[K[D^@7J/E992&!^TQ:S(O*]5@\^@$/+)RGUW;+-#I;ES-1>9_BA1"X M^1723#*.AWVMQP;':&'!6^S+ST>(M^-!I-SM MV?PZE4'F9T(X)5SNC@HUY6].FI8!-<;&,]=4.33=/>4UEV[DDMV2X\2-&R@8'W($]^:%IP5P;8DMCSP"1%SXAUM(%-# M0)?'./M$<;SG_',_KJ F018O@"M#+Y0:#.(-8+W89C-@621A<+$9ZMTH\1&G MROH2S,+=EPOGHQ#3 AD/"I;-WO:;96ZI-.(1!UU<^$K,RSA>EZ)# MZQ\V?W1\D#$(QD LKG&3[B%#OPD3.U<(._C,(VG>/;<7U K'R1P"SKHR\(D\ M&V_/XL,7KIY#W?\FKB$Y,[&A;HDR);K 4U6RYVZL3Q1+GF$N>&M(9B/9Z'D% MSR%T.L-7RB3+4\5J#9"DL_!VYXO&)AH-F>6&S6B3HZ[8I'MF!"_TL'&(!)), M+1$N9.R(^I;""^UZ!SYQYC.$%$Z3)Z:#K_%%1',]_GUJ3!,..A_$?WIJ;(=L MNT6&!2*VEXQRY183\9V_X!3]9Q<'" ZIK#T>WW/850S,JX&RX>R17#S7[2<6 M"4OV_&2Y(['WR.$]G(@1+2O'NB/N0!X,"*[\&1 F<(@J[N70M41!1'QO$X''8EC*U9 M@?@DF1: '/8W/3JY!Z1<9P&?3]?=HT"!G/(I#&42W2.U[PTK9L^"Z,M/$/SI M^1%NZ-;!N10F9E_DK$ O@S MC/K#9%0A\%KQM>*^']>&4NBR$,R27BS+,Q;:(6[8<&MO@TC(%PNW;9'FEDW8 MCBCAF:VYU=R88YCC/<,M[+KCG3QRK,+SE;VT^4NJ@B6B!MU8P00-#]F1PD1# M_I;D7%#KTBSK;ZF?ZPM30M^2"@CN_M'Z+=.[29E4HO 2R2=0F87"#ZYYZ1IH MP7O JR'A;LG)ZP.VO_!.$CZ_(0O(_L&N!#*4D#&'!SN!.$*'! ?>+7-]?BRT M2 S$ K)RX3WI;P_HMD'N?QGKNNCF^YLF.1>&AF2/<:T+(TAN$VWAM6HR9V'T MAPFC0/X0Q=4*J5G>5[.>%=7P+8'H29K=Y]-#04&R41-8,L3RV,^X6#MG&X$V M;''I>,/+WV+"KV+C!G$@XC(K7"N(W,UDN =%O)_=]%&$&9*LOZZK[_]&(J(. MYG,B)#RG+T92_-<^HK&?[,\$^M#\+QC0VN0"8'3M(K M&]O(B9$F91W\@HW MK4M-_?_LO6MS&U>6)?I7$',]-ZB(%(ND+-DNSTR$+-NWW%U5]EA57=&?*A) M@DPKDO?;C[),/ *1D0RSC0W=9!)"/\]AG/]9>BS(H>=4V-CZW MJ\V<72PU ARGV1N!2& U9]J.HKY!&:.77/N4+,?%R7 A?F+< MTQLK+!W/,XB[LZDIN2H&PI7*FE5OC_:+E%.\&>.YJ!:YRA6/POE4RFE8%T[X MPF9=HNX;:]7359/3!A+?'* ,MY]S!8O=,M51#(L4R:.$'5,9Y.[#S#JC_:F0 M0NYO+DN2NB+BR?/&8=644#LW.65T[XKSR>MZ:QGD3HLDDOKA.AQ?):B'G3!W M:0I&/W,6F^OI?$ _[QTZPAIE^-,DN\L^Y]3V3]B&5O4ZJ8 _UWQ0",5RT7TB MXZUOBTEV\$)\VBU\'Y[E[1HM8_N)>$R<]^UW;[ .7"TEWU6OP>PP M6ZJ _!"2Y)-Y\#WFP5I=HS)&Q)-AF[-5HY57U# L=(%\H%=CR0 P\1N#IT0Y M8D+AWH0J44Q(6P%U4:'"_I8D/>!0JAJ MZ;;L\*SKIK0[Q'-G]-\FV&PU&F]0AR<3\ 7L23Q?%A%I7JYD7P8Y8Y M?%*ZP#M"X@2O*DO026*8PQ2%52" G@Y.BTNR:ZI9.'>35K?$V4XXK)['ND;? M7D$C#UBQ(L7H&#HUONJJ"-YRK7;#8W-/$)B/"(%Y=8+ G" P3PH"\Y9,J& ^ M8@9D$"3\-]B?(_=T=@^&&Q!,(,5(P0F'').Z6%,"@5'@]3J?"?NY\8JFAGJP M'#QZD>2G(ZC6+H^;%KW96F^TCET[%(H<9@Y[DR9:4Q3F#['Y %Y.9%>7%^@< M%OYPE)-PBGSN6@^%<%K0["NOUEV^*IL-F$\6P7WC8,R*++%FY+3@IGG]CCV/ MU;+-C$&.);KTKZCD$,<> *_<>V,_8EH\?>98WN<9TC@I#.--.#S6RC<$AC#. M/1_D^"Y\4G>J%D3.A/[MU31;#G3V6-/^E"7[>A((72ELE M0F8TYSB2Y]&%//1)CL7-:/1*";XZ$8]F:LPPO/?" C*"U8TK6Z9DD5>5PU00 MJK].-X:P.S&] RU@=F9!^A&&LN"VGINB?FYUB449?/^2^C@:D040^OO(G]1F M[@I=8GAD$M$^PHQV^U]%J._D(1G&'*_"S!H'7NAHOOC?ZPHEL4B\NS?P--/F MMA6/ 78-_?R;)E^!)>Y;6RS!/G$*9%Y0YQ4.! M=I+=8NLHEL//IFKQTF"']U&[!QMB#S%FWC+KD?-?ID\$[X/>H_ **X3+'A4D M=VNM&6Z]O2VD7XF!,_R\E+^6%(^E^%>#S]BQHO$$XV94N=YM#I _(^-ER(+Q MPZC*$:!/P#=Q$>0MC%=X1@HNP^&S@(Z##%O9REA2'JG7^J>G33@UM](QF%C+ M7S;S:U8278RLCM)YH> M=GDR:4U0O8]EL;YIF$PPSJO)9UP30+?:4#VZ$CFYB^@(AMUJI 5Q+*HMJSQ'O]UST,U M0/KT!XP3^R*WQO'(Y%*I+-$HM7"X"CLKD'.CMB)ZE-AE U'ZB=>D#S.GUHL% MWT2TQ*=GNW:+7!%1K0_/BY;5!),@W:N-9-TW^0'6^'SR_69%MQ9RK]W2O_O> MJDO?ER;BXIL-G@LE[ZZP6<7/1 \F[66#$I#QP:$X\GS42BY8)S!M#B1%6G[V M>:D@:'".I0Q1[@T^T8WPG9NK^/H(*G1DQ(^HT,.<2=&6#1LKWS@'K7,)OP#B ME%LON1YM><\/(KQJ$EZ;K_W:IU_#W5> MN26V$(1>4],H# W&[ME-_-VQUTLG0YHCR?/17Y=K86D( ^L=XE7Q"T"!H.J+ M%^2>P ]I_4]";?*%/L*B@+)'W6R45\_;>>9.U\2"'QL<(-*-C"75WP<;=K!Y MG[B?EJU*B57)=?#%V[ @J;.]J0KV,]Q+*9J*+:'=IUG%VR\29X_+#/W;@QB2 M7<>JN-8V';]>:)(C'7GC5+Y0)&8YL[6(;O$VS\-SVQ[8M$(CV6Y8OD(0ZY*) M"0LZMII"D6/;G[(=*[AG^QJWG?GIG)H;'AZQ!I(AG)ON\19\0D?$CM;9L40) MS)8D2H86(PP9VW2T(4<>UF3[)PC_<-I6.8?D3BJ-6=F+J*BV3IG7KG[/\I^_^DLO]OH+6*ASQ>6O^'A(4@2X(*<#U4IO;5]?:[&E0C M0(C"JOH;18D 9SR+KR\A>NK/!K^XPS'0P(\HD8-@K3".(9*4.%^EKXN&6GTG M*TX&X9;MM\(3*0-.,#YFX._233C]PEQW8%-B&1KQ-@G1+@6LZD)ZL614-3O9E\HPZ(72(A=W3 MTH613H&W)MFHC/M4"%D87(0-^6H1X6"-(.0SL*;MC^EYKLFTBM92+PAW]1'E MD@EQ)ER"R%=N>3&[&Q%6EQ2;WG"&"+]E=_2:6$GXZ3B^GQ.>B6"H).>BI0O M@;R+/5#QMUB>0+;";)*0_]]"RK:]&>(S@E26XV:S_-Q-$Q6\A/DN$B,)USYM M'X#R"PGA=9![ZN$';,@8@V[6R("Q6IS)@PEOE&H-E]5&2BG%-H(CD%J5$(.S M,<( 1!E*\G?RN^"/3YE11\5S!MJYO^->2%N!"EFC*R)9!'ZYM52-8"SND*%+ MIC'XSX1Y) &S+?4\-NM2#=BGF%UPU4[D:]>KS0R#C:6_) ]^TW80)(,S22F? M6O0.^V/[&M>P"HRL/M.>NB\DHSD$;2%ZIF)5<_.H\?7E1KVW4:."P2DJ,.-%1@X>%"QR909DOQ@,(XI\^+(D:5?7TE&OM-4 MX[["(**6H'R:K.3(B;K@&M5Y. ;E0.-$GGQEC^Y8N QFH4T[DS MFWPIJ4"_:V25[9ZE8S6(MYB &V(EHC$.9X0?$^9[2@L#Y_I-&SU_/@E#%KA'PA!DH= MIHC#3T#W"6OELL@Y4Q))YUS1A60D:K"J*3>;I="'A'DT*4;P%*8\8/N^X'6A MW04M,O>;:R6),4!&%.&1?@ &WT9 )$@3$GQL&,FYIK5)?*Z,9Q8=!GG%=(^& MOSW6@:ND,0G(*#U[U2OJ%+UL4&+ZH#WHG):S.9NTV"H[V"MU'O.L"8H9$$U74.58-^#+[4UEX[9XBB'"BN/''#L8^BDW:0\[\'P MS#;*=)^B_'HK9=(]WB8ZQLE-$^ZB=91,Z_..I^86STVO]PGR??X@[ST,US/U M QH!D;;Y>5,51T3PR0-7["1@S;$TW-7E@-JM"OI 7-1I9HFPS;,.<>_^4N@/ M=8= G82)DVC(H/T),?&!A8>.T%'25O@(/MP=]-#&B96R75L9;93V>A<]]5A^ M>X2\W=Y-S?N^:^]-TNS@GAX@MC^,8'ID$A[\@,/\PS]UM$FIX&^%!ZUA';AZ M-.X58V05Z\++'BF[D9">/U1ITD;#L$>T&%,EMDV7$/N0H9F*LSHW#)#@7H4Z M/B9_4'"(1/*0FH9\]=G+9Z)>2Y'U#!4,@B\9< XI$H.S4$?&G("!&:N0RT[@ M87+C*$9=:.J!@6"*;F.LW]3&3)^0US-"(;G]7,2/1Q_%+MK;@9R'\CUO.\;% M*C@2?G%]C4HX074M2&-PB[5=.(5:VYFZYAH4$:H)!N6XZ6BHXG%$=R9Q,0T?$D>/K M<+M)\$O"?U @%JWU/IE3;-G]3QN!1*BEQA1:U@TXNEX,2S5T"!TC4&.J>#@' M/IZ7P6Y4=WRR5V4P^K0PXYV(;C!'AVYKVBH^D!^KF>7M'ORU/1[U3T M^^V+?@?(E_[U]=MO7__?R8IV:,?/#+8N+EF?".' MD5[6IH^R#4\BRA_K"'MR,BYC,G2 \[16K6 M5!7A^:V[^MG/)MJJ38>49ET)7(RT!!A)..$?W;&1TLK>HW4$]RXJ7'K>_DKX M=YC:#P*\@]OQ.)#WW6AW#QR*Q!>F3;LD7JC;*N&D"8- /A^#H<.EPQ);"0EA MF-I?-O6#YO:U9=,HK/402+\!LPF'A =L.A-5 8!5J.TU*T8@=TVCV*] 6N7;&.-8,S: M%>\543!L\FB3+8IBQ-;1)7*V=OK'SGUZ1A!.JMF[E%J#+\J+.-T%7IB, MO+V)%)=BHFY4&6@P+K>X8[RW;D!%J6R3[=/K1I%7?4AR8=+.;HIY6-[SOMJ5 M84N88*N)SCBA7>\+;6O:GV,)#YLL\^-5AETGJ2:GN_T1PP)9C6L\:MKU\T0B M.N;$N"@R!D>@/@Z)V_C0ND<4KL!"0[,J$?8SCW#.% QUZ2\1JECIHYE27LTN"JE#6[ M*MTA'WN!;,*^C/0%FL-(4(/9JISR#+A)HX-NT^IEAT^%>)OSR?=0#LIIW6;< MQ$JE4D:<$P# /9)9)I)V:/GS82)XJD**B:)$BZ) D&:JJJ%EK/57!H8X:%?$ MGU"J)HN$29&S#69B_WIVNDQY/(KU8>B%$%;AWOM>:V!-E,ME,2]9R]36QUXC MR<--BR.:O;Y'ZT=*QI6>,.Q!\3\.BJ_ZAG7_&=$''J7$>,@"W\-ULDT&OV+W MHN9/+9W6X=WM:ASYQ0% M>T:9Q-:E6<+BFQX7UP3?K=V\-C'=VSY (P.J#_G]X( @X G)::UM)J\ M0%I_^\"'Z/"AY?,&0X/ZE"+L6'4N O1&@6/WCF]L$P*A59@VK!H^62ZC$DFW M83E#I>KBXI+P&YHPR\'C%Y[]TGY&3@>WSH),NT!GNO+6CEZ%8,I%P@(GZ7[B M_P,5;HOS@5<^LX>RMC+N,-DV&QWJR""(H U%DC L',2\X,I]]L&3HBM/B@;= M1MZ'U3^!VK(+J>?GT%"1C(L[3982&F@S]<3Q7FQM)7(GY/@N0CO M"'1,P1O(J/@U+RVCA53PD+^0:0I^,-6Q=-+0PE 5W#,JT?E:5(Q]TB]<[/E- M7BV&[W=N[/G(&6)'+E9\B).39J[=L$2Z0.7%(FDUJRO-;L\LCXFTDOW8:F $ M'94,)1_G]XV'PJ]1N+0AO3Q_>0$->0*:JY"\*R_F$%Y(Z4UTH[\_>BJRZL!\(Z8 +8?=/OB_2UYM*CU;XNEC9;(OT1@T9#,#CS(/BM3P-#DO-*'-$3.$K M\'B?9%WRJU-=\E27_.3JDJ^QY?Z2;R>7ED)E9"@$VB^SSU^]S"X^_Z+'XP(S M/1=_P.+%\\F/R?E:XJG)L""-Z$9%B $GP&00 "-DS &O7:P&53?G; M^&BZ[2,T<"FK?B+R)I1B57!7-$F:S(K;-:-&8OP(;(1P:VF5PO GB2/\X2Y4 MDZ R. 5A20NI32%B6U Y3="_S5IR!;U@O3,O1MG.PU2V2?),T- M]6T';.A=D>AOV'FK^MEIBV (V]>5I'#-K=(+"1E%/E:)&VSEIPQGEU4'";#. MX^/'S &6P(!*X3J)K3ZB#1 #C @3IPE!&*74*(G_@Z44OMERIVH7]A0B)LDJ M=]T,H7%K!!GB@ZPF4,V\CR5VDOFIL'6-Y$3_ M8$6[L$,X/D9?,_NH$9$V\.JCNT.@''$=*]I!'VGN5@##%#E>8>(-.*',-"MP MP-[KLHX.];DP$M<2?AC]6R?J77Z,$K?*J1W;6OR:9]0BOSXK0PCWS6+1PU)/V# M>TBH=!$\I8IPD6U>%='0#860C!P'IF-&Y):?7;[2C#C[M&>4@4$27$KE_.?V MMBK)Z>9_"1JC_&_ES122&XW$6L24\Y(D:OCSHEE=Y[7[0=&YAG7%5.6[XID0 M?&XG5Q>634:[DB!B\[ GG[L/%, :D3 (IF[*U7R2?*W7BD:U&$$\T]\&=[-\ MEN[/]JE)YFDT;H)'8W1&6JCI<)1*=Q@P"&@'2[K RGYBRQ5^?6UB+Z"B8$*A ML_+9,&^'1Y9*MS%"FC1A-@IO:NC2X=K3;>1NR!."<*[QDC >&G_SEAEF.4.I MA6F(HX[UUN]C[6#.39%22[C)$S6Q\(@D+Q=92IF-4^G:LYBJ\N"1'"0T!6<< ME8V)&6A;10U+*9$;1 R D]E;KGTK;N=; K!2I#IW28X/1\RL (:PZB90*ZEL MNG8X$!N[\:8"N($W>T8):/I#ITN!@#VIN#9R)WAKC7.5AH-ZL[RPC66S^/;?PR9^,B@.F*<4K8JH-E@]YF M/]N8SD5^\&SEPHQ,,/9G6!JJR SB@ _&HR2K8&A0.U+,ND"B[6\C+T\6-!VR4@C4;BMW;<.%@3\D&!Y?TL!Q(-RW?NL\R2+QY<6I M2GRJ$G]R5>(GX^QQ;B8$KQQ9('C)K F+_#_P]EG':XJ,S9?,WT#5KZ9V#!;B MLR0T! 8/2AD0DIB@BU'TW5K#2!JOXR:P0$,E3?Y!@N,;51?\2Y6"-+ 4,:&?:CIZX MCT),8[!)I1L!A7+;N95$G32 1DED77?#!(//.+B(*UZ6L!/!7H?9VJREF9EZ M6QHAF:47IH*3(^J(K)F^FL=$L[:B]K=ZZ]V)_G:@YI(PKS@9O90SGSD&/==. M\:>]T:5G4 M(YIGBK_@C,_R3=7B M/3WL='(35G0Q-"K<(4() Z*E]KZ_WT%HGM8]UN4$W*-NY3N\N-R[*W7!1-9X MBC\B1X/GZK'G3K7,GG2?"9<5KWIM:Q1LD)2L[P6S($;Y M0Z.$3.SO0;(GW(63I::;M;#;"MI%+I4B,EBO#-@2V_E)5F3G4/6@#]YS&1@U M:UWKRCGEV]@:-PH>"_'*G 3=-U.1D^G4]&^K#1-_R*;T=] QT(?2(>@'N(>^ MN^:7!]TU'?T.]7D,&).&[UV)/'53Z]C\ 8,V,%*C Q-#5!)XCRO/B/$8'O\) M]E>]L?7N.JR.WR15JZ$L*$M%.S8$P/?K&VOO4ZL)X>D%J5[29GLK9^S56?[, M\B8I2 YMP"]>#+8!IU_%5Y;-G,%=X@?]VV9Y&T[ U1KNC%%^OJ4_D82$W.+J MXO+*+OMO/W[SEON)7W,2U=10BZID,PT><9)L,CY[6N#24FZ L#85A8YTU@D- MF.UGS_^F*G$)5W?I=S]MF)V#'KZMHVX!2V8$<:K3L&XR<2'=@_5R-MC3&Y"9 M0?*Z%9F&+I^93NCG%Y_;?.:K:1X&_?F/[ZMB&P?\(@YX_RN9^;,BZPEZ 8=* M).L"]3H:[=D&R#%H#=2MMFCR40QWW;C$V0$4_4_%H(D%Z4X;'Q_I^Y&!8)JC MNJF?3TL.S,(J*(.7O!4$<#WV3,@)CY4/@CV[IC\#S9+/;B@<",< WYIUJ8H[ M6D?47B8Q$;I5P502= Q0C73'N>^Z8;RN*#?G\EW^GM;1A)5E(/VG M)3P$\>8 N2_(=9%GOFO(2:F*8\EO>_5W7:F7%U_H2M5]S]Y:Z@GOM7"ZU8C MNV\:++HFOQPN3^E@ ;&?T-G$+X)-/+MZ=O;-F&4$UR#V*'!WM$VI&QTGW1V MDX[TR41SN56-RRSAO,3:?\"K,2$[S,%<<'O.\@W=4+B*US>4KHY_[0K=D?'; M,I4BAVYFQ#H)^^'!-99T_!LZ@&.C?3R2&+@=S%P)X/#P<-N %=:O%5[J[/*9 M%-2(MC57^9^PW5M28Z#>,$>GR9\L("E>$S:^16OJ4*^:\$('SWSZ+.%S$'8> MIL"O*1<7GK,ETQM\VPX[TV>7YUR1_%1G31:$TMV'2US?_ZP_A8O^' M3YBPG5T*KCO4DO6+%;DPJ!-_54B0(^G!5GBV>T$<.B^;FXWE1\K+]]_N_GD[.0T*H(0HVCTQ%X-M4B3T3%Q M)FF7_;'MKL;JD'V[;[]>O=R[7]]@E)T[/GV M+Z.>S<=XAP-LSM.LA%Z>*J&G2NBG6 GEPF(,F-3L#Z-2=MC\SR]>? +R%M?BLVE<,L'VI&PEK5M M0X@V@J'1WB22Y4AMEMD6;Z8E(FO"L_W7)E\):T'X\27,IA@@%,$N242)K2*3 MHRL4JV:42*']S\ MW\_?GL=AE1%AY$U\_46Y2M^_.U3\YGDX*((5O\2[7W79*% CL\F9,^N'&ZM. M'4$':,^HQ%08B!R^+68%TP9=Z@PHK^_A[\WC9:Z9"\P8W<2IG5BG(,#M+L'5 M05+?7/,F357.5*>SFR[FK\3'0N)B+V;J?'(<%_&[E,M)=5X[C$_QPQ"IWLB6 M5]Q8Q%=MUI38QQMV+A#^'Y83YQ*12-0;(]/4B>+5,81GUVIA:=UM+E/!"2NO7UV('VL/Z)$+[@TR[+UP(X%@!+^K MSF=K1PV0OACQ%;7:NDCCHB7(NY(W.834UNQYA_V63:[#;+1""; JI%3:2D!D MB8L-8^S(/;R5^HY,?>D33S :=?-!=P965EY67K+.F8)U,>&*;_!PUU#.@[IN MV*[H%@WW-&2* FZHH,>E%00C7%EOO)@F,4Y.PT+8B/8F6PZ?CG4 Z_L8&] : MT8RIM>WQ?:AC3U#3G..D?S JII['>Q@T0NR94#.C-,H50>"EK8V]0]":7#V8 MX9HH>BM^! 'JV*W:S9)":%E:(+*7=QYZ9>!,W>4FWN+@D_J WP6#F!JU9%U5Q>T-T(@)Y"@OX[,M7SR97 ME\_#X?=R\L57EU_QJ.:37+__Y5?[E MBW\67[WZXE7QU>*+:;'X'^RK\B]^"/'MY>N??WC[[]^_?O.W'W]^^\^O+C\/ M0:1\Z9.JYM&S3BY?3^AI)_*XQROFP?L9S0%D'C'AW5?.3X33IFS?6>^!\JR] MYEB<8QRD"18(X([($VI3 NYY/_;#;$Y0^$ MC6 *@E$,L2#DM!UM*(:Q2^.11?Z=B =EN(WC.11>!3U*2ZUATOR1=TMJFJKZ M(9TSAF#35P)+& I54;3>9:H!E&A9Q35+F-XSE[8R@ +/OXEELJ\>JTPR\30 M<\IZ$V8HQR) L:SFQ>)TE;3"91UTG5E0&=H9*Y71W8G.D?]<44E#\+)ZH&T9 M?:,3>R0(P4@: -UWLZ\'+!' ?L'=FMV((S:,?+66DI[@<%A#ELXF;KXE [;V M@B.S@^9.R_GDT8)$?-74^5VY"D?_V9L?_^.';Y]??O4LS$$8G&4YBVUZQ]+W MT&>R1PJFJ975RKLI#V,6]F3PZG)"Z>85.?YAJY9BT&[0E-D;!U2%PJ V2S6& M<9-PII)*:ZMJ3E':#T'XK@BH&JXF70LBMBY 6KM_4.4D\] O77 QA8<,FCEZ;1<;.#WSH.A MK)I;P4CP#4#[%BQ'M8T',S\ZBW:P*/N\G$&1R$IG/!9A'BR;%<;R8@(K&V; M7([#":]K^\NGCQM;?V3ZV 5C MNX]T%,&%9S[U,!;(1^5H;LE;V$_@X#L&YD"'7]U\\L^C08Q!Q)A U/$=P3V# MXD_(F_#%:G-+.9@AFNB >N1 MPPS8V"-'F=N;HM^$0Y?/J^X;(].X&;M7ZL_J7J T 64E-[PCI#XD@9FZ+/4F MN!&$LI6T0.(>L3L6'8IPLK;%P!(5-\CI1Y8KET3()]_O52:T0AB E;;5%MK"P4)N)/EW^]Y/"TO:?GH(]- M%(T9/*MMQ]/28J=;<>PRZ UX$/1ZP?.=5DHG4Q(C# P6A;D ]JG@HVO> M0G5PV;2,3\TKT*B_IDE>XR#B94"-9YM:A;]EI7+H\%N;!"K!RECF+= VT&= M5GYX04!2G$95<^WB'L-%$T?SL0_L6_A^7>_KUS3_J$V".34=(6X

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◑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end

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